Translational science - the very idea : transformations in contemporary academic health research? by Rushforth, Alexander
 
 
Translational Science- The Very Idea: 





Submitted for the Degree of Doctor of Philosophy in Organisation Studies 
 
Surrey Business School 
University of Surrey 
 
September 2012 



















In recent years translational research has been one of the central goals of science and health 
research policymakers in England and Wales (Cooksey, 2006; Department of Health, 2007). For 
these agents it carries the promise of a solution to longstanding problems regarding the role 
played by public sciences in relation to innovations in medicine and public health. The research 
in this thesis explores how this abstracted, ‘flattened’ framework (cf. Latour, 1990) is 
transformed within a territory its champions are seeking to conquer: local academic research 
practices. Translational research is given the Science and Technology Studies (STS)  ‘treatment’, 
which subverts often lauded, seemingly self-evident claims presented by scientists, engineers, 
policymakers and so on, helping instead to illuminate science and technology as real, situated 
artefacts built by people in local and specific situations (Woolgar et al., 2009).   
With such sensibilities in mind, the aim of the research is to describe how the idea of 
translational research transports into local academic knowledge production sites of the type 
policy authors are seeking to enrol, reporting on how aspects of the local production practices 
are adapted to accommodate this goal and where resistances occur. In short this thesis reports 
on how translational research is performed and ‘worked out’ in real-world knowledge producing 
settings within universities. The empirical chapters are structured around three separate case 
studies of research groups hosted by medical schools in English universities. These are 
institutions which alongside training of the medical curriculum, practise research, and 
increasingly it would seem, engage in near-market activities, reflecting wider shifts in the 
mission of the university in society (Etzkowitz, 2008). The primary method used to generate data 
was qualitative interviewing, supported by documentary analysis. One case study also granted 
access for observation of meetings over an extensive period. In writing each case study the 
objective was to capture how translational research has transformed (or not) mundane 
knowledge producing practices of researchers in these settings.   
The empirical contribution of the thesis is towards a small body of work Wainwright et al. (2009) 
labelled ‘social studies of translational research’. So far studies have been mainly historical in 
scope, focussing for instance on failures to translate highly promising basic science discoveries 
 
 
like stem cells into routine clinical practice. Other studies have used alternative approaches like 
discourse analysis. Yet studies have said little about the situatedness and performativity of this 
term itself in the working lives of scientists in university settings. By using a range of STS 
concepts and methods – including ANT derived notions like ‘immutable mobile’ (Latour, 1987) 
and ‘objects’ (Law and Singleton, 2005), and symbolic interactionist work on ‘boundary objects’ 
(Star and Greismer, 1989) - this research has attempted to make a substantive addition to this 
literature. The theoretical contribution comes from adding empirical flesh to recent calls to 
synthesise theories on mobility/fluidity with theories about the function of place in 
contemporary technoscientific production (Henke & Gieryn, 2008). As Henke and Gieryn argue, 
this is important in order to provide a better account of how artefacts travel than is currently 
provided by STS theory. As a seemingly geographically dispersed form of production, 
translational research provides a useful lens through which to consider issues of mobility and 
place. I will also critically reflect on the frameworks used in the course of empirical analysis 
which draw from earlier laboratory studies. By treating them as topics and not just resources of 
STS inquiry, the thesis considers some of the strengths and limitations of these earlier works in 
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1. The Research in this Thesis: An 
Introductory Overview 
 
This thesis examines how an idea- translational research- is transformed into practice by groups 
of researchers currently working in academic medical science settings in English universities. 
Drawing on concepts and theories of science and technology studies (STS) - particularly the 
approach of actor-network theory (ANT) - the study seeks to enhance sociological understanding 
of this term by observing how it is extended, accommodated and resisted by researchers in real-
world academic settings. This study provides a timely intervention, given slow but steady 
awareness emerging of a need for improved sociological accounts of this phenomenon (see 
Chapter 3), not to mention the great importance being attached to this concept in 
communications between various scientific, medical, public health, policy, industrial and civic 
communities over recent times (see Chapter 2). On this basis, the research questions to be 
pursued over the course of this thesis are as follows: 
How does the idea of translational research transport into local academic knowledge production 
sites of academic medicine which policy authors are seeking to enrol?  
What aspects of the local production practices are adapted to accommodate this goal and where 
do resistances occur?  
As will become clear throughout this thesis, arriving at a working definition of this concept is not 
a straightforward task. There is however several familiar narrative threads which typically cluster 
around the term. The metaphor ‘translation’ is a means of inscribing movement across 
boundaries. In medical and science policy discourse the boundaries usually being referred to are 
between the social worlds of the laboratory and the clinic. Indeed the catchphrase ‘bench-to-
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bedside’ has often been used as a short-hand summarising movements across these boundaries. 
What warrants attention towards such boundary movement is the need of institutions in ‘post-
industrial’ (Bell, 1973), ‘late-modern’ (Beck et al., 1994) capitalist societies to innovate much 
more successfully than they do at present.  To survive into the future institutions will rely on 
emergence and acceptance of innovations, and capacity for innovation is reliant upon a strong 
science base (Nowotny, 2008). One of the anxieties which the notion of translational research 
taps into- especially in the UK- is the failure to ‘translate’ from a strong science base into 
successful market and clinical innovations. ‘Falling behind’ fears frequently draw on United 
States and Japan as frames of reference, as these nations have demonstrated significantly 
greater success in exploiting scientific discoveries for commercial purposes (Freeman and Soete, 
1997). In the private sector, in order to remain competitive, pharmaceutical and biotechnology 
industries will need to successfully exploit novel insights which scientific research- including 
university-based research- is capable of producing. Governments are drawn towards articulating 
alignment between university science and this industry because it promises to enhance the 
health and wealth of populations in the form of breakthrough treatments/diagnostics and 
economic growth respectively (Nowotny, 2008). Likewise for public-sector healthcare systems to 
keep-up with technological developments and health challenges of changing demographics,  
requires efficient means for ensuring rapid translation of safe and cost-effective health 
innovations (radical and incremental) into routine clinical practice (McAnanay et al., 2010). The 
category of translational research both points to these priorities and offers itself as a solution. 
This phenomenon is therefore no simple artefact of scientific curiosity, but carries performative 
definitions of what publicly-funded medical science can and therefore ought to achieve, and how 
it should do so. It is proposed that in order for scientific research to attend to this goal, it must 
develop and demonstrate ways of negotiating and collapsing the boundaries which inhibit 
‘movement’ of innovation ‘from bench-to-bedside’ (Wainwright et al., 2009). Translational 
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research therefore implies the redrawing of boundaries, away from autonomous social worlds 
towards formation of new interactions and styles of practice between bench and bedside.  
One of the most striking features one notices of translational research is its sheer plasticity: it is 
a term that appears highly transportable across communities with particularly diverse interests 
and institutions. Part of the challenge of studying this phenomenon therefore is deploying and 
developing tools which can adequately map-out and make sense of the mobility and durability of 
this idea as it moves across diverse network spaces. Deploying appropriate tools is one way in 
which this thesis advances sociological knowledge of translational research. Another is by 
providing an account of the real, mundane struggles that are experienced within a key 
population expected to shift this category ‘from rhetoric to reality’: academic researchers. 
Rather than being a unified whole, today contemporary science is usually thought of as being 
characterised by quasi-autonomous fields with distinct ‘epistemic cultures’ (Knorr-Cetina, 1999). 
The comparative scope of the design in this thesis makes it especially well equipped to capture 
how a dis-embedded framework like translational research relates to quite diverse epistemic 
and institutional arrangements across the social worlds of medical academic research. With such 
concerns in mind, the main aim of the thesis is to explore how translational research is 
accommodated and made ‘workable’ in different research settings and report on the kinds of 
problems that have so far emerged in respect to pursuing this goal.  
As this phenomenon has at the core of its concerns problems regarding innovation, it is logical to 
bring into the study sociological theories of innovation. From here there are a number of 
different models for studying innovation, many of which have been attacked by writers like 
Latour (1987). One such approach, associated with earlier trends in history of science and 
technology, is to link successful innovations back to minds of great individuals, usually with 
particularly special sets of entrepreneurial and/or scientific-engineering skills. A second- not 
always mutually exclusive- explanation credits the ‘diffusion’ of an innovation with inner 
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qualities of the innovation itself. This account has been commonplace in explaining for instance, 
the emergence and stabilisation of scientific facts and machines at the expense of rival products. 
As sociologists and historians of science over the last three decades have convincingly argued, 
neither of these provides good versions of innovation processes. One problem is that they are 
‘Whig History’ forms of storytelling which are provided by the winners (Latour, 1987). Versions 
of ‘discovery’ and ‘invention’ are also very bad ways of reporting what scientists and engineers 
do because they leave invisible much of the effort, skill, and cost which characterise the work 
practices of these cultures (Woolgar, 1988). A third alternative provided by science and 
technology studies (STS) introduces constructionist sensibilities in order to account for the 
success of innovation. These versions typically emphasise the practices which go into making 
innovations workable, rather than relying on explanations which privilege either properties of 
the things themselves or hero-worshipping accounts of successful individuals.  To generate these 
insights the field of STS emphasises the use of close empirical research being carried-out 
amongst the very sites in which production, development and usage (innovation) occurs (Knorr-
Cetina, 1995). Following this third approach, the research in this thesis draws insight from 
original empirical materials generated through qualitative forms of analysis oriented towards 
scientists at work.  
The fieldwork for this thesis was conducted over the course of 2011 (Chapter 5) and the writing-
up of these materials into empirical chapters during 2012. Prior to this in 2010 I had conducted a 
small pilot study amongst clinical researchers in another university (Chapter 5). Drawing on 
these theoretical and primary empirical resources has enabled me to produce a version of the 
phenomenon which errs away from heroic or hyperbolic accounts, towards real, specific, 





Overview of Thesis Chapters 
Having introduced the topic of this inquiry, the next task is to set-out the context in which the 
idea of translational research has emerged to prominence over recent times. The second chapter 
provides an account of why this term is seen as important and by whom. This chapter also 
considers the various meanings that have been attached to the term. This then provides the 
basis for treatment of the concept throughout the rest of the thesis.  
Before embarking into a research journey, one should consult existing knowledge about the 
terrain they wish to explore. The third chapter begins with a review of the sociological literature 
which has been used to inform this research and to which the research in turn is intended to 
contribute. The second part of this chapter then elaborates further the primary theoretical 
approach - Actor-Network Theory (ANT) - that has been brought to bear on the phenomenon. 
Once a general overview of this approach is provided, I will outline a set of sensitising concepts 
that were central to performing data analysis and presentation. These were drawn in the main 
from Latour and Woolgar’s (1986) influential monograph Laboratory Life, with support from 
other relevant STS literature studying scientists at work.  
Having delineated the existing knowledge that has been brought into this study, I will start 
describing how the research has been carried-out and why certain tools and resources were 
thought useful and appropriate in doing so. This begins in Chapter 4 with an overview of the 
philosophical perspectives underpinning theories and methods of this thesis. The overview is 
followed by explication of the research design (Chapter 5), first in terms of the research methods 
and standards that were borrowed from text-books to inform the empirical analysis, then in 
terms of the actual practicalities of designing and performing the research.  
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The main empirical material is organised around three case studies, each concerned with a 
discreet research group based in medical schools hosted by English universities. Each case study 
is given its own separate chapter (6-8).  
Finally the concluding chapter (9) briefly summarises what has preceded, before embarking on a 
discussion of the main empirical findings, and indeed, what it is these contribute to theoretical 
and policy understanding of translational research. Included also in this chapter is consideration 
of the relative strengths of the theoretical approach adopted in this thesis, both for this 



















This chapter aims to provide an overview of the context in which translational research has 
emerged in English science and health research policy over recent times. It deals both with 
issues of importance that are attached to the concept, that is why it matters and to whom, 
before setting-out how the terms has variously been defined by a number of interested parties. 
This provides a basis for sketching-out how the term will be used in the context of this study.  
1. Background: Locating Translational Researc h in the UK- Old Wine and New 
Bottles  
One of the main reasons that the institutions of science hold such a grip on the modern world is 
that they are seen as indispensable to the growth and sustainability of modern societies, as the 
knowledge of societies is seen as dependent upon having a strong scientific base (Nowotny, 
2006a). Since the post-war period, the central condition for public subsidy of science- that it can 
and indeed should help to tackle the ‘grand challenges’ of society- has remained largely intact. 
However, what has changed are ideas about how this can be achieved (Rip, 2011). There have 
been a number of efforts to re-negotiate the science-society contract over this time-frame. 
These have evolved between the laissez-faire ‘linear model’ of the immediate post-war period 
with its efforts to separate applied from basic research, and later attempts to open-up spaces 
between basic and applied science (strategic science). Whichever strategy has been tried, 
policymakers have long struggled to tackle the troubled trajectories between promising scientific 
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knowledge and its application. An ‘innovation paradox’ -where a strong science base is 
perennially undermined by inability to capitalise on knowledge transfer- has long been 
acknowledged as a perennial problem amongst European policymakers (Freeman and Soete, 
1997, Willetts, 2010). Typically this narrative is repeated in juxtaposition to successes regularly 
achieved by rivals in the U.S. and Japan. Translational research is arguably the latest in a long-
line of innovation concepts proposed for tackling this deficit in the arenas of medical research- 
the most funded and arguably most prioritised area of the sciences today.  
As will be made apparent throughout this thesis, translational research does not hold a fixed set 
of definitions in place with regards its meaning. Yet I will try now to set-out for the reader some 
of the problems and narratives which are regularly associated with this term. This in part 
introduces translational research as a social problem rather than merely a narrow and esoteric 
scientific one. 
Funding Science: The British Context 
In the UK, successive governments have sought to position themselves as venture capitalists 
backing research opportunities and initiatives with an expectation of them leading to social and 
economic pay-offs (Etzkowitz, 2008). Typically, like most Western governments, they have been 
more likely to support high-tech innovation, as this is thought to hold the promise of bringing 
radical rather than incremental change in response to convergent problems faced by late 
capitalist states (Nowotny, 2006a).  Since World War II there has been a patchwork of different 
approaches utilised by British policymakers, similar to those followed in other countries. The 
interdependence between science and the state has been an enduring feature of their 
relationship, however, so has uncertainty in each camp about how best to coordinate and 
mutually control the other’s activities (Louis and Anderson, 1998, 86). Two broad caricatures 
have emerged in science policy literature to account for the changing relations between how 
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science funding has been managed, both of which variously describe the British experience 
(Freeman and Soete, 1997).   
In the first of these governments provide funding for scientists whilst granting them autonomy 
to pursue their substantive interests. This is based on normative assumptions about scientific 
knowledge and institutions as a public good. It is often thought to characterise the organisation 
of Post-War public science systems, particularly in the United States. This model was expounded 
most notably in Vannevar Bush’s oft-cited address to President Roosevelt (Bush, 1945) and 
found normative vindication in early sociology of science writings (e.g. Hagstrom, 1965, Merton, 
1973). Within this schema, authoritative communications take on largely horizontal forms and 
scientists can exit from one research interest to another with relative ease (Whitley, 2011). This 
‘linear model of innovation’ typically separates basic from applied research, with the former 
referring to research questions not primarily oriented towards application, and the latter being 
driven by specific practical-oriented questions (Stokes, 1997, this separation habitually 
reappears, see for instance Cooksey, 2006, 13-14). Linear model reasoning sees these domains 
as involving different competencies and thus requiring separate institutions. For instance, in UK 
and France for long periods applied research was manifested in public R&D institutions through 
the setting-up of large government laboratories, with universities, based on 19th Century 
Humboldt models, positioned as an enclave for autonomous basic research (Laredo and Mustar, 
2004, 21). As a standalone working model, the ‘frontier’ approach has been out-of-favour for 
some time. There are a number of powerful criticisms that have undermined its framework, for 
instance regarding the lack of accountability it can lead scientists to exhibit (Dasgupta and David, 
1994, 488), and its reliance on overly-simplistic understandings of technological innovation 
flowing seamlessly from basic research (Balconi et al., 2010, Godin, 2006).   
The second approach takes a somewhat different tact. Given the costly nature of much basic 
research and lack of predictability about how and when it transfers into technological 
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innovation, governments seek to create and foster institutions which prioritise material needs 
and maximise efficiency and efficacy of scientific research deriving from public funds (Dasgupta 
& David 1994, 488). In biomedical research in Britain- often taken as a key exemplar of science-
society trends (Nowotny et al., 2001)- this has involved various policy efforts seeking to predict 
and control where investments in basic science should best be made (Comroe and Dripps, 1976).  
Put simply: 
“The cornucopia of science contains many fruits, and the challenge is to pick the best of 
them.” (Van der Meulen, 1998, 398)  
The notion of strategic research suggests scientists should provide a strong platform of excellent 
knowledge from which others in the innovation system are able to innovate (Irvine and Martin, 
1984, Rip, 2002). An effect of strategic research initiatives is the blurring of the line between 
basic and applied research. This interventionist model is characterised by vertical authoritative 
communications, strategic interests of governments (not the substantive interests of scientists), 
and relative difficulty of exit for scientists (irreversibility) (Whitley, 2011). An early articulation of 
this discourse was evident in Lord Rothschild’s 1972 report to the UK Government, which sought 
to establish a customer-contractor relationship between government and science (Rothschild, 
1971). Similarly, the notion of principle-agent games, whereby governments play the role of 
principle (buyer) whilst researchers play the role of agents (seller) captures varying strategies 
employed by governments and research institutes in pursuit of their respective interests (Morris, 
2003).  
Efforts to stimulate the relationship between the science base and industry had been occurring 
since the 1980s, notably with the Alvey Programme, which introduced foresight as an instrument 
into technology policy, which recognised implicitly that ‘the UK science base could no longer 
pretend to support the full range of opportunities, and hence that prioritisation would be 
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necessary’ (Sheen, 1998, 250). The use of foresight co-evolved with the rise to prominence of a 
new research category of strategic science (Irvine & Martin, 1984). This ‘prioritisation’ was 
reinforced over the next decade, most notably in the 1993 White Paper on Science, Engineering 
and Technology, in which research councils were given mission-statements to support research 
and post-graduate training linked explicitly to national goals (wealth creation and quality of life) 
(Sheen, 1998, 260). During the 1990s the Department of Trade and Industry (DTI) saw an 
increasing university-industry nexus as key to repairing the technology gap in British industry, 
particularly its manufacturing base (Sheen, 1998). Tellingly, over this period, the DTI took over 
from the Cabinet Office the task of coordinating the Office of Science and Technology (OST) 
(Georghiou, 2001, 259), signalling the continued efforts to align public science with national 
economic and social needs. Despite almost two decades of efforts to make public science 
conducive to industrial innovation, the 1996-1997 Dearing Committee raised again perennial 
concerns about the need to sustain funding of civil R&D and university funding in order to 
remain nationally competitive (Georghiou, 2001, 260-261). The positioning of the science base 
as the engine of economic growth and competitiveness at the national level was a theme 
continued by the New Labour government who took power in 1997. Their 1998 Comprehensive 
Spending Review increased funding for science and technology, infrastructure, and outlined the 
costs of missing out on waves of new genomic discoveries as it had done in computing 
technology (ibid. 261; Nelson and Rosenberg, 1993). The 1998 White Paper Our Competitive 
Future: Building the Knowledge Driven Economy, also signalled a shift towards the biosciences, 
the area of science linked in to UK’s most successful industry (pharmaceuticals), that promised 
significant high-tech advances and that was lobbied for by the Wellcome Trust, an influential 
medical research charity (Georghiou 2001, 293). 
Despite a robust theoretical distinction between laissez-faire and interventionist models, both 
these logics come simultaneously to shape how successive British governments have invested in 
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science. The approach of ‘muddling through’ (Lindblom, 1959) has been used to tackle the ‘basic 
double-edged problem of how to get policy interested in the conduct of science, and how to get 
science interested in the problems of policy’ (Van Der Meulen, 198, 398)1. Although there are 
strongly interventionist components to the funding of scientific research in many parts of the UK 
research system, governments have rarely sought to micro-manage the minutiae of governance 
or research. Institutions of science are granted autonomy, with the caveat that they produce 
‘excellence’, value-for-money2 and their outputs promises to lead to (high-tech) innovation.  
Institutions such as citation numbers, university rankings (e.g. Shanghai Rankings), and Nobel 
Prizes, have been appropriated/developed by government agencies and public organisations as 
tangible measures of countries innovative capacities (Rip, 2011). These may be read as new 
public management-type governance initiatives aimed at steering ‘grass-roots’ research from a 
distance (Ferlie, 1996). In this context, research councils have been enrolled as particularly 
important ‘intermediaries’ in relaying governments’ various messages to researchers (van der 
Meulen and Rip, 1998). Together research councils’ institutes and universities constitute the 
science base- i.e. the ‘research performing sector’ of the British economy (Georghiou, 2001, 
256). Located at the interface of government and research, research councils’ role is seen by 
governments as ‘steering’ the public sciences towards innovative and enterprising research. 
Research councils have typically set-up strategic portfolios around important promissory areas of 
science which they wish to foster (Dasgupta & David 1994, 505). These initiatives are often 
captured under ‘umbrella labels’ uniting a diverse range of intellectual, cultural and instrumental 
interests around formalised agendas (van Lente and Rip, 1998b). Within these spaces research 
proposals compatible with strategic agendas of funders have an explicit advantage. As such, 
                                                          
1
 From this one might expect that the more interventionist notion of translational research will not be the 
only discourse at work in the current landscape of British science policy.   
2
 An example being RCUK’s introduction of new public management-type initiatives like full-economic 
costing of research.  
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portfolios provide protected spaces in which promising labels become more-or-less self-fulfilling 
(ibid.).  
It is argued that there are no ‘natural’ boundaries between categories like ‘basic’, ‘applied’ 
‘strategic’, ‘translational’ research: they are ideological constructs that carry certain interests, 
assumptions and expectations about how science works and what it should contribute. This 
follows recent revisionist arguments in science policy studies, for instance questioning the extent 
to which the post-war ‘linear’ model was in fact ever an empirical reality. Following Callon 
(1994), Croissant and Smith-Doerr argue instead this Cold War-era configuration was a 
‘boundary-making claim, a linear narrative to try to separate university research from the 
market, rather than reality’ (Croissant and Smith-Doerr, 2008, 702). Further support for this 
constructionist thread can be found in Calvert’s study of basic research against in the context an 
evolving funding backdrop, in which she found ‘boundaries between basic research and other 
activities are being actively contested because of increasing pressures for applicability in 
scientific research’ (Calvert, 2006, 200). But to say that these boundaries are constructed does 
not mean to say they are entirely fictional or ethereal3: these ideologies have had performative 
effects on the organisation of science, some of which are still present in today’s research system 
(Croissant and Smith-Doerr, 2008). As such, one might typically expect to find in ‘grass-roots’ 
academic settings a pragmatic co-existence between different ‘institutional logics’, not the 
entire displacement of one logic by another (Gibbons et al., 1994, Swan et al., 2010).  
Translational Research in English Research Policy 
Historically funding bodies like Medical Research Council (MRC)- and the medical science 
profession more generally- enjoyed some autonomy from government (Salter, 2004). However 
this arrangement, sometimes referred to as the Haldane Principle, has arguably given way in 
                                                          
3
 “Robustness is not an absolute concept, nor is it a relative concept either. It is a relational concept.”  
(Nowotny, 2006a, 5). In other words, it must be achieved (Latour, 2005, 138).  
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recent times to further government intervention (Georghiou, 2001). The erosion of this 
autonomy arguably reflects how state dependent institutions of ‘big medicine’ and biomedical 
science (and their promises for radical innovation) and public health more broadly have become 
increasingly indispensable to policymakers anticipating the impact of ageing populations and 
prevalence of chronic illnesses on public health care systems (Lowy, 1996, 52).  
A number of recent policy and funding initiatives introduced by government agencies are clearly 
sensitive to the perception of an innovation paradox. Establishing funding and institutional 
innovation to foster translational research has become a major priority of science/health 
research councils and charities in the UK. This more interventionist push has meant that other 
areas of the innovation system have been forced into considering this pathway, such as the UK’s 
NHS and university sector (Kaye et al., 2007, 739). In the context of national science/health 
research, explicit pronouncements about translational research as a key priority in future years 
for UK research institutes, including the NHS, can be traced back to at least 2003. Here the 
publication of the Department of Health’s Genetics White Paper, prepared the ground for what 
was to follow, as did the government’s 2004 10 Year Science and Innovation Framework, as both 
sought to position the NHS as a key research actor with whom academics and industrialists in 
the UK could utilise, particularly in translating frontier research into clinical trials.  
This was followed-up in 2006 with an Independent Report to the government authored by Sir 
David Cooksey, an eminent businessman, followed shortly the governments’ very own Best 
Research for Best Health published in 2007. The Cooksey Report sought to reorganise the whole 
structure of health research funding in England, in order to consolidate ‘excellence’ of basic and 
applied research, but also to build capacity for translational research (2006, 2-3). This has 
triggered a number of institutional innovations, including the establishment of NHS Innovation 
Hubs to support licensing and patenting of promising new therapeutics and diagnostics (Kaye et 
al., 2007, 741). The MRC’s strategy to meet these demands is premised almost exclusively on 
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translational research (Cairncross and Dusic, 2008, 17). MRC has in turn modelled its 
translational heuristic on the T1 and T2 models of the American NIH. T1 and T2 refer to 
identified ‘roadblocks’ in the translational research pathway (Table 1). Having being formulated 
at the Institute of Medicine’s Clinical Research Roundtable meeting in 2003, this agenda has 
been taken-up subsequently in NIH’s Clinical and Translational Science Award (CTSA) program 
(Woolf, 2008, 111). It is notable here how narratives shaping strategy in one national context 
(United States) travel and have the propensity to influence others4. There appears strong 
anecdotal support here for the argument that late-capitalist states engage in strategic ‘racing’ 
games (van den Belt and Rip, 1987) along similar technoscientific trajectories in response to 
‘convergent’ sets of problems, such as healthcare and employment (Bell, 1973, Drucker, 1993). 
Evidence of mimesis in the UK is further reinforced by shifting organisational routines of major 
research charities5 like the Wellcome Trust, which has assembled a Technology Transfer portfolio 
premised upon developing ‘promising translational initiatives’. Operating from an annual budget 
of approximately £60m, the main aim is to bridge the gap between promising fundamental 
research and commercially successful medical innovations which benefit society (see Figure 1)6. 
Funding is allocated amongst academic groups, companies, and partnerships initiatives between 
these two institutional spheres. The full range of initiatives to have been funded by the 
Technology Transfer to date is listed publicly on the Wellcome Trust’s website, under a page 
revealingly named ‘Technology Transfer Showcase’ (Wellcome Trust, n.d.a). This portfolio of 
unfolding and/or completed initiatives sends a clear signal to researcher audiences that research 
proposals must chime with their translational agenda. By definition, this sort of outcome is 
                                                          
4
 National innovation systems can be said to exhibit communication patterns of relatively ‘open-systems’ 
(DiMaggio & Powell 1983). 
5
 The UK is atypical in that charities account for an unusually high proportion of R&D funding for the 
science base (£392.7m = 12% in 1997-1998). The Wellcome Trust is by far the most prominent of these 
(Georghiou 2001, 257).  
6
 The focus is, for the most part, on pre-clinical initiatives oriented towards unmet medical needs, with 
some funds also going to research at a clinical stage. 
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expected to require levels of expertise and knowledge reaching beyond the capacities of single 
disciplinary confines. The requirement therefore is that applicants are trans-disciplinary in 
structure.  
The move towards translational research was also impressed as a key priority at the National 
Institute of Health Research’s (NIHR) inception in 2006, which was set-up in order to unite and 
promote government funded research in the NHS (DH, 2007). Whereas much of the translational 
emphasis for MRC was on basic biomedical research, for NIHR the emphasis is more on 
translating applied forms of knowledge into clinical practice (Cooksey, 2006, 7). The joint 
translational priority across MRC and NIHR is evidenced by the setting-up of a single health 
research budget shared between these two public bodies. This is overseen by Office for Strategic 
Coordination of Health Research (OSCHR), an independent office set-up at interface of the 
Departments of Health and Trade and Industry in order to manage the government’s health 
research strategy. Given the related interest in translational research, some consternation was 
expressed as to whether these two bodies (which together encompass the entire health 
research spectrum) should remain separate (Cooksey, 2006, 7). 
Since 2008, a series of collaborative projects have been set-up in order to support rapid 
translation of basic and clinical research, named Biomedical Research Units and Academic Health 
Science Centres respectively. Such high-profile investments signal to the academic research 
community that translational collaboration, particularly involving clinical trials with the health 
service, is seen as a priority in the current research landscape. In 2010, despite a new 
government and global economic crisis over the intervening period, Britain’s coalition 
government continued much of the rhetoric and priorities of New Labour’s support for 
conspicuous investment in translational research as a motor for long-term economic growth. The 
Comprehensive Spending Review of 2010 ring-fenced the science budget in real-terms over a 
five-year period and increased spending on health research in the NHS, for example through 
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allocation of £775m worth of funding across the 11 Biomedical Research Centres (Gibney, 2012). 
Likewise in 2011 Sir David Nicholson’s Innovation, Health, and Wealth report set-out plans to 
support existing Academic Health Science Centres with new Academic Health Science Networks, 
which together it is claimed ‘will identify high impact innovations and spread their use at pace 
and scale throughout their networks’ (DH, 2011, 19), thereby prioritising once again the need to 
stop breakdowns of innovations into routine clinical practice.    
This brief overview captures how over the recent times translational research has emerged as an 
increasingly prominent institutional pressure surrounding university-based researchers working 
within a very broad spectrum of health research in England. Indeed shortly after these research 
reforms prioritising translational research were introduced, an article was published expressing 
concern that narrowing focus around high-tech biomedical research in the NHS presented grave 
opportunity costs for other areas of health-related research such as family practice (Shaw and 
Greenhalgh, 2008, 2518). This serves as a reminder that such labels are not neutral, but carry 
ideologies and assumptions which have potential to court controversy as they interact amongst 




Figure 1: Wellcome Trust’s Depiction of the Translational Research Process 
(+Translational Awards) 
 











Table 1: T1 vs. T2 Matrix  
 T1 T2 
Aim Develop new intervention 
methods from knowledge based 
on laboratory findings; Ensure 
safe first testing of 
interventions in humans 
Bring T1 results to the clinic 
Setting Laboratories, clinical research 
facilities 
Community and Ambulatory 
Care Settings 
Investigators Appropriately trained clinical 
scientists adept at using cutting-
edge technologies 
Health care practitioners; 
Administrators; Academics  
Required Skills Molecular biology, genetics, 
basic science skills 
Implementing and evaluating 
clinical science in ‘real-world’ 
settings; Understanding 
multiple disciplines informing 
intervention’s design 
Main Challenges Biological and technological 




Infrastructure and resource 
constraints; Proving 
effectiveness amongst ‘moving 
targets’ 




2. Locating and Conceptualising Translational Research in the Thesis  
The immediately obvious point to make having studied this topic for two years is that I have 
struggled to find a common, agreed-upon definition of this term. Perhaps this is not surprising 
given what one commentator has observed: 
“Translational research means different things to different people, but it seems 
important to almost everyone.” (Woolf, 2008, 211) 
This is arguably due to translational research being a socially constructed discourse, rather than 
simply a ‘fact or normative attribute of contemporary medical knowledge-production’ 
(Wainwright et al. 2006b, 2053). One of the first observations to make of this concept is that it 
appears ‘indexical’ to certain networks. In the ANT lexicon this means that it is a term that has 
been stabilised, has presence and purchase within some networks and not others. The types of 
networks I refer to here can be associated with those networks of practices associated with what 
sometimes gets referred to as the ‘medical-industrial complexes’ of late modern societies. This 
positioning points towards several goals around which the label translational research is 
mobilised in contemporary innovation systems. In addition to offering a clinical utility, it is 
claimed translational research can also refer to civic and commercial benefits as aims from 
funding public health sciences (Summarised in Figure 2) (Lander & Atkinson-Grosjean 2011).   
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Figure 2: Domains of Translational Science  
 
Source: Lander & Atkinson-Grosjean, 2011, 539 
One of the more confusing aspects of studying the recent turn towards translational research is 
that it appears to have existed for some time, notably within the epistemic practices of 
biomedicine7 in the 20th Century. Biomedicine is a term (loosely) denoting research that lies at 
the interface of strictly biological and strictly clinical research (Cambrosio et al., 2006a, 3141). 
The latest emphasis on translational research can be read as an attempt to proactively foster 
stronger linkages between biomedicine’s biological and clinical worlds, premised on the earlier 
successes this field has produced. This historical bifurcation has been described succinctly by 
Cambrosio et al: 
“Alternative representations describe translational research as a bridge connecting two 
different worlds [biology and medicine] that only occasionally meet in an uneasy 
partnership… or as an emerging interface between the laboratory and the clinic that 
                                                          
7
 For the record the earliest known usage of the ‘bench-to-bedside’ notion was traced back to an Editorial 
in the New England Journal of Medicine in 1968 (Feldman 2008, 2).  
23 
 
should become a distinctive sphere of activity in its own right.” (Cambrosio et al., 
2006a, 3140) 
Such changing dynamics of translational research point towards an emerging shift in the 
epistemic cultures of 21st Century biomedicine: from one where laboratory and the clinic were 
bonded through coincidence and affinity, to one in which they are increasingly becoming 
bonded through necessity (see Knorr-Cetina, 1999, 1). What appears certain is that the label 
appears to have gained a new lease of life in medical and science policy discourse. Despite being 
sceptical of the notion that there is a single or historically constant definition of translational 
research to give the reader it is nonetheless helpful to identify some point-of-reference in which 
to enter into exploration of this topic. Arguably the most prominent definitions and discussions 
of translational research available in English policy context is one captured in the Cooksey 
Report, and refers to the process of moving discoveries out of basic and clinical research towards 
clinical application (Cooksey, 2006). This definition separates translational research from other 
categories of research such as basic and applied. In this discourse translational research plugs or 
bridges ‘remaining gaps’ between bench and bedside, thus building on basic and applied 
capabilities (Burgess and Tracy, 2011, 30). Images of interrupted flows are powerfully deployed 
in such propositions.  
Within the new regime of translational research (which this study is primarily interested in), 
there are two main representations of translational research. The first refers to the process of 
moving basic scientific discoveries made in laboratories towards interventions in humans. This is 
referred to by NIH and MRC as T1 translation (see Table 1). This definition is similar to that 
routinely found in industrial contexts of drug development. In this sector translational research 
(or ‘translational medicine’) is said to have great commercial promise in reducing delays 
between discovery/proof of principle and beginning clinical trials (Hurko and Rutkowski, 2005, 
31). Hitherto within the health research landscape, most of the focus and investment is said to 
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have been on T1 translation. This is perhaps due to the anticipated pay-off from large sums of 
investment put into developing basic science capabilities in fields such as genomics, proteomics, 
gene transfer, stem cell biology, structural biology and imaging into clinical investigation 
(Feldman, 2008, 1). Likewise it could also signify the relative power that certain (hi-tech) 
research fields have in courting funding, partly derived from their commercial linkages and partly 
from the promising allure of these prospective interventions hold amongst  investors in science 
(Shaw and Greenhalgh, 2008, Brown and Michael, 2003). Either way, to date it is largely 
accepted in policy discourse that too much emphasis has been placed on T1 translation of 
discoveries into clinical experimentation and too little emphasis on T2: adoption into clinical 
practice (Contopoulos-Ioannidis et al., 2003, 433).  
The second model to delineate then is one which encompasses the whole bench-to-bedside 
continuum, incorporating both T1 and T2 processes. It can be read as a strategic response to the 
propensity for T1 developments to be ‘lost in translation’ (Lenfant, 2003). The focus of the NIH’s 
and MRC’s strategy around these two prongs is an explicit response to this perception (Cooksey, 
2006). A number of prescriptive models have emerged which seek to prioritise the main 
development ‘phases’ needed in order for the translational promise to be realised in promising 
fields like genomics (Collins et al., 2003). A typical response has been to focus on different areas 
of priority in the translational continuum. These are typically demarcated into series of (largely 
stepwise) phases, which include:   
1) Movement of biomedical research into diagnostics/therapies  
2) Development into evidence-based protocols  
3) Development into clinical practice  
4) Evaluation of real-world impact on health (Khoury et al., 2007) 
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Although these displays for demarcating the social actors and processes involved in translation 
appear somewhat linear and overlook the presence of feedback, they are nonetheless helpful in 
terms of pointing towards prominent efforts by the medical and policy communities to map-out 
boundaries of the assemblages partaking on this general task. This broader ‘bench-to-bedside’ 
definition of translational research is what ‘macro-actors’ in the UK research and innovation 
system are currently attempting to project upon the world of academic health research. These 
models now appear to reflect standard ways of framing the translational challenge8, meaning it 
is this second definition with which my study seeks to engage. Social studies of translational 
research (reviewed in next section) describe this literature as concerned with the analysis of 
‘bench-to-bedside dynamics’ (Wainwright et al., 2009), however most of the writings associated 
with this problem focus upon T1 forms of translation. In following the scope of the phenomenon 
set-out by Cooksey, Khoury and others, I intend to incorporate T2 versions of translation into the 
study as well, thereby following the updated definitions of bench-to-bedside which social studies 
of translation should begin to take seriously (McAneney et al., 2010). 
Conclusion  
This chapter has provided an account of translational research within the context of English 
science and medical research policy and sought to articulate the kinds of meanings which have 
been attached to it through various sources. Even from this short description, it will have 
become clear that this is no simple task. Posed rhetorically, if there is no clear consensus about 
what translational research means within the populations I study, then why should I, the 
researcher, seek to impose one? Following a pragmatist strategy, I instead propose that a more 
productive approach is trying to look for what the term is being made to do, for what purposes 
and in what circumstances. The pragmatist tools introduced in this thesis to engage with this 
                                                          
8
 For this reason Khoury’s model is taken as inclusion/exclusion criteria in sampling the main cases in this 
study (see Chapter 5). 
26 
 
task- labels/metaphor, boundary objects, and immutable mobiles- are set-out in the literature 
review. It is important to qualify that definitions from within the world of policy and research are 
treated as useful entrance points to help design the empirical studies in this thesis, rather than 
fixed statements about what translational research ‘really means’. It is suggested that following 
this approach offers an attractive way-out of what would otherwise be a rather frustrating and 

















3. Translational Research and Social 
Science Literature: A Review 
 
Introduction 
The aim of this chapter is to review the literature used to inform the study of translational 
research in this thesis. Clearly one such objective of such a review should be to report on what 
has been said in previous sociological literature on the topic, pointing out which aspects have 
set-out an agenda for the research in this thesis to follow and which areas have been left open 
for potential improvements. One such general improvement I suggest is to pull-in knowledge 
emanating from a much larger body of research pre-dating and paralleling studies of 
translational research: what is  dubbed here ‘re-contextualisation’ literature (following a term 
coined by Nowotny et al., 2001). The first part of this chapter therefore is dedicated to reviewing 
literature on ‘re-contextualisation’ and sociological studies of translational research. The second 
part turns to the areas of STS literature brought-in to help answer the research questions and 
build on existing stocks of knowledge with regards this topic. This includes an overview of the 
relevant parts of the actor-network approach, research on boundary-forming activities of 
science, and a set of specific sensitising concepts drawn from STS laboratory ethnographies, in 






1. Substantive and Theoretical Contributions towards Translational 
Research 
To date there has not been a wealth of literature produced about translational research. In one 
of the few studies to have directly engaged with the topic, Wainwright et al. (2009), speculate 
that one reason for the relative absence of such studies could be that it is a relatively recent 
phenomenon. On a provocative note, I would speculate that to date the term has proved 
somewhat unwieldy and off-putting for social scientists because it has not been particularly well 
conceptualised. This is something I hope to put right through the thesis. In this review I identify 
with two types of ways that sociological literature engages with translational research. A first is 
included because it has been helpful in making me think about translational research and points 
to ways in which the problems addressed in this thesis can be of interest to audiences interested 
in studying the interactions between science and its context. However, the term translational 
research is not given explicit mention in these works. The second constitutes the most important 
body of literature as it is the one to which I aim to make a direct contribution: sociological 
studies which have addressed this topic explicitly.  I shall now provide an overview of each of 
these.  
Scientists, Innovation and ‘Re-contextualised’ Science  
The first type of literature drawn on during research on this thesis addresses implicitly debates 
and concerns which are typically associated with the term ‘translational research’ without 
actually using the expression as a marker for their work. This category encompasses vast arrays 
of literature from across a number of social science fields. Themes emanating from this literature 
have fed-into my thinking about translational research and how to go about studying it, which is 
therefore why I provide a brief overview of particularly key contributions.    
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One such area of work provides theoretical and (some) empirical attention to the changing 
institutions of academic science (reviewed in Hessels and van Lente, 2008). STS Laboratory 
studies have rarely accentuated the influence of the university as an institution in its studies of 
scientists. By contrast ‘re-contextualisation’ literature has placed particular emphasis on the role 
articulated by the university in society and how this has transformed over particular historical 
periods. In short, this has meant the Humboldtian model of the university as an institution 
supporting pure inquiry and training has been replaced by a more near-market institution acting 
as, amongst other things, an economic agent in society. This has shifted certain changes in 
knowledge production practices, most famously the claim that academic science is moving in a 
direction away from Humboldtian ‘Mode 1’ towards new forms of ‘Mode 2’ production (Gibbons 
et al., 1994; Nowotny et al., 2001). Work on ‘re-contextualisation’ of science has run in parallel 
to studies of translational research, but rarely have they intersected. This is perhaps beginning to 
change, with one recent article drawing on innovation systems theory in order to open-up 
understanding of the phenomenon of translational research (Lander and Atkinson-Grosjean, 
2011), although so far this is an exception. Works in these various traditions – Mode 2, triple 
helix, innovation systems and so forth- have focussed in part upon how new and old institutions 
interact in the ‘ivory towers’ of academic research in universities, for example, in strategic 
responses of academics towards meeting pressures like commercialisation and relevance. Of the 
former, studies have observed the strategies and boundary work tactics exercised by scientists 
reconciling new institutional pressures of commercialisation with older Mertonian-type norms 
associated with academic science (Webster, 1994, Etzkowitz, 1998, Cooper, 2009). Likewise, 
studies have begun to focus upon how academic scientists incorporate struggles for relevance 
into their practices (Rip, 1994, Hessels et al., 2009). These issues have become pronounced as 
the Humboldt model of European and North American universities as an enclave for pure 
research and teaching has slowly begun to lose ground to more entrepreneurial aspirations and 
cuts in public funding (Etzkowitz et al., 2000, Etzkowitz, 2002), which one might equate with a 
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general rise in neo-liberal politics (Slaughter and Rhoades, 2004). I would cite such sociological 
investigations into institutional changes in academic sciences as influencing the way my research 
questions have taken shape. However, some of the most influential theoretical contributions on 
this topic, especially writings reporting ‘Mode 2’ changes, have been criticised as overly-reified 
claims based on little primary empirical evidence (Weingart, 1997, Shinn, 2002). To compensate, 
using a concept like translational research, which is member-generated, helps one to address 
some of the general themes captured by these ‘re-contextualisation’ arguments without falling 
into their particular representational traps. Indeed evidence for this neglect can be read from a 
chapter and edited work one of these Mode 2 authors (Nowotny, 2006a), which mentions in 
passing the need for scientists to demonstrate translation, without providing any further 
substantive or theoretical elaboration on this cursory observation. These studies would benefit 
from taking seriously the performative role of metaphor and language in how scientists describe 
their activities, particularly as institutions of science such as the university appear to undergo 
significant transformations.  
Another set of studies useful for my understanding have been ones which focus upon networks 
of practice involving academic scientists, clinicians, policymakers, and other interested parties. 
Some of this work is historical in scope, focussing for instance on clusters of institutions which 
emerged post-war at the interstices of science and medicine to form new practices of 
‘biomedicine’ (Löwy, 1996). Such spaces in which biology and medicine meet and interact were 
labelled ‘biomedical platforms’ (Keating and Cambrosio, 2003) in which ‘bioclinical collectives’ 
come together (Rabeharisoa and Bourret, 2009). These studies point to the importance of 
various amalgamated institutions – theories, experiments, artefacts, practices, infrastructures - 
for facilitating translation between bench and bedside. But these historical studies take focus 
away from academic settings and focus more on hospitals as sites of research.  
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Also focussing on networks of practice have been real-time studies of (expensive) efforts to 
forge strategic research partnerships between biomedical scientists, industry and health 
services. These institutions appear less immediately identifiable with the norms and discourse of 
academic science, but more with institutional logics of triple-helix type initiatives. Studies in this 
vein typically reveal the struggles that were faced in efforts to translate research within these 
hybrid networks. One set of articles on science-policy collaborations in the UK Genetics 
Knowledge Parks scheme showed that the stability of agreed-upon definitions of scientific 
objects are often fragile and can change over time, as events and shifting expectations lead to 
the ontological re-specification of research problems attributed by certain actors (Robertson, 
2007, McGivern and Dopson, 2010, Swan et al., 2010). In Canada, Atkinson-Grosjean (2006) 
focused upon difficulties faced in forging short-term and lasting relations within strategic science 
policy networks called Centres of Excellence. The focus on ‘merchant’ or ‘translation’ science was 
made explicit by policymakers and industrialists at the outset of these projects, and, ultimately, 
failure to live-up to these heightened promises, which she claims led to their termination. 
Focussing on the same initiative, Lehoux et al. (Lehoux et al., 2008, 2010) described difficulties in 
conducting ‘epistemic conversations’ within such hybrid spaces, which they attribute to different 
political interests and epistemic cultures of those involved. Theoretically these epistemic 
conversations resemble the types of pidgins and creoles which must typically emerge in order 
for exchanges to occur in the processes of creating and articulating ‘trading zones’ (Galison, 
1999). Although somewhat intellectually derivative, where these real-time studies on networks 
of practice make a useful contribution is in pointing out that forced interaction is not necessarily 
a recipe for successful translation, suggesting more reflexive thought and effort is needed. In 
studying these novel contexts these studies reaffirmed the utility of existing sociological 
theorising on innovation which states how capacity to negotiate local coordinations whilst 
attaching different global meanings to objects is key to communication (and indeed success) 
within hybrid spaces (e.g. Star & Greismer, 1989; Galison, 1999). Unlike theorists like Galison 
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however, they do not focus upon the importance of actual physical sites in which production and 
interaction between the two worlds meet. The studies also argue that ‘academic culture’ is a 
cause of much inertia in these spaces without articulating in any great depth what practices 
constitute and extend this form of culture and how exactly these inhibit translation. Notably 
absent from these discussions is the institution of the university and the agendas it impresses 
upon research.  
Although not stating translational research as an explicit topic of interest, I find much of these 
diverse forms of literature informative because through studying science-innovation in action, it 
serves as a reminder that science and technology are cultural artefacts built through processes 
of social struggle. This then reinforces the appropriateness of introducing STS resources to study 
translational research in mundane practices. For my part it is hoped that scholars interested in 
institutional changes within academic sciences will find this study useful and informative.    
Social Studies of Translational Research  
The Second type of literature actually takes translational research as an explicit topic of concern. 
These types of studies are considered to be those which aim to ‘foreground the concept’ (Lander 
and Atkinson-Grosjean, 2011, 537) and/or to explore ‘bench-to-bedside dynamics’ (Wainwright 
et al., 2009, 41). Reflecting shifts in scope of policy definitions recent studies have adapted the 
meaning of ‘bench-to-bedside to incorporate T2 forms of translation, as well as T1, into problem 
area of ‘social studies of translational research’ (McAneney et al., 2010, Lander and Atkinson-
Grosjean, 2011). My own study also reflects this shift.  
A large proportion of studies which have engaged directly with translational research have been 
located in the frontier field of stem cell science, which has seen a great deal of social science 
interest more generally. One feature which was especially informative about this work on stem 
cells is its engagement with an emerging sub-field of STS sometimes called the ‘sociology of 
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expectations’ (Brown and Michael, 2003, Borup et al., 2006). The sociology of expectations 
focuses upon promises around prospective and emerging technoscience as a basis for collective 
action in the present. The explicit interest in translational research enters studies on stem cells 
for instance, because the promise of translation is the goal which brings all sorts of social actors 
together to form ‘communities of promise’, particularly its clinical actors (Wainwright et al, 
2006b; Martin et. al, 2008). From this it can be inferred that the metaphor translation also holds 
anticipatory promises within networks converging around many other areas of biomedicine 
(Martin et al., 2008). It is argued that translational research is neither a fact nor norm of 
contemporary biomedicine, but an aspect of the discourse (Wainwright et al., 2006b). Although I 
do not disagree with this position, I find the notion of discourse rather dissatisfying in regards to 
conceptualising translational research.  
In searching for a useful alternative to the rather vague notion of discourse, I found case studies 
in the sociology of expectations on the emergence of a promising new field of technoscience to 
be informative (Van Lente and Rip, 1998a, 1998b). These authors point towards labels as devices 
for constructing and ordering expectations by emerging macro-actors like research councils, who 
organised new agendas and portfolios around a promissory label called ‘membrane technology’. 
What this showed was that although labels are often saturated in sexy rhetoric, they are not 
necessarily inconsequential, as they can mobilise action to change priorities and organisational 
routines. Research reporting on an emerging ‘triple helix’ of university-industry-government 
relations (Etzkowitz and Leydesdorff, 2000) have shown how actors associated with each 
institutional sphere have different interests and means of moderating their interdependences 
(Louis and Anderson, 1998, 86). As such, the meanings and expectations which get attached to 
terms like translational research will become stabilised in different ways over time and as one 
moves across observing various network points. This makes the prospect of trying to set-out at 
the beginning one’s study with a concrete definition of translational research a rather daunting 
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task for the sociologist. Here I propose instead to treat terms like ‘basic’, ‘strategic’ and 
‘translational’ research as labels and metaphors which are instrumental: they are seen as helpful 
for imposing order on a heterogeneous set of practices, whilst, simultaneously promising to 
bring about change to an existing state-of-affairs which are regarded as unsatisfactory 
(Czaniawska, 1990). Labels and metaphors are enabling tools, that do not necessarily by 
themselves cause the advent of a new type of research activity called translational research, but 
invite a host of other interested actors – university researchers, medical charities, industry, NHS- 
to interact and collaborate in newly created, largely empty spaces (Rip, 1997). How these labels 
are ‘filled-in’ is a much more interesting, rewarding and feasible problem to address than ‘what 
they are’. But Van Lente and Rip’s theorising does not provide a clear toolkit for describing how 
the term transforms as it is mobilised into action. Therefore in addition to their theorising on 
labels in technoscience, I suggest introducing terms like boundary object and immutable mobile 
as means of capturing how the term stabilises, travels and endures (or not) as it is extended 
through networks into the hands of different people (for overview of these two concepts see the 
second part of this review chapter). This combined approach enables one to explore 
performativity of this concept as it relates to real-world practices.     
A second contribution in this literature has been the focus on difficulties of forging innovation 
through networks of practice and institutional barriers towards doing so. These studies have 
retrieved some of the practical implications from translational research by shining a spotlight on 
how increasing proximities and interactions between bench and bedside might bring about new 
tensions, risks, liabilities and boundaries (not just convergences and opportunities). Critically 
considering these issues is one means in which existing and future social science studies (of 
which I am counting this thesis) can offer a novel and insightful contribution to both empirical 
and policy matters of concern. One of the most common observations from social studies of 
translational research has been that the direction of this process is not simply one-way (bench-
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to-bedside), but will also follow a ‘bedside-to-bench’ trajectory (Wainwright et al., 2006b, Martin 
et al., 2008). For example, in stem cell research, it is thought necessary for clinicians and stem 
cell scientists to discuss from an early stage what questions are likely to be answerable and lead 
to useful applications (Wainwright et al. 2006b). Such feedback arguments re-enforce the idea 
that translational research is an intensely collaborative process (Wainwright et al., 2009). This 
appears to be a reasonable and convincing point to make. But the  story they describe in context 
of stem cells where policymakers subscribe to overly-linear models, naively assuming there to be 
a steady-state in the dynamics between basic scientific research, the clinic and the commercial 
sectors (e.g. Martin et al. 2008, 30) is not one I fully recognise in UK research policy discourse. 
From my own readings of policy and medical literature, these stakeholders appear to think more 
reflexively than this. For example, Cooksey Report acknowledged the ‘bedside to bench’ 
trajectory as being equally valid dimension of the translational research enterprise, as do a 
number of commentators in medical journals (Hammerschmidt, 2004, 5, Hallenback, 2010). 
Likewise although there is a tendency to underplay feedback in constructing phase models, there 
is at least some acknowledgement in these sources of there being potential for overlaps and 
feedback between them (e.g. Khoury et al., 2007).  
Where the contribution of work on stem cells has been generally useful for a study of 
translational research like this is in articulating how closer collaborations between bench and 
bedside induce unforeseen complexities in the relations between the worlds of science and 
medicine than are imagined by linear imageries. Recent case studies have exposed a number of 
examples of issues and boundaries which have already emerged and could do so further at these 
intersections. Martin et al. (2008) show how tensions emerged between different constituents in 
networks coalescing around the promissory object of Haemotopic stem cells, for instance over 
difficulties of recruitment into Phase II clinical trials. Drawing on Bourdieu’s notion of habitus, 
Wainwright et al. (2006b) point to institutional differences between the worlds of biologists and 
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clinicians as a source of tension and reluctance to pursue further collaboration. These case study 
findings suggest policymakers and other stakeholders should exercise caution towards 
deterministic rhetoric and grand narratives that translational research will diffuse seamlessly 
into everyday research practices. Together these micro-level studies suggest social scientists 
should continue to pursue how boundaries are constructed, experienced and negotiated by 
agents on-the-ground. Part of the problems which can emerge in relation to the metaphors of 
translation in areas like stem cell science is excessive hyperbole (Brown, 2003). Indeed in this 
field speed - moving from lab to clinic ‘as soon as possible’- has been an important dimension of 
resource mobilisation and collective action (Wainwright et al., 2009, 43). Sociologists can 
contribute versions of innovation which are not accepting of the hype surrounding a field like 
stem cells, or indeed emerging technoscience more generally (Michael, 2000).   
One of the consequences of there being very few studies on translational research, many of 
which have focussed on stem cell research, is that the findings naturally lean towards events and 
difficulties in that particular domain. Embryonic stem cell research promises breakthrough 
technologies which pose qualitatively new problems of risk for existing regulatory and ethical 
institutions (Wainwright et al., 2006a). Whether such hurdles to clinical translation exist in 
similar ways or to the same degree in cases of biomedical science where incremental (rather 
than breakthrough) interventions are under development seems less certain. Therefore studies 
of translational research should broaden to include cases dealing with less radical (and hyped) 
forms of translation. Additionally as the promise of stem cells has, thus far, failed to live-up to 
earlier promises, there is a risk of translational research being associated with an 
incommensurability thesis. During my own studies, I became aware that the notion of 
incommensurability between social worlds involved in stem cell research might not fit so well to 
the situations of other types of research. Rather than follow a Kuhnian-type thesis of 
incommensurability (1970), I drew influence from STS studies which look at how collaborations 
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between social worlds and their realities get forged, focussing especially on struggles to conduct 
what writers like Galison (1999) and Mol (2002) call ‘coordination work’.  
A key article in support of this tact in the sociological literature was written by Lander and 
Atkinson-Grosjean (2011). Their argument is that boundaries are disrupted by translational 
research- although disturbances can be a productive as well as inhibiting feature of translation 
work. These authors are particularly taken by the notion that boundary objects facilitate 
translational work between epistemic communities (an argument also finding implicit support in 
Swan et al., 2007). The most prominent examples of boundary objects are the 
research/application problems around which these communities converge on a given project 
(ibid, 538). Clinician scientists were identified as mediators (or ‘boundary spanners’) performing 
important ‘articulation work’ between laboratory and clinic (Lander and Atkinson-Grosjean, 
2011, 542). They state: 
“Throughout this process, ideas, artefacts and individuals crossed boundaries, moving 
from the clinic to the research lab and back to the clinic again.” (ibid, 543)  
This has influenced my thesis, which also utilises boundary concepts such as these (for 
elaboration see sensitising concepts review below). I find this depiction of translational work as 
one of ‘traffic’ between social worlds of laboratory and clinic/industry an immensely appealing 
one (see also Wainwright et al., 2009). Like them I also wish to foreground the concept of 
translational research and follow it into practice (Lander and Atkinson-Grosjean, 2011, 537, a 
vitally important analytic goal for social studies of translational research. But I have also sought 
to bring-in certain methods and concepts with a view to adding and improving upon their effort 
to pursue this aim.  
One aspect is that Lander and Atkinson-Grosjean rather overlook the importance of place in 
favour of mobilities (a more widespread problem in STS articulated by Henke and Gieryn, 2008). 
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Studying the places and institutions which get associated with translational research, reporting 
what happens there and how informants see this as helping translation are questions I tease-out 
through empirical chapters and consolidate in the conclusion. 
I find Lander and Atkinson-Grosjean’s (2011) aim of ‘foregrounding the concept of translational 
science [...]to illustrate how research, artefacts, ideas, diagnosis and treatment transport 
themselves between the clinical and academic environments in the biomedical innovation 
system’ (p.537) a generally attractive one. Although their study has helped to open-up this 
project, it has by no means has fully dealt with issues of transportation of the idea. Indeed 
although articulating this problem, their article provides little by way of empirical follow-
through. For my part, ANT terms like immutable mobile and inscription devices, as well as 
boundary objects, will be used to explore the concept’s mobilities further. This constitutes a 
useful and novel way of retrieving the practice of translational research.  Furthermore, Lander 
and Atkinson-Grosjean largely ‘black-box’ how epistemic cultures variously construct and 
accommodate translational research. STS teaches that sciences are not unified and therefore 
how translational research is defined will vary across localised practices of different 
communities. Perhaps one of the reasons that the translational literature has failed to pick-up on 
differences in how sciences accommodate and define this concept comes from the propensity to 
focus on single case studies.  My comparative study then foregrounds how institutions of 
different epistemic cultures are used to construct local definitions and practical responses to 
translational research. Overall then I address the transportability and travel of translational 
research in a way that other studies which claim to ‘foreground the concept’ have not. 
A general weakness of literature on translational research is that ‘academic culture’ is used as a 
major theme to explain the difficulties of ‘institutionalising’ translational research, but this 
theme has been under-elaborated. Bringing in laboratory study sensibilities enables a more 
wide-scale exploration of ‘academic culture’, which has been left untouched in two ways by 
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translational research literature. First few studies sample from the population of academic 
scientists. Many barriers academic scientists face in making the target concept work are not 
addressed by authors like Lander and Atkinson-Grosjean, because their study samples ‘boundary 
spanners’ (with infrastructures already in place to be mobilised). In entering into ‘ivory tower’ 
institutions of universities synonymous with ‘old-order’ academic science, there are perhaps 
more opportunities to observe resistance and controversy, given assumptions about the relative 
autonomy of this population and difficulties in transforming their practices. In sampling 
exclusively from ‘boundary spanner’ academic scientists, I suspect a number of controversies will 
have been missed. Second those studies that do sample from this population, like Wainwright et 
al. (2006b) have not drawn much from sociology of science literature: many of practices which 
characterise mundane activities of scientists are left untouched.  
Conclusion on Translational Research Literature  
The first part of the literature review has addressed existing sociological knowledge brought into 
this study about translational research. It was suggested that research broadly associated with a 
‘re-contextualisation’ thesis has been useful in terms of relating a phenomenon like translational 
research to broader transformations in contexts of academic knowledge production in recent 
times. An empirical arm of this literature has also provided some inspiration in beginning to think 
about how academic scientists reconcile the various pressures posed by such changes in their 
mundane work activities. Surprisingly sociological research on translational research has been 
slow to draw on this wider body of literature, and conversely, ‘re-contextualisation’ literature 
has neglected member-generated categories like translation and translational research as a way 
in for exploring some of these issues in empirical settings. In this sense, then, my research can be 
seen as a bridge between these two types of literature.  
Substantive sociological literature with an explicit interest in this topic has so far been thin on 
the ground. It has focussed for the much part on empirically-led criticisms of scientists’ and 
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policymakers’ discourse with regards translational research, posing that the prospective hype 
surrounding the term as a magic bullet for modern medicine is ill-founded, given short-term 
difficulties and resistances experienced by scientists and clinicians in fields like stem cell 
research. Although surely correct in their caution towards grand narratives, the sparseness of 
these studies  has meant much knowledge gathered to-date on translation originates from the 
context of stem cell research, a frontier field which hitherto has enjoyed only moderate success 
with regards translational research, but where political pressures and expectations are high. 
Another substantive argument deriving from this literature has been to dismiss accounts of 
translational research as following a linear model of innovation. As well as imagining bench-to-
bedside dynamics analysts then must also realise the importance of bedside-to-bench feedback. 
Despite agreeing with this emphasis on mobilities, I would also like to take the opportunity in 
this thesis to defend the importance of place in the social study of translational research 
dynamics. Overall then, the focus of sociological literature on single case studies, largely on stem 
cell translational research, have not provided the final word on translational research, and their 
program should be extended to include comparisons between the travel of this concept to 
different cultures of medical sciences and their local production sites. The fledgling body of 
sociological literature provides important but not exhaustive resources to tackle this aim. 
Therefore, I have seen fit to bring-in additional intellectual tools and concepts from STS, in 
particular the program often referred to as ANT. My use of Latour and Woolgar’s (1986) 
frameworks to help capture some more of the mundane aspects of scientists’ work makes a 
helpful contribution to studies interested in pointing to difficulties and possibilities of translation 
in contemporary technoscience. The sensitising concepts deployed to open-up further avenues 




2. Theories and Concepts for Locating the Mundane in Translational 
Research  
This section introduces an overview of key sensitising concepts and themes imported into this 
study from STS research on scientists. One of the most notable contributions to come out of the 
field of STS is to provide a provocative re-evaluation of previously received views about how the 
sciences produce knowledge about the world. In the grammar of Pickering (1995), scientists 
should not be understood as working objectively with ideas and objects as in old order 
depictions, but as engaging in struggles within a dynamic world of performances. According to 
ANT, the main approach followed in this thesis, scientific activity is about organising humans and 
non-humans into stabilised networks of association which are capable of producing certain 
ordered effects. In reality this process often fails as elements do not always hold together. 
Indeed reality is defined in ANT as that which resists (Latour, 1987), and scientists must devise 
ways of accommodating and working with known and emerging resistances. Such ‘dances of 
agency’ between humans and non-humans in science was labelled elsewhere as ‘the mangle of 
practice’ (Pickering, 1995). As an explanatory paradigm, retrieving the practice from science 
points towards the processes and struggles by which connections are made. In short, then, 
scientific activity should be approached as being concerned with the production of order from 
disorder.  
STS has provided a series of case studies and conceptual resources for analysing how scientists 
go about reducing ‘background noise’ and producing ‘clear signals’ out of this dynamic state of 
affairs. Latour and Woolgar’s (1986) influential text Laboratory Life articulates four such 
frameworks and details how these get constructed and imposed in the mundane work practices 
of scientists (p.37). Mundane is often taken to mean dull, grey, and uninteresting. Indeed the 
idea of being interested in ‘practices’ of scientists at work was thought uninteresting and 
irrelevant by earlier philosophy of science. STS’s concern for the mundane has therefore been a 
42 
 
very deliberate strategy used in order to produce stories about science and technology which 
retrieve and take seriously practices. ANT provides an alternative account of the materiality of 
science and technology in terms of local, specific, situated practices and provides tools which 
help to retrieve such practices. In doing so, this provides a very different story of the materiality 
of facts, truth, reality, theory, ideas and so on than is provided in prominent earlier versions of 
science.  
Setting-out on my fieldwork, the aim was to see what a ‘sexy’ new concept- translational 
research- looked like amongst the mundane work practices of scientists ‘at the coalface’. As I 
set-off on this journey Latour and Woolgar’s frameworks and associated STS concepts helped to 
navigate the mundane world of scientists. Each sensitising ‘framework’ is summarised below in 
brief, with an account of aims and approaches of the original versions and additional information 
as to which aspects of the frameworks were thought particularly relevant in opening-up 
questions about translational research in this study and why. Before addressing sensitising 
concepts from Laboratory Life, I will set-out other important concepts from ANT and related STS 
toolkits which are drawn-on regularly throughout the thesis, such as ‘translation’ (or 
‘transformation’), ’boundary objects’, and ‘immutable mobiles’.  
Transformation and Actor-Network Theory 
The ANT notion of transformation9 is a useful conceptual and methodological tool in exploring 
the networks of associations which are at the centre of scientists’ practical efforts to re-shape 
their societies. It is through these ‘actor-networks’ that science and technology are able to 
speak-for and intervene in the world and reconstruct the social contexts of which they form a 
                                                          
9
 Most ANT works in fact use the word translation, not transformation. But given the prevalence of this 
word and its adjective ‘translational’ throughout this thesis I decided not to keep the word translation in 
referring to theoretical issues provoked by ANT. Otherwise things would be altogether too confusing. 
Where I have kept the word translation is in locating its indexical uses and meanings in the networks of 
researchers who form my cases.  
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part (Callon, 1986, 20). Emerging from laboratory studies, ANT has sought to retrieve practices 
from the study of science and technology which had for so long focused only on the outcomes of 
science. ANT has led to accounts of how phenomena achieve durability and mobility (materiality) 
which are often very different from those routinely found in modernist scientific discourse (Law, 
1994). In the ANT scheme, materiality is a relational effect that is always embedded in ‘networks 
of the social’ (Law, 1994, 102). ANT questions how science and technology are able to exert any 
kind of force in a context where numerous actors ‘develop complicated strategies and many 
possible innovations with social and technical implications’ (Callon, 1991, 133). The answer 
seems to be ‘with some difficulty!’ Doing materiality, it turns out, takes skill and effort. It 
involves building networks out of heterogeneous elements; ordering actors and intermediaries 
to occupy positions and play allotted roles (assembling ‘actor-networks’)10. But objectifying 
elements into actor-networks is all the more difficult given that ‘the components of the 
networks, have, as it were, no natural tendency to play the roles to which they have been 
allocated’ (Law, 1994, 103). Furthermore once assembled, actor-networks must overcome 
efforts to break its ties and inhibit its expanse by other actor-networks (withstanding ‘trials of 
strength’) (Latour, 1987). Materiality then is the exception rather than the rule, as durability and 
mobility of (often unruly) objects is only built and maintained at great effort and cost. In ANT 
transformation is the work done to achieve such durability11 (Callon, 1986, 28).   
Successful transformation involves not only recruiting allies, but also establishing an equivalence 
between them (Callon, 1998, 52). This equivalence centres on an intermediary- like a machine, 
                                                          
10
 Actor-networks are taken to include both human and non-human elements. This is important for 
studying science because instruments form important parts of the networks that carry facts and machines 
back and forth. For instance, most scientific theories today cannot be performed or demonstrated without 
instruments (Latour 1987, 250-251).  
11
 On the flipside, an actor-network is an arrangement of constituent elements that have been 




product or scientific argument- that defines two objects (Callon, 1991, 144-145). Establishing this 
equivalence can take on a number of forms (for a detailed typology of transformation strategies 
and tactics see Latour, 1987). In the modern world, scientific knowledge is a prominent example 
of an intermediary, the equivalence of which typically gets established as follows:   
“A team of biochemists can define other actors and suggest the following translation: 
We want what you want, so ally yourself with us by endorsing our research and you will 
have a greater chance of obtaining what you want.” (Callon, 1995, 52) 
Successfully mobilised facts and machines, in Latour’s writings, eventually take the form of 
‘black-boxes’ amongst new users. Polonium for instance, went from being an obscure artefact in 
the hands of Marie Curie to a stabilised fact amongst ‘many more, but much less informed, 
hands’ (Latour, 1987, 138). Many of the new users therefore did not need to be as qualified or 
pre-occupied as Curie had been towards Polonium. On the contrary the success of the fact can 
be explained in terms of a great number of people being much less concerned than Curie, being 
content merely to treat Polonium as a ‘black-box’ around which to develop their local practices. 
To convince new audiences of the facticity of this supposed element at the time required the 
transformation of various interests and actions to the point that Polonium became a stabilised 
scientific fact. In order to extend their networks, scientists and engineers must develop implicit 
or explicit sociological theories, for instance about the users of a prospective intermediary 
(Callon, 1987, Akrich, 1992). Stabilised objects thus have ‘scripts’ about the prospective users 
written into them, which the users themselves must make sense of and negotiate (Akrich, 1992). 
A curious feature of stabilised objects is that often scripts and the transformation efforts that 
went into making them stable features of networks appear invisible at the end of successful 
innovation processes (Callon, 1986, 24). For actor network theorists, this is the reason why 
analysts and practitioners we study have both had great difficulty in being (relational) 
materialists. Given this contention, ANT states that successful transformations and materiality 
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should only be considered by sociologists after the fact and as more-or-less reversible (Callon, 
1991). 
Following ANT logic, one can postulate that translational research is one particularly prominent 
intermediary circulating the contemporary research system, but there may also be other actor-
networks complementing, challenging, and/or being silenced by it. Here ANT is used to explore 
the practical, real-world-making effects that efforts to transform translational research are 
having on-the-ground. In retrieving the practice from translational research, ANT offers a useful 
methodological tool for flattening macro-micro divisions which sociological and organisational 
theories often articulate (Callon, 1991). Part of the appeal of this flattening is that scale and 
agency are viewed as outcomes of action which are to be determined empirically, rather than as 
external properties of the world which analysts can know and decide about in advance. Actors 
are outcomes of actions (and organisations outcomes of organising), rather than inputs 
(Czarniawska, 2004). These features are imputed to analysts who have ‘followed actants 
around’. In advance here the semiotic term actant is used to refer to those entities whose 
agency has not yet been imputed to analysts. To take an example from this research, in advance 
it might appear common-sense to view formal bodies like UK government, MRC, or NIHR as 
macro-actors in stories told about translational research. Yet in the approach taken here, prior 
to analysis they are treated as actants, whose degrees of actor-hood are not yet determined. 
This leaves open the possibility that these cases are not being acted upon to any significant 
degree: whether indeed they are and where is an empirical question.   
Negotiating the Boundaries of Science  
The metaphor ‘translation’ implies movement across boundaries. STS literature on boundaries in 
science form a useful set of sensitising concepts with which to consider questions regarding 
boundaries researchers encounter in (dis)engaging with translational research. In particular, this 
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literature has been instructive in providing concepts about two forms of activity working to 
shape boundaries: closing (‘boundary work’) and opening (‘boundary object’). The metaphor of 
boundaries derives here from cartography.  
The concept of boundary work takes science as a system of knowledge dominated by a particular 
group of professionals (‘scientists’) in modern society. According to this scheme, professionalism 
is a mode of control, rather than simply an occupation. As a constructionist theory of science, 
boundary work sees the authority of scientific knowledge and scientists as being continuously 
contested and negotiated (Gieryn, 1983). As a professionalised group, scientists’ power has been 
accomplished through disciplining and creating new knowledge about aspects of the world to 
which other groups in society attach value. Boundary work thus follows the STS style of 
questioning received rhetoric of science, with scientists seen as a professional group interested 
in selling their product. Boundary work theorists have elucidated this by focussing on rhetorical 
strategies and tactics used12 to defend science from non-science, scientists from non-scientists, 
and the validity of scientific from non-scientific claims (Gieryn, 1995, 393). As demarcation is 
part of a ‘cultural and rhetorical game’ rather than essential characteristics of science, theorists 
are concerned with how scientists and others contest and negotiate these ‘social conventions’ 
(ibid. 398). For instance, the norms scientists use to distinguish scientific knowledge, methods, 
and institutions, are in fact resources mobilised as and when they are deemed useful to the 
situation at hand (‘surface norms’) (Gieryn, 1995, 400, see also Mulkay, 1976). In addition to the 
actual performance of boundary work, an equally important strategic aspect in the management 
of science is keeping this work hidden (Gieryn, 1995, 412-413). Analytically, essentialists do 
boundary work and constructionists watch it get done by others in society13 (Gieryn, 1995, 394). 
                                                          
12
 It is not just scientists who practise boundary work: they are also able to get others to defend their 
interests and further their rhetoric.  
13
 Boundary-work can be found in both the work sites of science and other sites such as courts, mass 
media, and public speeches (Gieryn, 1995, 412). 
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This work can be found routinely in the dramaturgical communications of scientists, which make 
interviews and public statements particularly useful data sources. Boundaries can also be seen in 
more naturalistic settings, through observing interactions or reading through relevant 
documents. In the context of this study, the notion helps one to consider the varying extent to 
which respondents describe translational research as a threat to existing boundaries (e.g. of 
professional autonomy or credibility), or whether they are simply able to handle it as ‘business 
as usual’. 
The notion of boundary work is often taken as synonymous with closure, but this association of 
scientists with closure strategies must be qualified. Boundary work does not simply close down, 
as by definition closure of one boundary causes shifts to others (as when redrawing a map). 
Boundary work is therefore an interactive process. In addition, as well as seeking to close-off and 
defend the boundaries of science, scientists must also routinely communicate with others. The 
notion of ‘boundary objects’ captures not only activities and practices which separate science 
from non-science (e.g. standardised procedures used by professional scientists for handling 
specimens), but also how social worlds are brought together in the process of making knowledge 
(Star and Griesemer, 1989). Boundaries between social worlds can be inhibiting in processes of 
knowledge production and exchange, but boundary objects help to open-up communication 
(Carlile, 2002, Fox, 2011). Transformation across these divides requires simplification, and 
certain objects can help to facilitate this14. In innovation contexts, for instance, boundary objects 
help to open-up conceptual and instrumental spaces allowing for different social actors to work 
together (Swan et al., 2007). Within this theoretical grammar, determining the absoluteness of 
definitions and standards is of little interest. Instead definitions and standards are interesting for 
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what they do, namely helping people to talk to one another and coordinate exchanges (Star and 
Griesemer, 1989).  
A neglected feature in writings on boundary objects is their propensity to ‘speak to’ people. This 
becomes instructive if one begins to consider the appeal of a metaphor like ‘translation’. 
Translational research was frequently acknowledged for its aesthetic qualities by respondents in 
my empirical studies, who would attach to it the statuses like ‘buzzword’ or ‘catchphrase’, which 
was ‘of the moment’, ‘in fashion’, ‘sexy’, and ‘seems to be everywhere’.  The analogy of ideas as 
examples of fashions and commodities (that can be ‘packaged’) has been documented by those 
interested in how metaphor comes to shape actions (Lakoff and Johnson, 2005, 105). Hence, 
although it can be criticised as a linear reification, translational research may also serve an 
instrumental purpose when acting as a boundary object bringing different groups together and 
helping them to converse. As such, the performative effects of translational research should not 
be dismissed, even if there is some scepticism towards rhetoric accompanying it. Hence this 
concept can be enrolled into this study as a means for considering the performative and practical 
dynamics of translational research as a device in the governance of research.  
There are certain similarities between boundary objects and actor-network theory notions like 
‘immutable mobiles’. Immutable mobiles are inscription devices which, as they are mobilised 
from one point of a network (a ‘centre-of-calculation’) to another, are stable enough to affect 
some sort of action in remote regions. To extend a device requires enough of its original 
coordinates to hold together as it moves between parts of a network (Latour, 1987, 227-228). By 
themselves inscription devices cannot achieve these ends, but rely upon agency of various allies 
who accept them as indispensable to their purposes and thus extend the materiality of the 
devices into other sites, thus extending the network. Transforming these remote interests and 
practices is far from a foregone conclusion. Translational research might be thought of as such a 
device, insofar as it is mobilised by interested parties like policymakers with a view to steering 
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distant events in research laboratories. The label gets attached to various formal devices like 
agendas and portfolios of research councils, which, through conversations, demonstrations, and 
media travel from centres-of-calculation (e.g. MRC Headquarters) to other peripheral sites (e.g. 
laboratories, universities) in the research system, and back again, without losing their form. In 
everyday practices mediation is facilitated by very mundane items, which provide flat surfaces 
on which to coordinate and mobilise definitions (Latour, 1990). Things like websites, emails, PDF 
documents, PowerPoint slides, application letters appear everyday means by which 
transportation of translational research definitions are made to last over time and endure 
through space (i.e. achieve action at a distance). But even if these items hold, in order to 
coordinate exchanges effectively, certain definitions attached to translational research by either 
party have to hold enough to transform the interests and enrol the support of allies. Part of the 
problem of extending inscriptions and definitions is that when put into practice elsewhere in the 
networks, they encounter trials of strength and resistances.  
Theoretically what likens the concepts of boundary object and immutable mobile is in pointing 
one towards the associations which must be forged in contemporary technoscience in order for 
stabilised effects and outcomes to be achieved. The capacity to open-up communication and 
frame equivalence in networks is a feature they share in common. They would suggest that the 
work done in negotiating local meanings and practices are of central importance in order for 
translational research to work in practice. It is precisely the ambiguity and plasticity which 
renders the term translational research so mobile and durable across different networks of 
academic research. It is not the presence of global standards, but the coordination work that 
goes into stabilising local practices and global definitions which is helpful in exploring the 
practices of translational research. A consequence of this theorising is that seeking globally 
stabilised a priori definition(s) of translational research appears an act of folly on the part of the 
analyst. Whether translational research is a successful boundary object or immutable mobile is 
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the important question which can be approached through descriptive empirical case studies. As 
such these concepts are conducive to the task of exploring the (relational) substance of the 
target concept translational research.    
History of the laboratory over a  Historical Period 
The framework set-out in the Laboratory Life chapter ‘History of the laboratory…’ explicitly 
sought to redress the issue of objectivity in science, particularly those arguments put forward by 
scientists and philosophers regarding the genesis and solidity of facts. Through ethnographic 
observation, the authors traced the production, circulation, emerging controversies and 
eventual stabilisation of a new scientific fact emanating from the laboratory. They found the 
word ‘discovery’ provided a particularly weak term for explaining how scientists go about 
creating knowledge of the world. Instead what they help to advance through this and 
subsequent chapters is an argument and set of methods which elaborate facts as things which 
are ‘constructed’ and ‘constituted’ by real people in mundane, highly specific, carefully 
organised workplaces and extended amongst other people with analogous practices working in 
similarly unusual places. The process of establishing truth is fraught with social struggle, thus 
refuting the storybook image of science as value-free. Yet the word constructed should not be 
read to mean that scientists can do as they wish with ‘reality’, as the non-human entities they 
bring into their networks frequently exhibit resistances. This chapter then was an attempt to 
claim that stories about the solidity of scientific facts should be told in terms of associations 
between human and non-human elements in the networks of scientists. In retrieving the 
practice from scientific work, one can produce a very different account of the materiality of 
science and technology than is provided in accounts of ‘discovery’ by scientists and their 
champions in the public domain.  
The approach of taking facts as constructed is certainly one which I have found useful in 
understanding how science works. Yet I will not replicate the initial project of Latour and 
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Woolgar’s chapter, as such constructionist arguments are now more-or-less taken-for-granted 
within STS. I wish instead to take forward a particular position expounded here which has been 
developed further by later ANT , stating that objects become stable inside networks of relations 
(1986, see also Law and Singleton, 2005). Once the relations holding an object together separate 
so does the solidified status of that object. Objectivity may be an outcome of scientific work, but 
this does not mean that science proceeds ‘objectively’. Similarly although stabilised artefacts like 
ideas, theory, patterns may be effects brought about by the extension of networks, they provide 
very weak accounts of that extension (see Latour, 1990).  
The ANT definition of objects is a helpful reference point in retracing the production practices of 
each case. In particular, the device developed in Latour and Woolgar’s original framework can be 
used to map-out which aspects of laboratory production practices the ‘idea’ of translational 
research is associated with, and how it gets transformed and stabilised within the work of each 
case study. Interviews, observations and documents facilitate the re-tracing of objects produced 
(or ‘things’ in production) by laboratories and their associates (Latour, 2005). With this aid I 
sought to trace in each case the products that were deemed ‘translate-able’ and networks in 
which these were made visible and stable (if at all). The aim then was not only to map out the 
connections which are associated through such objects (the net-works), but the work that is 
done in order to produce and mobilise such objects (the net-works, or work-nets) (Czarniawska, 
2004, Latour, 2005). Interview questions like ‘what does translational research mean in the 
context of your work…’ were prompts for generating data useful for retracing such connections.  
Inscriptions 
Following the organisation of material elements within the workspace of the Salk Institute 
Laboratory, Latour and Woolgar (1986) came to argue that diverse elements located within 
different part of the lab- benches, offices, libraries, meeting rooms- were connected to one 
another primarily through processes of writing. Practices of producing inscriptions are therefore 
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what connects very different looking actions ‘inside’ the laboratory (e.g. experiments) to those 
performed with the laboratory’s ‘outside’ (e.g. publishing). The inside and outside are therefore 
not autonomous realms but connected via practices centred on ‘performing’ inscriptions 
(producing, writing about, reading, circulating them etc).  
In Latour’s ANT, inscriptions constitute a particularly important technology in modern science, as 
they have the capacity to render ‘phenomena’ visible, provide them with longevity, and with 
greater mobility. In short inscriptions are important in science because they enable action at a 
distance. The production and dissemination of facts is described as a process of ‘black-boxing’, 
whereby inscriptions gain the status of facts because they have been extended across networks 
without being ‘opened-up’ and disintegrating (Latour and Woolgar, 1986). Latour and Woolgar’s 
account of black-boxing explained this effect not simply as a result of the content of inscriptions, 
but also because of the devices and associated actions which render them mobile (‘inscription 
devices’). The claims Salk scientists made about the enzyme TRF could be accepted as a fact by 
other laboratories if the latter could successfully assemble an inscription device (‘assay’) similar 
enough to replicate and confirm the Salk’s results. Alternatively, as is often the case in large-
scale modern science, smaller labs are often unable to afford repeating experiments made 
elsewhere and therefore are reliant on testimony of others. Kuhn’s (1970) notion of paradigm 
offers a powerful account of how some facts can acquire the status of being stable and trusted 
within scientific communities based on the testimony of others. Black-boxes can be stabilised for 
periods of time, before being opened again: they are only as strong as the networks holding 
them in place and so are always reversible in principle.    
Far from being straightforward accounts of nature by the modest witness of the scientist, the 
scientific paper can be read as a persuasive text composed of interlocking statements which 
have been designed to resist de-construction by prospective audiences. Part of the interest of 
laboratory studies and other early STS studies was with the styles of literary reasoning which 
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were mobilised in writings of scientists. What literary genre and devices characterised the 
construction of such seemingly persuasive accounts of the world was a question which required 
empirical scrutiny. Latour and Woolgar (1986) and Knorr-Cetina (1981) both dedicated sections 
of chapters to the real-time process of writing and re-writing  a journal for publication in a 
scientific journal by their respective laboratories. Latour and Woolgar (1986) noted how over 
time comments members of the laboratory make about the facticity of a given inscription 
undergo transformations in the level of stability attached to it. They provide a typology to 
capture the variation in ‘facticity’ attributed to statements by scientists. These categories range 
from Type I, II, III, IV, or V statements. Representing a sliding scale in terms of strength of claims 
towards facticity, ranging from the strongest- Type V- which remove all traces of a human voice 
from the statement, to the weakest- Type I- which are highly speculative and feature 
grammatical modalities like maybe, unlikely, not confirmed, potentially (p.84). Type V statements 
make claims which rest on assumptions of definiteness, for instance the statement ‘the protein x 
was added to the assay’ takes as uncontroversial the assumption that x is a protein. The 
statement ‘in my opinion x is possibly a protein’ carries significantly less certainty owing to the 
presence of modalities like ‘my opinion’ and ‘possibly’. These weaker Type I claims, typically 
found in talk between scientists at the lab bench and scribblings on earlier draft documents, are 
seldom found in final published statements of scientific texts, as the presence of modalities and 
human agency would undermine the persuasiveness of the claim to facticity. The fact would 
become an artefact. But according to Latour and Woolgar, at earlier points in their histories all 
stabilised facts are subject to controversies over whether attributions of certainty are to be 
credited.  
One of the most original contributions of Latour and Woolgar’s work was to put forward a 
radical claim about scientific facts: that what scientists referred to as facts were no more than 
the composition and reworking of numerous inscriptions which have withstood deconstruction. 
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This argument can be seen as the product of a larger project in the sociology of science whose 
aim was to retrieve the practice from science so as not to settle for accounts of reality that were 
based on the ‘picture-book’ versions which were available both in the public domain and 
philosophy of science. Facts are thus not quasi-religious revelations from nature which scientists 
modestly witness and report. The word ‘construction’ was therefore introduced as a better 
means of understanding how reality was ‘made’ rather than ‘discovered’ by scientists in the 
laboratory. Whilst still a controversial thesis in some quarters, in the context of STS the 
importance of inscriptions in the scientific production process has provided the basis for much 
important work in the intervening decades. My appropriation of this framework then is not 
concerned with further advancing a thesis about the construction of scientific facts through 
inscriptions, as this is a position already well advanced. Instead I look to explore how the notion 
of translational research is made visible and workable in the context of mundane writing actions, 
and whether such actions are transformed, accommodating and/or resistant of this label. How I 
do this and the implications of doing so will be set-out now in brief detail.  
The section on inscriptions in each empirical chapter of the thesis focuses on the practices of 
writing, particularly in relation to two institutions of scientists’ credibility cycle: grant 
applications and journal publishing. The aim is to consider the extent to which the emergence of 
translational research has transformed these mundane writing practices. This approach borrows 
in part from Hessels et al’s (2009) heuristic for studying impact of wider historical struggles for 
relevance experienced by disciplines have had on local practices of scientists. But rather than 
synthesise all actions on the credibility cycle with historical developments in the organisation of 
disciplines, I focus on two writing practices from the credibility cycle, in order to query whether 
suppositions that translational research is transforming the institutions of science is supported 
by empirical findings. The impetus came from wanting to explore a scenario put forth by Rip 
(2011) about the future of research in Europe over the next decade. One institution which Rip 
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identified for coming under increasing pressure from external audiences was that of grant 
writing and journal publishing. The implication was that translational research marked wider 
changes in ‘re-contextualised science’, whereby the context is increasingly ‘speaking-back’ and 
becoming more pushy in its funding of public science (Gibbons et al., 1994, Nowotny et al., 
2001). In this scenario, in order to receive funding, researchers across the sciences would be 
obliged to follow a new convention of including in these texts plans to convert preliminary 
findings from the study on which the application was being based into further proof-of-principle 
studies. In other words, researchers have to demonstrate (at least the potential for) translational 
research.  
Scientists, it has been shown, have for a long time had to tie their work into a broader ‘web-of-
reasoning’ with which those funding them are interested (e.g. Knorr-Cetina, 1981). Knorr-Cetina 
examined how in journal articles published by applied scientists terse statements about 
potential applicability of their product were included into texts otherwise saturated with 
technical discourse relating to narrow problem choices in their specialities. Such statements 
were carefully constructed to suggest only a plausible script for future action in relation to their 
product, rather than definitive statements about its future progress. Furthermore, statements 
were organised within the texts in such a way that authors themselves would not be accountable 
for developing these products further in a practical direction (ibid). By contrast, the implication 
of translational research for the institution of grant writing presented by Rip appears to be that 
scientists must include plausible plans for further development of findings and that they 
themselves will be held to future account for the promises they make. In other words, extending 
Nowotny’s ‘re-contextualisation’ thesis, these particular institutions are likely to undergo 
transformations as a result of interested parties becoming ‘pushier’ towards scientists. The 
sections thus offer preliminary findings on whether this scenario has materialised. If indeed 
translational promises do indeed now constitute a function of the texts these respondents must 
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write, then it could mark a departure from some earlier STS findings reporting the 
persuasiveness of statements according to standards of representationalism.   
Instead of following the whole process of writing journal and grant articles like earlier laboratory 
studies, where possible I conducted an analysis of statements found within successfully 
mobilised grant and journal articles (insofar as they had withstood deconstruction and enrolled 
intended gatekeepers like journal editors and grant review boards).  In order to distinguish 
between texts whose persuasiveness is based purely on representational claims and those in 
which statements about translational research also feature, selected documents were coded 
using Latour and Woolgar’s five statement types (marking ‘representational’ claims) and 
‘translational’ statements (marking instrumental, performative claims). The materials gathered, 
procedures followed and findings with regard the presence of each code and their relationship 
within written texts produced by each case is discussed in the respective empirical chapters. 
Overall patterns in the coding can be used to make inferences about the extent to which this 
important institution of science now requires these respondents to extend persuasive skills to 
include promises of relevance and legitimacy.   
As well as focussing on the content of mobilised inscriptions, analysis also focuses on the 
additional work scientists performed in order to mobilise inscriptions. After all, alone inscriptions 
do little- they must be supported by inscription devices. One of the sociological questions of 
interest here is the extent to which ‘traditional’ institutional outputs written by scientists carry 
credibility in contexts of ‘translational research’ which are thought to incorporate actions of 
agents with multiple interests and disciplinary approaches. Is mobilisation of additional 
techniques and efforts appropriate in order for inscriptions to travel in processes of production 




Microprocessing of Facts  
In the fourth chapter of Laboratory Life, Latour and Woolgar (1986) argue against received views 
of philosophy of science stating that sociological processes of decision-making are remote, if not 
irrelevant, to the ‘logic’ of scientific discovery. Instead, the chapter sets out to show how 
contingencies become certainties in the course of action and interaction. Through empirical 
observation of ‘routine exchanges and gestures which pass between scientists’ in the laboratory 
(p. 151) they reach the conclusion that the association between ‘facts’ on the one hand and 
‘nature’, ‘logic’, ‘scientific method’ on the other (charactering much of the received discourse in 
philosophy of science) are simply rhetorical effects achieved at certain stages in the career of a 
fact. These couplings rely on tautological claims, evidence for which appeared almost entirely 
absent from the forms of argumentation they observed being used by participants in the course 
of laboratory activities (1986, 151-152). The chapter provides a conceptual framework through 
which to analyse how facts get constructed as ‘logical’.  
The authors reported four exchange types they had observed from interactions in the laboratory 
which served an ‘information spreading function’ between participants (1986, 161). The first 
(heron Type I15) set of exchanges involved discussion between scientists about the facticity of a 
statement, referring either to ‘new’ or ‘long established’ facts. Type II exchanges occurred 
mainly between technicians at the ‘coalface’ of experimental activity and involved real-time 
discussions about correct ways of doing things (ibid.). Type III exchanges were largely strategic in 
character and were reportedly less common, concerning long-term development of things they 
were working on and how they might relate to future developments in their discipline (1986, 
163). Type IV exchanges were those in which claims about the status of  statements as fact or 
artefact was supported by reference to ‘non-technical’ characteristics of other researchers with 
whom claims were being associated (ibid.). As will be made clear in each empirical chapter of 
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 Not to be confused with exchange types in Literary Inscriptions section 
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this thesis, some cases provided better opportunities for original application of this framework 
than others.  
Overall my aims in using this framework in the empirical chapters differs slightly from the scope 
of their original objective, as it is not pre-occupied with elucidating the tautological character of 
much scientific reasoning. It simply uses the framework as a sensitising concept to delineate 
important ‘mundane’ aspects of scientific activity: real-time negotiations required in order to 
make science workable. The kinds of elements that are mobilised in order to stabilise exchanges 
then are key concerns in adopting the framework. This framework also makes implicit the 
assumption that places are important in the coordination of such exchanges. My analysis 
therefore considers in addition the function of place in production processes of these cases and 
builds towards further theoretical development of this issue in the concluding chapter of the 
thesis. One of the problems which emerged in applying this tool was that the exchanges traced 
by respondents did not occur simply inside single production-sites as in Latour and Woolgar’s 
study of interactions in the Salk Laboratory. Instead the nature of the questions being asked here 
necessitated movement into sites of production which were geographically distributed and 
‘brought in’ heterogeneous compositions of human and non-human elements which did not fit 
comfortably within certain of the ‘local’ boundaries respondents in each of the cases drew for 
themselves. One prominent a priori definition of what makes translational research visible and 
workable is the composition of research teams which include not only scientific researchers, but 
also prospective developers and end-users. In order to work in practice, this ‘technoscientific’ 
discourse requires extensive effort and negotiation by stakeholders to arrive at local 
coordination whilst retaining some of their global differences (Galison, 1999, 138). How then 
negotiations are coordinated and what function places play in ‘technoscientific’ production are 
fascinating and important questions opened-up in the course of applying and extending this 
framework in the context of these cases.  
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Cycles of Credit  
Perhaps compared to other frameworks introduced by Laboratory Life, the cycles of credit 
chapter addressed more traditional sociological questions concerning the social structuring of 
laboratories as organisations and the calculations and decisions made by scientists in respect to 
their careers. It did so through making a quasi-economic analogy with an extended notion of 
credit. This was expressed through a two-dimensional graphic subsequently labelled the 
credibility cycle (see figure 3). Their account of credit incorporated a critique of a number of 
disparate themes and arguments in previous sociology of science literature with regards how 
and why credit and reward gets bestowed amongst scientists. This is not the place to rehearse 
these criticisms in full, merely to give a general critical overview of the framework, and explain 
how it has been taken-forward in relation to accommodation of two mundane concerns- 
scientists’ group structure and careers- around practical issues provoked by translational 
research.  
The framework states that scientists are constantly struggling to mobilise resources (human and 
non-human) which can be associated with one another and eventually be converted into new 
facts primarily through the medium of publication in scholarly journals (see figure 3). Scientists 
gain and enhance reputation from publishing and being cited by institutions in reputational work 
organisations of scientific fields (Whitley, 2000). Scientific practice is therefore concerned with 
utilising and extending the cultures in which scientists are embedded (Pickering, 1995; Knorr-
Cetina, 1999), and primarily actions can be understood as amenable to pursuit of credit. Forms 
of credit displayed on the graphic are not particularly useful in and of themselves, but in relation 
to other actions to which they can be linked in the cycle. As a primary form of ‘social capital’, 
institutions of credit exhibit something approximating a ‘use-by-date’: if not reinvested in 
subsequent cycles then it can be eroded. Accumulation of credit can have a kind of reinforcing 
effect in attracting further resources and enabling more rapid and extensive conversions of 
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credibility (Mulkay, 1977). As a product stabilised through networks, credit is not evenly 
distributed. The processes by which credit is accumulated and distributed, far from being 
harmonious, is characterised as one of social struggle. Indeed Latour and Woolgar liken scientists 
to military generals who must exact strategies about which positions to occupy on a given 
battlefield (e.g. carving-out an association with a problem which will force rivals in their agonistic 
field to bestow credit upon them). Senior scientists such as the heads of laboratories have 
accumulated greater levels of credit and can mobilise much larger and stronger networks than 
junior members of a laboratory, who are seeking to gain enough credit simply to be accepted as 
competent practitioners within their communities. As such, various members of the laboratory 
make quite different calculations and definitions of their careers. For instance, the head whose 
name is frequently attached to the laboratory as a formal organisation and location is able to 
speak of their career as paralleled to that of laboratory. Conversely, the junior post-doctoral 
researcher or PhD student will seek to associate themselves with larger, established, stronger 
allies, such as senior scientists or the laboratory, so as to strengthen their own credibility as 
‘commodities’ in the job markets for scientists (Knorr-Cetina, 1981). The asymmetries of credit 
distributed amongst individuals in a laboratory warrants one of the main bases for the divisions 
of authority observable within these settings (1986, 229). As senior members have accumulated 
greater credit, they are able to assume the position of head and spokesperson over other 





Figure 3: Credibility Cycle for a Scientist 
 
Source: Rip, 1994, 11 
Part of the appeal of this framework in approaching group structure and careers is to pose these 
units as the outcomes of performances and organising, rather than properties of individuals and 
the organisation. This is in keeping with the general ontological positioning favoured in this 
thesis of the world as one of flux and performances, not as fixed and Platonic (Pickering, 1995). 
Thus group structures are reconstituted in the course of work organisation, as credit is variously 
distributed and contested amongst members of the laboratory, for instance in relation to a 
specific claim or a piece of work. As such ‘the scientist’ as an individual is best seen as an 
outcome of the organising done by associated actor-networks, rather than a kind of discreet 
subject existing prior to collective work. Credit in its extended form also offers a felicitous 
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concept through which to explore careers of groups and individuals as it often occupies a central 
place in how scientists come to tell of the activities of themselves and others. This account of 
scientific practice provided a much stronger general explanation of the day-to-day actions 
observed by scientists in the laboratory, than earlier versions of scientists being driven by norms 
or intellectual puzzles. These explanations are not wrong per se, however they explained only a 
very small fraction of observed behaviour (Latour and Woolgar, 1986). Furthermore, without 
calculating issues of credit a given selection would deliver, it seems highly improbable a scientist 
would ever be able to mobilise the capital to satisfy these wants. One of the appeals of the 
credibility cycle is that in addition to being generally applicable, it can also accommodate 
variation in observed actions. For example it gives a plausible connection to seemingly disparate 
actions one can observe scientists performing such as discussing results from an inscription 
device, hiring new staff, and writing a grant application. The applicability of the credibility cycle 
as a general model for (de)constructing individuals and small groups of scientists in this study 
became clear during observations of weekly team meetings (in Chapter 8). The definition it 
provided of scientists’ investment decisions and actions as mobilised around an extended notion 
of credit enabled me to make sense of exchanges I observed during meetings, for instance over 
which grants to submit for, how to write project reviews, which deadlines to prioritise and so on. 
Here the primary problems being voiced by participants regarded short-term problems in 
converting forms of credit, as opposed to what constitutes an important societal problem their 
science can address (i.e. normative or truth-seeking motivations) (Knorr-Cetina, 1981). The 
priority of producing publications in scholarly journals, credit for which could subsequently be 
re-invested in further cycles was also reinforced through interview accounts with respondents 
pointing to the formal assessment standards of the REF placing varying levels of constraint on 
individuals and the group.  
63 
 
As such, the credibility cycle could be used as a general model through which to explore the 
actions and selections of scientists. However, the original model has not been without its 
criticisms. Part of these can be related to the fact that how science is organised in Britain today 
is different from the situation of scientists in California in the late 1970s. The emergence of the 
REF as an important disciplinary control measure in respondents’ accounts and recent 
modification of the original credibility cycle graphic to include such performance measuring 
devices (dubbed ‘organisational devices’ see Hessels et al, 2009; Figure 4), meant that 
application of this framework would have to feature this issue. This and other governance 
initiatives have been designed and implemented with a view to ‘auditing’ academics, part of 
what some Neo-Foucauldians see as an expression of neo-liberal governmentality practised by 
contemporary universities (Shore and Wright, 2000, Deem and Brehony, 2005). One of the 
questions I had been interested in exploring concerned gaps between producing work deemed 
‘excellent’ and work which would have an ‘impact’. This simple sounding interview question (see 
Table 2 in Chapter 5) enabled me to get respondents to talk about the difficulties of putting the 
idea of translational research into practice whilst retaining commitment to more ‘traditional’ 
objectives like publishing in respected scientific journals.  
Likewise it has been argued (I think fairly), that the original model did not pay sufficient 
attention to the funding landscape in which scientists struggled to capture resources (Slaughter 
and Rhoades, 2004). Thus Rip’s (1994; see Figure 5) model which includes struggles for 
‘legitimacy’ and ‘relevance’ in addition to ‘facticity’ was taken as a version of the framework 
which promised to navigate certain institutional pressures which informed scientists’ practical 
mundane struggles. This appeared appropriate not only from readings of emerging data, but also 
at the outset given how narratives which typically surround strategic questions of science 
funding frequently latch onto concerns for relevance and legitimacy.       
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Figure 4: Latour and Woolgar’s Credibility Cycle now including ‘Organisational 
Devices’  
 
Source: Hessels et al., 2009, 396 
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Figure 5: Cycles of Activities including struggles for ‘Relevance’ and ‘Legitimacy’, as 
well as struggles for ‘Fundability’ and ‘Facticity’  
 
Source: Rip, 1994, 10 
Conclusion on Sensitising Concepts  
This section has set-out various motifs and concepts which empirically-derived studies in the STS 
canon have offered the research in this thesis. Despite their widespread influence, much of 
these contributions have yet to make their way into studies explicitly concerned with 
translational research. The actor-network theory approach has arguably been the most 
influential of STS research programs, bringing into focus the importance of networks in the 
studies of knowledge practices in activities like science, technology and medicine. Its emphasis 
on associations has done much to advance the focus of STS scholars and many outside the field 
on the practices and contingencies of knowledge production, in terms of bringing allies into the 
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laboratory and subsequently ‘translating’ (or ‘transforming’ as I put it) the interests of further 
allies beyond their immediate centres-of-calculation. Indeed the term translational research 
itself has a curious Latourian ring to it. In addition to ANT, STS research on boundary activities 
have done much to contribute to an understanding of how scientists and their allies forge and 
maintain stability despite local differences of interest. In addition to these resources, the 
empirical chapters draw-in insights from laboratory ethnographies of scientists at work. In 
particular, four frameworks set-out in Latour and Woolgar’s (1986) influential text Laboratory 
Life, have been put to use here for the purposes of locating the mundane work practices of the 
scientists forming the basis of the case studies. It is through its empirical case studies 
accentuating the mundane aspects of laboratories, field sites, museums, observatories, and so 
on that STS has been so successful in challenging the grand narratives of science. This literature 
has therefore provided a logical basis on which to study translational research in a way which 
demystifies and circumvents any hype which might accompany its ‘common-sense’ usage. 
Together with sociological research on translational research, this conceptual apparatus 
provides a strong – although not altogether indestructible- basis on which to conduct the 









4. The Philosophy of STS 
 
Introduction  
This chapter seeks to capture how laboratory studies have challenged some of the standard 
tenets of received philosophical and cultural thought about science, and in doing so, provides a 
compelling case for using constructionist theories and methods to study the forces of 
translational research in this thesis. This section provides the intellectual background to and 
justification for the relativism behind theories and methodology discussed in Chapters 3 and 5 
respectively, and put to use in the empirical case studies. 
The style of STS has been to take revered and standardised ideas and concepts- science, 
technology, law, the market- and convert them into objects of study (Woolgar et al., 2009, 22). 
These ‘black-boxes’ thus move from ‘from matters-of-fact’ to ‘matters-of-concern’ (Latour, 
2005). In this vein laboratory studies have typically taken phenomena like facts and machines, 
and used ethnographic sensibilities to explore how they are made (Latour, 1987). This approach 
appears counter-intuitive to modernist discourse, which assumes such phenomena to be both 
objects and objective (Law 1994). But by retrieving the practice from science, laboratory studies 
have shown how objects and objectivity are made rather than given.  Following this tradition, 
this thesis seeks to give translational research the laboratory studies ‘treatment’- in 
problematising this concept by opening it up to constructivist methods and concepts. In doing 
so, it is expected that the study will produce a very different account of translational research to 
those found elsewhere, e.g. in policy rhetoric.  
The chapter begins by focussing on what these studies have said about the manufacturing (read 
‘construction’) of knowledge, as the complex, contingent outcome of local contexts. Attention of 
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the section then moves towards clarifying an aspect of constructionist thought that laboratory 
studies have helped to develop, namely its rather unique ontological-epistemological stance. I 
then consider the sometimes uneasy relationship laboratory studies-derived STS claims have had 
with philosophy of science before finally advocating the use of constructionist methods in 
studying translational research. 
Background 
Since the 1970s, STS Laboratory studies have reported first-hand about the social processes of 
scientific observation and experimentation, activities which had previously been deemed too 
uninteresting or irrelevant by sociologists. Laboratory studies can be described as ‘the study of 
science and technology…at the root where knowledge is produced, in modern science, typically 
the scientific laboratory’ (Knorr-Cetina, 1995, 140). Traditionally the method for observing this 
production is ethnography, with some discourse analysis (ibid. 141)16. Laboratory studies were 
influenced by earlier social constructionist traditions in sociology and anthropology concerned 
with the cultures and practices of groups in their work contexts (Knorr-Cetina, 1981, Collins, 
1985, Latour and Woolgar, 1986, Traweek, 1988, Pickering, 1995). Like anthropologists, 
laboratory studies wanted to treat science as a form of culture on which insights could be 
opened-up through qualitative inquiry.   These studies followed and helped extend the social 
constructionist perspective in the social sciences (Berger & Luckman, 1967), by applying its ideas 
to the very ‘factories’ of contemporary knowledge production (i.e. laboratories). This paradigm 
perspective holds that although patterns are the persistent feature of all social life, no one 
pattern is necessarily persistent or stable (Barnes, 1995, 67). This is the foundation of a relational 
metaphysics.  
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The laboratory studies agenda differed from earlier philosophy of science accounts, in rejecting 
the need to ask cognitive questions17. Instead the former were interested in analysing the 
processes through which knowledge is constructed in its everyday settings, thereby retrieving 
‘context’ (‘non-rational’ things: personal, social, cultural), as a central feature in the 
organisation, management, and performance of science (Knorr-Cetina, 1991).  
Are STS Laboratory Studies relativist or realist?  
Clearly this methodological approach projects a relativist epistemology. Following a number of 
constructionist traditions, particularly ethnomethodology, it is assumed that all categories, 
routines and habits are socially constructed, no matter how stable they may appear through 
common-sense readings. For Garfinkel (1967), this statement about the social world is evidenced 
by the observation that routines evolve and alter over time. Categories get constructed but 
become problematic, as shown in his case study of Agnes, a trans-gendered person taking part in 
a census. As such, one should not lose sight of the social construction of phenomena, however 
routine they might appear.  
Thus, STS can be seen as an empirical and methodological extension of earlier social 
constructionist writings. This is because, despite some discontinuities STS has continued to fulfil 
what constructionists wanted social scientists to do: study things as contingent accomplishments 
of people and to study how these things get done (e.g. by looking at ‘speech acts’ and ‘discourse’ 
rather than, say, statements or deduction). As a general paradigm for social science inquiry, 
social constructionism is often (somewhat stereotypically) criticised for its alleged irrealism: 
upholding the naive position that everything in the universe is socially constructed. However, 
speaking of Berger and Luckmann’s (1967) treatise on socially constructionism, Hacking rebuffs 
these criticisms: 
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 What statements/methods should be considered scientific/technically feasible.  
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“They did not claim that everything is a social construct, including, say, the taste of 
honey and the planet Mars- the very taste and planet themselves as opposed to their 
meanings, our experience of them, or the sensibilities that they arouse in us… They did 
not claim that nothing can exist unless it is socially constructed.” (Hacking, 1999, 25) 
STS constructionism has fleshed-out this point empirically, and in doing so has set-out its own 
niche position on scientific knowledge; one that is, simultaneously, epistemologically relativist 
and ontologically realist (Woolgar, 1988, 54). Contrary to some criticisms, then, like more 
moderate accounts of social construction, STS does not refute the existence of an independent 
reality, or even of scientific facts (Latour & Woolgar 1986, 80, 82). It also acknowledges that the 
objects ‘natural’ scientists study differ, compared with say actions studied by sociology 
(Sismondo, 1993, 531). The dual position enables the articulation of some sort of distinction 
between natural and social sciences. In particular, natural scientists’ knowledge claims are said 
to allude to external referents (material objects) (Barnes et al., 1996), whilst social scientists 
study self-referring elements of knowledge that people hold of how their societies work (e.g. 
actions) (Cicourel, 1974, 45) and therefore lack this relation to an ‘independent’ reference 
point18. Social science knowledge is therefore validated by looking at its incidence among the 
very people who believe in it (Barnes, 1995). An important implication of the realist position is 
that it helps to overcome certain reductionist weaknesses in earlier sociology of science, 
whereby ‘the content of science becomes transmuted into the simple reflection of social 
interests’ (Callon et al., 1986, 8). For example, ‘interest models’ of science (e.g. Barnes, 1977) 
gave little consideration towards how laboratories are constrained by access to and control over 
material resources, which are vital ingredients in investigating scientific problems (Latour, 
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1983)19.  It is not just humans that provide ‘resistances’, but also non-human elements (Latour, 
1987).  
Despite acknowledgement that the natural and social sciences are constrained differently by the 
realities they study, STS retains the relativist position that scientific knowledge is constructed 
rather than discovered. This is captured most clearly in their stance towards the ‘pre-existence’ 
of material objects, which become social objects as they begin to enter the meaningful parts of 
the social world of a scientific community (Sismondo, 1993, 524-525)20. Hence scientific 
knowledge is always constructed because its objects cannot pre-exist. Quite simply, ontology is 
the consequence of science (Knorr-Cetina, 1993, 558) and it is only in alienated social world that 
existence of objects, and indeed statements about them, are posited outside the realms of 
human intervention (Bauchspies et al., 2006, 14). Overall, the dual-position is seen as significant, 
because it accommodates empirical distinctions between natural and social sciences, whilst 
reinforcing the latter’s mandate to investigate all of the sciences (as ‘fair sociological game’)21. 
This methodological commitment to symmetry is credited to the Strong Programme in SSK, who 
held that successful and failed claims should be treated the same way by the sociologist (Bloor, 
1991). This logic was also extended towards claims being made inside and outside of the 
established institutions of science, for instance by treating now discredited para-psychology 
claims the same as one would established ‘scientific’ claims (Collins and Pinch, 1982). Such 
provocative positions are illustrative of STS’s propensity to subvert taken-for-granted 
assumptions held about scientific knowledge.    
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This chapter has argued that reflexivity of STS constructionism has done much to challenge the 
‘naïve realism’ underpinning the rhetoric in received views of science, which ‘speak about 
theoretical objects as if they were on the same level as the banal realities of everyday life’ 
(Collins, 1998, 878). In this sense STS marks a radical departure from essentialist philosophies of 
science. As Randall Collins notes, the reflexivity of STS constructionism is felt by many 
practitioners and philosophers as an affront to their ‘sacred object’ of truth. The typical 
emotional response to reflexive statements about the social construction of knowledge is 
therefore one of embarrassment.   Conversely, STS has not escaped critical feedback from 
philosophers of science: 
“Their ambivalent relationship with philosophy...gets these studies into trouble - the 
trouble consisting in the belief that constructivism must be understood, or must prove 
itself worthy, in relation to philosophical doctrines.” (Knorr-Cetina, 1993, 560) 
Philosophy of science has been concerned with demarcating the special nature of scientific 
knowledge. This is incompatible with STS, which sees such a task as sociologically useless and 
based on out-dated myths. Given this state-of-affairs, most relativists have maintained that it is 
not their responsibility to bring philosophy back into constructionist STS: 
“It is hardly conceivable that a phenomenon like modern science, which is so intrinsically 
linked to modern society as an institutional and collective arrangement, should not itself 
display social features which philosophy must come to grips with if it is ever going to be 
au courant with the world in which it lives.” (Knorr-Cetina, 1993, 556) 
Hence although STS does not conform to certain standards set out by philosophers of science, 
given the lack of reflexivity apparent in these standards, perhaps this is no bad thing. As STS is 
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concerned with the problems human beings face in producing knowledge inside the world, its 
constructionist toolkit is surely appropriate in opening-up the complexities of translational 
research. Indeed if STS has demonstrated success at tackling the ‘hard cases’ of scientific and 
mathematical knowledge (Bauchspies et al., 2006), then this would suggest it is equally well 
equipped to tackle other cases related to science, technology, medicine, and increasingly, law, 
economics and business (Doing, 2008). I think that in the context of studying knowledge and 
innovation, constructionist methods are helpful and useful. It is the applicability and efficacy of 
its methods and theories which has made me appreciate STS. Quite simply, case studies and 
concepts developed by previous generations of STS scholars has helped me to better understand 
science, and deploying them in this study promises to help better understand translational 
research. Furthermore, as few practitioners, policymakers, or members of the public appear to 
think in these terms, constructionist methods provide a valuable resource in the context of social 












5. Design of the Thesis 
 
Introduction 
The purpose of this chapter is to describe the research design and analytic procedures used in 
conducting this research. It will do so first by outlining the methods used, the key theoretical 
assumptions behind these approaches, and why these were deemed appropriate. The chapter 
then describes how the design was implemented in practice.  
The methodological paradigm underpinning the methods procedures in this thesis is social 
constructionism. Paradigm wars between different approaches have received a vast amount of 
coverage in books and articles on social science research methods, and this is not the place to 
regurgitate well-worn arguments. Suffice to say, the constructionist approach adopted here has 
its roots in the works of philosophers like Schutz and sociologists like Berger.  
Despite research being a practical activity, textbook representations of methodological routines, 
agreements, and debates have the habit of removing the practice from research (Seale et al. 
2004, 1). As such, decontextualised methodological rules, advice and general principles have a 
tendency to appear rather abstract and removed from the day-to-day experience of conducting 
research (Ibid., 5). For Seale et al. (2004) there are limits to the use of methodological 
frameworks, which are helpful insofar as they fulfil two functions: social and political. Their 
social function is in encouraging principled choices to be made in the course of research practice, 
such as appropriate use of methods and adhering to good practice. The political function is in 
allowing researchers to make claims about the importance of their work, through attaching it to 
a particular paradigm position (Seale et al., 2004, 3).  
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This chapter starts by looking at how these two dimensions have shaped the research design of 
this thesis. Much more attention has been paid towards the social function of the methodology, 
as it is these considerations which traditionally fall within the ‘frame’ of a methodology chapter 
(see Goffman, 1974, Chapter 1). Hence although these are not hard-and-fast rules for 
guaranteeing good social science research, they have nonetheless provided useful guidance in 
shaping the design and conduct of the research in this thesis. After this section, the chapter will 
shift focus towards the types of research devices used and the rationale for doing so, then to 
recounting the practical steps that went into conducting fieldwork and analysis.  
Political and Social Functions of Research Methods  
In a reflexive, ‘confessional’ frame (Van Maanen, 1988), I will outline briefly some of the political 
motivations in following the methods/procedures adopted hitherto in this research.  
In short, one of the main reasons qualitative methods and a case study design were identified 
early-on as strong candidates for conducting this research is that they have historically found 
favour in the ‘normal science’ of STS. Kuhn (1970) observed that as a scientific field matures, 
researchers tend to become increasingly reliant on standard problem-solving techniques that 
become part of the ‘normal science’ of a field. Having widely accepted ‘search routines’ is helpful 
in enabling fields to amass knowledge and grow, as it helps to simplify complex tasks. Although 
recognising that paradigms can constrain researchers, Kuhn also understood that they enable 
people to think (Kuhn, 1970). As STS has matured, it has developed tried-and-tested ideas and 
methods that are very helpful in opening-up an understanding of science. Qualitative research 
and case studies are two such features. The worldview underpinning qualitative research, that 
data should be ‘generated’ (read ‘constructed’) through forms of inquiry that are ‘open-ended, 
flexible, opportunistic, and require constant redefinition of what is problematic’ (Jorgensen, 
76 
 
1989, 14) is seen in STS as much more conducive to studying how knowledge develops amongst 
scientists.  
Making arguments in the form of case studies was one of Kuhn’s many legacies on the field of 
STS (Law, 2008, 626). Part of Kuhn’s impact then was to shape the very normal science 
proceedings of STS itself. For instance, case studies documented failures and struggles ‘to bring 
objects and effects into existence, in the laboratory and in the wider context’ (Knorr-Cetina, 
1995, 559). Case studies also enabled sociologists to capture the lines of controversy and 
disagreement that marked efforts to establish new knowledge as facts, and the social forces 
shaping these outcomes (Collins, 1985). These studies of scientists at work also provided 
exemplary empirical case studies of organisations from which organisation theorists could 
benefit (Czarniawska, 2009). The aim of laboratory studies was to open up the cultures of 
science to ethnographic sensibilities and methods. This would allow for the complex, non-linear 
dynamics of innovation to be captured. All this, of course, reveals that STS has its own history 
and agendas which are separate from those of whom it studies. STS scholars have their own 
professional interests, audiences, and problems in which its members are concerned with 
engaging: this study is no different. In following these standards, it is hoped that the results of 
the work will attract attention amongst audiences interested in STS and organisational sociology. 
Indeed both the empirical and theoretical literature from which this study has been inspired 
(and to which it hopes to make a novel contribution) have used qualitative case study 
approaches, rooted in social constructionist thought. Hence following tradition and standing on 
the shoulders of earlier giants in the field of STS seems like a reasonable and logical choice to 
make.  
Good research practice does not exist in a vacuum but is determined by a research community. 
As members of a collective (e.g. paradigm, field, discipline) it is important that research is well 
crafted and incorporates good practices, whilst recognising that standards are always more or 
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less contestable. The irony of doing social science research as a social constructionist is 
recognising the situatedness of these standards, whilst remaining compelled to follow them 
(Hacking, 1999, 23). It is important for collectives to have these methodological guidelines, as it 
enables identity formation, responsible behaviour, and higher quality research to be crafted. 
This section will now link the mode of inquiry with wider epistemological assumptions with 
which they are associated (‘Case Studies’ and ‘Research Methods’). This is an important aspect 
of crafting good research, as it enables one to specify the strengths and limitations of the 
procedures used to gather and interpret empirical data. The term qualitative research 
encompasses a very wide umbrella of techniques, methods, paradigm assumptions, research 
traditions, and disciplines. Three that have been highlighted for this study are qualitative 
interviewing, direct observation, and document analysis. Although these techniques enable 
different forms of interpretation, they are often used in conjunction under the banner 
‘ethnographic research’. The interactive nature of qualitative research is helpful in exploring 
phenomena that one believes to be non-linear and multi-formed. When performed successfully, 
it can produce various forms of data that facilitates rich insights into people’ experiences, 
accounts, memories, opinions, understandings, thoughts, ideas, emotions, perceptions, 
practices, actions and activities (Mason, 1996, 36-37), as well as about discourses, narratives and 
organisations permeating their local situations (Mason, 1996, 37). 
Research Methods 
For the empirical case studies qualitative interviewing has been identified as important means 
for generating data about translational research. Given the diffuse and under-theorised 
characteristics of this phenomenon, the qualitative interview appears particularly apt, as: 
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“Interviews are a highly efficient way to gather rich, empirical data, especially when the 
phenomenon of interest is highly sporadic and episodic.” (Eisenhardt & Graebner, 2007, 
28) 
As a research method the qualitative interview is taken to be based around relevant, purposeful 
conversations that are conversational, flexible and fluid in style (Mason, 2002, 225). Generally 
speaking, the approach has found favour in traditions that privilege accounts of social actors, 
agents, individuals, or subjects over other data sources and that propound the centrality of talk 
and text in illuminating the social (ibid.). Interviews with scientists frequently yield data on how 
they move from ‘tacit assumptions to explicit articulations’ about science and what 
norms/values are enrolled in accounts that defend/prosecute their interests (boundary work) 
(Gieryn, 1983). The perennial criticism that interviews produce knee-jerk reactions is scarcely 
problematic, as this would support the accepted STS point that scientists draw on norms that 
suit their situation at hand (Mulkay, 1976).  
Constructionists believe that evidence and theories they themselves produce is also context-
bound, situation specific and rooted in interaction (Mason, 1996, 41). Qualitative interviews are 
thus mobilised on the basis that actions and actors are social processes about which researchers 
‘co-construct’ data with participants (Mason, 2002, 226). The qualitative interview technique has 
traditionally invited a level of flexibility and reflexivity largely absent in methods like survey 
research. Rather than being an embarrassment to the researcher, lack of ‘objectivity’ is accepted 
as an inevitable and indeed useful component of the qualitative interviewing technique (Latour, 
2005). This does however make the issue of reliability contentious, as given the highly 
interpretive nature of the methodology and technique, it is not always clear whether other 
researchers in the same context would draw roughly the same results (Prior, 2003, 149). The 
same criticisms apply to observation and documentary analysis, which will now be discussed. 
The relative strength of these criticisms is considered at the end of the section.   
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Direct observation is useful for exploring phenomena as they occur in real-world settings 
bounded by time and space (Jorgensen, 1989, 9). This is apt as the research questions in this 
study are concerned with how a phenomenon ‘works’ as a social accomplishment in particular 
situations and settings. Such characteristics are at the very ‘foundations’ of (non-)participant 
observation’s inquiry and method (Jorgensen, 1989, 13). Like interviews, this approach has a 
propensity to generate data that captures the non-linear characteristics of phenomena. 
Observation methods resonate with the broader theoretical and methodological thrust of this 
thesis and its own intended scope, as: 
“Direct observation is especially appropriate for exploratory studies, descriptive studies, 
studies aimed at generating theoretical interpretations… [and] findings of participant 
observational research certainly are appropriate for critically examining theories and 
other claims to knowledge.” (Jorgensen, 1989, 13) 
Insights from data gathered using observation can be used to corroborate and cross-validate 
other forms of data, as well as develop existing theories and suppositions. This can include any 
of the dimensions mentioned above (see Mason, 1996, 36-37), but as they occur ‘naturalistically’ 
(rather than ‘artificially’ via the interview process). This technique is often thought to have the 
advantage of generating data which is less guarded than interviews, although the notion one can 
be thought invisible in observation settings is dubious (see below section ‘Becoming 
Immersed?’). 
As Latour and Woolgar (1986) note, scientists routinely produce texts to be read, cited, and 
broadly influence (at least they hope) others in their tribe. As texts are akin to a form of material 
currency in this activity, documents provide a very useful resource to consult and/or examine. 
Following a very general definition, ‘documents are things that we can read and which relate to 
some aspect of the social world’ (MacDonald, 2001, 196). In essence then analysing how people 
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are represented in documents is another means of observing ‘what people do’ (Prior, 2003, 114). 
I would add that they also enable observation of how humans attend to non-humans. All 
documents are socially produced and are thus never neutral statements of fact (Macdonald, 
2001, 196). Most documents also aim to be persuasive and performative in some form, in that 
they do not intend simply to represent aspects of the world but to change them (ibid.). The 
breadth of the above criteria meant a lot of the information sources drawn on before and during 
the pilot and main case studies qualified as ‘research documents’. In researching the study a 
number of policy documents and trade journal articles were consulted in relation to translational 
research. Likewise hand-searches and full database searches of scientific journals were carried 
out to develop ideas about the definitions, emergence, changes and understandings of this term 
over time. The other major resource one can consult in this respect is the internet. Search 
engine searches were routinely carried out, albeit with some scepticism as to the quality of 
sources.  
There are a number of strategies for scrutinising documents. This thesis draws on Latour and 
Woolgar’s five-fold typology for studying argumentative techniques in scientists’ statements (see 
Chapter 3), which was deployed in order to code formal texts produced by members of the 
cases. This approach is akin to discourse analysis (DA) (although they do not call it this), as it was 
adopted in order to study the kinds of entities members of the cases recruited into textual 
accounts and how referents and entities were interlinked (Prior, 2003, 118). Hence in DA: 
“One has to attempt to get a picture of the ways in which the network of references 
interlock. It is, perhaps, what we might call a matter of intertextuality.” (Prior, 2003, 
122) 
Although useful, one cannot understand how problems are resolved in practice using documents 
alone (Prior, 2003, 121). To answer such questions documents should be supplemented with 
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interview or observation data.  Another way of generating data about documents is not by 
looking at their content, but by observing their use as resources in naturalistic settings. Prior 
urges researchers to observe how documents (as intermediaries) are made to carry agency 
(following ANT) in organisational encounters and settings. This lends an extra-dimension to use 
of documents in qualitative research that goes beyond simply treating them as inert receptacles 
of text (see Prior, 2008).  
In sum, each of these methods should enable the researcher to construct interesting and 
insightful stories about how the phenomenon is made to work within different settings and 
situations.  
Case studies  
Although no single format exists for carrying-out case study research (Eisenhardt, 1989, 40), it 
has come to be seen as a particularly useful tool for building theories in new topic areas and/or 
developing further insights into phenomena on which little is known (Eisenhardt, 1989, 532, 
Eisenhardt and Graebner, 2007, 26). Hence case studies will be deployed in an effort to 
contribute to our understanding of the dynamics of translational research, as well as to make an 
‘idiographic’ contribution to theoretical issues proposed in the literature review (Platt, 1988). 
Case studies generally involve investigating phenomena in a naturalistic context a feature which 
distinguishes them from experimental research designs (Yin, 1994). According to Miles & 
Huberman’s definition: 
“Abstractly we can define a case as a phenomenon of some sort occurring in a bounded 
context. The case is, in effect, your unit of analysis.” (Miles and Huberman, 1994, 25) 
One of the most important features of case study research is the scope of its sampling logic. As 
with quantitative research, there is usually an implicit belief that the cases selected somehow 
belong to the population of interest (Patton, 2002, 238). But in terms of scale, the case study 
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strategy is ‘ill-equipped to address the questions “how often”, and “how many”, and questions 
about the relative empirical importance of constructs’ (Eisenhardt & Graebner, 2007, 27). These 
sorts of questions have been more the domain of survey research, where the interest is to look 
for certain features across a relatively large number of cases (Hammersley et al., 2000). Instead 
with case studies, the ‘overall idea is to become intimately familiar with each case as a stand-
alone entity’ (Eisenhardt, 1989, 540).  
The approach one adopts should rest largely on the types (and scope) of questions one is asking. 
Some models, like Yin’s, are based upon realist epistemologies and designed with a view that 
case studies should attain generalisability. By proxy claims about generalisable knowledge 
depends upon the social world being structured, and that cases can be fixed, stable, and are 
‘out-there’ in the social world for researchers to capture. In this vein, with regards sampling, Yin 
(1994) argues that the researcher must determine in advance what constitutes the main unit of 
analysis (e.g. ‘the organisation’), and must not stray too far away from this towards embedded 
sub-units (e.g. individuals’ experiences) (Yin, 2003, 45). This realist version of cases is one which 
constructionists would refute.  
The case study strategy being adopted here is one that seeks to (re)construct each case as an 
end in itself (Becker, 2000). I intend to tell stories about each case and how they got to be that 
way (ibid., 229), and to draw comparisons between important aspects of each case. Miles and 
Huberman note that ‘studies may be of just one case or of several’ (Miles & Huberman, 1994, 
24). An advantage of performing two or more case studies (rather than one) is that it allows 
comparisons to be made (Becker, 2000, 227). Recognising distinctions enables in-depth analysis 
of how a phenomenon varies according to particular situations and contexts, therefore hopefully 
contributing ultimately to a more nuanced understanding than had previously been available. In 




Not only is Becker’s design more conversant with the emergent and iterative mode of inquiry 
that ethnographic methods inspire, but it also refutes the existence of a fixed reality ‘out-there’ 
that researchers can simply capture (e.g. the ‘organisation’). Becker’s cases are not treated as a 
priori structures of the type found in survey research, but as things that are co-constructed over 
the course of the study (Becker, 2000, 227). It follows outliers should be taken as potentially 
important aspects of cases rather than inconveniences or irrelevances (Strauss, 1987). As a 
constructionist researcher I believe Yin is incorrect about maintaining ‘the organisation’ as one’s 
main unit of analysis. With ANT and other constructionist approaches to organisations it is the 
process of production (‘organising’) in which one is interested, not ‘the site’ per se. Yin’s 
approach implicitly assumes the phenomenon and the site to be somehow the same thing. But 
these three sites were not the only ones which could logically have been sampled and a great 
many things could have been studied about each of them which were not. Following 
constructionist organisation theory (Czarniawska, 2008), the formal organisation is just one of 
many products of organising and its relative importance should emerge through (not prior to) a 
description of the production process. With this in mind, the main sampling approach used to 
construct each case was to ‘follow the actants’ (Latour, 2005) in order to describe organising 
which produces the phenomenon, rather than sticking to the production sites as the main units 
of analysis. This has the advantage of bringing into focus organising which occurs above, below, 
and beyond the formal organisation: important inputs which Yin’s pre-occupation with formal 
organisations renders opaque. Hence although for practical purposes of presentation each of the 
three chapters appears to focus on a formal organisation, the actual content deviates from this 
framing by attending to ‘organising’. Becker’s model is more sympathetic to the specific 
concerns of STS, particularly as it does not require the analyst to impose a unitary framework on 
their cases (as Yin’s does). Instead the fluidity and flexibility of this style is conducive to mantras 
like ‘follow the actant’ (Latour, 2005), whereby the researcher describes the scientists’ efforts to 
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build a structured world, rather than forcing them to conform to abstracted criteria of 
demarcation imposed by previous researchers (Callon et al., 1986, 9). Hence: 
“Knowledge of an organisation resides in the first place with the actors; observers may 
have knowledge about an organisation, which does not result from any privileged 
access to reality.” (Czarniawska, 2008, 7) 
The observer’s view will always be theory-impregnated, but in order to be reflexive one should 
be transparent about introducing existing literature into the case. Although literature helps 
identify salient features of each case and its parameters (Miles and Huberman, 1994, 26), it 
should produce ‘sensitising concepts’ rather than definitive concepts with which to construct 
cases. Indeed analysts should avoid, where possible, trying to apply rigidly the relationships 
between variables and explanatory theories from the outset (Eisenhardt, 1989, 536). In this 
thesis the ‘context of the case’ follows an empiricist definition in which ‘context’ encompasses 
literally those texts brought before the researcher, primarily in the form of materials displaying 
the actant’s knowledge (e.g. data), but also some existing social science resources (Czarniawska, 
2008, 7).  
In selecting a constructionist approach one is making a particular set of commitments towards 
the treatment of scale. Clearly Becker’s model makes an explicit epistemological statement 
favouring depth over breadth. It follows a logic that the complexity of the social world and small 
sample sizes are such that it is inappropriate to expect significant generalisations from case 
studies (Stake, 2000). The only form of ‘external validity’ it can hope to produce realistically is 
‘naturalistic generalisation’ (ibid.), or ‘generalisation within the case’ (Creswell and Miller, 2000). 
The design may also be transferable to other case studies being carried out at a later date 
(Lincoln and Guba, 2000). Case studies form an appropriate basis for a ‘phenomenon-based’ 
contribution (Eisenhardt & Graebner, 2007) to translational research. Whereas the lack of 
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breadth is often pointed as a weakness of case study research, in the context of STS intervention 
in science policy, depth of studies is taken as a considerable asset, given that policymakers 
frequently lack detailed understanding of complex innovation concepts (that become 
oversimplified and linear).  
One blemish often accused of this type of cross-sectional design is that one cannot be confident 
in determining whether findings about patterns collected from one moment in time will apply at 
another (Bryman, 2012, 390, 392). For this purpose a longitudinal design would clearly be 
preferable. Yet observing patterns at different points in time is not desirable because it renders 
the findings more ‘valid’ as Bryman seems to be suggesting, but because it provides for more 
interesting stories about shifting ontologies of objects and how social relations get ordered 
around them over time. This benefit is exemplified by case studies of innovations in the social 
construction of technology tradition (Bijker, 1995). Intellectually then whilst longitudinal studies 
constitute a formidable ‘trial of strength’ (Latour, 1987), I do not believe it lends itself well to the 
practical demands and finite resources of PhD research. The decision to carry-out cross-sectional 
studies is thus one driven as much by pragmatism as any normal science ideals. Clearly the 
selection of case studies will always be determined by people’s willingness to take part and the 
general feasibility of conducting fieldwork (e.g. within a reasonable time-frame) (Yin, 2003). 
Encountering ‘resistances’ when scaling-down is after all an inevitable part of doing research 
(Latour, 1983). Another criticism typically levelled at this kind of study is that its ethnographic 
methods are ‘overly subjective’. On the contrary ‘being limited to one’s own perspective’ should 
be seen as a position of strength rather than weakness, as it allows movement to take place at 
relatively little cost between one’s theory-impregnated position and reality that is documented 
by respondents (Latour, 2005). As Latour notes, this ‘flip-flopping’ describes how all scientists go 
about ‘discovering’ knowledge and is therefore a particularly weak criticism of constructionist 
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methods. Hence this ‘subjectivity’ need not impede the production of robust knowledge, as 
robustness itself is a relational concept.   
Methods: Putting the Design into Practice  
Research Ethics 
In his account of what it means to be a good qualitative researcher, May argues the importance 
of accounting not only for what has been produced, but also how it was produced (May, 2001, 
29). This is important in considering the wider contribution of research to society and the kinds 
of responsibilities it should carry (May, 2001, 29-30). One frequently overlooked dimension of 
this ‘how’ question is the issue of research ethics. An ethics application was submitted to the 
University of Surrey’s Ethics Committee prior to the pilot study, which was granted on 15 
February 2011 (see Appendix 2).  This was then carried over into the main case studies. As 
professional adults familiar with the world of research, the respondent populations have not 
been deemed a vulnerable group. Similarly, lines of questioning are not intended to focus on 
issues that could be deemed particularly ‘sensitive’. Providing information sheets (Appendix 4), 
gaining informed consent (Appendix 3), storing data according to the 1998 Data Protection Act, 
anonymising accounts, and being sensitive to questions that might cause distress or offence are 
measures deemed satisfactory to protect the research subjects’ wellbeing and ensure the ethical 
robustness of the study. Details such as names of individuals, organisations, research papers and 
other clues which might unravel the identities of informants have been changed or omitted. For 
instance, the names of individuals in the empirical chapters are made-up pseudonyms. Likewise I 
have sought to make opaque the identity of the universities with which the groups were 
associated- all that I have indicated is that these can be considered research-driven, as opposed 
to teaching universities.  
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In making such decisions it is clear that research is not a value-free activity, as it involves 
considering and developing a critical stance on moral questions.  Hence the increasing 
prominence of research ethics would appear to support the STS constructionist view that 
knowledge production is not ‘freely produced’ but reliant on the resources ‘out-there’ in nature 
and society (Czarniawska, 2009). Positivism produces an objectifying representation of human 
beings which appears to run counter to contemporary research ethics discourse. An inability to 
confront questions about research ethics, owing to its objectivist perspective and passive style of 
writing, is another flaw in positivist views of knowledge production. The use of reflexive, ironic 
styles of writing should put constructionists at an advantage over others traditions, particularly 
positivism, as they can openly acknowledge problems encountered during the research process 
and how these were resolved.   
Pilot Study 
The aim of this section is to report on procedures followed in the pilot study and reconsider how 
this exercise informed the design of main studies. The prospect of doing a pilot study was 
proposed by my supervisors near the beginning of the PhD. At this point in time my knowledge 
of the social world of biomedical science, medical schools, and universities was quite sketchy. 
The pilot provided a means for expanding my understanding and generating further research 
questions (Yin, 2003). What was needed was an organisation that was relatively local, would 
allow access to do a small case study, and corresponded to the study’s population of interest. By 
the end of the first year the following ‘purposive sampling’ frame had been constructed (Patton, 
2002, 238): 
- Research-active units 
- Located broadly within the biomedical sciences 
- Claiming to be carrying out translational research (in public or private) 
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- Have agreed to take part in the study 
We decided to get in touch with a university-based clinical trial unit (CTU) carrying out drugs 
trials on behalf of commercial clients. The Director of the centre was contacted and agreed to 
meet, enabling me to learn about the centre’s activities before formal interviews began. She 
agreed the study could take place once favourable ethical opinion had been obtained. An 
application to the University Ethics Committee at Surrey was submitted and given favourable 
opinion.  
Respondents were recruited via a ‘snowballing’ technique (Morse, 2007, 238), with the help of 
the director, a critically-minded ‘gatekeeper’ familiar with the inner workings of the organisation 
and therefore able to advise who it would be appropriate to interview (Hammersley and 
Atkinson, 1983). Two of the members identified were shortly to leave, thus meetings were 
promptly arranged. Prior to interviews scientific publications by the researchers and their 
colleagues were read. This allowed me to ask about translational research in relation to 
examples from their own work. Interview schedules were drawn-up for the sessions. These were 
constructed abductively out of theoretical literature, how to interview books, discussions with 
supervisors, and informal meetings with the director. However writing the schedules themselves 
required translating theoretical questions into interview questions (Wengraf, 2001) (See Table 2 
in Chapter 5). The supervisors offered reassurances that that the schedules were adequate and 
made additional suggestions.  
The pilot study ended-up consisting of interviews (n = 5) with members of the CTU based within 
a research university in the south of England. Appendix 1 displays the roles of CTU members and 
the duration of the interviews. The pilot interviews were helpful and revealing in a number of 
ways.  They provided me with confidence in the sampling criteria, including reassurance that 
cross-sectional interviews with academic scientists  about translational research would be a 
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fruitful means of generating relevant data about this underexplored phenomenon (Eisenhardt 
and Graebner, 2007). In addition, capturing the experiences of different members of the 
organisation appeared to be a useful strategy that has been taken forward in later case studies. 
Shortcomings in my knowledge about this professional world were also greatly improved by the 
pilot process. Despite earlier apprehensions, there appeared some merit to Strauss & Corbin’s 
argument that not having deep prior knowledge of a phenomenon enables researchers to see 
important things that would otherwise appear ‘obvious’ (Strauss and Corbin, 1990, 42). It was 
recorded in post-interview fieldnotes how I felt I was questioning much of what the respondents 
took-for-granted, and that this tactic should be taken forward. Academic units appear suitably 
convenient bounded entities along which to begin constructing and distinguishing case studies. 
However, the fact that structures and parameters of the CTU only became clear to me once had 
fieldwork commenced, has reinforced the appropriateness of Becker’s instruction to determine 
the boundaries of the cases during the study rather than before (Becker, 2000, 227). 
The sessions suggested that some lines of questioning in the interview schedule had been more 
successful than others. For example, respondents were able to talk at length about their career 
structures and how translational research intersected with the specific problem choices. Most 
were much less knowledgeable about the provenance and national policies on translational 
research. Hence subsequent schedules in the main studies were adapted to incoming findings in 
the data, further reading and practical experiences. When analysing the interviews, I found there 
to be some ambiguity and interpretive flexibility towards translational research across situations. 
For instance, reading the website of the centre, its faculty, and the university’s technology 
transfer office was very revealing in terms of the promissory rhetoric that shrouds translational 
research, particularly when organisations are attempting to project a favourable outward-facing 
image. ‘Backstage’ however, there were some reservations. When asked about the term, two 
respondents (physician and marketing officer) expressed scepticism towards translational 
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research, adopting a tactic of ‘dismissal’ (Oliver, 1991), citing it as a cosmetic relabeling of what 
existed before. It was seen simply as part of the games being played, and of little interest or 
importance to them. Notably in their roles, these two respondents were not constrained by 
institutional pressures to the same extent as the other respondents, who were more inclined to 
show ‘compliance’ (Oliver, 1991), possibly because of the managerial responsibilities their roles 
demanded. This indicated that it would be undesirable to restrict sampling in the main studies to 
managerial figures alone, but to access a range of respondents. The multiple local ontologies of 
translational research also appeared to reinforce the utility of ANT in providing a set of devices 
with which to make sense of this variability.   
Main Case Studies: Designing the Sample 
Having completed a pilot study I was looking to move onto cases which would constitute the 
main empirical basis of the research in the thesis. The precise number of case studies had not 
been decided upon, but I knew I had wanted to do more than one so as to lend the study a 
comparative angle. One of the most important phases in the course of ethnographic fieldwork is 
designing a sample frame and gaining initial access into the population in which one is 
interested. 
Constructionist approaches to case study research stipule that the research design should aim to 
be exploratory and accommodate surprises. This theoretical position impacted on the sampling 
approach adopted here. Once initial access had been secured, the main sampling logic was to 
‘follow the actors’ (Latour, 2005) and organising they did in relation to the phenomenon. Prior to 
the fieldwork on the main studies, my sampling criteria was to conduct case studies on 
researchers and their teams whose research agendas related to at least one of the definitions of 
translational research set-out in a medical review article (Khoury et al, 2007). This helped 
provide inclusion-exclusion criteria for populations relevant to this phenomenon (Patton, 2002). 
The articles’ scripting of different roles for academic researchers in relation to translational 
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research concurred with both NIH’s translational research policy in the U.S. (Woolf, 2008) and 
MRC-NIHR’s in the UK (Cooksey, 2006, DH, 2007). Given that academic researchers working on 
related problem areas were being positioned as responsible for taking-up this challenge within 
the formal policy discourse, for this reason this population bracket was deemed relevant to this 
phenomenon. When names of candidates were suggested to me by colleagues, I checked on 
websites whether their work met with Khoury’s framework and/or whether they had declared 
an interest in translational research. When either of these criteria could be met, I then made 
contact with the researchers. Although there was this initial rationale for going into these sites, 
at the early stages of fieldwork the character of their relationship to the phenomenon was 
uncertain. As a practical step in identifying case studies, I first encountered formal organisations 
as ‘candidates’, because these were sources of information that were publicly visible at the 
outset. But it was through the writing of the case studies that the relationship between the sites 
of production, actors’ organising and phenomenon became known. Indeed the very rationale for 
doing empirical studies was that I did not know the answer to these questions.  
The aim of this thesis is not to generalise theoretically as with most statistical probability and 
some qualitative non-probability studies (Saunders, 2012, 42). The aim of the case studies is to 
present an authentic account of the practices of populations in the studies. There are no hard 
and fast rules for what constitutes exactly an authentic qualitative account- this is something to 
be negotiated between author and reader of a text. Authenticity can be enhanced through 
gaining access to information provided by an appropriate cross-section of elements relevant to 
the workings of the groups. This number cannot be determined in advance, but must be 
decided, as it were, after one’s initial entrance into the field, as one’s knowledge begins to 
increase. The dictum ‘follow the actor’ is useful in this regards, as starting by contacting and 
conducting interviews with senior employees can leave traces of other elements on which they 
depend for getting things done. In addition to people, I could also access non-humans such as 
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grant applications and journal articles discussed during interviews and/or meetings, although 
this brought with it different kinds of access issues, such as confidentiality restrictions or 
institutional payment barriers. These various traces can then hopefully be pursued further 
through the course of fieldwork and into analysis.  
 
Once initial interviews with seemingly important individuals22 had been conducted, adopting a 
‘snowballing’ approach was deemed compatible with the ANT logic of ‘follow the actor’. Hence, 
after these initial interviews the range of people eligible for the study was broadened to anyone 
these initial gatekeepers had earmarked as relevant to this problem, who I predicted would be 
relevant, and who would likely be accessible for an interview. In sampling interview respondents 
within each of the cases, the sampling frame resembled a form of heterogeneous purposive 
sampling in which ‘participants with sufficiently diverse characteristics [were selected] to 
provide the maximum variation possible in the data’ (Saunders, 2012, 45). This was a decision 
informed by experiences of conducting the pilot study, where I found differences in 
respondents’ answers towards certain questions about translational research, where different 
versions about actor-networks emerged. In practice such ‘technical’ sampling considerations 
must also be offset against practical concerns for expediency and pragmatism. The snowballing 
logic where respondents were included on the basis of their being recommended or 
volunteering themselves into the sample (Saunders, 2012) did not always yield participants. This 
I found to be a frustrating feature of doing qualitative research. Of course one of the reasons this 
causes anxiety is because it injects uncertainty into decisions about when to cease sampling. This 
situation, often associated with non-probability, qualitative studies in real-world settings, brings 
the controversial voice of the researcher into the foreground, who must exert their own 
judgment about when to cease sampling rather than follow ‘objective’ standards/conventions. In 
                                                          
22
 They adopted positions as spokespersons for their organisations and occupied positions of formal 
seniority within the institution of the university e.g. as professors.   
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the cancer case study (Chapter 6) I was forced to end sampling before the full population had 
been sampled, which was a decision made out of necessity owing to the sluggish response rate 
to adverts for participants. In the other two studies, close to a full sample of group members had 
emerged, thus removing such a dilemma. In the case of gaining access to observe weekly team 
meetings of the obstetrics group (Chapter 8) a date was agreed in advance for when I would stop 
attending for which both parties were content.  
 
With such intellectual and practical constraints in mind I decided to cease with sampling in each 
case based on the following criteria: when it became clear that there were no more volunteers 
available/forthcoming, when I had already sampled enough of a heterogeneous cross-section of 
those working in the groups, and having made a judgment that raw data transcripts generated 
hitherto would provide materials of sufficient quality to proceed in re-telling (through the 
medium of my written text) how the problems of translational research are worked-out within 
these production sites. One means of judging the latter criteria was through referring back to 
fieldnotes and listening back to audio recordings to ensure I had been able to ‘return’ from the 
field with responses which I thought helped both answer my initial questions and helped me to 
understand their practices better than I had done before. On each occasion I was largely 
satisfied with the quality and quantity of data. Clearly this approach to designing and conducting 
empirical research is not completely infallible. But in following certain standards of ethnography 
and in trying my best to pursue important values such as honesty, transparency and clarity, it 








Journeys into the Field 
As expected, it was not easy to enrol informants into the study: it required perseverance, nous, 
compromise, and luck. In his description of gaining access to a police department, Van Maanen 
states that any researcher must undergo ‘a lengthy process of examination’ before s/he can 
‘penetrate the back regions’ of such an organisation (1988, 85). This was not my experience on 
entering the settings for this research: my experience was one characterised more by apathy 
than mistrust. Perhaps this was due to variations in the types of professional organisations 
involved in his study and mine. The processes of applying the sampling frame and gaining access 
in each case study will now be recounted.  
Two colleagues acted as important brokers in putting me in touch with the gatekeepers who 
would become crucial in helping me gain access to the three cases. I had discussed informally 
the criteria for inclusion of cases in my study.  When names of candidates were suggested to me 
by these brokers, I checked on websites whether their work met with Khoury’s framework 
and/or whether they had declared an interest in translational research. When either of these 
criteria could be met, I then made contact with the researchers. But at this stage I knew little of 
the details of how their work was translational, beyond my visits to their websites and 
reassurances from the fact that they had volunteered themselves to my colleague that they 
were eligible for the study.  Hence although there was rationale for going into these sites, at the 
early stages the character of its relationship to the phenomenon and the actors-actants 
implicated in this work process was little known. As such gaining access for interviews and/or 
observation was crucial to fulfilling the aims of the research.  
To become more familiar with each case, the tactic was to gain initial interviews with seemingly 
powerful individuals23, then once these were conducted adopt a further ‘snowballing’ approach. 
                                                          
23
 They adopted positions as spokespersons for their organisations and occupied positions of seniority 
within the institution of the university e.g. as professors.   
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This was deemed compatible with the ANT logic of ‘follow the actor’, as interviews pointed a 
trail towards other elements gatekeepers were reliant on for getting things done. Hence after 
these initial interviews the range of people eligible for the study was broadened to anyone these 
gatekeepers had earmarked as relevant to this problem and who would likely be accessible for 
an interview. This approach did not always work: potential gatekeepers would lose interest, turn 
out to have no one ‘beneath’ them, and/or could not persuade others to take part. This I found 
to be a demoralising feature of doing qualitative research. Nonetheless, it was only through 
entering the field and writing of the case studies that the relationship between organising of 
actors-actants, the sites of production, and phenomenon could be known. Therefore, the 
snowballing technique was deemed to be both theoretically consistent and practically useful for 
the purpose of designing case studies. The finer details of gaining access to each of the three 
case studies will now be discussed.  
In the Obstetrics case, interviews were arranged initially with two GP/academics (both 
professors) researching in the field of primary care. The first colleague had spoken to them 
about the possibility of my carrying-out interviews, which had paved the way for me to contact 
them by email. Interviews were subsequently held. It was hoped that these one-off interviews 
would ‘snowball’ into main studies (Morse, 2007, 238),  but soon it emerged that one of them 
did not have a large enough team to merit conducting a full case study (although his interests 
and experiences of translational research provided a great number of interesting questions for 
exploration). The second professor, when asked, could not think of anyone else in his team who I 
could talk to. I asked him about this in a follow-up email a few days later to which I received no 
reply. However, this interview was useful given that he was the head of the department hosting 
what would later become my obstetrics case study. As such, the interview provided important 
insights into the strategic vision members of research groups in the department (including 
obstetrics) were expected to follow.  
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Shortly after carrying-out these interviews, my colleague put me in touch with the head of 
Obstetrics group, a nascent collective that had recently moved into the same public health 
department as the primary care professors. The Centre Lead was an academic clinician 
(consultant/professor) who was expecting an email from me, having spoken to my colleague. An 
interview was arranged. Before the interview I had been planning to inquire about the size of his 
group and what opportunities there might be for further fieldwork, including interviews and 
observation. However, to my surprise, I did not have to wait until the end of the interview to find 
out: during his interview he invited me to observe meetings in order to learn more about how 
their research was coordinated. His role as gatekeeper was thus crucial in the story of how this 
case study came to be framed. I recognised that observation could potentially provide another 
dimension to the case study, by allowing me to observe their organising in situ. I took up his 
offer, which resulted in attending weekly team meetings as a non-participant observer. This 
lasted for longer than anticipated (8 weeks), owing to the suggestive insights being thrown-up 
and their willingness to accommodate my needs. I also attended the group’s inaugural week of 
lectures and dinners, as well as data-monitoring and trial-steering committee meetings. I was 
also sent minutes of meetings and their clinical trial protocol documents.  
The cancer case study started when I was introduced to the Director of a large Cancer Faculty by 
a colleague at a lecture we had both attended. This belonged to the same large medical school 
as the obstetrics group, although they were located in different faculties. The two faculties were 
identified within the school’s portfolio as being primarily research-led, although they did also 
perform teaching duties. The head agreed to be included for an interview in my study and a 
meeting was promptly arranged the following day. After the interviews, the sample ‘snowballed’ 
(Morse 2007, 238), as he put me in touch with a professor who was principle investigator (PI) of 
a laboratory in the faculty. He was interviewed and afterwards put me in touch with someone 
who worked for a major charity that had just recently become part of the institute (and is 
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physically located in the main headquarters). I also asked the PI to suggest other members of his 
laboratory who could be interviewed. Although he was willing in principal for me to do more 
interviews with members of the lab, he was apprehensive about me entering as an observer. In a 
conversation we had immediately after our interview, he cited concern that this would take-up 
too much time and cause too much disruption to the work flow of the laboratory. Likewise he 
told me that he did not want his PhD students to be considered for interviews, as he was 
concerned about their time-management skills and saw involvement as an unnecessary 
distraction. 
The interviews I did manage to conduct took a long time to arrange, but eventually a senior 
lecturer, two post-doctoral researchers, and a technician were interviewed out of the 23 people 
in the laboratory. One post-doctoral student replied to a circular email I had written that was 
sent around the lab by the PI for the second time24. After our interview another post-doctoral 
student came forward one week later, apparently having spoken with her interviewed 
colleagues about the experience. Once this interview was completed, nobody else came 
forward. The senior lecturer had been mentioned several times in the PI’s interview, and 
appeared to be presented as a key player within the laboratory. I decided to ‘cold call’ him with 
an email, to which he obliged. After our interview, I asked him whether he could put me in touch 
with a technician in the lab. The importance of the technician’s role emerged as important 
within the senior lecturer’s interview as well as in STS laboratory studies (Shapin, 1989). The 
senior lecturer showed me to a technician at work in the laboratory, asking him in front of me 
whether he would be interviewed, to which he agreed. At this point I became satisfied, as well 
given the time constraints and difficulties in getting access, that I had interviewed a reasonable 
cross-section of the laboratory.  
                                                          
24
 No one came forward on the first occasion. 
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The gatekeeper for what became the diabetes case study was the Dean of a medical school. This 
was based in a separate university to the aforementioned cases, providing reassurances that 
findings about the travel of translational research and associated concerns were not simply 
peculiar to one particular university. I contacted him via email after a colleague who had worked 
with him before recommended him. The past interactions of my colleagues with this person was 
(I suspected) key in getting him to partake in the research. He responded positively to the email 
and we arranged to speak over the phone. During this meeting he stated that he would be 
willing to circulate an email to colleagues requesting phone interviews. He was less receptive to 
the idea of me entering the field as an ethnographer, as he was conscious of placing a burden on 
colleagues who were already very busy, and suggested that I would be unlikely to receive any 
willing volunteers for this request. Furthermore given the considerable distance of the university 
from where I lived, he suggested it would be unpractical to return for face-to-face interviews at 
different times. With this in mind I sent him an email describing the research and what it would 
involve, which he initially forgot to send around, doing so once I had sent a polite reminder. 
After two weeks there had been no replies, at which point I contacted each of the people to 
whom the gatekeeper had carbon copied into the email. At this point I received two replies from 
the PI of a diabetes group and a clinical researcher sometimes affiliated with the group, who 
would subsequently emerge an important respondent in the diabetes case study.   
Phone interviews were conducted on consecutive days. The clinical researcher recommended I 
contact a post-doctoral student who he co-supervised with the PI. The PI said he would ask two 
more people in his group- a full-time PhD student an academic-clinician doing a PhD part-time - 
to participate in the study. These three people came forward and interviews were promptly 
arranged over the telephone.  At this point it became clear that the diabetes group would 
constitute an appropriate entrance point around which to build the third case study. Despite 
only having informal links to the diabetes group, there was still strong reason to include the 
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clinical researcher in the sample: the PI made it explicit that the clinical researcher was an 
important ally linking his basic research to his translational operations. Finally I conducted an 
interview with the Dean of the medical school who had acted as gatekeeper to the laboratory. 
The sample ceased here after it became apparent that the group was actually being newly 
assembled and there were no other formal members of the group apart from other PhD 
students, a category of respondent with whom I felt I had reached ‘saturation’.  
Interview Schedules 
Wengraf recommends that within semi-structured interviews, interviewer’s questions should, in 
most circumstances, be kept to a minimum (2001, 72). In practice this meant trying to allow the 
respondent to get to an issue of their own accord and introducing a number of prompts rather 
than pointed questions per se. Nonetheless, the schedules served as a reminder of issues I 
wished to see covered during the interviews. At various points I would scan over the sheet in 
order to check which themes they had addressed in their responses. Below is a table which seeks 
to distil questions discussed in interviews and link these back to theoretical issues in which this 
research is interested (Table 2). The aim of the table is to show that the interviews, whilst 
flexible, were directed rather than aimless conversations. The Theme column lists some 
important concepts/ideas (based around relevant literature, notably Latour and Woolgar’s 
frameworks) explored through the interviews. Following Wengraf’s dictum that ‘a theory 
question is never an interview question’; the tables present a Theory Question column which are 
then translated into Interview Questions. Unfortunately the original schedules have been 
omitted, because they were written as a practical reminder for me to use in the sessions, rather 
than to make for easily accessible documents to be read by others at a later date. The table 
therefore presents a more user-friendly version. I recorded in my interview fieldnotes that the 
schedules appeared to work well on most occasions. On some occasions they were little needed, 
as the more verbose respondents covered a lot of these sub-themes of their own volition 
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without being prompted. For interviews with more taciturn respondents I was more reliant on 
the schedules. The order of questioning would be modified slightly according to the flow of the 
conversation and the extent to which respondents were able to answer the initial interview 
question/theme. The fieldnotes also state that all of the questions were asked in every 
interview, except once, where Turin in the third case study was in a hurry and had to conclude 
the study before I had chance to ask all of the questions. The issue of ‘rapport’ will now be 



















Table 2: The Interview Schedules 
Theme  Theory question Interview question/prompt 
History of the Laboratory/ ‘Object 
Lessons’ 
Local meanings of translational 
research? In what networks is it 
made visible? What work do 
these associations do? What are 
limits of involvement?  
What, if anything does 
translational research mean to you 
in the general context of your 
work in X… 
And what about on project Y? 
Who would be you collaborators 
and what do they do?  
Inscription Is translational research made 
present in writing actions? 
Whose agenda does this 
conform to? 
Where does funding generally 
come from? Do you follow vision 
of a particular council? Where 
would you publish?  
Microprocessing What are the issues in 
collaborating with others? How 
are boundaries negotiated?  
 What processes are involved in 
working with others? Do you 
agree about everything? Where is 
the common ground?  
Cycles of Credit Group Structure; Careers of 
individuals and formal 
organisation 
Is your role tied into translational 
research? What are your priorities? 
Are you concerned about the 
REF? How well-funded is your 
area? Is translational research 









This section reports, from my fieldnotes, experiences of conducting fieldwork and impressions I 
had of the people and what I thought was their impression of me.  
When I first entered the obstetrics group as non-participant observer I was not at all familiar 
with the local context. I had gone in wanting to get a ‘sense’ for the day-to-day articulations and 
negotiations involved in doing research, and how translational research intersected their 
organising. However, I did not know how to look for this, or which utterances or actions were 
pertinent. To compensate I scribbled down as many fieldnotes as I could during and after the 
meetings. The first two meetings were very confusing experiences in a number of ways, as I had 
little idea of what to expect and felt as though I had been thrust into the deep-end of their 
organising activities, equipped with little knowledge of their local idiosyncrasies, acronyms, or in-
jokes (the group would sometimes laugh at things someone said which I did not understand). In 
the days following the second meeting I spoke informally with my supervisor and told him that 
the meetings seemed quite routine, mundane, and that no mention was made of the issue at the 
centre of my research. He replied with something I had not considered: perhaps this was the 
point. Not much does happen at these meetings (at least not much of any excitement); people 
may be bored; the day-to-day realties of these people in this ‘backstage’ setting may not be 
permeated with sexy, fashionable ideas. This triggered the realisation that even if the time spent 
as a non-participant observer yielded little by way of direct insight into how translational 
research ‘works’ in this naturalistic setting, this in itself should be treated as an empirical finding, 
rather than reason to dismiss the case. As such I decided it would be worth continuing to attend 
the weekly meetings and made a request to the Centre Lead about making further visits, which 
he granted.    
Over time, although still not fully embedded in the local knowledge of the group, I became more 
attuned to the meetings, their format, content, and some of the general problems these people 
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were facing. Being able to record and listen back to recordings was obviously helpful in this 
regard. Even though I had believed that the informants were never particularly riled by my 
presence, I felt as the weeks passed my turning-up became more familiar part (albeit temporary) 
of their meetings.  I had recorded people seeming less surprised on entering the room to find me 
sat there, an inference based upon the types of greetings I would receive from the informants, 
who had also come to know me on first-name terms. This was reinforced by the fact that they 
had also invited me to an important week of events they had planned which included the Centre 
Lead’s inaugural lecture, two trial steering committee meetings, education program meetings, 
and CLRN meetings. This was also complemented by my attendance at ‘social’ events, such as 
two evening meals in restaurants and two wine receptions. The familiarity I had built-up meant 
in interviews I was able to pinpoint specific studies they had conducted of which I had some 
prior knowledge and integrated these specifics into the interview schedules (for instance, I asked 
the Senior Clinical Lecturer to relate translational research to the epilepsy multi-centre trial for 
which I had observed the steering committee meeting). Again, perhaps owing to the rapport I 
had built, I found respondents were helpful in engaging with the questions I presented to them 
in interviews.  
As the cancer and obesity case studies did not afford me access to observe meetings or other 
occasions for organising in situ, I was unable to generate similar data sets to those reported on 
in the Obstetrics case chapter (Chapter 8). As such it is my impression that I never got as close to 
these people’s contexts and was not able to become as saturated as I was in the obstetrics. This 
is not a complaint, but a ‘confession’ as to potential limitation to parts of this research. However, 
the fact that interviews and documents were the main sources of data did not mean my 
experience with these cases was completely devoid of familiar relations. During my visits to 
carry-out interviews in the cancer laboratory, I was able to take cursory glances at the 
laboratory’s benches and offices, recording the lay-out in notes immediately after leaving. On 
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one occasion I spent approximately 4-5 minutes by the benches, having been introduced to their 
technician by the senior lecturer after our interview.  This afforded me first-hand a ‘snapshot’ of 
the laboratory space, which complemented interview accounts describing the laboratory life in 
which informants were variously embedded. The inside of the building was very different to the 
offices of the obstetrics group: it was a molecular biology laboratory resembling many of those 
depicted in STS laboratory studies. This reinforced the expectation that the cases being studied 
in this thesis were embedded in distinct epistemic communities, so much so that the very 
physical built environments in which they worked looked completely different to an outsider. As 
an organisational unit it could be likened to a factory which ‘stocked’ the various resources, 
human and non-human, abstract and material, needed to assemble experiments (Knorr-Cetina, 
1999, 27). As an organisation, the object-centred-ness of the bench spaces was one of the most 
striking features I noticed on entering this building, meaning it was an idiosyncratically-designed 
workspaces centred around assembling resources which would enact and respond to emergent 
demands of experiments (ibid.). The individual work spaces of the benches always appeared 
quite cluttered, with large numbers of bottles and containers stacked on the shelves, trays of 
pipettes, stacks of test-tubes, beakers, micro-scopes, micro-assay machines, sinks, and 
microwaves situated at the lab benches. There were computers situated at the end of the open-
plan room, which along with the laboratory benches were assigned to those (technicians, post-
doctoral researchers, PhD students) whose roles were more-or-less inextricably tied to material 
elements of the laboratory’s activity (Latour & Woolgar, 1986, 188). Away from this large, open-
plan space there was also a kitchen area with a large table for carrying out meetings.  Next to 
this were personal offices for senior members of the laboratory, less immersed in bench work. 
Swipe cards were required to access the laboratory, meaning I had to phone the secretary in 
order to be let in and which always reminded me of my status as a visitor.  
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Most of the people who came forward to be interviewed for this case study were enthusiastic 
about taking part (although one person was noted as appearing rather bored during the session 
itself). Each person asked me what I was studying after the interviews and appeared interested, 
if a little confused, about what I told them. The two post-doctoral researchers held longer 
conversations after the interviews had ended (approximately 5-10 minutes), about life in the 
laboratory, what they thought of their colleagues and how they enjoyed working in the area. 
Although I have deemed it inappropriate to draw on some of this data because of its possible 
sensitivity (e.g. complaints about work colleagues, conditions), having these informal exchanges 
did help to ‘paint a picture’ of the laboratory life and engender at least some degree of 
familiarity with this somewhat esoteric organisational unit. Other senior members I interviewed 
would inquire about my research, but also engage in small-talk conversations. These might 
include what university I was affiliated with, what discipline I was in, and, how data could 
possibly be generated from verbal exchanges taking place in interviews.  
Retrospectively I believe I was unable to build the same levels of familiarity or closeness with the 
diabetes case as in the obstetrics case, or even the cancer case. Again this was surely due to the 
restrictions of access, with the fieldwork limited to interviews. Partly this feeling was also no 
doubt influenced by the fact that these had to be done over the phone, a medium which 
precludes face-to-face interaction. Unless one can access a parallel universe, it is difficult to 
determine whether carrying out phone interviews is to the ultimate detriment of the data that is 
generated. In some ways it was helpful, as I was able to follow the interview script more closely, 
without disrupting eye contact and other deferential gestures. Certainly all but one of the 
respondents were willing to give-up their time to answer further questions during the interviews 
(the information sheet stated they would last for approximately 40 minutes) and made an effort 
to give detailed answers. However this case perhaps did not elicit the range of local issues and 
subtle nuances in the same ways as observation fieldwork can. This was compensated for by the 
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more focused set of interview questions and deeper technical knowledge of translational 
research I had developed by this point. Indeed in the small-talk after one of the interviews, an 
informant even asked me if I was a doctor. Likewise, although this case perhaps did not 
permeate the deep spaces of this site, the interviews were very lively and did produce a lot of 
rich data about the challenges and boundaries these people face and the types of credibility and 
career investments they have made.  
The Role of Non-Participant Observer 
Although I gained rich access to the world of obstetrics over this period, I believe that the role of 
non-participant observer remained largely intact, at least in the context of meetings with the 
team, trial steering committee, and educational program. There are different possible 
explanations for the relative lack of attention or scrutiny I felt I received as a researcher entering 
these settings. Before the interviews and trial steering meetings I had provided participant 
information sheets which had given brief details of the study (see Appendix 4). Likewise I had 
given brief overviews of my research in the emails that the gatekeepers in the cancer and 
obesity cases had circulated to colleagues. Perhaps one of the reasons for the general lack of 
scrutiny was that they had read through this information and had their concerns/curiosities 
satisfied. Likewise they could have been satisfied that the study had received a favourable 
ethical opinion or that their participation would be unlikely to unearth any sensitive information.  
Another factor which meant I could adopt the role of non-participant observer with relative ease 
was determined by the general lack of interest the informants displayed towards my research 
and the purpose of my visit. Most inquiries made about my research were usually in ‘small talk’ 
gaps after interview tapes had been switched-off and before we parted ways (when they had 
been given the ‘cue’ that the formal part of the interview had ended). A common theme in their 
inquiries would be how on earth the interviews could be converted into data, what stage I was at 
in my PhD studies, or how I could possibly derive any interest from observing, let alone listening 
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back to, these meetings. Other sessions ended with small talk about the weather, or my journey 
to and from the location. As I was not asked for help on any issues I believe they did not 
considered me a member of the team: I believe I was treated more like an ‘acceptable 
incompetent’ than ‘working patrolman’ (Van Maanen, 1988, 89). Perhaps the ability to act out 
the role of non-participant observer here was a mark of the continued existence of a ‘hierarchy 
of sciences’. My position as a social scientist was however never openly derided or ridiculed. 
Indeed on some occasions informants would even explain their willingness to participate in the 
studies by referring to common academic values, such as a willingness to help others in their 
research and to further science, thus stating an equivalence rather than difference. Perhaps 
though the general lack of interest I felt they displayed towards my research was summed-up 
during the first meeting, when I was asked to ‘say a few words’ about the purpose of my visit 
and my intellectual background. I provided what the fieldnotes described as a ‘pithy’ off-the-cuff 
answer to this question (which I hadn’t been expecting). This was met with what seemed like 
general acceptance and polite indifference (judging by the fact that no one raised any 
questions). I was also to repeat this request during the later trial steering committee meetings I 
attended, where, similarly, there were no follow-up questions. 
Overall, although the informants did not express a great deal of interest into the reasons for my 
being there, I realised that this perhaps also helped me to avoid resistances of the type that Van 
Maanen and other organisational ethnographers have encountered (where potential informants 
are mistrusting of the ethnographers’ intentions). I think we both recognised that as someone 
who is to all intents-and-purposes an outsider from their specialist community, it would have 
been ineffective and strange to ask me for advice over most matters arising in their work. 
Although this arrangement was rarely articulated, I think it was understood by both parties. In 
one meeting my presence did become more visible, when an informant turned to me and asked 
‘any suggestions?’  This was met by laughter from the others, which I took as a sign that the very 
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notion of me contributing to the team’s actual work was absurd and worthy only of humour. As 
such my role as non-participant observer worked well for both parties.  This ability to adopt the 
role of non-participant observer does not mean that I was completely invisible and that my 
presence had no effect on the way informants conducted themselves in the meetings. It would 
be disingenuous to report that I had no impact whatsoever on the course of the meetings and 
that the divide between my participating and not participating was always easy to distinguish. 
Likewise it would also be disingenuous to state that my being there never created any tension, 
as during first obstetrics team meeting one person complained to the Centre Lead that he had 
not foretold them about my presence. The latter apologised for having not informed other team 
members, and also apologised to me that this issue had arisen in the meeting. This apology 
appeared to diffuse the problem, much to my relief. I did not see this as a big problem, as they 
were objecting to the lack of communication rather than the idea of me being there to study 
them. But these utterances were rare and for the most part, as far as I could tell, the informants 
were content going about their ‘normal’ business whilst being observed. Overall, despite some 
initial nerves and some frustration at the amount of travelling required, the fieldwork experience 
was not particularly taxing on my emotions. Ultimately fieldwork was being carried-out in a 
comfortable, familiar type of setting (university) which risked little of the ‘occupational hazards’ 
and emotional traumas of the type Van Maanen described of doing research in organisations like 
the police force.  
Treating the Data 
The primary empirical materials for the case studies were sourced from interviews, observation 
and documents. Having taken informed consent, the interviews and observations benefitted 
from use of a digital voice recorder. This enabled me to record what was said with much greater 
accuracy than is available through relying purely on fieldnotes or, worse still, memory. 
Transcribing recordings will always provide the scribe with a great deal of control over how the 
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data in its raw form comes to be represented on the page. Although this is unavoidable there are 
some measures one can take to mitigate this issue. For the sake of consistency across the data I 
had decided beforehand to write transcripts in a verbatim style, which omits some of the 
minutiae that can be captured in approaches like conversation analysis, but still includes word-
for-word what was said in the session (Bryman, 2012, 485). This is a common style used in 
ethnographic writings intended to persuade readers who were not present at the scene of the 
fieldwork of the authenticity of the author’s testimony. Quotations are thus deployed by 
qualitative researchers an ‘immutable mobile’ (Woolgar, 1988, 79) with which to support 
arguments in the text: providing mobile and accurate representations of what was said to them 
by respondents. The quotations are indicated through use of conventions like indented 
paragraphs and speech marks. Where the interviewee omits words, for grammatical clarity, I 
have inserted the missing words inside square brackets. Another convention has been to include 
three dots to signify where, for purposes of length and relevance, certain words or sentences 
uttered by interviewees have been omitted from the quotation (Bryman, 2012, 485). This rather 
linear style of reporting was deemed a sufficient level of detail and accuracy for the types of 
research questions being asked.  
Once the transcription was completed, the interview and observation transcripts and other 
documents were exported into the Nvivo software package. The advantage of using this 
software will be made clear in the subsequent discussion of the approach used for coding the 
data. As discussed in the literature review and empirical chapters, existing STS materials have 
been utilised to accentuate certain topics and themes in the process of data analysis and writing. 
In terms of the data coding approach, I drew influence from Ritchie and Spencer’s ‘Framework’ 
for qualitative data analysis (Ritchie and Spencer, 1994). This identifies five stages: 
1) Familiarisation 





5) Mapping and interpretation (this being the stage at which key objectives of qualitative 
analysis are addressed) 
Familiarisation describes the early phases of listening, reading, and making brainstorm notes 
about one’s data. As the name implies, the purpose is to become more familiar with the content 
of the data. I tried to follow this advice by making fieldnotes immediately after each session, 
recalling how I thought they went, what salient points emerged, and whether there were any 
distinct surprises that came out. Such records provide ‘experiential data’ that is useful in coming 
to write-up the research (Saunders et al., 2003, 227). Shortly after interview and observation 
sessions I listened back to the tapes before transcribing them into word documents, all of which, 
except for two interviews, I did myself. I subsequently read back over the two which were 
outsourced to check for accuracy. Strauss and Corbin (1990) recommend first-time qualitative 
researchers transcribe as a means of familiarising themselves with data. Although this did seem 
to work, on a confessional note I should state that at times I found this to be tedious and 
frustrating.  
Identifying a thematic framework should occur before the indexing stage. At this stage a priori 
issues guiding original questions and interview topics, notes made during the familiarisation 
stage, emergent issues raised by respondents themselves, and recurrent themes or patterns of 
particular views or experiences are all combined as inputs into the process of constructing a 
thematic framework for indexing, sifting, and sorting material (1994, 180). The data was 
examined and referenced against these framework(s). Ritchie and Spencer advise that it is 
usually the case that one has at least an implicit idea of what this framework will be before it is 
formalised  at this second ‘stage’ (ibid, 179). Indeed having read around STS literature before 
fieldwork had begun, a number of its key themes and motifs had already influenced the writing 
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of interview schedules. It was during the period of conducting pilot studies I first read Latour and 
Woolgar’s Laboratory Life and this undoubtedly had a big influence on the types of questions I 
was asking of respondents.  
Once a framework was identified, it was applied to individual transcripts and documents. This 
indexing stage was still provisional: if applying the framework did not appear to work then I 
would have reconsidered. Yet I was persuaded of its utility when it became clear that it could be 
applied across large sections of the data.  It also proved useful for building a common index 
across individual transcripts, thus enabling me to ‘identify common and divergent themes 
between populations’ (ibid, 180). For example, I was able to contrast with relative ease how 
different respondents answered similar questions, through using the ‘tree node’ in Nvivo. 
Indexing helps demonstrate that fieldwork and analysis were conducted systematically across 
each case, thus adding credibility to subsequent comparisons.  
After indexing the transcripts with thematic framework, Ritchie and Spencer instruct that data 
be taken from its original context and rearranged into an appropriate theme. This charting 
process requires one to place distilled summaries of respondents’ views or experiences on 
charts. It is therefore described as a process of abstraction and synthesis (ibid, 184). Charts can 
be arranged by theme (each theme across all respondents) or by case (for each respondent 
across all themes) (ibid, 182-183). These charts enable one to ask the question ‘are there 
similarities/differences in theme within/between cases?’  
This framework appears to pre-date advances in computer-assisted qualitative analysis, as this 
stage is actually done automatically if one uses the Nvivo package: node functions allow one to 
change interfaces from whole transcripts to node themes through a simple click of the mouse. 
Furthermore one can easily trace statements placed under theme back to their original source 




For the final stage of mapping and interpretation: 
“The analyst reviews and charts the research notes: compares and contrasts 
perceptions, accounts, or experiences; searches for patterns and connections and seeks 
explanations of these internally within the data.”  (Ritchie and Spencer, 1994, 186) 
It is this final stage which Ritchie and Spencer argue fulfils the functions and objectives of 
qualitative research, as it can encompasses: defining concepts, mapping range and nature of 
phenomena, creating typologies, finding associations, providing explanations, and/or developing 
strategies (ibid, 187). Each of these functions have been variously utilised in answering the 
questions of this research in the empirical chapters of this thesis, therefore providing me with 
confidence about the utility of this framework in providing a robust,  systematic, and transparent 
tool for data analysis. I also found it to be user-friendly and easy to follow. Further credibility 
comes from the fact that the ‘Framework’ has been used many times before (ibid, 193), as a 
cursory glance at its citation numbers in Google Scholar concurred.  
Checking Validity 
The procedures to ensure validity will now be discussed further. Qualitative approaches to 
collecting and analysing data are often said to rely too greatly on individual intuition and 
judgment. Despite this view being naïve towards practices of knowledge production in all 
sciences (Latour, 2005), for any qualitative study the audience nonetheless are entitled to ask 
about the credibility and believability of the findings (Bryman, 2012, 389-390). Most criteria used 
for assessing validity of data have its roots in quantitative methodological traditions, and are 
perhaps ill-suited to qualitative studies. However, some of these criteria can be adapted to fit 
with qualitative research (ibid). One way of tightening the construct validity of case studies 
before and after the fieldwork is to draw suitably from existing theories (Gibbert et al., 2008, 
1466, 1468).  Latour and Woolgar’s (1986) framework was found to be helpful in this regards, as 
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it was itself formulated out of empirical findings of similar types of production processes and 
their sites. Reflexive researchers often question the ‘confirmability’ of their findings, i.e. whether 
their values have intruded too greatly on the findings (Bryman, 2012, 392-393). A limitation of 
interviews is that they can sometimes produce knee-jerk reactions and retrospective 
sensemaking (Eisenhardt & Graebner, 2007, 28); meaning findings can be accused of being 
skewed or cherry-picked. Constructing systematic measures for responses helps overcome 
charges of cherry picking data, persuading readers that a single or cluster of themes have been 
investigated and analysed rigorously.  Again using Latour and Woolgar’s framework as sensitising 
tool in data analysis across individual transcripts for all three cases adds rigour to the findings. 
Clearly use of a rigorous coding system (like Ritchie & Spencer’s ‘Framework’) is also helpful in 
this regard. Interpretations of interview findings can also be sensitised through field notes 
recording  ‘primary observations’ of what happened at the time (Saunders et al., 2003, 227), 
such as recording how respondents answered questions. One striking example was when people 
would respond in ways which, from where I was sitting, signalled ‘that was a stupid question’. 
Here I concluded that I had uncovered knowledge which was so taken-for-granted by 
respondents that it was ‘blindingly obvious’.  
How findings are presented through writing is usually convergent with the type of paradigm in 
which the study is located. Different paradigms traditionally have their own genres of reporting 
that usually carry connotations of validity (for a review of validity measures across traditions see 
Creswell & Miller, 2000). Writing findings in ‘depth’ is the lens that has predominantly found 
historical favour amongst constructionist audiences, where ‘depth’ is a value-laden concept 
carrying post-modernist implications (Lincoln and Guba, 2000). In particular it implies using types 
of narrative genres different to the passive voice usually found in ‘scientific’ texts (see Gilbert 
and Mulkay, 1984). Van Maanen’s (1988) ‘storying’ encompasses styles refusing to project 
passive, disinterested voices. For instance, using his style of ‘illustrative tales’ to depict particular 
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aspects of the cases is consistent with the case study strategy and paradigm-position taken in 
this study, as well as arguably being more attention-grabbing. Descriptive writing styles 
synonymous with the ethnographic tradition are most appropriate for capturing complex 
phenomenon of the type in which this thesis is engaging (Latour, 2005).  
In sum, claims of validity are usually presented to the reader based on reassurances that certain 
standards and criteria have been followed. Being transparent about the research design and 
fieldwork are considered important features which increase rather than reduce validity of the 
findings, reassuring the audience that the researcher is conscious of the strengths and 
















6. Empirical Analysis: Transforming 
Cell Signalling?  
 
Introduction 
This chapter looks to consider how the idea of translational research effects the mundane work 
organisation of a laboratory working on processes of molecular cell signalling in a cancer 
institute belonging to a university medical school. The case study draws on the insights provided 
by a group of five respondents working as full-time members of the laboratory. They consisted 
of De Jong- a professor and principal investigator of the laboratory, Mendez- a senior lecturer in 
charge of the ‘dry section’ of the laboratory, Enfield- in her first year as a post-doctoral 
researcher having also completed a PhD in the same laboratory, Madeira- who was also in her 
first year at the laboratory having joined as a post-doctoral researcher, and Morales- a 
technician. The study also benefitted from gaining access to interview the Head of the Institute 
and a local engagement officer representing a major research charity within the Institute. This 
helped to provide information on the immediate governance and organisational context of the 
institute and university in which the laboratory was hosted.  
As with each case study, data was collected transcribed into Nvivo and coded, accentuating 
especially Latour and Woolgar’s (1986) four frameworks- history of the laboratory, inscriptions, 
microprocesses, and cycles of credit- as sensitising concepts. As with the structure of the other 
empirical chapters, the findings will be ordered under these themes. Each section will elucidate 
both empirical findings and where appropriate link these with broader arguments and concepts 
in the theoretical literature. The chapter concludes with a brief discussion as to what aspects of 
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the idea of translational research have travelled and the extent to which it engenders innovative 
modes of organising within the context of this case.  
History of the Laboratory 
This section provides a general background into the case, by mapping-out how, when related to 
specific objects, translational research is made visible in relation to the networks on which the 
laboratory is subsistent.   
Translational research was defined by the Head in view of the networks of relations assembled 
under the formal guise of the Institute. This brought into view the Institute’s strategy as being 
formulated around enabling translational collaborations of various sorts to occur between 
constituent elements like research laboratories, research charities and local NHS Trusts. This was 
framed as a response to wider signals and disciplinary controls being projected by external 
‘macro-actors’ on whom they are dependent as a research-led organisation. Definitions given to 
translational research by the School’s management figures were made to act as ‘immutable 
mobiles’ sent back towards other ‘centres-of-calculation’ to whom they were variously 
dependent and accountable: 
“I think at the moment we’re benefitting from the fact that government agencies in 
particular are interested in the idea of impact... That may not always be the case: we 
may go back to a culture where blue skies thinking and curiosity-driven research is 
afforded a greater priority and there is less of this obsession about, you know, driving 
things to the later stages of the translational pipeline. But for the moment, the 
searchlight is shining on the bit that we do best.” (Head) 
Immediately then it became clear that translational research, as a governance device, was 
having some influence on the actions of the Institute. From the Head’s interview account the 
actor-network of the institute consisted of formal allies- research laboratories, administrators, 
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local NHS trust, cancer charity – all brought together under the label translational research. 
Translational research could thus be seen as a boundary object for framing their mutual 
interests. Each ally of this actor-network appeared to have their own expectations and interests 
in associating with the Institute. For example the charity was primarily concerned the goal of 
improving cancer patients’ clinical outcomes: 
“I suppose in five years’ time what we’d want to see is that some of the local 
engagement will have translated into cancer patient benefits and patient outcomes, so 
people will be diagnosed earlier with cancer and people will have better outcomes from 
the disease, they will live longer. They will also have better understanding of how to 
prevent getting the disease in the first place.” (Local Engagement Officer) 
The concern of the Head was not only to bring about clinical pay-offs, but to meet various 
standards expected of research-led organisations. In large part this meant ensuring researchers 
met the standards of ‘excellence’ set-out under the REF. In addition each of the institute’s quasi-
autonomous research groups were positioned within this actor-network and made to account 
for ‘impact’ of their work. Strategically this was defined in terms of the stages of the 
translational pipeline along which their work could (convincingly) be aligned: 
“The way that the institute is designed is that we have the sort of infrastructure- those 
types of people with the right skills sets- to enable anybody to be able to plug into it and 
get the right levels of support, whatever stage they are in the translational pipeline.” 
(Head) 
In view of the faculty’s portfolio each research centre was allocated a particular role in relation 
to their translational vision, framed in terms of their respective expertise in basic, pre-clinical 
and/or clinical research. More clinically-oriented researchers for instance were expected to 
develop a translational component to their work in view of an administrative centre headed-up 
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by the Head himself, charged with providing the governance necessary to scale-up findings into 
clinical trials that tested for novel diagnostics and therapeutics. The basic researchers were 
expected to demonstrate an ‘impact’ more through translating research into commercial 
opportunities such as patents, licensing and spin-out companies via the university’s technology 
transfer office. The laboratory at the centre of this case study was positioned as fulfilling those 
more basic elements of this pipeline metaphor. The Head recognised the laboratory as a 
legitimate player in this regard: 
“You’ve got to have something to start. You’ve got to have an A to get to B. If all the 
work is just focused on the B, i.e. the patient, you won’t have anything to translate. It’s 
important to have a balance, but I think it’s important to cross-pollinate between people 
at both ends of the pipe, to educate, to have doctors and clinicians who are familiar with 
the language of science and understand at least the principles of what the fundamental 
research is about. But you’ve also have got to motivate, by exposing basic scientists to 
the big clinical questions. And out of that cross-pollination experience has shown that 
you get interesting new ideas which have taken both elements to make a practical 
reality.” (Head) 
Translational research is thus transmitted as a label with internal marketing purposes, where the 
Head, as spokesman for the entities, looks to ‘nudge’ from-a-distance scientists like those in this 
case, to adjust their behaviour and ‘mentality’. But how do respondents in my case define 
translational research in light of the mundane activities and practices of their laboratory? This 
will now be elaborated through further discussion within which the idea can be located. As has 
been intimated, the laboratory is expected to meet certain criteria imposed upon them by the 
senior management figures in their host Institute, who are in turn responding to demands of 
others. Interviews with the Head and local engagement officer helped elaborate a general 
definition of translational research inscribed on the laboratory through the spokesperson of the 
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Institute. However, interviews with laboratory members brought into view more specific 
networks of relations through which translational research is defined (and transformed) at their 
local organisational level.    
All of the definitions given over to translational research were intertwined with the laboratory’s 
central focus on a core family of proteins: PI3 Kinases (PI3K). As a basic research laboratory, the 
research agenda was focused around exploration of various facets of this phenomenon. This 
meant their research ‘started’ at the very basic cellular level, through analysis of cell signalling 
processes in the ‘dry section’ of the laboratory. With the help of technology transfer office 
Madeira and De Jong had co-founded a spin-out company which had begun to scale-up these 
techniques into novel inscription devices marketed towards commercial and academic 
laboratories. This company had then been sold on to big pharma, owing to the commercial 
promise of the developing technology in helping to screen for novel targets in pathways to 
disease. Despite relinquishing control, both were kept on as consultants by the company for 
their expertise about the science behind the technology. Thus as well as bringing money into the 
university and laboratory, the venture also brought about steady stream of income to be 
reinvested in the laboratory. This highlights two definitions of translational research circulated 
towards the Institute’s management. In one sense they were fulfilling commercial arm of the 
Institute’s translational ‘portfolio’ by creating profit for the university in financial terms. They 
also could claim to be delivering on ‘impact’ motifs by improving the technologies at the centre 
of search processes used in drug development, which might ultimately produce diagnostics and 
therapies which get brought to market, thereby constituting their work as a general ‘public 
good’.  
As well as concentrating on these fundamental processes of cell behaviour, another work section 
of the laboratory focused on ‘wet’ research which scaled-up cellular findings into work on whole 
organisms. Mouse work was performed as a means of modelling diseases that affect humans. 
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This involved breeding mutant mice with particular diseases (cancer, arthritis) and conducting 
experiments in relation to possible therapeutic treatments. Accordingly if results show the 
efficacy of giving a specific small-molecule inhibitor to diseased mice then it may be taken-up by 
others elsewhere in the translational pipeline (‘externalities’). Ideal typically this would mean 
seeing their findings taken-up by others through various phases of process-driven work at pre-
clinical proof-of-principle stages, before entering human trials and stages of regulatory affairs, 
then eventually entering the market. As such, the work done in their laboratory is presented as 
an important initial stage in the translational pipeline through which principles are proposed for 
others to test and exploit. The association with the ‘translation’ metaphor given over to their 
work on disease processes is identified by respondents as a key boundary object around which 
their collaborations with those beyond their specialty are forged. Publishing in esteemed 
scientific journals like Nature or Science was deemed by respondents as bringing attention and 
‘presence’ (Latour, 1987) to these findings amongst potential suitors, especially pharmaceutical 
companies. Mutual interest in an aspect of disease is thus what brings them together. Such a 
definition enabled them to balance their primary interest in producing research of ‘scientific 
excellence’ alongside work which met ‘impact’ or ‘relevance’ criteria.  
This broad ‘coming-togetherness’ definition also enabled respondents to frame some of the 
work they do which feeds-back from the clinic into the laboratory as ‘translational’. Hence as 
well as flowing in the direction of ‘bench-to-bedside’, their work can also focus on problems 
which are ‘bedside-to-bench’. This is especially apparent in some of the paid consultancy work 
De Jong did for big pharma, in which his expert knowledge about the role of molecules in cells 
means his voice is listened to in regards to what happens when drugs based on said molecules 
are given to patients. Likewise in partnership with another big pharma, the laboratory had 
gained a large MRC grant to test for haematological malignancies in patient samples, thus 
indicating flow of research materials from hospitals back to their academic laboratory. 
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Translational research is thus a means of labelling and communicating episodes of working with 
others out of mutual interest in disease. This was also a definition which the Head of the 
Institute accepted as legitimate and had integrated into the portfolio of the Institute.   
One of the most notable themes coded in these interviews was the presence of ‘boundary work’ 
in demarcating the limits of their involvement in the translational process. In interview accounts 
respondents constructed a moral order which sought to carve out an enclave for their 
involvement in this type of endeavour whilst simultaneously justifying their locating of these 
boundaries. In particular although supporting the movement of their findings into clinical 
studies, they strongly resisted the notion that they themselves should become more strongly 
involved in clinical research, wishing instead to maintain their position as a basic research 
laboratory: 
“I think translational work is a dangerous game because you can work with doctors, 
clinical fellows, but, you know, you still have to maintain your identity as a basic 
researcher. And I think what I prefer to do is work with clinical fellows or clinicians and 
so on, then they take the work, it is theirs, so you don’t have to try and become a 
clinician. I cannot become a clinician, I have no aspiration to. I’m in the wrong business.” 
(De Jong) 
Therefore, as well as being made accountable for their actions by others (e.g. senior 
management), the respondents are looking to delegate certain tasks to others in this extended 
(and fragmented) production process. Time and again the spatial and temporal distance of their 
findings from actual clinical application prompted respondents to bring into view network 






Having mapped-out several ways translational research is made to order objects that are made 
visible within networks, I will now discuss the results which arose from coding data using Latour 
and Woolgar’s Inscription framework. Through intermittent visits to carry-out interviews, I was 
able to observe the lay-out of the space which constituted ‘the laboratory’. The actions I 
observed as particular to this space appeared to correspond with accounts of mundane activities 
and practices of scientists as centred on writing (in an extended sense) (Latour and Woolgar, 
1986). Through the lens of laboratory studies, the space of the laboratory appeared like a 
production line (Knorr-Cetina, 1981, Latour and Woolgar, 1986) for assembling various forms of 
writing, from the work benches in which ‘results’ are read off inscription devices, to the library 
where books, journals and SOP guides were read and annotated, to the office spaces containing 
personal computers. To the outside observer, writing thus appears central to organising in the 
laboratory.  
As discussed previously, Latour and Woolgar’s study of acts of inscription was greatly facilitated 
by rich access to their respective laboratory over an extended period of time. The restrictions 
placed on access to the spaces in which these actions took place necessitated some degree of 
pragmatism in considering this framework within the context of this case. It has resulted in a 
choice to discriminate interviews and publicly available documentation as key resources with 
which to make sense of this aspect of their activity. This means focussing on forms of persuasion 
enacted within important textual outputs by the laboratory, namely grant applications and 
journal articles, with participants’ interview accounts used to support inferences. As in the 
previous chapter, the aim is to consider the extent to which the idea of translational research 
appears to inform writing practices and whether this pressure requires a significant departure 





From the interviews it was revealed that grant writing was the domain of senior members of the 
laboratory, who have acquired the know-how to acquit themselves successfully in practising this 
action. However, for less senior members of the laboratory learning to write grants is not 
something about which they yet had knowledge. De Jong and Mendez occupied managerial 
positions, whose roles entailed articulating alignment with the social world  (Fujimura, 1987), 
including responding to the pressure to demonstrate ‘translatability’. For this reason the written 
outputs sampled for study here were authored or co-authored by these two respondents.  
Using the Institute’s webpages and interview accounts I was able to identify those funding 
bodies from whom the two respondents had been successful in securing support since re-
locating to the Institute.  Grant applications are made publicly available on the websites of 
various funding bodies. I was therefore able to search the names of the PI and S/L in the funder’s 
websites. This yielded results from the BBSRC (n=3) and a research charity with which the 
institution had strong ties (n=2). Applications made to the MRC were not found. The texts were 
exported into Nvivo and coded according to Latour and Woolgar’s five statement types.  
Findings support the argument that scientific writing is a form of practice (Latour, 1988, 218), as 
grant applications appeared as a type of game in which participants encode information in 
particular ways with a view to persuading their audiences to act in certain ways (namely 
agreeing to fund proposed research). Indeed De Jong reflexively acknowledged that he and 
others would routinely adjust aspects of the information content in grant applications to meet 
the expectations of a particular audience. For example, the Biotechnology and Biological 
Sciences Research Council (BBSRC) were thought to be less interested in contributions to disease 
studies and more in contributions to basic science problems and possibilities these might hold 
for commercial exploitation. Research charities on the other hand were very much interested in 
possible patient benefits (again ‘translational’ being identified with an interest in ‘disease’ within 
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the context of their work). ‘Forward looking statements’ were a prominent feature of the 
respondents’ grant applications, albeit the content of promises would differ according to the 
grant body to whom they were applying: 
 “I will put some forward-looking statements in there, that it helps the economy, that 
sort of stuff, you know. I’m not saying that I’m going to cure a disease, but I am saying 
that ‘look, based on this people might actually start to set-up a company’. But I’m not 
proposing to do it, you know, there is a different way of putting it.” (De Jong) 
Inclusion of promissory statements was thus reported as an effort to second-guess what the 
grant body to whom they were applying would be interested in funding. Within several 
respondents’ interviews this aspect of their practice was framed as a ‘game’, with the 
participants proposing that despite inclusion of such statements being essential, it would be 
unlikely that they would be held to future account should these promises fail to accrue. Likewise 
there was a general attitude that these statements were not as decisive in decision-makers’ 
evaluation of these texts as those statements pertaining to technical problems to be addressed 
by the research. Speculative, performative statements have always been important functions of 
grant applications, as by definition gatekeepers are being asked to invest in the potential of 
proposed research. But the substance of these statements appears to differ according to the 
anticipated interests and expectations of the respective audience. Grant applications submitted 
to bodies with a greater interest in medical research were identified more explicitly with 
‘translational research’ agendas by respondents than with the BBSRC applications. The former 
engages with disease processes (as opposed to fundamental cellular processes, as in BBSRC 
funded research). However, even BBSRC grants (thought to be a ‘basic science’ champion) 
include some ‘impact’ statements with regards the potential social utility of research. As the PI 
stated, he will include these ‘translational’ statements on more of an ad hoc basis, typically 
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towards the end of the content of BBSRC applications (see below italics). This statement was 
supported by analysis of grant writings: 
“This is a fundamental science project that will enhance our knowledge about basic 
biological phenomena. In the past, the biology of PI3Ks has impacted on science far 
beyond our own field, mainly because these enzymes control fundamentals of biology. 
This proposal also has the potential to benefit industry, as it might identify PI3Ks as new 
targets to develop medicines against. In the longer term, it is very likely that this 
research may lead to a better understanding of disease processes and to the 
development of new medicines.” (BBSRC 2, emphasis added) 
The difference between promissory statements referring to ‘scientific’ outcomes and ‘practical’ 
outcomes in this excerpt appears to be that the former would result from uptake of new facts 
within the scientific community, whereas the latter would require other externalities to come 
into play (e.g. pharmaceutical companies). Whereas one suspects promises about basic 
contribution have always been part of writing practices in many scientific fields  persuading 
gatekeepers of the social utility of research appears to be a more recent addition within fields 
whose sponsors and gatekeepers engage in missions of strategic/translational science (van Lente 
and Rip, 1998b). Even though they are identified as a ‘basic science’ laboratory applying for 
money from a ‘basic science’ research council (BBSRC), there is an identified requirement that 
they include statements predicting consequences beyond the immediate context of their 
discoveries.  
The interests of medical research charities in practical outcomes from research they fund means 
that research proposals must be centred on the disease(s) about which they are concerned. In 
applications to the research charity there was explicit systematic mention of specific types of 
diseases to which the research contributes, such as cancer, as opposed to general contributions 
to knowledge about cells work in relation to an open-ended number of disease processes. 
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Typically, the interest in a specific disease like cancer is not simply ‘bolted-on’ at the end of the 
text in an ad hoc manner, but is the central problem being studied and is therefore much more 
prominent across the statements comprising the text. As with the BBSRC applications, the 
research is also framed as ‘translational’ by way of making more specific promises (other than 
contributing to general stocks of scientific knowledge). For instance they make claims about how 
results might constitute the basis for later cancer therapy developments. This can be read from 
the following statements rich in grammatical modalities (italicised):    
“This work will determine the contribution of the PIK3CA oncogene to energy 
metabolism in cells with similar genetic background, and may result in the discovery of 
new drug targets and/or biomarkers for oncogenic PI3K signalling… (Research Charity, 
emphasis added) 
Thus we aim to systematically investigate the contribution of oncogenic signalling (with 
initial emphasis on the PIK3CA oncogene) to the deregulation of bioenergetic processes. 
In addition to increase our understanding of basic cancer biology, these studies may also 
have repercussions for the design of therapies that target cell signalling or bioenergetic 
pathways [in cancer].” (Ibid. emphasis added) 
That respondents’ pointed-out these particular aspects of their writing practices to me when 
discussing ‘translational research’ in interviews supports the argument that this term is used to 
label, simplify, communicate, order and package more complex processes. As a label it is both 
immutable and mobile as it feeds-back between centres of calculation (e.g. research councils) 
and peripheries in the research system (e.g. laboratory scientists), helping to frame equivalence 






Scholarly articles authored and co-authored by De Jong and Mendez were subjected to one time 
‘advanced search’ on Pubmed online database. Those papers to which my institution granted 
access were selected, downloaded and exported into Nvivo. These encompassed ‘research’ 
types of article published in scholarly journals (n=14). Again each article was coded using the 
same five statement types. The results of this analysis will now be discussed further.  
Of the fourteen articles coded for analysis, six were coded under Type I-IV statements only, with 
the other eight articles containing both representational and performative statements. Two of 
the six ‘representational’ articles had been published in a specialist journal, two more in another 
specialist journal, and one each in Nature and Science. These texts were replete with arguments 
saturated in technical discourse. This can be characterised by the low count of grammatical 
modalities, with statements instead being presented in such a way as to make various ‘facts’ 
speak for themselves, with reference to human agency excluded from statements.  This 
‘technical’ rhetoric can be juxtaposed with other titles in which more ‘pathos’-driven rhetoric 
was accentuated. The (hopeful) basis of projections about the practical pay-off of the work in the 
latter titles appears to be based on assumptions about the scientific validity of the research: 
“Such an approach could be applied…to the pharmacodynamic validation of new drugs 
by enabling an accurate assessment of target inhibition in primary tissues. This 
technique has the potential to significantly contribute to making the concept of 
personalised cancer therapy into a clinical reality.” (Anon) 
Notable within certain articles was the presence of statements containing modalities in the form 





“These results define PI3K as a potential therapeutic target in inflammatory disease.” 
(Anon) 
 
Part of the expectation in these titles then appears to be that the persuasiveness of a text will be 
assessed not only in terms of contribution to an important intellectual puzzle in their given 
specialty or field, but also in terms of possible practical utility to be accrued from the results, for 
instance in terms of commercial or clinical developments. Notably, part of the literary strategy of 
performative statements is that possibilities are included (such as therapeutic targeting), but not 
known-barriers to such possibilities (Knorr-Cetina, 1981). The statements can therefore be 
understood as an additional type of attempt at ‘black-boxing’ (Latour and Woolgar, 1986). As 
with De Jong’s remark about grant writing, the promises in these texts are carefully articulated 
so as not to render the authors themselves accountable for driving forward subsequent 
translation. Part of the rhetorical strategy found amongst these performative statements was to 
silence agency of the researchers who have produced and championed these inscriptions from 
their laboratories and instead impute agency into the new facts themselves. This technique 
could be found in the above quotation and was repeated in another article: 
 
“This technique has the potential to significantly contribute to making the concept of 
personalised cancer therapy into a clinical reality.” (Anon) 
 
These performative statements are written in such a way as to suggest it is the new fact itself 
which, acting alone ‘have potential’ to be the driving-force of subsequent translations. 
Alternative ways of framing promising results, such as ‘we think it has potential’ or ‘in my 
opinion’ appear less solid because they would reveal it is the authors themselves who have 
attached this meaning onto the object for persuasive purposes. This follows a realist discourse in 
which objects (which represent nature) provide a firmer foundation for claims about the world 
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than meanings and opinions imputed by humans. This is a literary strategy of the text used to 
‘talk-up’ the product, which is hyperbolic rather than misrepresentative (Knorr-Cetina, 1981, 
101). Explaining the institutionalisation of this translational discourse within the function of the 
texts published by these titles is beyond the scope of this study. However, what is notable is that 
such requirements would appear to affect the need for respondents’ to extend their discursive 
repertoires, appealing not just towards audiences located in their own technical world, but 
engaging also with broader discourse of strategic (or translational) science. Without learning and 
mobilising these skills, they would be unable to bring in grant money and publish articles in 
certain titles, and therefore continue/advance as practitioners in their community. Hence 
struggles for facticity and fundability are met with wider struggles in the institutions of their 
fields (journals and grant applications) for relevance and legitimacy (Rip, 1994).  
 
The need to include (clinical/commercial) translational statements might constitute a dramatic 
departure from writing practices depicted in earlier laboratory studies. But from the PI and S/L’s 
account, it became noticeable that the need to include such statements is not presented as a 
problematic shift in writing practices, but as something which has already become quite ordinary 
and routine for them. This particular component of writing practice thus does not constitute a 
significant boundary to their strategic engagement with ‘translational’ work: they consider it 
‘doable’ (Fujimura, 1987). Empirical findings regarding the routinisation of these extended 
inscription practices appear to have been under-appreciated in STS. Theoretically this finding can 
be accommodated by existing theories, which postulate that scientists will pragmatically ‘speak 
to’ a range of audiences in the course of their practices: this just happens to be another interest 






Translational research requires subsistence on types of networks other than those covered in 
earlier laboratory studies literature. In these emerging contexts there appears a heightened 
focus on being able to communicate effectively amongst allies outside the parameters of the 
laboratory’s local expertise and focus. Data on microprocesses which occur in conversation 
during such interactions was not available to me. As such, synthesis of Latour and Woolgar’s 
original framework with empirical findings has been restricted. There were openings in the 
interview data which are suggestive of the local negotiated micro-processes which help 
constitute fact-making processes in this laboratory setting and therefore suggest the general 
utility of Latour and Woolgar’s framework. For instance ‘shop-floor’ talk is cited as a common 
feature of the processes of setting-up and running experiments: 
“I: Can you talk to colleagues about where you might have gone wrong? 
Enfield: Yes. It’s very common. I mean everyone tends to have their own project but it’s 
very much like… you troubleshoot with your friends, because that’s the only way to 
understand.”  
It also became apparent that the members of the laboratory held regular meetings which were 
cited as important in terms of negotiating and articulating project work. Projects which were 
conceived both as ‘doable’ and likely to lead to publication were said to be the ideal type against 
which articulation processes were framed by laboratory management. However, despite these 
openings, the lack of access to observe such occasions in situ hamstrings any attempt at 
providing a rich description of this framework in relation to collaborative work in action. Instead 
then this section considers how in their interview accounts respondents describe articulation 
work in and around the laboratory, particularly with reference to projects they see as having 
translational ‘ingredients’ (i.e. those with strategic alignment to commercial/clinical interests in 
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the social world). This will mean highlighting from interviews those boundaries which facilitate 
and disrupt exchanges, and enable decisions within such assemblages.  
As shown in the History of the Laboratory section, translational research signifies bringing 
together elements of an actor-network and that which enables them to communicate. In this 
sense it meets the formal definition of boundary objects. But this mutual interest is insufficient 
on its own to sustain collaboration throughout- other boundary objects come into play, some of 
which are more physical. For instance, mass-spectrometry instrumentation developed in the 
laboratory was scaled-up into commercially applicable technologies. Here representations of the 
technologies’ potential utility in commercial laboratories facilitated bringing members of the 
laboratory into contact with commercial actors, via a spin-out company and technology transfer 
office. After this coming together had occurred and partnership had been forged, there 
appeared to be much ‘repair work’ occurring in regular negotiations between the laboratory and 
commercial clients. Sustained periods of regular communication were depicted as central to the 
process of scaling-up their discoveries into a commercial context (by way of developing a spin-
out company). As the technician reports, this required regular formal and informal meetings 
with those using the technologies, in order to ‘iron-out’ problems. In addition to these ‘business’ 
meetings, one of the means by which collaborations and translations are established was 
through ‘networking’ and presenting at conferences: 
“I think what is satisfying is that I keep on being vocal about how to use it at big 
conferences and things like that, and some small companies have taken it forward and 
made it very successful, meaning some of the big boys have started to say ‘oh actually 
we also need to do that’ and they go back and do it.” (De Jong) 
In these communication contexts face-to-face meetings are identified as crucial. Most 
respondents recognised face-to-face meetings as an important ingredient in articulating 
132 
 
translational projects, particularly as these were thought to carry greater risk to stakeholders. 
This is captured in the interview account of the institute Head: 
“So, for example, even today most productive meetings happen in person. Until a face-
to-face meeting has occurred, then you know the possibilities of Skype, social 
networking, or whatever else electronically, just doesn’t work. We are talking about 
large investments here, not only in a financial sense, but also in a personal sense, in 
terms of time and reputation. It really depends on people trusting each other and 
understanding each other’s motives. It takes a lot of face-to-face meetings- but we do a 
lot electronically too.” (Head) 
Trust comes into play as an important resource in these projects, which is best established by 
way of face-to-face meetings, supported via intermittent electronic communications by 
telephone and new media. Another aspect of making translational work doable is having a 
network in place so as to facilitate collaboration as and when it is deemed appropriate. This 
means having formal and informal ties with local clinicians, drug companies and in-house 
departments like technology transfer offices. Discourse on networks has often presented the 
idea that they enable the reallocation of action. In this regard De Jong and Mendez describes 
how scaling-up discoveries does not require him to possess significant expertise on clinical 
problems, as he is able to delegate this responsibility to clinicians within his networks (in this 
instance his informal ones): 
“I remember during my career development I went to New York and they said to me 
what do you know about clinical trials? I said nothing but I have a good friend and that’s 
what he does for a living. I meet him every Sunday, so when the time comes I’ll find 
out.” (De Jong) 
133 
 
This technoscientific aspect of their networks is facilitated by recourse to commonly agreed 
upon techniques and standards. Mendez describes how having ‘productive methodologies’ in 
place which are commonly accepted by scientists and clinicians alike that facilitates interaction: 
“Well, we all know that certain pathways are important for cancer: clinicians and 
scientist know this. We understand the genetics the same.” (Mendez) 
Talking to clinicians and reading medical literature is one means by which the general processes 
of translational research is made possible for basic scientists. In terms of scaling-down clinical 
phenomenon into their laboratory work, this communication enables the scientists to focus their 
experiments on problems that are in the clinic- such as breast cancer treatments – before 
carrying-out cell-based studies of them. But despite ‘common ground’ there is also a negotiated 
division of labour within translational work along lines of local expertise: 
“Clinicians know the pathology much better; and different types of breast cancers and 
different types leukaemia’s and the genetics of leukaemia, and how to classify them. 
And I know more about the physics and mathematics, the technologies that we use to 
do understand some biology and biochemistry.” (Mendez) 
In sum, despite the lack of data on naturally occurring talk making it difficult to scrutinise Latour 
and Woolgar’s microprocessing framework, concepts like actor-network, boundary object and 
boundary work were useful in opening-up the communication processes occurring inside multi-
disciplinary spaces of interaction comparable to those observed in case studies. De Jong and 
Mendez were careful to draw the boundaries of their involvement and defend this articulation 
during their interviews. Thus although the immutability and mobility of the name remains intact, 
much of the actual collective actions to which this term gives a name are marked by uncertainty. 
The concern for constructing boundaries of collaboration and expertise could be read as an 
attempt to preserve their ‘identity’ and strategic position in forms of work to which they had 
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become accustomed and had achieved some success. Exploration beyond the boundaries of 
their existing expertise was portrayed as strewn with risk, and led the Institute Head to describe 
translational research as ‘hard and dirty work’. As is discussed further in the next section, De 
Jong’s reported propensity to pursue such risks was framed within a repertoire of enterprise. It is 
such risk calculation which appears to constitute a significant boundary to more whole-scale 
adoption of translational research as the strategic position for the laboratory.  
Cycles of Credit  
Applying the cycles of credit framework generated an enormous quantity of coded data within 
the transcripts of this particular case. This section will provide an overview of these findings, 
starting with the sub-topic of group structure before focusing on the construction of individual 
careers of scientists in relation to the idea of translational research. 
Group Structure   
De Jong identified that shifting from ‘basic’ towards ‘translational’ types of problem choices 
would necessitate significant transformations in human and non-human elements constituting 
the laboratory. For instance, at present parts of the laboratory’s workforce, like technicians, are 
employed in order to process experiments focusing on basic cellular processes. One of the 
implications of this re-configuring could well be ‘downsizing’ the ‘human resources’ elements 
like technicians. In their accounts De Jong and Mendez evoked a sense of familiarity with their 
employees, owing to the relatively small size of the laboratory and the feelings of ‘co-presence’ 
this engendered. As De Jong states, one of the occurrences which ‘keeps me awake at night’ is 
running out of money to pay his employees: 
“You see they come here from all over the place, they put trust in me, and then, you 
know, if I say ‘you can’t do your work anymore because I have run out of money’ then it 
is not fair on them because they have come from France or Italy or Greece or wherever. I 
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have a responsibility to them…I mean within reason. But for me to run out of money 
because I spent it too quickly…”  
One measure by which he seeks to temper this risk is by not expanding the size of the laboratory 
to an extent that actor-networks begin to unravel: 
“I think it can grow a bit too fast. And I talk with friends of mine who’ve got a big group 
of people and I say ‘do you enjoy your work’ and they say ‘no’. I’m in control. I’m in 
control. Do you think [the Head] is in control? His agenda is set by all sorts of 
organisations…” (De Jong) 
Moving to occupy a more explicit ‘translational’ position over an area of scientific field risked 
coming at a heavy price for De Jong, namely loss of his managerial control, coupled with 
subsequent loss of reputation and betrayal of interpersonal relations.   
Concerns those respondents other than De Jong and Mendez had towards problems posed by 
translational research can be read in relation to the types of roles they were accustomed to 
playing within the organisation of the laboratory. For example, the technician’s role does not 
infringe upon layers of organising concerned with aligning the laboratory to the social world. 
Here then the hierarchical dynamics of the laboratory become clear, as the technician for the 
most part is expected to obey and accommodate rather than pro-actively (re)write this sort of 
script. The notion of translational research is therefore kept largely ‘black-boxed’ by the 
technician, who can imagine only very indirect ways in which this idea permeates his mundane 
activities and practices:  
“…I: Does that motivate you… 
Tech: …Yes if I think about my role and how it may influence on a more general sense, 
then yes I am aware of it. But on a daily basis I’m more aware of the routine aspects of 
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my job. But as you ask me these questions and I think about my role, you really start to 
realise about what I do and the real impact it has.” (Morales)  
 
Within the routine aspects of laboratory organising, Morales recalled being exposed to 
exchanges about translational research mostly within team meetings: 
 
“I: Is it something that would be said in meetings in any shape or form? 
Tech: Yes, we have lab meetings all the time and this is something that gets discussed a 
lot. ‘What are the potential impacts of the work that we do? And will it get developed 
into something that will help people?’ So it does get discussed, but I really see what we 
do as grass roots - we’re actually a long way from getting it produced and onto the 
market.” 
 
Within the accounts of the post-doctoral researchers, it is similarly on these occasions that the 
organisation’s concerns for translational research are brought explicitly into view. In these 
meetings they will be asked to report on the progress of their projects and suggest new 
directions they were considering. The meetings were said to provide an opportunity for 
members to ‘troubleshoot’ amongst colleagues. For the post-doctoral respondents, much of this 
advice will come from more senior members of the laboratory. Interestingly, both respondents 
described seniority as relating to degrees of knowledge members had acquired rather than 
simply a function of their formal roles within the employment organisation. In other words 
seniority is determined to some degree by credibility, not just formal rank. Yet the member of 
the group to whom they reported showing greatest deference in these occasions was the PI. It is 
he after all who is seen as possessing the know-how about aligning experimental and social 
world levels of organisation. In this way the post-doctoral researchers see themselves as being 
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dependent on the PI to help them further their own capital accumulation as scientists. Such 
practices appear to provide strong intimations about a power-knowledge nexus enacted within 
the microprocesses of the laboratory (Foucault, 1978, in Latour & Woolgar, 1986, 229). From the 
various interview responses it can be inferred that on such occasions the post-doctoral 
researchers and others have been asked by De Jong to account for how they intend to articulate 
an alignment between their proposed experiments and translational agendas.  
 
“You have the ability to take your project in whatever direction you want for quite a 
while without him interfering. So he isn’t a micro-manager, he sort of isn’t necessarily 
leading. It’s more like a conversation. He might be holding the more strategic part of the 
conversation but the conversation is not necessarily him saying ‘you do this’, or ‘you 
have to make the project this way’. He might just give you these ideas.” (Madeira) 
Typically for post-doctoral researchers this ‘type of conversation’ appeared to occur in later 
stages of project articulation than for more experienced researchers, who are expected to have 
this strategic know-how incorporated more readily into their work practices. For the post-
doctoral researchers then, the problem of translational research was an intermittent one 
occurring at various points in the life-span of a (4-5year) project. As well as filling the portfolio of 
the laboratory with ‘translational’ projects, part of the rationalisation De Jong gave of this 
management tactic was to afford early career researchers an opportunity to build-up their own 
credentials and know-how with regards articulating project work in a way which was responsive 
to this ‘growth area’. As well as giving the so-called next generation of scientists a ‘flavour’ for 
translational work, the PI described how he would - where appropriate- permit them to take 
ownership of this work and pursue it further in their subsequent careers beyond this particular 
laboratory. Here then is one way in which the idea of translational research is said to be 
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translated into existing practices of the laboratory, namely by informing and justifying the hiring 
and training of staff.  
 
As implied by earlier discussions, the PI is a key linking-pin of the actor-networks of the 
laboratory through which translational research is made visible. There are aspects of the 
laboratory’s work which fall on his shoulders. For instance, it is he who consults with drug 
companies, interacts with clinicians, and accounts for the laboratory’s academic performance. 
One aspect not yet covered by these earlier discussions is the struggles the PI has faced in being 
made to account for aligning his laboratory’s research output with the formal standards of the 
REF. When discussing publication targets this alignment was black-boxed by respondents, as 
each displayed confidence that the regularity with which they would publish in top journals like 
Nature and Science acquitted them well for this process. But one aspect of the process with 
which De Jong had encountered some difficulty was accounting for their output in terms of 
‘impact’. An ongoing debate at the time concerned which particular examples of work done by 
the laboratory could fulfil the ‘impact’ criteria of the REF. It emerged that what the PI had 
thought worthy of impact and what was deemed satisfactory by the Head of the Institute were 
two different matters. For one, work which had eventually been scaled-up into commercial 
developments and clinical trials, had been accomplished elsewhere, before his lab had moved to 
the current institution and was thus disqualified from the criteria. Here then was one aspect of 
the REF to which he displayed criticism: 
 
“So I think I would find that silly because everybody knows it takes ten years. Everybody 
knows that to get it to work you have to move places. So I think it is a bit short-sighted in 
a way to look at it like this. I don’t want to take all the credit for this clinical work, but it’s 
something I have at least facilitated.” (De Jong) 
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In contrast then to publishing basic research in top journals in order to meet ‘excellence’ and 
acquire (re-investable) credit, clarity of the means by which they could be credited for meeting 
‘impact’ criteria was more opaque. Another problem in aligning their work to this agenda was 
that the criteria does not formally acknowledge commercial exploitation of research, one of the 
‘trump cards’ the laboratory’s ‘translational research’ activities he felt entitled to play. Finally, 
the publication of ‘Review’ articles in prestigious scientific journals- commenting on existing 
state-of-the-art in scientific knowledge and proposing directions in which an academic field can 
and should move (including its clinical potential)- was not able to meet REF standards (as 
interpreted by the Head): 
“Then I asked him [Head] what if you write reviews in Nature/Science and he answered 
‘that’s just vanity, it doesn’t count’. But, you know, not everybody writes reviews in 
Nature, there are only a few people in the world who are allowed to write in Nature- this 
is influential stuff. You are setting out the directions for the field as a whole- clinical, 
basic, whatever- I mean this is impact-type stuff so I don’t know why this would not 
count.”  
From this excerpt it can be deduced that periods of time in which the PI (as author and 
spokesperson of the laboratory) was positioned under this ‘impact’ script appears to be 
relatively short and the techniques management use for implementing this script can be 
informal (through conversation). As such, the REF’s criteria of impact appears to De Jong less like 
an ‘iron cage’ in which the laboratory is constantly trapped, and more like a leaky roof they 
cover-up on occasions which accentuate this problem. At the time of the interview this 
controversy had not been resolved, although the PI intimated that he considered this matter 
more pressing for the Institute than his laboratory whose major objective in meeting the REF 
was still its publication and grant targets.  
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In sum the group structure of the laboratory is adjusted slightly to accommodate pressures of 
translational research. This is done intermittently and in a way which appears to (re)affirm 
existing circuits of power. The post-doctoral researchers had the task of aligning their projects 
with ‘translational’ agendas delegated them by senior members of the laboratory at various 
points in the life of a project, namely through conversations in meetings. This form of task 
delegation was reasoned to be appropriate to the levels of competence post-doctoral 
researchers were expected to possess. For their part, the post-doctoral researchers appeared 
content to distance themselves from such responsibilities and concentrate on their main work 
tasks. By common consent much of the responsibility for constructing a vision for the 
laboratory’s engagement with translational research was said to be the responsibility of the PI, 
whose role was to manage and build the reputation of the laboratory. He therefore had to 
ensure the continuing operations of the laboratory and account for the research being done 
against the expectations encoded in certain scripts like the REF. Efforts to stabilise definitions 
and stories about the laboratory’s activities were not completely accepted by the Institute Head. 
This suggests that arguments about robustness and relevance have to be fought and negotiated 
and when common definitions stabilise, this is a relational achievement (Latour, 2005, 138; 
Nowotny, 2006, 5). As will be argued in the next section, this positioning within the group 
distinguishes De Jong’s account of alignment between translational research and career from 
those of the other respondents. This general topic will now be taken-up for further discussion.  
 
Careers 
The extended notion of credit will now be applied to study scientific careers and the orientation 
of researchers towards translational research as a capital investment. There were diffuse 
patterns across respondents’ accounts in relation to their careers as individual scientists. Much 
of this can be attributed to the individual’s positioning within networks of the laboratory 
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(‘hierarchy’) and the credit each had accumulated to date. The post-doctoral researchers 
accounted for their current employment positions as a procedural step in their intended career 
paths as scientists. They told of being incentivised by the goals of learning a range of skills which 
would further qualify them as competent practitioners of science and equip them with necessary 
forms of capital to be mobilised in pursuit of paid employment in academia. In doing so they 
would also fulfil their responsibility towards the laboratory of producing interesting research 
which would result in publications in scientific journals. Both during their PhD research and into 
their post-doctoral training these two researchers had focused on kinase proteins Alignment 
with a particular family of kinases promised a broad range of advantages from which their 
careers might stand to profit. By becoming associated with a formal organisation (the 
laboratory) with a reputation in this topic area the post-doctoral researchers hoped to boost 
their own credibility as scientists. In particular the post-docs told of how the reputation of the 
laboratory with using particular techniques in particular problem areas would reflect well on 
them as individuals in the eyes of prospective future employers recruiting expertise in this 
problem area. In terms of explanations which chime with the credibility cycle model, 
respondents spoke about investing in areas which would yield doable research problems- i.e. 
promise a return on their investment: 
“I: So what attracted you towards this change? 
Post-Doc 2: There were a few things- I was looking to gain a new skill-set when I started 
my post-doc. As well as my cell biology background I also wanted to have new skills so 
that if I wanted to go find another job or I wanted to go move into industry then I also 
now know x, y, and z.  This lab does a lot more animal work and I had never worked 
with mice before. So that was one aspect. Also the mass-spectrometry aspect I thought 
could be quite applicable if I wanted to move into industry.  It’s more of a new 
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technique, so I thought it could actually look good on my resume to have this entirely 
new skill set.” (Madeira) 
 
How they had come to occupy this strategic position in the field was narrated as much in terms 
of accident as design, but having moved to occupy such positions they had come to consider 
some of the potential pay-offs it might afford them as individual scientists: 
 
“Post-Doc 1:There are so many interesting questions to answer and to do experiments 
with, especially with the system that I work with. These enzymes are phenomenal, in 
terms of how little is understood yet how important they are- they’re very highly 
conserved within evolution, they are important in diseases- but we still don’t know 
what they do. So for me I’m trying to work on different aspects of it.” (Enfield) 
One of the potential pay-offs of focusing their growing expertise on this topic was the relative 
ease with which they could align problem choices with growing external demands for 
translational research they anticipated would occur in future. Growing interest in this idea within 
their own and other scientific fields was interpreted as potentially leading towards opportunities 
for them to accumulate capital as individual scientists, by joining forces with a PI and laboratory 
with a reputation for translational research which they hoped would make them  a more 
marketable commodity in future: 
“I: Interviewer: So is that something you are conscious of yourself, or… 
Post-Doc 2: I’m not as much yet, but that’s part of the reason I came to this lab was 
because I thought it would be a good place to learn how to think that way- because I 
never did that in my old lab as much. And I think that is an important skill just from a 
purely financial point of view, from a security point of view, for so much more funding 
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nowadays you have to be able to have translational research and be able to have ties 
to industry or potentially want to go into industry.” (Madeira) 
For Enfield, the need to articulate her interest in basic science with external translational 
agendas was something which she believed would be advantageous, if not obligatory, to her 
career. Yet her lack of know-how as to how to go about doing this was the cause of some 
insecurity, both in terms of long-term future employability and her ability to acquire competent 
member status in her tribe. For some then translational research connotes a certain degree of 
disembedding effecting loss of ‘ontological security’ (Giddens, 1990). 
The career-paths of post-doctoral researchers were modelled on typified versions of scientific 
careers ‘laid-out’ within their field: where success was measured in terms of ability to move 
away from laboratory bench work towards acquiring responsibility for more managerial aspects 
of work organisation (ultimately becoming PI of their own laboratory). Conversely for the 
technician whose role is attached to ‘routine’ experimental processes, translational research was 
something that management worried about. His own career path was constructed away from 
academic science: 
“I: Is there a trajectory in terms of career development that you look to? 
Tech: I guess so, I’m part of a service and I’m becoming more involved with the 
administrative side of it too. It would be towards maybe managing a service facility for 
example. That’s where I see myself going in the long term, in the short term its more 
expanding my knowledge in the area. The past three years I have really been focusing 
in particular techniques and machines, so now my focus is to become more of an 
expert rather than a generalist.” (Morales) 
 
Translational research was very much part of the ‘bigger picture’ to which he was contributing in 
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small part, but had little influence on the kinds of investments he would make as an employee of 
the laboratory. 
 
For the figure of the PI, unless they take-up an altogether new type of role at the level of the 
field or a more managerial position within the university, further career development is typically 
tied into the fate of the laboratory in terms of expanding its operations and reputation within a 
given problem area. As one might expect, the concerns of De Jong (as a tenured professor) with 
regards career development were not centred upon questions of financial security, so much as 
loss of reputation he had built up over time in his field. Therefore ensuring the laboratory was 
organised in such a way as to ensure continuing success through credibility cycles was much 
more of a priority than getting individual experiment to run properly (as with post-docs and 
technicians).  
 
The fieldnotes recall that interviewing De Jong was first suggested by the Institute Head on the 
grounds that he was an enterprising figure with ‘a strong commercial vision for translational 
research’. His reputation for this vision also arose amongst his colleagues with whom I spoke and 
this theme emerged regularly (I felt largely unprovoked) from our interview discussions. 
Conversely I was surprised to find that my interview with Mendez- who had after all co-founded 
a spin-out company with De Jong just prior to the fieldwork- did not produce this kind of 
account. For Latour and Woolgar scientists often begin to describe their careers in such an 
entrepreneurial way when they come to take charge of their own laboratories, as this is when: 
“…they may begin to cash credibility in their own name. They may thus say they ‘have 
had ideas’, that it is ‘their’ laboratory, and that is they who have managed to attract 
money and equipment in the interest of securing the basis for their operations.” 
(Latour & Woolgar, 1986, 229) 
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Mendez had not yet reached such a position. Conversely then  an entrepreneurial repertoire 
emerged at various points in data from De Jong’s interview, notably during passages discussing 
his career development and the risks associated with pursuing translational work. Notable 
features exhibited in De Jong’s account include unwillingness to play by the rules expected of 
him by more conservative colleagues (‘laggards’) remaining embedded in basic science: 
“You know, I have to say that what you do not know you find a bit strange and I think it 
is fair to say that I go to basic science meetings and I feel that I am sometimes a little 
superficial compared to my colleagues. Because, you know, you can’t do everything, 
there are only 24 hours in a day. I work on fifteen subjects. I do mouse work, cell work, 
I talk to companies. This comes at a cost. You are broader. I think some of my 
colleagues are so specialised in a very small area. I was in that area before, but now, 
when I talk to them I obviously don’t have that depth of knowledge anymore. And 
sometimes, you know, you are looked upon as if ‘ooh that was a stupid question’. But 
it’s a small price to pay, I don’t mind. I don’t mind.” (De Jong) 
Conversely those basic scientists who stuck relentlessly to exploiting and specialising in existing 
forms of knowledge were brandished as conservative and risk-averse: 
“There are people here in the cancer centre that have a mouse which may have a 
metabolic phenotype but they don’t look at it because they are nothing to do with 
cancer…I think people should look a little broader in their work and think a bit more 
translational. I think this is all about translational- you don’t necessarily have to do it 
yourself, but, you know, you can actually give it to someone else or talk to another 
person…I think colleagues of mine that have no translational inclination, they say ‘I 
can’t be bothered, I don’t want to do it, I want to look through my microscope, nothing 
is going to happen’.”  
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Disposition towards exploring translational research (a ‘new’ institution) as opposed to ‘playing 
safe’ by specialising in basic research marks him out as an enterprising figure: a leader rather 
than follower. Similarly on several occasions he remarks about his propensity to ‘stick to his 
guns’ and ‘see through’ decisions after periods of deliberation. The opportunism used to portray 
his past actions was applied to his interest in translational work and more generally to the very 
family of PI3Ks on which he had built his reputation. For example the ‘decision’ to focus on 
experiments using blood cells was a pragmatic one emanating out of ease of access to this tissue 
type. Likewise, the interest in exploring translational aspects of his basic research was reported 
as emerging serendipitously as a result of an unexpected linkage between the family of kinases 
he had discovered and human diseases: 
“I have to say that some of the targets I worked on were highly expressed in blood cells 
and it was like a natural door if you like.” (De Jong) 
The know-how he acquired from this time in his career with regards aligning his basic research to 
disease processes was something he claimed he had pursued ever since. Hence although not 
exactly a ‘Eureka moment’, he was able to pinpoint a particular event which triggered his 
interest in translational work. This interest was defined in terms of the strategic advantages it 
would bring in terms of increasing the size and reputation of his laboratory. As the kinases he 
had discovered had been a growth area of research in his scientific field over the past 15 years 
and he had received credit for this, it was perhaps not surprising to find that the organising of his 
laboratory was very much centred around running experiments which would lead to publication 
on this topic. Out of this came many pay-offs. Pursuit of translational research was therefore just 
one benefit afforded to him by the ‘interpretive flexibility’ of PI3K as an ‘epistemic object’ 
(Knorr-Cetina, 1997):  
“I have a real passion for science. I think it shows and I want to use it. I want to use it to 
make business, to do good papers, to train people.” (De Jong) 
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In terms of future development, he described a desire to remain close to the laboratory and 
increase his profile as ‘a basic scientist with an interest in translation’. He was however also 
conscious that to do so would mean adapting to growing demand for work in the lab to 
demonstrate ‘translational’ qualities, which in the short term meant becoming more acquainted 
with expectations of funders like MRC (as well as BBSRC). It would also mean having to negotiate 
various political pressures from the institute calling him to expand the size and scale of the 
laboratory. He had so far resisted this on the grounds that it would bring about more variables 
over which he would have less control.  
As discussed above, interacting with stakeholders outside of basic science can be time-
consuming and potentially risky in terms of detracting from other forms of work for which they 
might well receive more credit. The ability to profit financially from undertakings outside of the 
laboratory such as consultancy work, patenting and royalties for books can be said to add 
credence to the model of the scientific-entrepreneur (Knorr-Cetina, 1981, 79). Yet despite the 
emergence of authorship and risk in accounts of more established individuals, the notion of 
scientists as entrepreneurs is a dubious one. In part this is because they remain to all intents and 
purposes dependent on the government (as ‘employees’) (ibid.) in order to work. Ability to work 
‘may depend on decisions made at top organisational levels’ (Knorr-Cetina, 1981, 77), thus 
restricting the extent to which scientists can be said to have ‘control over their ability to work’ 
(ibid, 78).  In advancing in their careers scientists adhere to a set of institutions stipulating how 
individuals are to pass through the ranks of laboratory hierarchy, suggesting in fact that they are 
anything but rule-breakers.  
In sum what forms ‘translational research’ is expected to take and how important it will become 
as their careers develop are ambiguous, open-ended questions. As well as the potential 
advantages of pursuing translational agendas, for respondents the sheer ambiguity of this 
pressure also appears to carry threats of ‘ontological insecurity’ (Giddens, 1990), with regards 
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shifting the laboratory’s problem choices in this direction. The improvisation of aligning 
translational research with work they had been doing on Kinases might suggest more broadly 
that under present conditions in order to travel in a way which ‘speaks to’ scientists and 
engenders changes in practice, the idea of translational research must be re-embedded 
alongside existing mundane activities and practices, rather than altogether displacing them. This 
might mean that in settings where this would risk bringing disruptions to existing operations and 
symbolic attachments, the idea would be more likely to encounter degrees of avoidance and/or 
defiance (Oliver, 1991). Making sense of this problem was thus a matter of improvising based on 
what they already knew and had come to expect about this given problem. Methodologically, 
interviewing researchers at varying stages in their careers provided the advantage of revealing 
the uncertainties and ambiguities which beset members of this laboratory. What became clear is 
that these respondents’ deal routinely with overdetermined information out of which they are 
trying to make some sense. Against this process, it has been found that translational research is 
but one pressure of which they are expected to consider.  
Chapter Conclusion  
This chapter has presented findings from a case study of a molecular biology laboratory’s 
engagement with the idea of translational research. Each of Latour and Woolgar’s four 
frameworks for studying the mundane aspects of scientists’ activities and practices were used as 
initial sensitising concepts through which the data was coded and analysed.  
The history of the laboratory section found that in general translational research was defined in 
terms of that which brings them together with others (a boundary object), notably clinicians and 
commercial actors. The term also circulated as a boundary object between members comprising 
the host cancer Institute and was promoted as a management tool for internal marketing 
purposes. Through interview responses I inferred that sustained embedding and positioning of 
the laboratory’s research in norms and activities seen as becoming of basic research appeared to 
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sustain degrees of resistance towards the institutionalisation of translational research. Senior 
management figures like PI and S/L, instead projected strategies of compromise with which they 
sought to guide actions towards these field pressures (Oliver, 1991). Hence aligning basic cellular 
experiments with specific classes of diseases was seen as one means of meeting translational 
agendas whilst retaining their identity as a laboratory interested in basic science whose main 
currency was still in ‘Science/Nature Papers’.  
Owing to types of data generated from fieldwork on this case, some of the analysis reported in 
this chapter does not mirror that of the previous case. This is particularly the case in terms of 
applying Latour and Woolgar’s notion of microprocessing. In the absence of data gathered in 
situ, this framework was instead used as indicative of a broad set of motifs against which to 
explore and code for patterns in the interview data. In doing so it was found that certain 
important boundary objects came into view in instances where respondents described the 
processes of working with allies in the commercial and clinical worlds (i.e. when doing 
‘translational’ work). In a commercial capacity, one such mutual interest can be inscription 
devices into which the university’s technology transfer office and big pharma had expressed 
interest. The shared goal of seeing the mass spectrometry technology they developed scaled-up 
into commercial usage was clearly a key reason for interacting with commercial actants. In terms 
of interacting with clinical actants, mutual agreements about the factual status of knowledge on 
genetics enabled them in part to ‘speak each other’s language’.  
Despite identifying ’common ground’, the respondents were also keen to (re)draw boundaries of 
their involvement in such processes, by way of ‘boundary work’ tactics. This would allow them to 
retain sufficient levels of local expertise so that they could ‘retain their identity’ as a basic 
science laboratory and ‘stick to what we’re good at’. Compared with most aspects of the 
previous case study, here the discourse of translational research appears to have engendered 
boundary-perturbing effects which are more problematic to participants in this local 
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organisation context. Reasoning from laboratory studies (Fujimura, 1987), it can be argued that 
dramatic alterations in categories of problem choice (for example from very basic to very 
translational types) is likely to meet some resistances where this would necessitate step-changes 
in the places and practices which are said by participants to constitute ‘the laboratory’. One of 
the boundaries then in moving towards translational problem choices in a ‘purer’ form 
(measured by carrying out research with patients) is the disruption this would likely cause to 
those routine aspects of organising to which respondents have become accustomed and 
attached.  
Applying Latour and Woolgar’s inscription framework to written outputs of the laboratory 
yielded some illuminating findings. Their account of scientists’ concern for producing statements 
evaluated as factual and fundable via a series of ongoing interconnected actions (see for 
instance their credibility cycle diagram), although still current, clearly does not cover all of the 
struggles now faced by scientists in this case study. Latour and Woolgar gave little attention to 
the struggles scientists faced in enrolling support of funding, possibly because the laboratory 
they studied received regular income stream from the U.S. NIH, therefore having rarely to justify 
the utility of their research. Rip’s (1994) extended model goes some way towards compensating 
for this in reporting increasing pressures for relevance and legitimacy at the field level, arguing 
this has meant scientists are now required to justify their local research in these widened terms 
(Rip, 1994, Rip, 2004). This requirement was pertinent to certain inscription tasks observable in 
the data in this case, particularly the practices of writing grant applications and journal article 
reports. In engaging with translational types of research, certain respondents required 
confidence that projects could be funded and would lead to publication. This means they must 
mobilise a range of persuasive skills to enrol gatekeepers like medical research funders and 
journal editors, to an extent that was not appreciated in Latour and Woolgar’s study. Although 
speculative Type I statements have long been present within scientific journals and grant 
151 
 
applications, these were usually made in relation to contributions towards puzzles recognised 
inside the scientific specialty/field. Many of the texts included here also included statements 
with regards the wider practical utility of the findings. These sit alongside existing Type IV and V 
statements, rather than displacing them altogether. For Latour and Woolgar and for Rip, this 
part of writing practices was defined in terms of struggles for facticity. But demands for 
relevance implied by these particular findings suggests that discourse of strategic (read 
‘translational’) science has become more widespread and influential across stakeholders in the 
research system since Rip’s (1994) article was published. Perhaps as a result, at the local level 
scientists have had to become more accustomed to making promissory ‘utilitarian’ statements, 
so much so that, for some, it is considered already an ordinary part of routine practice. In the 
context of these case study findings, it might therefore be prudent to include struggles for 
relevance within the parameters of credibility cycles, and not external of them.  
From the cycles of credit section, it was found that translational research was a concern for 
certain respondents more than others, owing largely to the function of their respective roles in 
the organising of the laboratory. Notably this was a problem the PI was expected to deal with as 
the most senior member in charge of managing research agendas and formulating strategy. As 
such the problem of translational research appeared not to disrupt the hierarchy of the 
laboratory to any significant degree. The PI framed translational research as carrying some risk 
to their (main) pursuit to publish on basic science, as it could potentially detract from the 
scientific reputation of the laboratory and its members. However, he and Mendez saw 
commercial involvement as beneficial for bringing money into the laboratory in the form of 
licensing and consultancy fees and further successful grant bids, as well as enhancing its 
reputation. Hence where it could feasibly bring in credit without disturbing knowledge-power 
dynamics, translational research was earmarked as ‘doable’ area of problem choices for the 
laboratory to focus upon. Positioning their interest in PI3K within the parameters of a cancer 
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institute relieved ‘struggles for legitimacy’ in large parts for this group compared with 
researchers interested in other diseases which carry stigma like obesity (discussed in next 
chapter). This is not to say that the ‘struggles of legitimacy’ segment of Rip’s (1994) model is 
necessarily entirely redundant, simply that surprisingly it was less pressing in the context of this 
case.  
In considering their career development individual scientists recognised increasing demand for 
translational work over recent times and anticipated this becoming a growth area over the 
coming years. Such an orientation is highly suggestive of translational research as a self-fulfilling 
prophesy (Merton, 1948). Strategically this meant needing to become more outward-facing 
towards social actors in commercial and clinical settings. For the post-doctoral researchers, exact 
details of how they would do this were not particularly clear, as they did not yet have the 
practical know-how or network of relations in place to do so. Establishing such linkages with the 
social world is something ‘De Jong does’ and is not something they are expected to do. One 
post-doctoral researcher stated one reason for her joining the laboratory was influenced by its 
reputation as a basic research laboratory with some success at translational work: therefore 
associating herself with the laboratory might give her exposure to this type of work and transfer 
credit onto her as an up-and-coming scientist in search of tenure. However this instrumental 
account of her decision-making in relation to translational research was coupled with other 
investments in mouse-work and mass-spectrometry techniques. For the more senior members 
of the laboratory the investment in translational research was not expressed so much in terms of 
securing employment and professional status. De Jong’s priorities were to continue day-to-day 
concerns of keeping the operations of the laboratory running, something at which he felt he had 
achieved. However, aligning the laboratory output with the ‘impact’ agenda of the REF had been 
somewhat problematic.  
153 
 
Whereas certain of Latour and Woolgar’s sensitising concepts appear to have retained their 
utility in explaining the activities of these scientists, aspects of these frameworks, including 
scientists’ inscription practices and struggles for relevance, appear to effect mundane practices 
in a way not captured in earlier analyses. The extent to which this should lead to theoretical 
synthesis will be discussed further in the concluding chapter.   
In the context of this case, the aspects of the idea of translational research which appear to have 
travelled go beyond simply that of a name. Rather, the problem appears to involve changes to 
certain clusters of practices distinct to some of those depicted in earlier laboratory studies. 
Although these findings might lead one to state that this idea has engendered innovative modes 
of organising practices in the context of this case (Czaniawska and Sevon, 2005), this must be 
tempered with the consideration that certain of these dimensions now appeared routine and 
unproblematic for some respondents. Those aspects of the phenomenon thought to pose a 
threat to existing routines were subject to intense boundary work tactics within the accounts of 
respondents. Therefore, in local research practices where novel forms of articulation work are 
required which pose risks to scientists’ current work routines, there is likely to be defiance 
and/or compromise, if not avoidance displayed in strategic responses of organisations and 
individuals towards this agenda (Oliver, 1991). Findings also reveal that concerns about how to 
accommodate translational researcher are also intermittent and off-set by other events and 
pressures in their environment of which they are seeking to make sense. Overall translational 
research appears to require integration into existing mangled practices (Pickering, 1995), 





7. Transforming Diabetes? 
 
Introduction 
In this chapter STS materials are utilised in order to explore how the idea of translational 
research ‘travels’ within the specific and contingent context of a research group’s mundane work 
practices. It takes a case study format telling of a mostly basic science group researching a 
prominent disease in ageing adults: Type II diabetes. The main body of the chapter is structured 
around findings generated through pragmatic application of Latour and Woolgar’s four 
frameworks in analysing data on this case. It concludes by considering the effects of translational 
research on this local context and by reflecting back on the utility of existing STS materials in 
studying and accounting for these findings. Before doing so, it will briefly introduce the ‘cast of 
characters’ around which the case study is centred.  
The sample size for the study was six, with five researchers and a Dean of the medical school 
(see Appendix 1). The sampling of this case differs slightly to the other two empirical chapters, in 
that not all respondents identified themselves first-and-foremost as members of this formal 
organisation (which is referred to subsequently under the pseudonym ‘diabetes group’). One 
respondent in particular, Bateman, as a clinician with a laboratory in the University Medical 
School’s partnering hospital, did not affiliate himself with the diabetes group. He was brought 
into the case when earmarked by others as part of the informal network with whom the 
diabetes group would collaborate. Likewise- Kapoor- who had just started as a PhD student of 
Bateman’s on the NIHR’s academic-clinician track, was planning to learn his trade in the diabetes 
group’s laboratory space later into his PhD, but resisted speaking on behalf of the diabetes group 
when asked about specific organisational practices. Neither of these two respondents spoke in 
ways which would meet Douglas’s (1986) criteria of group members: defined through 
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identification of ‘we-ness’. However, as they were recognised as part of the network through 
which the diabetes group subsisted and were accessible for interviews, they were brought under 
the case. By contrast other respondents spoke of themselves as members of the diabetes group. 
These respondents worked in the group’s formal space, which was located in a large shared 
laboratory facility on the third floor of a building on university premises, situated directly 
opposite its NHS hospital partner’s building. They included McGregor, the PI, who had only 
recently founded the group. Another PhD student- Turin- who was also on the NIHR’s academic-
clinician track, but 18 months into the course and by now more familiar with laboratory work 
than Kapoor. Finally there was Thompson, a PhD student in the first year of his course with 
training background in basic science. The study was also able to benefit from an interview with 
the Dean of the Medical School in which the diabetes group and Bateman’s laboratory were 
hosted. He shared similar research interests and in the past had collaborated with both 
McGregor and Bateman, identifying his role as linking-pin in helping to bring them together. His 
role of Dean also meant he was able to talk more broadly about translational research and the 
strategic responses formulated by the medical school and university in response to this pressure. 
The findings from analysis of empirical materials will now be discussed in further detail.  
History of the Laboratory  
As with treatment of data in the other empirical chapters, the objective of this section is to apply 
ANT devices in order to map out allies brought into play and local meanings given to the objects 
that were used to define translational research. The section begins by reviewing the definitions 
attached to the term by the Dean of the Medical School, then considers how this immutable 




From the perspective of the Dean, writing and implementing a translational research strategy 
was cited as a means of meeting the (co-evolving) institutional control of the REF, particularly its 
‘impact’ criteria: 
“Dean: I think in the REF one significant difference with the previous assessment is that 
they actually improve credit for impact. Now what that makes people like me think 
about is that we don’t look just to this next REF, but we look to say the next ten years, 
you know because if these same individuals are still here we have to demonstrate that 
these people’s research has impact and actually we have to show evidence that it has 
actually made a difference. Now that process involves translational research. As a 
school we have to think about the types of infrastructure and mechanisms that we 
have to put in place in order to ensure that we do have an impact.” 
Part of the ‘infrastructure’ in place was the formal ties between the medical school and the NHS 
University Hospital situated across the road from their university site. It was hoped that this ‘co-
presence’ (Goffman, 1967) would serve to bring social actors from university laboratories and 
the hospital closer together, so as one could benefit from the knowledge of the other. Again this 
coming-togetherness marks translational research as a boundary object, working to open-up 
communication between these two worlds, in this instance at a local geographical level. In the 
Dean’s interview, translational research was also defined in a way that went one-step beyond 
the older category of strategic science, in that it was no longer deemed sufficient for researchers 
to have promising basic science findings, but instead were being encouraged to pursue more 
explicitly ‘technoscientific’ (cf. Latour, 1987) modes of work organisation. Again this was in part a 
strategic response for accommodating demands of the REF: 
“Dean: In the past we do the research and then we forget about it. We then have to 
wait for somebody else – an industry or someone else- to come and pick that 
research up and develop it further. The classic example is that you do research and 
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throw it across the track to the next trial, and hope that somebody else picks up and 
runs with it. But the thing is with that often people who have developed the trials 
have developed insights which may get lost once they are picked-up by someone 
else. You do not only need to involve someone else but it’s helpful to have some 
people involved who are further down the pathways as well.”  
According to the Dean, the medical school’s research agenda was structured around 
engagement with the MRC’s vision for translational research (with its ‘T1’ and ‘T2’ gaps). As such 
the MRC is credited as a key macro-actor in transmitting this immutable mobile into the medical 
school. At the local organisational level, the process of aligning particular research practices of 
individual research units to different components of the MRC’s de-contextualised framework 
required some ‘interpretive flexibility’: 
“I: So is the school’s vision tied in with the MRCs definition of translational research? 
Dean: More or less. I think we will not cover every aspect of it... but I think in the areas 
that our research does cover, that MRC-definition is what we are trying to do.”  
How these diffuse types of research corresponded with translational research was 
acknowledged to vary, but was nonetheless something for which each was said to be 
accountable. The Dean described how he wanted to get even fundamental scientists to start to 
respond to this agenda: 
“And for me the challenge is trying to work out where that work can move, to work 
which could then be translated if you like. So I think trying to do things which are 
applicable in any kind of health context. At the moment they are simply working out 
‘how does it work?’ So ‘what are the neurological implications for cancer?’- that’s what 
I’d like them to do.” 
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Another aspect of early stage translational work, which described a significant proportion of the 
work done in the school, was ‘bedside-to-bench’ research, in which human materials (from the 
local NHS hospital for instance) were transferred into the School’s laboratories in order to gain 
fundamental insights into disease processes. It would be hoped research findings could then 
feed-back in a ‘bench-to-bedside’ direction: 
“Dean: But then it is a case of taking this type of work through …trying to put a context 
to it and say ‘yes I have discovered this protein, but could it be about biomarkers of say 
cardiovascular disease?’ and things like that.”  
In addition, the Medical School also encompassed research focusing on the MRC’s T2 gap, such 
as studies working on implementation and validation of interventions (which have already been 
tested and developed) into routine practice in the health service. Aside from being translated 
into the formalised strategy of the Medical School, a notable feature of the Dean’s account was 
how translational research was construed as a problem of adjusting individual behavior, with the 
subject position of a ‘good scientist’ being defined in part in terms of getting them to do more to 
align problem choices with this challenge: 
“I: Okay and as a dean, are the researchers expected to pursue this agenda in some 
way or another? 
Dean: Well I think they all understand that they are not working in a research institute; 
they are working in a medical school. So the purpose of a medical school gives us 
several things we have to do. Apart from doing excellent research and publishing good 
papers, getting grants, and teaching, there is an expectation that the medical school 
will also contribute to making a difference in terms of health, whether on our patch, 
nationally, or internationally. But I think that’s the general culture that we are trying to 
put into the medical school, where everybody- including the person doing research on 
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basic molecular processes- thinks that, ultimately, the work, the mission, has to be to 
change health in some way.”  
Translational research is evoked here as a central idea in the institutional order of medical 
schools25. Notably however the emphasis on practical contribution does not altogether displace 
other goals like ‘excellence’ in publication. Here again the idea of translational research appears 
to enable certain agents to act-at-a-distance (via talk and texts) encoding information which 
looks to ‘nudge’ scientists into acting in certain ways.  For their part researchers in this case were 
aware of circulation of such messages and general (albeit ambiguous) instructions they carried: 
“I: What kind of vision do they [the school] have then which you have to be aligned 
with? 
Bateman: It’s a tricky one that. I think the usual things like innovative research, you 
know, patient benefits and so on. It’s all kind of general things which you’d expect, you 
know? Innovation and patient benefit I think are the main things. Clinical relevance and 
so on.”  
Definitions of translational research given by ‘coal-face’ respondents frequently referenced what 
they assumed were taken-for-granted delineations institutionalised in the medical research 
arena. For instance accounts pointed to institutionalised ways of ordering research themes 
picked-up from attending large medical research conferences. Here translational research was 
reported as an intermediary stage at the intersection of basic and clinical categories of problem 
areas, which were claimed to be broadly accepted and legitimated within medical research 
discourse. But how was this de-contextualised label transformed by mediators when brought 
back into the particulars of the Diabetes Laboratory’s local research practices? Through which 
                                                          
25
 His account (re)defines how medical schools, as a type of institution, should ‘think’ (Douglas, 1986). 
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networks were definitions made visible? What forms of work did these connections seek to 
accomplish? These are the questions to which the focus of this section will now shift.  
Within the MRC’s schema, the domain in which the group in the present case study was said to 
be operating was ‘T1’. The thrust of the group’s interest in linking basic research on diabetes to 
practical clinical outcomes was summed-up by the PI, McGregor, through the example of their 
interest in ‘dampening inflammation’ in body tissues: 
“McGregor: We are very interested in inflammation and trying to dampen 
inflammation, because we feel if you have inflammation it has the effect of 
exacerbating diabetes. That may be one of the driving forces for type II diabetes and 
cardio-vascular disease.  So if we can find a target to actually dampen that without 
causing any other side effects then pharmaceutical companies would be keen to 
develop that knowledge.”  
Producing new knowledge of inflammation could, they reasoned, lead to greater possibilities for 
targeting this effect through new drug treatments. Hence the coupling of the group’s specific 
interests with translational research was defined first of all in terms of a near-market positioning 
with pharmaceutical companies: ‘bench-to-bedside’ or ‘lab-to-market’ research. Here the 
‘bedside’ is constructed as pre-clinical then clinical stages of drug development performed by 
pharmaceutical companies. This focus was anticipated as helping to establish, via university’s 
technology transfer office, future opportunities for spin-out and licensing agreements. A 
consequence of pursuing this basic research is coming into contact with clinical materials and 
their associated clinical researchers. Here then a second illustration of translational research is 
brought to bear in terms of ‘bedside-to-bench’ research: 
“So we would go from the clinical-type elements and then we would bring it back down 
to the basic science. So it would be going from something that is already developed 
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and is given to patients in terms of drug treatment, and we look at what the additional 
benefits are and how that actually works at the molecular level.” (McGregor) 
A particularly prominent feature of such ‘bedside-to-bench’ collaboration in the context of this 
case was described in terms of formal and informal network ties with the local NHS hospital In 
particular, the gatekeeper led me on a trail towards Bateman, clinical researcher with a 
laboratory located in this hospital, with which the diabetes laboratory had particularly close 
network ties. The role of clinician enabled the latter and his clinical colleagues to approach 
patients coming into the hospital with diabetes or endocrinology problems as potential research 
subjects. This in turn provided basic scientists in McGregor’s group with a convenient conduit for 
accessing clinical materials, such as patient samples. Bateman’s laboratory also included certain 
pieces of ‘hi-tech’ instrumentation and inscription devices, notably a ‘state-of-the-art’ machine 
for monitoring body’s energy expenditure, the purchasing of which had recently gained some 
local and national media publicity26. One of the bases of the diabetes group’s collaboration with 
the clinical research laboratory had been over use of this equipment. Here then mutual interest 
in running experiments using this specialised instrument and materials brought the groups 
together, triangulating basic and clinical work on energy expenditure into complex research 
processes subsequently labeled as ‘translational research’. These had been identified as such on 
the basis of tackling problems which fed-back between typified modes of basic and applied 
clinical research. This association brought a ‘presence’ (Latour, 1987) of relevant clinical research 
to their basic studies on cell inflammation.   
Much of the collaborative linkages pointed-out by McGregor and Bateman alike were defined in 
terms of PhD projects co-funded and/or co-supervised across the two research organisations. 
These boundary spanning-projects and their associated individuals were cited as providing 
                                                          
26
 Incidentally funding for this expensive custom-built piece of equipment had been awarded through a 




concrete examples of ‘translational research’ projects conducted between basic and clinical 
contexts.  One such project was Kapoor’s, whose PhD looked at the effects of certain drugs for 
controlling obesity paths, first by carrying out clinical observation study of the effects on the 
whole-persons, which would then be triangulated with findings from fundamental experimental 
studies on cellular responses to these drugs. Another clinical research fellow, Turin, was 
carrying-out PhD work across the two laboratories with McGregor and Bateman as co-
supervisors. As an academic-clinician he was training in basic science laboratory in order to study 
the effects of food intake on weight control at the molecular level, and to study its pathological 
effects. The work was designated as part of a translational process because it took clinical 
samples and experimented on them with fatty oils. The process of taking samples from ‘bedside-
to-bench’, growing them with and without fat cells and comparing results, it was claimed, could 
lead to promising findings which could then be ‘taken through’ to tests on animals and humans 
(‘the translational stage’): 
“I can see if I do it in the lab and I see that chronic is worse than intermittent [weight 
loss] and which are good paths then I can use it to go and do research which would 
look at what course of action is better [for patients]. I would obviously need to do 
research which would prove that in terms of clinical trials, but I can see that what I did 
it in the lab and then go on to see its clinical context- so it’s following the process 
through- having a basic science and clinical interest means I can do both.” (Turin) 
This PhD problem is framed as a means of linking Turin’s existing interest and knowledge about 
clinical issues with new skills acquired in relation to basic laboratory science. Translational 
research thus labels the bringing together of his basic and clinical focuses.  
As well as the links with the hospital’s clinical laboratory, the diabetes group’s translational remit 
was extended to collaborations and interactions with pharmaceutical industry. For instance at 
the time of fieldwork there was an ongoing five-year collaborative partnership between the 
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group and a large multi-national pharmaceutical company. The basis of the collaboration was to 
explore the effects of fat tissue in cell stress, but with added focus on how such stress might be 
reduced through targeted interventions. This linkage brought their basic exploratory work into 
contact with those engaging in the ‘next stage’ of translational research (e.g. proof-of-principle 
studies). Again PhD training was an important boundary object in establishing the laboratory’s 
network connections with this ally. Thompson’s PhD was funded and co-supervised through this 
same company. In the context of Thompson’s work, translational research was brought into 
focus predominantly when referring to formal sponsoring of his work: 
“Thompson: I guess you could say they are the kind of industry pharmaceutical 
company who are trying to translate my basic research into a more pharmacological 
output.”  
The project thus involves in part a shift around the interests of his more immediate supervisory 
team in the diabetes group and industrial supervisors. From the management’s perspective, 
collaboration enables members of the group access to large and expensive equipment without 
themselves having to purchase and maintain this fixed capital and supporting infrastructure: 
“I: Would you troubleshoot with them [industrial sponsors] or would that be more the 
academic supervisors’ role? 
Thompson: No I could also go to them. In fact they’ve got some specialised techniques 
they use up in their lab. I’ve not gone there yet but I will be learning a few things with 
them. So they can show me further techniques as well.” 
These illustrations suggest the network ties associated with translational research to be based 
on negotiation of what ANT calls ‘equivalence’: the drug company can use students as a 
relatively cheap means of doing research; in turn the academic group brings in various forms of 
capital through which to support and extend its operations. Likewise the diabetes group and 
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local clinicians are brought together through access to each other’s know-how, labour force, 
equipment, and materials. Translational research helps to rationalise such relationships, bringing 
in a normative justification and putting a dramaturgical spin on organising being done within the 
laboratory, for the consumption of various audiences: Deans, REF panels, potential allies (e.g. 
future sponsors), prospective staff and students, and so on.   As a metaphor for innovation, 
translation thus appears to provide a post-hoc rationalisation of otherwise complex and messy 
local research practices in much the same way as metaphors were argued as doing in accounts 
scientists produce for describing their activities (Black, 1962).  
Inscription 
This case study is unable to draw on grant applications as documentary material on which to 
base analysis of this section. Likewise evidence taken from coding of journal articles (described 
in brief below) pointed towards ‘traditional’ passive modes of authorial voice used in the 
accounting for empirical phenomena in these texts (Gilbert and Mulkay, 1984), as opposed to 
more speculative, contingent, promissory statements regarding practical utility of findings (see 
examples in cancer case study). With these considerations in mind, the decision has been made 
to concentrate on how writing actions were accounted for in interviews with respondents. These 
actually provided a great deal of insights, especially from McGregor, who was able to reflect on 
first-hand experiences not only of submitting grants, but also assessing them.  
One initial observation to report in relation to grant applications is that like the cancer case and 
unlike the Obstetrics case (See Chapter 8), this group did not concentrate on applying for 
funding from a single funding council or program. Instead they applied to a number of 
organisations: private sector firms like pharmaceutical companies, research councils like NIHR, 
and charities like British Heart Foundation and Diabetes UK. In describing the pursuit of grants 
the respondents with responsibility over this task, two senior researchers- McGregor and 
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Bateman- described how they would make decisions about which funding body to court on the 
basis of likelihood of interest in a given research problem on which they were working: 
“I: As a researcher do you generally follow the funding bodies’ statements, visions? 
McGregor: Yeah, to be honest we only apply for the ones which sort of fit with the 
research that we’re doing. So the BBSRC are very interested in the sort of basic science 
elements. They don’t really want to hear about the medical research. But we can still 
do that element of the project without compromising what they wish to have.”   
The instrumental orientation of this action and impression given of grant writing as a ‘game’ in 
which researchers must persuasively transform the interests of funders, so as to get the latter to 
follow the former’s interests (Type II and III transformation in Latour, 1987), is further reinforced 
in the accounts of respondents: 
“I: Okay would they expect on say grant applications for your research to be aligned 
with their interests?  
Bateman: Oh yes absolutely yeah. If you want to apply to Diabetes UK then you have to 
put a diabetes spin on it or else they won’t be interested.”  
McGregor had sat on a board for assessing research applications at a major charity funding 
research into diabetes. He described in detail how translational research- the identification of 
the ‘next step’ to which the current proposal could lead- was an ‘obligatory passage point’ in 
winning funding from the committee: 
“McGregor: I think it is because they can sell it to the patients or sell it to the sponsors, 
you know, and when they go to the meetings they will generally say ‘we are funding 
this, that we hope is going to lead to some clinical outcome’ …So they are really 
critically reviewed because you know the people that are funding the studies – the 
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patients- have spent a long time trying to get this money… So the committee is very 
conservative and wants to be absolutely sure that there can be an outcome from the 
research. It’s not about being speculative. Blue sky projects don’t work very well either. 
It has to be a very much step-by-step approach. Funding bodies- and I think this is 
across all of them actually- don’t want to take that sort of risk very often.”  
As spokespersons for this charity, the peer review board will not accept abstract promises of a 
clinical pay-off: applicants must position the proposal in relation to other stages of the 
translational spectrum towards which their findings might credibly be scaled-up. ‘Translational 
research’ was recognised as a prominent labeling device (‘boundary object’/’immutable mobile’) 
used by these sponsors to frame the basis of funding exchanges with researchers: 
“I think you can do pure science if you want to but I think in terms of funding streams 
and particularly with what we are interested in, you have to put translational medicine 
in there.” (McGregor) 
The presence of interest groups in the organisation of their research and the alignment of their 
field with these groups’ interests makes the question of whether the scientists here are driven 
by research problems or clinical improvement an ambiguous one. Suffice to say, although lacking 
textual data in the form of grant application forms, it appears from interview accounts that 
translational research is already something of an ‘obligatory passage point’ in order to secure 
funding from a number of major sources. As well as exhibiting credibility as scientists, applicants 
must mobilise rhetorical skills in being able to put ‘a good spin’ on the proposals as key to this 
particular writing practice. 
With regards the presence of translational research in written journal articles, a search on 
PubMed yielded 9 papers accessible via my institution. These were downloaded and converted 
into NVivo software for coding. Again Latour and Woolgar’s five statement types were used 
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alongside identification of promissory instrumental statements in order to code the data. I was 
somewhat surprised to find no recorded instances of performative promissory statements in the 
texts, which instead displayed a prevalence of technical scientific discourse throughout. Part of 
this surprise perhaps came as a result of what I had been expecting, given the seemingly explicit 
requirements by grant awarding bodies for translational research to be demonstrated through 
these texts. It seems then whilst explicit focus on translational research is de rigueur in some 
institutions (e.g. grant writing) it can be less explicitly present in others (e.g. scientific journal 
titles).  
As with grant applications, decision-making around journal submission were described as guided 
by consideration of which title will most likely accept the research, as opposed to moulding 
research from the beginning around a particular title’s interests. Thus identifying journals 
synonymous with translational research and then tailoring research problems to interests of 
these particular titles does not provide a convincing explanation of the processes of problem 
selections and writing made in the laboratory. Here again instrumental factors come into 
consideration when organising writing of articles for publication: 
“Well as of yet I haven’t gone through that process. But I know where they send their 
work is an important decision. Other colleagues will discuss this in meetings and they 
always think of impact factor- that’s a key way of ranking journals by their 
effectiveness: how many people read the journals or the articles from those journals, 
and also their global distribution of the journal- whether it is available online, whether 
it can be accessed. There are several things they take into account.” (Thompson) 
With regards audience, a number of cross-disciplinary titles were identified to which 
‘translational’ work could be submitted, considered in terms of ‘impact factor’: 
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“Dean: Actually there is a wide variety. I think because of the nature of the work you 
can go anywhere from the best, which would be something like Nature: Medicine, then 
you have a long way down to all sorts of others [laughs]. The Journal of Clinical 
Investigation is another excellent one. The other specialist ones are things like Diabetes 
Care, Diabetes, Circulation, all of which I have published in over the years.”  
In order to write papers for such titles, a division-of-labour would emerge, with different experts 
focusing on particular sections of the paper. McGregor would frequently play a role of lead 
writer, giving him greater authority for editorial control. Part of the tacit skills required in order 
to write in these collectives was expressed in terms of tact, deference and learning about areas 
beyond one’s immediate intellectual purview. This appears a qualitative departure from forms of 
journal writing implied as routine in Latour and Woolgar’s study, whereby scientists write 
disciplinary texts with a view to being read and cited by others in their specialist network. The 
findings of this section appear to support the assertion that scientists must become adept at 
incorporating a large number of demands into their practices (Fujimura, 1987, Pickering, 1995). 
The varying demands of translational research on their writing appears to be something to which 
they must adapt, albeit, at the time of fieldwork, respondents accepted such demands as already 
a largely routine, mundane, and unavoidable aspect of their practices. The coverage of 
translational research as an explicit matter of concern appears somewhat patchy across their 
field of diabetes research: explicit instrumental statements appear de rigueur in grant 
applications to research charities in diabetes, less so in submissions for basic research sponsors 
like BBSRC, and largely absent from content of published scientific journal articles. However, the 
findings in this section have led me to conclude that within the context of this case, growing 
demand for translational research requires extensions in the persuasive writing practices of 





As with the previous case study chapter, this section reports on the results of applying concepts 
like ‘inscription devices’, ‘boundary object’, and ‘boundary work’ to the analysis of data. 
Specifically it is interested in how communication and consensus worked out in networks despite 
apparent demarcations between collaborators in ‘basic’ and ‘clinical’ research camps. Again this 
section utilises data generated through interviews. These sessions were helpful in terms of 
pointing to boundary objects which come into play in the course of collaborative work and in 
gaining insights from researchers about the challenge of engaging with researchers outside their 
own specialist networks. However, they do not provide detail of how boundary objects are 
actively (re)constructed in interactive settings. As such the section offers more of an opportunity 
to consider the utility of ‘boundary object’ and ‘inscription devices’ as abstracted sensitising 
concepts in the study of multi-disciplinary research contexts than it does an opportunity to 
engage per se with the ‘microprocessing’ framework presented in Latour and Woolgar’s book.  
As a formal organisational unit the diabetes group does not have access and control over all of 
the resources needed to conduct important aspects of research, but instead relies on being able 
to redistribute action through networks of allies when required. As well as members of the 
laboratory not requiring legalistic ownership or legitimate control over all resources, they are 
not required to stock ‘in-house ’all forms of expertise embodied by varying social actors: 
“McGregor: So we have the basic scientists, the bioinformatics, the pharmaceutical 
industry and also the clinicians. So that’s how we sort of build around our team. I don’t 
know all the clinical things so I can go and access them, and I don’t know enough 
bioinformatics so we can ask them on various elements as well. And we have 
collaborators as well who can help us on other aspects that we do that are different to 
bioinformatics.  So basically there are lots of different people we call on.”  
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One key finding from accounts of respondents was the recognition that although working 
together, they did not necessarily share the same goals or sets of interests as allies. For 
McGregor one key facet in explaining conflict avoidance was their propensity ‘not to disagree’, 
citing common techniques, as well as shared normative frameworks to which both they and 
clinicians subscribed. Although norms as motivations are thought to provide weak indicators of 
scientists’ behavioral outcomes (Mulkay, 1976), it does appear feasible that ideas and rhetoric 
surrounding patient-oriented research may play some importance in helping to unify and 
rationalise the collaborative endeavours in which McGregor has been involved, albeit the 
context of this case provides little by way of further detailed empirical explication of this point. 
Of more robust footing were references towards common themes (such as links between 
diabetes and obesity), methods and technologies shared across the practices of the diabetes 
group and hospital laboratory. In collaborating with clinical fellows, locating consensus around 
devices used to represent and analyse a given phenomenon in which they shared enough of a 
mutual interest was cited as important. As was mentioned in the History of the Laboratory 
section, use of hi-tech equipment in the clinicians’ hospital laboratory would provide reason for 
the basic and clinical researchers to work together. Furthermore, within this interactive space 
the running of experiments through PCR techniques was identified as something to which both 
sets of researchers can become attuned: 
“Thompson: Well we all use PCR. RPCR, that sort of thing. The quantity of polymerase 
chain reaction to express the level of gene expression in our samples. We also used 
western blotting/glossing- so that’s also a similar technique but instead it’s to look at 
the protein content within a cell- for a specific protein. So we’ll both be using those 
techniques.”  
There is recognised to be some asymmetries of expertise with regards knowledge of specific 
aspects of such boundary objects, however, chasms were not said to be so great as to distort 
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altogether information exchanged between members situated across the two worlds. The 
apparent ability for both to understand (or be taught about) readings from an inscription device 
helps form a basis for collaboration to work: 
“Thompson: The results both basic and clinical scientists produce are very 
interchangeable and one would certainly understand the other. So maybe a few 
techniques which are a bit more abstract in the basic scientist’s work that a clinician 
may not fully grasp just because they also have the medical side to have to focus on. 
But I’m sure they would understand if they read around the subject- a bit of 
background.”  
The availability of Standard Operating Procedures inscribed in manuals and shared intranet files 
is said to facilitate learning to operate shared machinery. Likewise it is accepted that at certain 
points some textually mediated engagement in clinicians’ ‘scientific literature’ is required in 
order to make collaboration ‘doable’: 
“I: To do this kind of work do you actually need to understand what it is they are doing, 
or can you leave them to it with their own specialties? 
McGregor: No we tend to know, or we tend to find out their expertise and to then use 
it. Especially when we are writing papers as a team, or I’ll be writing the papers, so I 
have to understand their knowledge. But obviously I would have to gain some of the 
knowledge through the literature.” 
The issue of trust is also raised in relation to such collaborations, with recognition that reading 
clinical literature alone would bring basic scientists only partial familiarity with information 
needed to do such work. In addition, basic scientists appear to rely on the credibility of clinicians 




“McGregor: So you do need some of their knowledge. Obviously, you know if you are 
selecting patients in terms of the criteria for certain studies, then you know, if they 
[clinicians] tell me that someone has a hypertension, they are hypersensitive and 
would have to be excluded from the study, then obviously I wouldn’t necessarily go 
and research that element because I would have to take their clinical expertise as 
given…So for those parts of the studies where they have clinical input, in maybe 
designing parts of the protocol for what patients should be selected or not, then I 
would leave that to them.“ 
McGregor then provides a hypothetical illustration of having ‘a sense for’ knowing when to 
intervene in relation to a finding, thus bringing a research problem back under his expert 
jurisdiction: 
“If there is something about [a clinician’s] interpretation of ‘oh well we’ve found out 
that protein x does such and such, and that’s important clinically because of such and 
such’ then I might go and look at the data as well and see what that is.”  
As such tacit inclinations appear still to be important facets of scientific practice (Collins, 1990), 
despite changes in context and production sites of science towards greater levels of 
technoscientific collaboration than was captured in situations described by earlier laboratory 
ethnographies. As with the previous case studies, concepts such as boundary object and 
inscription device help to account for formal and informal means through which ‘common 
ground’ is established when basic and clinical scientists are brought together in the course of 
articulating research projects designated under the label ‘translational research’. As such the 
STS-inspired notion that scientists rely on objects and devices in bringing them together with 




Cycles of Credit  
From utilising Latour and Woolgar’s cycles of credit framework to code and analyse data, it was 
found that accountability for issues of translational research was not distributed symmetrically 
across the group. The section will begin by describing how accountability towards this problem 
was spoken about and enacted  by respondents, before moving on to consider how careers are 
constructed in relation to the problems of translational research.  
Group Structure 
In contrast with the previous case, it became clear that the forms of social control associated 
with translational research remained enforced from quite a distance and with little regularity, 
with the senior management of the Medical School allowing large degrees of autonomy and 
interpretive flexibility with regards how this group responded to this problem. There was little 
indication that the researchers themselves had (yet) been made to account formally for how 
their work would meet criteria of translational research, be it through face-to-face meetings or 
in mediated forms. Part of the explanation for such a flexible governance approach was 
attributed (by both Dean and researchers) to the relative ease with which, when called for, it 
was thought the group’s research could be aligned in a credible fashion with translational 
research. Despite general awareness, a notable feature in the data was the varying forms of 
responsibility and accountability distributed in relation to this object. The PI was the member of 
the group responsible for linking together tasks associated with this problem and formulating a 
strategic vision, in contrast to others whose day-to-day concerns focused around problems 
situated at the experimental level of work organisation.  
One of the PI’s responsibilities was to apply for grants, which requires amongst other things the 
translation of general societal problems into specific research problems being addressed in the 
laboratory.  As well as being formal leader of the group, through interviews with PhD students it 
became apparent that McGregor acted as legitimate head and spokesperson the group (Knorr-
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Cetina, 1999). The PI occupies a more managerial role in relation to the research, steering and 
articulating levels of work organisation in a way which delegates action to members of the group 
along formulations of ‘rank’, competency, and mundane considerations like time-tabling.  
 
Insights into the effects of translational research on processes of grant applications were simply 
not forthcoming from more junior respondents’ accounts, as they had not (yet) begun to forge 
such networks. Staff and students were hired by the PI in order to work on distinct projects 
positioned around a common research theme in which (they hope) the laboratory will become a 
reputable player.  Having a group focused around similar theme in the same place is also hoped 
to bring about opportunities for troubleshooting and internal collaboration, thereby building 
local expertise within the group (a theme in laboratory studies and communities of practice 
literature). In interviews the objective of McGregor as qualified spokesperson of the group was 
to build and extend their operations through cycles of credibility conversions: 
 
“McGregor: I suppose personally I’m quite a high drive, get things done, get papers 
published person. I think part of that as well is to encourage students and staff. We 
have lots of PhD students I’ve supervised, fourteen that have passed and I think I’ve 
got five or six at the moment.”  
Within this institutional context there were asymmetries of knowledge and accountability 
towards translational research. Interestingly, for example, it was Kapoor’s supervisor (Bateman) 
who foresaw a likelihood that his student’s research would develop in a translational ‘direction’, 
with Kapoor himself still unsure of the details how his work would progress in such a way. Hence 
although he agreed with the general goal of developing an interest in translational work through 
his PhD, the specificities of the problem choice and his contribution were still unclear: 
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“Kapoor: Through my work I would like to help the rest of the scientists already trying 
to find obesity through brown fat and aiding them and giving them tools to actually 
quantify and see whether their drug or method works. That’s my broad area of 
research. So I hope it will help all these researchers who are in the process of trying to 
find a drug or a cure, or a fat or a weight losing measure.”  
As with the cancer case study, the practical problems posed by translational research appears to 
occur in ways which reconstitutes existing power-knowledge dynamics in the group (Latour and 
Woolgar, 1986, 229). This credibility appeared to reinforce McGregor’s overall position as leader 
of the laboratory, as it meant he was the only member qualified to manage across all main levels 
of its work organisation (Fujimura, 1987). From having sat on committees awarding grants, being 
lead author on scientific publications, supervising students, McGregor also had much greater 
degree of control in relation to organising actions in response to this problem. His ability to 
exercise control legitimately was based on his credibility as a more senior scientist and his more 
senior occupational role the institutional order of a university. But McGregor was himself 
manager of a division in a larger organisation, meaning he could be made accountable to senior 
management figures in relation to the outputs of his group, including its translational pay-offs. 
The REF, for instance, was a matter of concern for more senior academics, such as McGregor and 
Bateman. The PhD students interviewed lacked detailed knowledge of the REF criteria, with two 
even not initially recognising the name of the exercise. They dismissed explicit engagement with 
this concern as beyond their responsibilities, although they were brought under line with its 
goals through other means, such as career incentives (see ‘careers’ section below). Again a 
power-knowledge nexus appears in part to inform how accountability relations get worked out 
within the group. Although PhD respondents expressed a general normative commitment to the 
idea of translational research, they were ignorant of the co-evolving institution of the REF and its 
call for ‘impact’: 
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“Thompson: I’m only familiar with the outcomes of the previous one- is it RAE?- I don’t 
think I’ll be in a position for submitting that work because they really look for high 
quality experienced work. I might be able to contribute towards other members of the 
group or even supervisors, but no, personally I won’t.”  
 
At the time of fieldwork McGregor and Bateman described how management of the Medical 
School had given only intermittent attention to their respective responses to impact demands. 
This control had been loosely enforced and respondents had not been hard-pressed to come up 
with an immediate set of solutions to these problem areas.  
To conclude, within the group translational research and the co-evolving institutional control of 
the REF were more of a concern for those in managerial positions. This in turn consolidated the 
position of the PI as head and spokesperson of the group, suggesting that the problem of 
translational research does little to undermine the more traditional form of hierarchical 
organisation in the group. As will become clear in the next part of this section, translational 
research is a problem which early-career researchers anticipate having to provide solutions for in 
the processes of pursuing their individual careers in academic science.  
Careers 
One noticeable difference respondents here had from the other two cases was that they spoke 
of their group as having not yet fully established a strong strategic position in their field of 
research. By contrast then, much of the talk of careers- be it those of individuals or the group- 
were framed around goals of securing such position.  
As a PI, McGregor’s career was aligned with success of his group. Much of his concern for the 
strategic positioning of the group centred on their ability to compete in markets for translational 
research in the near-future. In a recent scenario presented by Rip (2011), scientists unable to 
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demonstrate credibility for translational research will struggle to attract funds from a number of 
research sources in the next decade. This scenario was found already to be apt in the context of 
this case: the laboratory was applying for funding from small grant bodies for ‘preliminary 
studies’. Until they had such studies in place, McGregor and Bateman claimed they would be 
unable to win funding from MRC, who fund projects capable of scaling-up such basic research 
findings: 
“I: Where do the majority of your funds come in from- the MRC, NIHR? 
McGregor: Not for mine no- with the MRC it is actually very difficult to get funding 
from them.  You need to have preliminary data in place in order to be eligible. So at my 
stage we’re not really looking for that at the moment. We’re more looking for the 
grants to get preliminary data so as we can then get in a position to apply for funding 
from MRC.”   
The market for research which did not follow this model was thought too small and therefore 
too risky for them to pursue:  
 
“No, I mean I think you can do pure science if you want to but I think in terms of 
funding streams and particularly with what we are interested in, you have to put 
translational medicine in there, because the days of doing science for the sake of 
science, you know, are sort of gone. You know the days of looking to see what a 
molecule does have gone- it has to have some practical use or offer some practicality 
that you think has long-term future that you are looking into with your basic science.” 
The relative lack of existing stockpiles of credibility in their strategic position was construed by 
the group’s leader, McGregor, as a problem to be met by encouraging rapid cycles of credibility 
conversions As a relatively new group they were not yet endowed with the promising results or 
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reputation to compete for large MRC grants in translational research, which were seen as the 
domain of the ‘big players’ at other prestigious universities. Taking preliminary results through 
further translational steps was therefore a future goal McGregor hoped the group could achieve 
by way of rapid credibility conversions and moving towards grants at an ‘intermediary’ stage 
between their current preliminary studies and desired big program grants: 
“McGregor: Well there is the NIHR program grant. They’ve got a development fund as 
well which is designed to develop projects- to then be in a position to apply for 
program grants.”  
Hence translational research is positioned as an obligatory passage point in order to continue 
and extend operations in the foreseeable future. Translational research grants from MRC are 
seen as the ‘royal road’ for competing successfully in this hostile environment and building-up 
credibility required to apply for this funding is a strategic priority for McGregor and his diabetes 
group. Yet another concern relates to the field of diabetes research in particular. Predicted rises 
of obesity and diabetes to levels of epidemic provided respondents with some confidence that 
this field of research would continue to attract investment. Yet they were also wary that there 
was increasing competition with others moving into occupy a strategic position within the area 
of diabetes research: 
“McGregor: I think the trouble with type II diabetes is that it is incredibly competitive, 
because you have Oxford, Cambridge, Imperial College London- lots of these 
universities that have very high calibre diabetes research departments…Those things 
are a lot more difficult now and you are competing against the same people each time 
who are very high calibre… I think money is a lot less than it used to be. And I think it 
will get a lot worse and that people are going to have to think about other avenues to 
try to support their research, look further afield and think about their research in a 
different way. I think it’s going to get tough for the next few years.”  
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In terms of short-term strategies, recruiting clinicians as PhD students to be trained in the ways 
of basic science was a strategic effort to forge networks with the local hospital and build-up 
expertise and reputation for research at the interface of these two worlds. Likewise having PhD 
students co-funded by pharmaceutical companies would add further layers of equivalence 
between themselves and the industrial partners needed to build a profile in ‘bench-to-bedside’ 
research. The group could also focus on articulating lines of experimental work deemed to be 
‘doable’ in the context of their laboratory resources which could then be packaged as 
‘translational’. For example, conducting a PhD project around fatty acids was convenient for 
Turin as he could gain easy access to these samples as a clinician working in the local hospital: 
“I’m looking at oils and comparing saturated fats. I’m growing cell lines- I’ve done that 
and now I’m looking at clinical samples. If we get fat samples then we have a good 
access to fatty acids…clinical research is easier to get access to because we are on the 
ward seeing patients.” 
Hence although modest in comparison to the contributions of large grants in translational 
research, Turin and his supervisors were keen to align basic experimental problems with 
resources in the laboratory and wider clinical problems in a manner which was ‘doable’ in the 
time it would take to do a three year PhD. As such, translational research is not necessarily made 
to denote research which is significant in scale of contribution, but can be used to rationalise 
and package quite modest projects which meet with its broadly accepted criteria.  
As with McGregor, Bateman was looking towards larger program grants around translational 
research as something to work towards for his laboratory. This was seen both as ‘where things 
are going’ and as a ‘natural step’ in the trajectory of current preliminary research being carried-
out. Thus current research is defined in relation to this prospective problem even though at the 
time of fieldwork his work did not fit easily into the category of translational research: 
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“Bateman: That is kind of basic work with a translational element – you can translate it 
to patient care actually, the management of obesity and so on. I think [the Dean] is 
more involved in that side of it at the moment. But I am trying to… I will be working 
more on that with time.”  
Possible career trajectories varied considerably between, on the one hand two PhD students on 
NIHR’s academic-clinician program (Kapoor and Turin) and, on the other, one co-funded by a 
pharmaceutical company (Thompson).  Kapoor had yet to become fully immersed in the 
diabetes group and therefore identified less with this group than the clinical laboratory. His 
career trajectory was constructed in terms of the NIHR’s formal academic-clinician path, with 
training in basic science seen as an interesting and necessary step on this path. The problem of 
translational research was one which he saw as consonant with his intended career trajectory, 
requiring little by way of ontological re-specification away from the career-type he looked set to 
follow. Translational research was therefore spoken of in a very positive and enthusiastic 
manner in relation to future career developments.  
 In being co-funded by a pharmaceutical company, Thompson’s possible career development 
could deviate significantly from his clinician colleagues, with the degree providing a possible 
platform for work in industry-based science. The status of his PhD work as basic  science with the 
promise of scaling-up into industrial developments made ‘translational research’ seem a ‘good 
investment’ in in terms of building a reputation for a career in industry. The demand for 
scientists here is seen to be much greater than demand for reputable scientists in academia 
where there is oversupply competing for dwindling demand from state funding agencies: 
“Thompson: Yeah well I think it is pretty tough for anyone at the moment. But I think 
the fact is there’ll be more opportunities in industry, because the organisations are 
running more like a business which need new employees regularly. Whereas I think 
academic positions are a bit harder to come by.”  
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Investments were being calculated in his accounts according to levels of security they seemed 
likely to bring. Other considerations- strategic positioning, normative commitments, and 
personal motivations- were ranked as secondary in terms of importance compared with such 
issues. Although translational research would likely form an important problem category along 
which to align his future problem choices, he recognised that he might not find academic 
employment, which would thereby render this concern redundant. This enabled some deferral in 
terms of how confronted this problem within his account. For now he would try to publish as 
first author in order to boost his value as a commodity in the market for academic scientists 
(Knorr-Cetina, 1981). 
By contrast, Turin did not appear to share Thompson’s concern for publishing scientific papers 
over the remaining period of his PhD, as he had already published systematic reviews whilst 
working as a clinician. Securing his place on the NIHR academic-clinician track provided some 
assurance of being able to continue to do research in an academic capacity after his PhD. He 
declared an interest in pursuing translational research in his future career in the form of follow-
up studies to his PhD work. However, the opportunity to discuss further his career plans was cut 
short by the respondent, who had to finish the interview abruptly (see Methods chapter). The 
account of Kapoor gave was very tightly coupled to the institutional career structures of 
academic clinicians and associated norms. Translational research was taken to be consonant 
with such norms, which, Kapoor claimed, had been a strong influence on his behavior and would 
continue to be so: 
“I am funded by NIHR so I definitely support the goals of NIHR and I try my best to 
incorporate the values of NIHR into my behaviour. There is an interest in patients. Which 
is largely in keeping with Diabetes UK and Wellcome- they are all the same – do ethical 
research; research that will have a health impact; do something from which patients and 
everybody benefits. I think that is what we are doing. Those are the right values.” 
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 Carrying-out studies further up the translational ‘ladder’ was seen as a ‘logical step’ in terms of 
continuing to align his actions in this way. However, Kapoor was the one respondent across the 
cases, that, when asked questions about career did not speak in economic language, such as 
‘investment’. This could be a potential weakness in Knorr-Cetina’s and Latour and Woolgar’s 
theories. However there was a strong possibility that he was ‘saving face’ within the interaction 
of the interview: as someone who had spoken of his primary commitment to patients, it would 
be embarrassing to then talk about his self-interest in forging a career. Indeed frankly it would 
be hard to imagine he had got to the position he was in without having made such calculative 
decisions at some stages of his career. Furthermore, he spoke at other points of keeping results 
secret until the point of publication, suggesting he was- like the other scientists in my cases- at 
least somewhat concerned about issues of credit and reward.  
In sum, respondents in this case constructed versions of future actions in relation to their 
careers against signals from the market for diabetes research. The (arguably post-hoc) 
rationalisation, by some, of careers to date in terms of alignment of their problem choices with 
translational research was a means of strengthening their credentials as individual scientists in 
markets for future employment. Aligning future problem choices with external funding agendas 
in support of translational research was seen increasingly as an obligatory passage point in order 
for them to continue and prosper in a career as an academic scientist. Again this anticipation of 
translational research as representing ‘where things are going’ marks it out as a form of ‘self-
fulfilling prophesy’ (Merton, 1948). The construction of individual career pathways formulated in 
accounts appeared to correspond with levels of accumulated scientific capital and various 







The aim of this chapter was to describe how translational research ‘works’ in the mundane 
practices of a small group of researchers working in the area of Type II diabetes. In doing so it 
looked to extend existing empirical knowledge on the subject of translational research through 
use of STS materials. Simultaneously it looked not only to use these materials as a resource, but 
also as a topic whose utility could be considered in relation to this task (see conclusion).  
The history of the laboratory section showed that translational research was defined along 
institutional categories prevalent in the medical research arena, as those studies which ‘plug a 
gag’ between basic and applied studies. It showed that researchers at the ‘coalface’ articulated 
an alignment between their own complex research processes and this abstracted 
label/metaphor. This section also brought into view a network of allies through which this idea is 
made visible and thus ‘doable’, which included collaborators such as clinicians and 
pharmaceutical companies.  
Applying the inscription framework highlighted how translational research has become an 
important consideration (a ‘box to tick’) for researchers in this case responsible for writing grant 
applications. Part of the rhetorical skill needed in practising this action involves being able to 
transform highly specific, specialised scientific problems into something which can credibly 
promise to make a useful contribution to clinical treatment of diabetes. The need to write 
persuasively can also be extended to the task of making NHS ethics applications. As such, 
struggles for ‘facticity’ (cf. Latour and Woolgar, 1986) are also met with struggles for ‘relevance’ 
(Rip, 1994) and ethical robustness in the practice of writing. Yet despite an extension in the 
persuasive rhetoric deployed in these situations, the ability to adopt the passive voice of 
scientific author is still a necessary component of writing in others, such as for journal articles. 
What was striking from this section was that seemingly innovative modes of organising (versus 
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earlier STS case studies) fitted alongside more familiar aspects in a way which was accepted, 
mundane and largely institutionalised.  
The microprocessing section helps to build an argument for the importance of ‘inscription 
devices’ and ‘boundary objects’ in bringing together and forging common forms of 
understanding between the basic science group and its clinical and pharmaceutical allies. These 
could include items mundane as use of common pieces of laboratory equipment and readings 
from a PCR machine, as well as the suspected links between diabetes and obesity as a clinical 
problem. This finding suggests that social studies of translational research have been so far 
opaque with regards how basic and clinical worlds are able to work together at the level of 
mundane, everyday work practice. The literature has so far concentrated on questions of failure, 
such as why large-scale funding pushes in programs like stem cell research have failed to 
translate into clinical treatments, concluding that there are huge cultural differences between 
basic and clinical worlds. However this ignores how it is collaborations between these two 
worlds are able to function at all successfully (even if it is at just one phase of the pipeline).  
Finally the cycles of credit framework helped to show how the travel of the idea of translational 
research had been transformed into a problem for which managerial figures were made 
accountable and responsible. This means they are able to author and then delegate certain tasks 
in relation to this problem. The lack of a strong strategic positioning in markets for translational 
research meant a priority for the group was to build a reputation through rapid movements 
through credibility cycles oriented towards this problem, for instance in the form of small grants 
which could be later exchanged for larger MRC grants in translational research. For early career 
respondents, the importance of translational research varied according to their existing credit 
levels as individual scientists, training needs, and career structures. The findings in this section 
suggest scientists will respond proactively to the challenges of translational research in 
situations in which it is calculated as being in their interest to do so.  
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In concluding this case study, it remains to ask what aspects of the idea of translational research 
have travelled to this site. The name has certainly travelled, as it labels some of the types of 
projects they have done in the past and look set to continue doing. Aspects of the practices 
consumed under this label are also present here and deemed ‘doable’, such as writing of grants 
and establishing ways of working with clinicians beyond their own specialist domains (as seen in 
sections on ‘inscription’ and ‘microprocessing’ respectively). Yet certain problems associated 
with translational research are not yet deemed ‘doable’ for the group and individual scientists, 
such as winning large MRC grants. As such they must extend their operations in respect to this 
problem in order to compete with any success. What is clear from the findings then is that 
translational research is deemed to be ‘where things are going’ and thus takes on the 














8. Transforming Obstetrics Research? 
 
Introduction 
This chapter uses empirical findings to describe how the idea of translational research interacts 
with the mundane work activities of a particular group of researchers specialising in obstetrics 
and gynaecology in the scientific and regulatory field of Health Technology Assessment (HTA). By 
the end of the chapter it is hoped that a convincing account of the ‘transformation’ (Latour, 
1987) of this idea in the context of this case will have been provided.  Latour and Woolgar’s four 
frameworks constitute the primary ordering devices around which the chapter is structured. The 
chapter will conclude by considering what aspects of the idea of translational research have 
travelled and the extent to which incorporating this idea entails innovative modes of work 
organisation in this particular case (Czarniawska and Sevon, 2005, 10). The case study is based 
on data generated from spending ten weeks following around six participants who at the time 
comprised the full membership of the research group. As elucidated earlier (Chapter 5), this case 
study was able to benefit from rich access to observe obstetric team meetings, clinician network 
meetings and clinical trial steering committee meetings. These six members included the Group 
Lead- Quereshi- an academic-clinician practicing gynaecology with broader interests in 
methodology and medical education; Matthews- a senior lecturer (S/L) specialising in systematic 
reviews; Kumar- a senior clinical lecturer (SCL) focusing on issues around obstetrics (her area of 
clinical practice); Pereira- an academic-clinician learning his trade as a post-doctoral (post-doc) 
researcher; and two others focussed more around getting the clinical trials to ‘work’, including 
Morrison- a clinical trials manager, and Aziz- an obstetrician in the local hospital. There were also 
interviews carried-out prior to the case study with a Dean of their host (mainly applied health 
research) faculty and an academic-clinician who had just joined the faculty.  
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History of the Laboratory  
Taking the ANT definition of an object as the point of departure, this section analyses how 
translational research was defined in relation to their networks of allies by respondents in this 
case study. The intellectual ‘glue’ holding the group together was a collective commitment to 
evidence-based medicine (EBM). Norms and values of EBM and HTA were strongly supported by 
all members of this group and were found to be reiterated by Quereshi in his inaugural lecture 
and by respondents in interviews. As the Centre Lead suggested, this may well have derived 
from the NIHR’s general championing of T2 translational research since its inception in 2007 
(having ‘trickled down’ from the ‘cosmopolitan’ to ‘local’ level (Rip, 1997)). Indeed Quereshi 
himself was open about the notion that he (and therefore the group) practised a type of ‘ritual 
conformity’ towards the vision of the NIHR (DiMaggio and Powell, 1983, Oliver, 1991): 
“Our vision is very much tied into what NIHR does, so we respond to NIHR’s calls and 
very often we succeed. Sometimes we don’t succeed, but as long as we are doing 
things on the NIHR line- the HTA line- then that works fine… I think they 
are…interested, if you like, in the extreme end of translation where you are figuring out 
this thing that is translatable already, whether it should be used in the NHS or not.” 
(Quereshi) 
There appeared to be strong elements of ‘mimesis’ in their adoption of the idea of translational 
research (at least in its form, if not substance) (DiMaggio & Powell, 1983). This cognitive 
category might be extended sociologically and be displaced by the statement that they are 
following a fashion, which functions as a kind of collective choice mechanism in organisational 
and scientific fields (Czarniawska, 1997). In this case the label ‘translational research’ was used 
interchangeably with ‘applied research’. As such incorporating ‘translational research’ does not 
require significant disruption to existing resources, inscription devices and routines with which 
they operate in their day-to-day work organisation, as in a sense it is already internalised. The 
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versions of translational research presented in the course of interviews were very tightly coupled 
with EBM and HTA norms that new evidence should come from clinical studies, usually 
randomised controlled trials (RCTs), along with synthesis of existing evidence through systematic 
reviews and meta-analyses (Greenhalgh, 2006). The legitimacy of clinical trials and by extension 
the researchers who perform them is that they provide scientific evidence to support the ‘gold 
standard’ of clinical practice (Timmermans and Berg, 2003). The meaning given to translational 
research by Quereshi in response to the interview question ‘what does translational research 
mean to you in the context of your group’s work?’ was related primarily towards the type of 
clinical trials they had performed historically: 
“For me it means we conduct clinical trials which test the applicability of something 
that has emerged from lab research, to patients. It is about doing research directly in 
patients, with newly observed molecules, devices and so on.” 
There are a number of different types of clinical trial and study. This group carry-out Phase IV 
clinical trials, largely in the form of RCTs, that assess the ‘overall risks and benefits’ of 
interventions which have already received licenses and are already part of clinical practice in the 
NHS (UKCRC, 2006, 15). Hence the metaphor of translational research- originally used in 
pharmaceutical drug development- is being picked-up and appropriated within the context of 
applied clinical research. In the context of this case ‘discoveries’ refer to the potential 
shortcomings of existing interventions on the market (discovered for instance through 
systematic reviews), which they then translate into ‘proof-of-principle’ studies in order to 
produce scientific evidence for relevant decision-makers. The clinical trial functions as a means 
of ‘scaling-up’ from promising discovery towards workable intervention (Dehue, 2001). For the 
obstetrics group, the research they do simply occurs at a later stage in this translational 
‘pipeline’ than pharmaceutical development. Systematic reviews were also framed as part of 
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their translational process, as they could potentially contribute to changes in clinical guidelines 
and constitute a basis for follow-up primary studies (e.g. trials).   
The translational hope of this research is to ‘displace’ (see, Latour, 1983) existing standards (or 
lack of standards) informing decision-making in clinical practice. Publication of guidelines was 
identified as the boundary at which the group’s involvement in the ‘career’ of the fact ceases 
and becomes the domain of an external network (Latour & Woolgar, 1986). In order to be 
translated into these spaces the researchers require subsequent acceptance and championing of 
the object by external gatekeepers. In affluent nations like Britain HTA and EBM are increasingly 
able to influences decisions of health agencies like National Institute for Clinical Excellence 
(NICE) (Webster, 2007, 34). For researchers such as these, operating in HTA field thus provides 
ready-made ‘infrastructure’ and ‘strongly-convergent network’ (driven by ‘macro’ actors like 
NIHR) in place to support (and legitimate) this type of translation (see Callon, 1991, 1995). The 
NIHR funds HTA research with a view to it being translated more-or-less immediately into 
evidence that will inform clinical practice. In terms of the translational potential of the group’s 
research, operating in this field means there is ready-made demand for the production and 
dissemination of the facts they produce: 
“On a day-to-day basis we do this study on [Intervention X], and if it shows that this 
actually works then in the next six months the NHS changes its policy and says 
‘everybody will get this test and in this condition”  (Quereshi) 
This is not always typical of the situation of researchers in other fields: in comparison the 
infrastructure in place to scale-up the research for the cancer and diabetes groups was sparser 
and networks had relatively weaker convergence. Hence this field as a whole benefits from 
positive externalities in the form of ‘the state’s regulatory apparatus in regard to the public 
health-care system’ (Webster, 2007, 168). The institutionalisation of HTA within public health 
care systems means there is relatively high demand for the types primary and secondary 
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research they perform, albeit this also means they face competition from others supplying these 
‘products’. In systematic reviews parts of a study are pre-specified to the researcher, sometimes 
with questions provided on a given complication, intervention or outcome. Once completed, 
synthesised evidence from systematic reviews usually gets written into guidelines and reports to 
inform clinical decision-making, like clinical practice guidelines, which are made available 
through international databases such as PubMed or Cochrane, and/or in Royal College or 
National Guidelines. Support from state apparatus towards HTA also enabled respondents’ 
claims that the speed of their findings’ translations into clinical practice gave their work greater 
legitimacy and relevance than other areas of the sciences, especially much basic research: 
“This feeling in the academic community that you are a good scientist if you do basic 
science and talk about stuff no one can understand...if that’s supposed to be better 
than tracking thousands of women on a clinical trial then you know...It’s usually the 
case that, at things like conferences it’s dominated by basic scientists; it’s always been 
the case actually...and systematic reviews are sometimes not even considered as 
research, because they think you are putting together other people’s research as data 
and so it’s not your own...which is not the case. But it’s the case that if you do basic 
science, you are considered a serious researcher, you could call it.” (Kumar)  
The majority of the group’s external funding was received from the National Institute of Health 
Research (NIHR), in particular the Health Technology Assessment (HTA) program. HTA is a 
relatively new form of science emerging since the 1980s concerned with overcoming deficits to 
existing evidence informing clinical practices and replacing it with more robust scientific 
evidence about efficacy and cost of clinical interventions. The stated practical outcomes from 
HTA programs are clear: improving patient outcomes and efficiency of allocating scarce 
resources in health care contexts (Lehoux, 2006, 2). Unlike the other case studies in this thesis 
which apply to different funding bodies for grant money, the group align their strategic vision 
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with just this one funding body. Following Latour’s (1987) influential typology on 
transformations, the group’s use of translational research as a metaphor for clinical innovation 
resembles his type I transformation, as the scientist (a relatively weak contender) can profit from 
‘piggy-backing’ on ‘a vastly stronger’ ally (110), in the form of the state’s regulatory apparatus. 
Large bureaucratic public health systems are prominent allies for the scientists, who can profit 
from the HTA movement having in large part already recruited, drilled and forced the state’s 
regulatory apparatus to be ‘simultaneously interested and obedient’ to their facts (Latour, 1987, 
172).  
This framework, as appropriated by later ANT (Law and Singleton, 2005, 336) thus provides the 
blueprint for making sense of what is otherwise a particularly unruly object of inquiry. For this 
particular case, the cost of adapting their practices towards the problem of translational 
research is relatively low as they already produce findings which are readily ‘scaled-up’ via an 
extensive actor-network: HTA. It is ostensibly the name as opposed to the contents of the idea of 
translational research which has been transformed through the group’s mundane practices.  
Used as a label to package their work, translational research provides normative rationalisation 
which serves to further defend and legitimise their actions when brought under scrutiny (cf. 
Meyer and Rowan, 1977, Czarniawska, 1997).  
Inscriptions  
This section considers the persuasive skills enacted by scientists in the acts of producing 
inscriptions for external audiences. It was found wider pressures for translational research have 
effected a change in the situation of scientists, to the point where they no longer have to appear 
persuasive simply in terms of their claims for validity and credibility (as in Latour and Woolgar’s 
framework), but also in terms of the relevance of their work.  
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Latour and Woolgar’s inscription framework suggests a number of ways of studying the 
persuasive skills deployed by scientists in the course of fact creation. Some of these are more 
practical for my purposes than others. Unlike Latour and Woolgar, one of the problems I faced 
was gaining access to the full spectrum of writing activities performed by members of the group. 
As well as having rich levels of access, these authors also enjoyed the benefits of observing 
interconnected forms of inscription occurring within a single geographical production site: the 
laboratory. One feature distinguishing the activity of this particular group from that of scientists 
presented in earlier laboratory studies was that a great deal of the inscription activities occurred 
outside the traditional material setting of a laboratory (as the ‘workplace’). Indeed the work of 
this group may be likened to that of a ‘bioclinical collective’ whose knowledge production 
processes extends beyond the confines of the laboratory (Rabheriosa & Bourret, 2009). The 
meeting room I observed constituted perhaps just one centre in which acts of inscription 
occurred. This is a problem other ethnographers have encountered: where the action is 
perceived to be occurring elsewhere (Law, 1994). One aspect of Latour and Woolgar’s 
inscriptions framework I was able to take forward was analysis of the rhetorical construction of 
written outputs by the group’s members, in the form of journal articles.  
I performed an author search for Quereshi on Pubmed Database and Cochrane Library and 
downloaded all of the articles for which my institution had access (n =8). I decided to select for 
analysis those articles reporting on clinical trials in which he had collaborated. The articles I 
accessed appeared to require little by way of (terse) promissory statements at the end of articles 
(see van Lente and Rip, 1998b). Articles reported on clinical trial questions about discreet clinical 
problems, the answers for which ‘should’ be translated rapidly into clinical practice on the basis 
that they have followed robust scientific procedures. This is corroborated by Quereshi’s 
interview account of translational outcomes as ‘part-and-parcel of what we do’. In reporting 
results Quereshi and his colleagues do not diverge from technical discourse that typically 
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characterises the genre style of scientific journals. For example, the conclusion section of a multi-
centre trial on breastfeeding interventions is written not in terms of potential promises for 
further research, but with matter-of-fact certainty which typifies much of the discursive style 
typically reported of scientific journals in STS (Gilbert and Mulkay, 1984): 
“A universal service for initiation of breast feeding using peer support workers 
provided within antenatal clinics serving a multiethnic, deprived population was 
ineffective in increasing initiation rates.” (Anonymous) 
Statements in these text seek to persuade through use of type IV and type V statements that 
omit agency of the researchers from the accounts and instead make the ‘methods’, ‘findings’’ 
and ‘conclusions’ ‘speak for themselves’ (Latour & Woolgar, 1986). Drawing tentatively on 
findings from the previous section, the relative proximity of their knowledge products to clinical 
application may mean the researchers are not required to make terse promissory statements 
about potential future developments of their work (of the type found in more upstream, basic 
science journals and grant applications) . In their field relevance is internalised in the applied 
character of the clinical problem choices their research field has been made to deal with (Rip, 
1997). As the label ‘translational research’ is interchangeable with ‘applied research’ and 
somewhat implicit in the types of studies they do it does not appear to require the respondents 
to change how they seek to persuade these external gatekeepers on whom they are dependent 
for publication. Therefore in terms of their interaction with the social world (Fujimura, 1987), 
translational research does not appear to have disrupted the flow of practices in performing this 
specific aspect of textual inscription.  
Additional Coordination work 
At the level of production work (Fujimura, 1987) it appeared that contra disciplinary 
laboratories, this group was unable to ‘stock’ the resources necessary in order to perform their 
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experiments. This was because getting ‘technicians’ to set-up inscription devices and perform 
experiments was not something that was performed ‘inside’ by members of the group in a single 
production site. They were instead reliant upon outsourced markets of clinician and nurse 
volunteers situated in multiple hospital wards across the UK. As the clinical trials manager 
explained: 
“I suppose if you have multi-centre trials you sort of have staff who are removed 
from… you know… they are not part of the central research team I suppose. What I 
mean is they are not employed as part of the research team. So there will be staff at 
each of the centres who we are relying on to recruit patients and complete data and 
everything. So potentially that could be difficult in that they are not directly employed 
by us. Obviously we are very much reliant upon them. So I suppose that’s a challenge 
to getting it done.” (Morrison) 
Recruitment is a persistent problem within the NIHR’s HTA funding stream, with around 80% of 
studies requesting either more time or more money (according to Quereshi in his inaugural 
lecture). To make the trial team’s inscription devices (questionnaires) travel and act at a distance 
requires the enrolment of allies in the form of NHS staff and patients. On their own the 
researchers are not strong enough to enrol and drill these elements; they require institutional 
support. Comprehensive Local Research Networks were set-up by NIHR as a key initiative to 
support timely completion of clinical studies within the NHS (NIHR, n.d. ). Prominent researchers 
conducting MCTs with regularity in the NHS are invited to submit applications to this ‘sales 
network’ (Pinch, 2008, 477) for recruitment of participants into clinical trials. The group I 
observed had successfully enlisted the support of the NIHR shortly before I began fieldwork and 
during my stay I was invited to observe the inaugural meeting for their new CLRN. Without this 
meeting, respondents would be unable to ‘scale-down’ the phenomena in which they were 
interested into a statistical form. What I observed here then was a sales-pitch to an audience 
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composed of clinicians, nurses, and NHS R&D department officials. Performing these kinds of 
projects with any success thus requires researchers to engage as salespersons at certain points. 
Salespersons can be seen as ‘mediators’ (Pinch, 2008): in this case helping to move about 
inscription devices (e.g. questionnaires) from their centres of calculation (e.g. offices, trial 
steering committee meetings) to the peripheries (e.g. NHS maternity wards) and back again. 
One of the chief tactics used to build this network was conducting formal face-to-face meetings 
with prospective allies, which can be interpreted as a kind of co-present ‘interaction ritual’ 
(Goffman, 1967). The organising of the meeting can be read as an effort by the researchers to 
render themselves indispensable to the audience (and their absent colleagues), so as the 
researchers in turn will reach their own goals (successfully running MCTs) and associated 
interests. The intermediary object around which the meeting was framed was the clinical trial. 
The occasion of the CLRN meeting was even framed by some speakers as an effort to ‘sell’ 
involvement in their studies. They did so by presenting its benefits.  
Public displays have long been important in the history of experimental sciences. Robert Boyle, 
for instance, used this ‘literary technique’ to demonstrate the uses of his air-pump technology to 
the Royal Society (Shapin and Schaffer, 1985, 57).  Public spectacles are a means both of 
presenting products in front of agnostic audiences in order to show what they can be made to 
do and for supporting the spread of a particular ‘discourse’ or ‘form of life’ (ibid). The inaugural 
meeting of the CLRN provided a spectacle centred on presenting the utility of the researcher’s 
product- multi-centre trials- so as to enrol audience members into actor-networks needed to 
complete such projects. More generally it sought to institutionalise NHS clinician’s participation 
in research projects.  
Like Boyle’s Royal Society demonstrations, those present constituted a very select ‘public’ (ibid, 
58). Individuals from relevant NHS Trusts were invited on the basis that they themselves could 
be persuaded to participate in the researchers’ multi-centre trials and would also go on to help 
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recruit colleagues absent from the meeting. Like air-pump science, MCTs are expensive, 
‘temperamental’ to run, and therefore a somewhat scarce commodity. In other words both 
resemble ‘big science’ (ibid, 38). On its own then the product appears rather cumbersome and 
unlikely to ‘sell itself’, meaning in order to travel from the centres to the peripheries much extra 
coordination work is required. Yet unlike public meetings held for Boyle’s air-pump, the product 
being promoted here could not be demonstrated immediately in this particular time and place. 
Instead various numerical and visual inscriptions were composed onto PowerPoint slides (as 
‘immutable mobiles’) in order to re-present in a performative way successes of past clinical trials 
brought to patients, which were not directly witness-able by the audience. What was made 
present and absent was of central importance to the rhetorical construction of these 
presentations. For instance, the messiness of designing MCTs which I had observed during trial 
steering committee meetings was notably absent in the presentations given to this audience. A 
rather linear account of innovation was given instead, whereby past successes of clinical trials 
(stripped of all their transformation struggles and contingencies) in bringing about altruistic 
patient benefits were made present. Analogies with successes of past trials were then used as 
the basis for constructing promises about future trials in which the audience were being invited 
to join. In the narratives of the presenters, through following the short ‘detour’ proposed by the 
researchers and giving them what they want, the audience will be able to overcome the 
‘blockages’ and get what they want: a return to the ‘main road’ (Latour, 1987, 111). In this 
instance, one of the main roads is the improvement of patient care. The audience were being 
defined as a professional group whose primary interest lies in the advancement of patient care. 
But in addition to the patient-benefits, throughout the presentations speakers imputed benefits 
clinical trials could bring in future as capital for the audiences’ departments, individuals’ 
curriculum vitae and NHS performance assessments. Furthermore, it was not only the brilliance 
of the product which was used to enrol the audience, but the competence of the team involved 
in replicating past successes (cf. Shapin and Schaffer, 1985, 56-59). Hence the success of the 
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product is inextricably linked to the credibility authors and champions of the trials, particularly 
their leader and spokesperson: Quereshi.   
Once the merit of clinical trials was ‘established’, deficiency statements were introduced by 
speakers. Based on these accounts, the only problems associated with running clinical trials were 
the apathy of individual clinicians and the bureaucracy of NHS Trusts (all other contingencies 
were black-boxed). The presenters then offered themselves as solutions to these two problems 
across the course of the talks. This mode of persuasion follows precisely the formula of 
transformation presented by ANT: projection of a desirable goal, followed by a problematisation 
in reaching that goal, then presenting oneself as solution to that problem (‘if you do what we 
want, you will get what you want’) (Latour, 1987). Alongside the ‘sales-pitch’, the CLRN meeting 
also allowed for exchange of tacit knowledge to occur between those working on similar 
problems. Prompts for audience questions were purposefully introduced between formal 
presentations. In these spaces, the audience would project difficulties they had experienced in 
trying to carry-out research in their departments (e.g. NHS bureaucracy) and suggest solutions 
with varying levels of conviction.  
Having occasions to meet face-to-face appeared important in order to coordinate these ‘big 
science’ projects. Over the time I spent observing this group, much discussion was centred on 
problems not only of how to attract the interest of busy NHS staff, but also maintaining it over 
the course of studies which could last for three years or more. Holding occasional face-to-face 
meetings could not guarantee the mobilisation of NHS trusts into their trials. Emails and 
newsletters were to be sent out every few months to ‘top-up’ enthusiasm among participating 
NHS staff. Even then, behind-the-scenes, collaborators on occasion would express a lack of 
confidence that formal meetings and written communication were sufficient to maintain 
enthusiasm towards the research. What were deemed more valuable were informal relations 
amongst the local clinicians. It was the contention in team meetings that holding face-to-face 
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meetings such as CLRN encounter would produce a certain level of enthusiasm amongst allies 
that could not be achieved remotely, for instance via forms of media. In a sense then the 
respondents appeared to exercise a vernacular version of interaction ritual theory, whereby 
face-to-face encounters enhance emotions and energise people, thereby influencing how they 
perform subsequent actions (Goffman, 1967; Collins, 2004). Indeed during intervals at the CLRN 
meeting, two clinicians with in attendance with whom I struck-up a conversation volunteered 
the opinion that holding such face-to-face meetings was vital in order to retain their enthusiasm 
for partaking in a clinical trial, given their typically high workloads.  
Although Latour and Woolgar’s account of scientific production processes stated that skill and 
effort is needed to coordinate production and mobilisation of inscriptions, the cost of doing so 
appeared less constraining in their disciplinary laboratory than it did in this form of multi-sited 
‘big science’ production context. I would like to emphasise here just how difficult and expensive 
it was to produce inscriptions even at the mundane level of running ‘experiments’, given the 
need to coordinate multiple forms of organisation, regulation, and paradigm. Nonetheless, the 
notion of scientific facts (and clinical ‘evidence’) as inscriptions is helpful for retracing the 
practised skill and efforts which go into producing and mobilising such black-boxes.  
Microprocessing of Facts  
Drawing on analysis of ethnographic fieldwork, this section reports on the findings generated 
through applying Latour and Woolgar’s microprocessing framework within the context of this 
case study. As this microprocessing framework was originally formulated out of observations of a 
single disciplinary laboratory site, the multi-disciplinary context of this case provides an 
opportunity to reassess the extent to which this part of existing knowledge about routine, 
mundane aspects of fact creation provide an adequate picture of scientific activity in 
contemporary sites of ‘translational research’. In the following passage I will use Latour and 
Woolgar’s theorising on microprocessing in order to explore how ‘translational research’ 
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interacts with this ‘mundane’ aspect of work activity. In this particular case study I was able to 
explore an (a priori) property strongly suggested by translational research- multi-disciplinarity- 
as this was very much apparent in one of the important production sites to which I was given 
access: the trial steering committee (TSC) meeting. Before reporting on specific findings which 
emerged from applying Latour and Woolgar’s microprocessing typology to observed exchanges, I 
will set-out some additional findings and details about the composition and function of such 
meetings.  
Defining the Trial Steering Committee 
Trial steering committees and their ad hoc, quasi-independent Data Monitoring Committees 
(DMCs) can be seen as institutions for ensuring the production of regulatory and epistemic 
objectivity in clinical trials (Cambrosio et al., 2006b, Berg et al., 2000). The TSC meetings involved 
a heterogeneous array of participants from different professional and epistemic communities. 
One trial meeting for example was composed of obstetricians, neurologists, specialist nurses, 
clinical trial managers, epidemiologists, medical statisticians and social scientists. The main 
objective of the meeting was to establish agreement about the content of the institution around 
which the trials were being coordinated and regulated: the trial protocol document (CT-Toolkit, 
n.d.). Despite varying interests that one might expect these attending members to profess about 
their involvement in research- whether it be saving humanity, contributing to science, gaining 
recognition, fulfilling administrative goals- the key purpose of this meeting was to design a 
protocol that would ensure the ‘successful’ completion of the study (measured against rapid 
conversions between forms of credit). Indeed according to the faculty head , who had a stockpile 
of credibility in designing clinical trials in the arena of public health, this goal constitutes the 
‘glue’ that enables these particular assemblages to work together: 
“I think that the different disciplines who are involved in these studies can all see the 
common goal, which is to get the study done, to gather the data and to do so in a 
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robust way. I don’t think anybody has any particularly different or divergent views 
about getting the study done.” (Faculty Head) 
The organisation of this work in these meetings did not hinge so much around structures of 
social authority, as they did through object-oriented structures. As discourse occasions, these 
meetings provided a space in which ‘the features, reactions, and requirements of technical 
objects are continually exhibited and expressed, and in which everyone can, in principle, assess 
and follow technical needs and co-shape the strategies adopted’ (Knorr-Cetina, 1999, 173-174). 
This ‘management by content’ repertoire which set the tone of the meetings meant that 
different people would step-forward as ‘spokespersons’ on behalf of problems posed by the 
object and potential solutions. If this repertoire fails, for instance in there being serious 
disagreements about the protocol design and implementation which emerge in the course of a 
trial, then there are international standards which can be referred to.   
In assembling the TSC, Quereshi and Kumar brought together people, with whom they had 
familiarity, having worked with them before and even identifying some of them as friends. 
Hence these previous linkages with obstetricians and statisticians suggested the committee was 
an extension of existing networks of allies forged by the researchers. However, this existing 
association had to be introduced to new members on the committee. One of the first exchanges 
which occurred during each of the meetings was for each person to take turns introducing 
themselves around the table. This suggested that not all of the participants had met one another 
and that in order to work better, it would be helpful for members of this internationally 
composed team ‘to put a face to a name’ (Urry, 2003). During this ritual, the post-doctoral 
researcher, Pereira, stated that he was present at the meetings in order to ‘gain a feel’ for how 
clinical trials work. This is one example of respondents recognising that meetings provide 
opportunities to pass on tacit knowledge that is not made explicit in textbooks and protocols.  
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Meetings for trial steering and data monitoring committees thus appear a necessary action in 
order to organise the production of clinically ‘objective’ knowledge through MCTs. The meetings 
also help to establish familiarity and trust between different epistemic and professional 
constituents on the trials, and provide a forum for exchange of tacit knowledge. Without such 
occasions it appeared that clinical trials would not be considered workable.  
Observing Epistemic Conversations 
Observing such occasions proved conducive to exploring Latour and Woolgar’s microprocessing 
framework, as it provided the appropriate setting for participants in the clinical trial to air 
disagreements with parts of the trial protocol document before it was to be finally submitted. 
This contrasted with other types of occasions I attended during the fieldwork, like weekly team 
meetings, where I had recorded a scarcity of direct references to ‘technical’ procedures or 
arguments occurring in exchanges.  Without opportunities to carry out extensive ethnographic 
fieldwork of the kind Latour and Woolgar enjoyed in production sites, it was not possible to 
observe all of the dimensions of this framework in relation to the process of constructing ‘logic’ 
and ‘proof’. Despite cross-sectional scope, the findings have nonetheless revealed certain 
potential weaknesses in Latour and Woolgar’s original formulation when applied to ‘hybrid’ 
research settings such as this one. I was able to observe and record TSC meetings for two studies 
which were about to begin recruiting patients. Passages transcribed from the meetings were 
coded under the general theme ‘microprocessing’ and sub-coded according to Latour and 
Woolgar’s four exchange types. This section is organised around discussion of empirical findings 
in relation to these exchange types, and where appropriate, considers how far the original 
framework is corroborated in this altered production context.  
The most alarming finding from analysing these meetings was that only two of Latour and 
Woolgar’s four categories of exchange emerged in any kind of recognisable form. However, the 
two which had emerged- Types I and IV- were prominent recurring themes in the data. I found 
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Latour and Woolgar’s observation that Type I exchanges typically revolve around ‘new’ facts 
rather than ‘long-established’ ones was contradicted by my findings. The results will now be 
discussed in further detail.  
Boundary Objects 
During the meetings, the chair moved through different sections of the document so as to give 
an opportunity for those present to scrutinise its content. A lot of the time the statements made 
on behalf of facts would foster agreement amongst participants. Facts and proposed methods 
around which members appeared in agreement were thus interpreted as analogous with 
‘boundary objects’ (Star and Griesemer, 1989) and were coded as such. I identified a range of 
boundary objects which functioned to simplify information and enhance communication 
between these people. The stabilisation of facts within the meetings could be inferred from the 
data when no one appeared to challenge a part of the document or a spokesperson’s statement 
about that part. 
A prominent boundary object, first pointed out to me in interviews, was the mutual commitment 
to EBM methods. This point appeared to be supported by observation of TSC meeting given that 
the central role of statistical methods was never once questioned in exchanges in the meetings 
(despite being set-out in detail in the trial protocol documents they were discussing). Hence 
agreement about the facticity of Type I statements appears to be at least one source of 
establishing certainty in the course of interactions involving ‘hybrid collectives’. I also observed 
on several occasions Type IV statements where participants would defend certain data collection 
and reporting procedures proposed in the protocol document on the basis that these adhered to 
general standards for reporting clinical trial data within their scientific community. Participants 
would also support their efforts to assume a position as credible ‘spokespersons’ on certain 
standards by calling on the ‘presence’ (Latour, 1987) of reputable macro-actors behind the 
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standards, as with a discussion centring on the governance structure of the trial proposed in the 
protocol document: 
“Quereshi: What is being proposed here is fairly standard- and it is based on what the 
MRC recommends.” 
Such ‘Type IV’ statements appear to corroborate Latour and Woolgar’s basic point that the 
facticity of a statement does not arrive at this status because of its innate correspondence with 
‘nature’, but because it has withstood a whole host of deconstruction efforts, both ‘technical’ 
and ‘non-technical’ in character. Hence whether studying exchanges in a disciplinary laboratory 
or a multi-disciplinary hybrid collective, the notion that the ‘logic’ of a scientific fact cannot be 
dissociated from the ‘socio-logics’ of its construction remains convincing. 
New, Non-Controversial Facts 
The importance of ‘trust’ in upholding the credibility of spokespersons (and by extension their 
statements) is especially important in instances where asymmetries in expertise within the 
group were made apparent. Here Type I statements, primarily in relation to new facts, were 
supported by Type IV statements regarding the authority of specific participants as qualified 
experts able to ‘vouch for’ new facts. There is one analogous example given by Latour and 
Woolgar, when describing the dependence one junior scientist had on the experiences of 
another in lending a statement its fact-like status. Similar deferrals to the expertise of others 
enabled potential ambiguities to be overcome relatively quickly during the TSC meetings. Closed 
controversies were subsequently re-told at the end of the sessions as ‘tying up loose ends’. 
Although there was disjuncture in experience levels of participants, an additional source of 
dependence clearly emanated from the fact that certain members of the TSC lacked local 
expertise around certain inscriptions proposed in the protocol document. Several times 
Quereshi reiterated that not everyone in the collective was in possession of expert knowledge of 
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all facts. Instead standards were suggested and ‘vouched for’ by members positioning 
themselves or being positioned by others as spokespersons, as occurred during the course of an 
exchange in one study meeting between the chair (an obstetrician) and statistician about the 
statistical modelling proposed for analysing data: 
 “SC member: I feel the same [as the chairman]. It is an important clinical question and 
as it stands the protocol from a clinical point of view seems appropriate. But the 
statistical model, and the way the question will be answered by that is beyond my 
comprehension. There is an assumption that this has been approved by the people who 
are experts… [Agreement]… 
Quereshi: The knowledge lies elsewhere [points to statistician… laughter]. [Statistician] 
has acknowledged the appropriateness of this model.  
Chair: I should just then add the caveat at this point that we’re going to need more info… 
I think the issue needs to be resolved ASAP before the study starts, we need a meeting, 
especially with statisticians.”  
Here the statistician offers to ‘vouch’ for the scientific credentials of ‘standard’ methodological 
procedures proposed to carry-out the study, an endorsement which is taken as credible given his 
expert status both as a statistician knowledgeable about the latest standards for what passes as 
‘fact’ within this field and someone who has had experience as a statistician on these types of 
studies. Trust thus appears a key aspect to the social structure enacted by this collective, as it is 
needed foster agreement about statements (and continue making the new fact). It was not 
always clear from the data collected whether the participants invested trust in individuals or in 
more abstract expert systems like scientific disciplines to which they would refer and could be 
associated. The statistical approaches remain ‘black-boxed’ in the course of the meeting, to be 
‘opened-up’ at a later (more appropriate) time.  
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Established, Controversial Facts 
Despite enactment of ‘multi-disciplinary’ skills, inscriptions and boundary objects, it is not always 
easy to broker total agreement on these occasions. At times efforts to form consensus around 
certain standards broke down and controversies emerged over particular efforts to do so. 
Notably the facts whose status was being questioned were those which constituted ‘soft’, taken-
for-granted ‘parts of the furniture’ in the epistemic machinery of some respondents, but which 
were challenged as artefactual irrelevancies in statements by others in the meeting. In one 
meeting for instance a lengthy exchange broke-out amongst participants about how many times 
the trial’s data monitoring committee (DMC) should look at the data during the collection period 
of the study. The controversy occurred mainly between a statistician and trial chair, focussing on 
whether by looking at data regularly over this period the DMC would unduly influence (‘bias’) 
the results. Speaking on behalf of statistical standards, the former argued that this carried the 
risk of discrediting the findings in scientific terms (a type I statement). The chair disagreed with 
this argument, stating that it would be helpful in order to determine whether useful data was 
being generated, and that the study would be completed on time. In putting forward this 
opposing statement, the chair re-constituted the statement as an artefact, which although 
perhaps not meaningless per se, was simply not important in relation to the particular set of 
circumstances being discussed. The chair supported his position with a Type IV statement, 
arguing he had done many studies before in which checking during the study had been common 
practice and had never caused the findings to be discredited. The issue was not resolved directly 
in this meeting but deferred to another meeting, which appears to correspond to Boden’s (only 
half-joking) observation that the main outcome of meetings in organisations tends to be 
arranging another meeting (Boden, 1994).   
As well as pointing to a common set of goals in place, participants could foster agreement and 
understanding via common sets of facts and standards upon which they could all agree 
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(boundary objects). Type IV codes could be located prominently amongst those instances where 
claims about the facticity of Type 1 statements were being defended by their claimants in the 
face of uncertainty and criticisms being voiced by others in the course of exchanges. It was found 
that Type IV statements could settle uncertainties expressed towards ‘new facts’ articulated by 
certain members, who would entrust others to act as reliable spokespersons (‘experts’) on 
behalf of facts about which they themselves were ignorant. In instances where black-boxed facts 
appeared to be being opened potential controversies were closed very swiftly. These findings 
are analogous with observations Latour and Woolgar made, albeit one might speculate that the 
need to trust and defer to the statements of others and those uttering them becomes 
heightened in contexts where diverse epistemic cultures are brought together and conduct 
‘epistemic conversations’.  Another point Latour and Woolgar made was that Type I exchanges 
about long-established facts were much less common than those concerning new facts. I have 
found that this was not the case here, as a majority of the fact-oriented statements being 
challenged concerned those facts which were for certain participants ‘long-established’. 
Controversies emerged when other participants retold the statements as having artefact status, 
such as when claims about appropriate stopping points for DMC to enforce were challenged.   
Cycles of Credit  
The utility of the credibility cycle as a general model for (de)constructing individuals and small 
groups of scientists in this study became clear during observations of weekly team meetings. 
Here the primary problems being voiced by participants regarded short-term problems in 
converting forms of credit. The ultimate objective of conversions being discussed in these 
meetings was to produce publications in scholarly journals, which could subsequently be re-
invested in further cycles. This finding was also reinforced in interview accounts, with 
respondents pointing to the formal assessment standards of the REF placing varying levels of 
constraint on individuals and the group. Interviews also provided a useful platform through 
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which to explore ‘inner thought processes’ of respondents concerning credit investments, 
particularly in relation to longer-term strategic considerations like careers.  
As the focus of the original credit framework was on individuals and group structures as they 
arise from laboratory work, this section will also take as its unit of analysis how these issues are 
constructed through (and not prior to) processes of work organisation enacted by respondents. 
The section will thus be structured first around respondents’ backstage accounts of group 
structure and whether translational research constitutes a priority, before focussing on how 
careers of individuals are constructed in relation to this idea.  
Group Structure 
In participating in this form of social organisation the primary objective for these respondents to 
meet was publication. This seemed to be heightened through their assessment as employees by 
the university in the REF exercise. Pressures from the REF constrained the groups’ operations in 
a way which did not always align with the notion that research should be judged by its practical 
promises or outcomes. Although sympathetic to the general goal of the REF, when questioned 
about gaps between validity and utility of research the respondents certainly acknowledged that 
the REF’s goals were not necessarily always compatible with utilitarian goals, particularly within 
their specialty: 
“I think there is some way in which it has to be done, but it is a little bit unfair to expect 
everyone to publish in high-impact journals, because there is differences in what 
impact a specialty has...if you are in medical education none of your journals are going 
to be good in high-impact terms. If you are in internal medicine then what are you 
going to do? You do not always get into the Annals of Internal Medicine or the New 
England Journal of Medicine? So if you take Obstetrics and Gynaecology, then the top 
journal has an impact factor of three or something like that.” (Kumar) 
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There was some concern that those studies which had most translational impact (in terms of 
being read by specialists in their own medical specialty) were not necessarily those which were 
being valued under the REF’s criteria: 
 “I: But is that the best way to make your research useful- to publish in a high-ranking 
journal- I think you mentioned the Lancet? 
Kumar: No probably not, no, because the British Journal of Obstetrics and 
Gynaecology, it goes to every single obstetrician free of charge if you are a member of 
the Society. And people are more likely to read their own specialty journal than read 
the BMJ. So it may not necessarily be the case.”  
Here the pressures to produce papers in ‘excellent’ scientific journals and pressures to produce 
work which had an important ‘impact’ on clinical practice were in contradiction at the level of 
their social worlds. The priority of publishing papers was also a goal Quereshi repeatedly 
reiterated to other participants during team meetings, for example as occurred during a 
discussion in with Matthews about an external project that Matthews had been pursuing outside 
of the group i.e. with a team at another university: 
“Quereshi: The first thing is that they should lead to publication.  
Matthews: Absolutely. Well this one is a HTA project.  
Quereshi: The second thing is that if they are eating up a lot of your time then their 
impact on other work should be assessed. The third thing is that if it takes up a lot of 
your time then it should somehow be supported by funding. This project seems to 
meet all those criteria from what you have described. 
Matthews: Oh yeah it does.” 
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This exchange can be read as an example of leadership by the Quereshi, who is setting-out (or 
re-iterating) this organisational goal and making sure it is being adhered to amongst members of 
the team (Perrow, 1986, 69). What I interpret from this short exchange is that publication is not 
just something that individuals should do in order to meet some external organisational goals, 
but is also being enacted as something that ‘we do’ as a collective: following this institution is 
projected as a key goal within the organisational storytelling of the participants. Another 
indication of this from meetings was that congratulations would be expressed when a colleague 
would announce they had a paper accepted for publication in a ‘good’ scientific journal.  
Another agenda to which the group had had to respond was that of the faculty. From the 
faculty’s perspective, Quereshi was taken as a ‘sound investment’ because of his successful 
publication record and the promise of further capital accumulation. Another reason was that he 
was able to package his group’s research as compatible with the T2 type of translational 
research in which the department was looking to build its reputation as a major player in the 
general health research arena. In my interview with the Faculty Head, it was made clear that 
translational research (or the promise) was seen as a credible position for candidates which 
employers like him were looking to invest. Quereshi and faculty head acknowledged HTA 
infrastructures enabling research to be translated into guideline making, recommendations and 
public policymaking in a relatively straightforward fashion put them at an advantage in the REF 
compared with researchers operating in other fields. What constitutes a translational outcome 
in this field is also something for which they can receive credit (for instance as named authors on 
NHS reports or clinical guidelines) in fulfilling the REF’s ‘impact’ criteria. Publishing guidelines can 
be carried-forward as a form of capital to be reinvested in subsequent episodes of accountability 
like the REF or curriculum vitae. Thus being ‘translational’ does not detract as an opportunity 
cost from being ‘excellent’. The problems posed by the REF are thus posed as a facet of 
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individual behaviour: getting members in the group to meet its targets, rather than an 
‘infrastructural’ issue.  
How the careers of individual scientists are constructed out of this complex state-of-affairs will 
now be the topic of further discussion. 
Careers  
In public sciences incentive structures are typically oriented around reputations in intellectual 
specialty/field and promotion in employment organisation (e.g. the university) (Whitley, 2000). 
Most respondents at some point in their interviews acknowledged such rewards as one of the 
moral purposes for investing in work (see Perrow, 1986). Hence their stated reasons for 
publishing went beyond meeting the minimum requirements of organisational needs and into 
the realm of individual rewards. This section will focus on those respondents identifiable with 
academic roles, whose job requirements identified the need for them to publish in scholarly 
journals. It is worth noting that although not falling into this category, Morrison as clinical trials 
manager and Aziz as an obstetrician expressed ‘hope’ of becoming named authors on journal 
articles, so as to meet formal and informal assessments of their job performance by employment 
hierarchies and gain some ‘credit’ for the skill and effort they had invested in the making of the 
research.  
Of the four participants eligible for analysis according to these criteria, one exceptional case 
emerged in the course of this study. When discussing her attitude towards publishing, Matthews 
claimed only to be motivated towards satisfying the minimum REF targets expected by the 
university. As the exceptional case, she expressed an attitude towards this work in more 
instrumental terms than her colleagues, as ‘just a job’ needed to provide security. She exhibited 
a general strategy of compromise towards the REF in order to retain employment status, 
consisting of more specific tactics like ‘placating’ and ‘accommodating’ goals of the REF, whilst 
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‘concealing’ her non-conformity to its guiding norms (Oliver, 1991). This frontstage compliance 
was coupled with a backstage ‘attack’ on the sources of the institutional pressure and how 
knowledge was valued within the REF framework (ibid.). The effects of such measures she 
claimed was that it created incentive structures which prioritised personal gain at the expense of 
research which could have a patient impact. The achievement of this latter goal was something 
she herself claimed to be motivated by in choosing a research field: 
“...And that’s what we really need to know. Not ‘I’ve done a randomised trial and I’ve 
published it in the Lancet and isn’t that wonderful’, I’m actually more oriented towards 
what people really need- what patients really need.” (Matthews) 
This could be best achieved through greater professional autonomy by removing the excessive 
managerial constraints of the REF. As a firm champion of EBM and HTA, Matthews professed 
that research she and the group did could be ‘truly’ translated into improved patient outcomes, 
however, the presence of the REF was creating a barrier to the institutionalisation of this 
translation. This account thus presents the dual goal of making research more ‘translational’ and 
making the workforce more ‘accountable’ as fundamentally incompatible. The resistance by 
professionals towards increased management controls will appear unsurprising to those familiar 
with research on new managerialism (Ferlie et al., 1996). Although not her primary ‘passion’, in 
her account systematic reviews constituted a reasonable compromise between research which 
was patient-centred and research for which she could attract funding and thus pass through 
cycles of credibility, at least on a short-term basis. Matthews’ compliance with this institutional 
control and continuing participation in the credibility cycle was thus justified as a temporary 
move before she could ‘escape’ (Oliver, 1991) from the clutches of the REF and carry-out a 
career in research assessed according to different criteria: 
“Well it’s finances really. When I have the money to go part-time I’ll do it. And I’ll do 
research that I think needs to be done, not what ticks boxes for the hierarchy.”   
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Her complaints about the REF chimed with recent human relations and sociological commentary 
on the stresses and strains of work intensification brought about by increasing managerial 
control of professions, especially in studies of higher education (Ogbonna and Harris, 2004). In 
an actor-network sense, Matthews was struggling to position herself between goals of the REF 
and those who would be evaluating her. To avoid this route would mean to have her security 
undermined. This response differed markedly from the disposition of other researchers 
interviewed in the group, two of whom, by contrast – the Quereshi and Kumar- were clearly 
invested in the group’s research not just as a means of continuing in employment, but as a 
strategy for gaining recognition and reward in their intellectual field.  
Quereshi, as an eminent scientist with over two hundred publications against his name, had 
clearly invested more than the ‘bear minimum’ required by employers. Perhaps unsurprisingly 
he presented a very different disposition towards the demands of the REF in relation to his work 
requirements and his career ambitions, as a constraint he felt largely comfortable about 
meeting. The institution of tenure enabled a level of employment security for the professor 
which the others lacked. He also had the reputation and know-how to continue publishing and 
meet the REF targets with relative confidence. In his case one of the goals emerging for him was 
to maximise reputation through publishing in esteemed journals. As the individual in charge of 
long-term strategic direction of the group, Quereshi role requires he attracts attention of other 
scientists in his field ‘as a name, a location, a set of topics, and someone to be reckoned with’ 
(Knorr-Cetina, 1999, 221). He had founded the group and built-up its reputation in the field of 
EBM, meaning he could attract early career researchers into the group, who learnt to assemble 
trials and write systematic reviews, thereby bringing further publications and future 
collaborations to the group. Quereshi had a reputation amongst other respondents as a 
particularly industrious worker, as in his absence others would joke about the (exaggerated) 
number of projects he would be working on at any one time. He was also identified by other 
213 
 
respondents as someone continually looking to extend the scale and intensity of the group’s 
operations, for instance by re-locating to the new (respected) host institution and hiring a full-
time clinical trials manager.  
Like Quereshi, Kumar expressed attraction towards rewards from publishing in high-ranking 
journals, for instance, during our interview she described feelings of excitement gained as an 
early-career researcher on having had articles accepted by high-ranking journals: 
“Kumar: I think it’s a good feeling when you get published in the high ranking journals, 
so if you never publish there you aren’t ever going to get that feeling… 
I:  So it’s a worthwhile achievement to be published in those top journals? 
Kumar: It is, yes because it’s so difficult to do, that if you’ve done it you’ll think it’s 
worth it, so yeah.”   
Kumar’s complicity with strategic ‘rules of the game’ could be read from the account she gave 
about the decision-making processes that goes into investing in either clinical trials or systematic 
reviews. Although multi-centre research is being increasingly institutionalised under the HTA 
program, not all researchers have the capital or motivation to invest in these studies. But for 
those who can compete successfully in this activity the rewards are clear. This type of study was 
seen by Kumar as a potentially rewarding area of investment, given demand of external actors 
like NIHR for these types of studies. From her perspectives then, although multi-centre trials are 
seen as much more difficult/exhausting and costlier to run than systematic reviews, they are 
considered more effective in building individual and group reputation and credibility (as well as, 
strategically, that of their faculty, university and local NHS Trusts): 
“To change clinical practice, you do need collaboration in this day and age, you cannot 
function without it...you cannot do a credible single-centre trial. Unless that is the 
question can be answered within a single hospital. But think about it, how many 
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studies looking at women in one centre have been published in the BMJ or Lancet?” 
(Kumar) 
Systematic reviews were seen by Kumar as easier to assemble, however, the competition for 
these funding opportunities is seen as strong, meaning the team also had to develop 
competencies in running clinical trials, particularly in their specialty of obstetrics and 
gynaecology, as they could not meet and capitalise on organisational expectations by being 
reliant on funding from systematic reviews alone. Likewise systematic reviews are seen as less 
‘sexy’ and therefore marketable towards high-ranking medical journals like the Lancet and New 
England Journal of Medicine, as well as to the REF, much to the annoyance of a number of the 
researchers. Deciding on which type of studies to seek funding for is not simply discussed as a 
matter of short-term planning and organising, but also a matter of strategic investment made by 
individuals and organisations. In this excerpt the Kumar focuses around the problem of how she 
as an individual and the research group might best be positioned within future markets for 
research funding and academic capital when making managerial decisions about investing in 
clinical trials or systematic reviews: 
“I: Out of the reactive, and if you like, proactive research studies, which would you 
prefer? 
Kumar: I think the reactive applications … [laughs]… I think… I’ve just put this one in 
this month and I am planning to put one in at the end of the month and it is extremely 
tempting to put in a reactive one because you think you stand a better chance. You do 
all the work in this area, then the brief calls, then there is the huge temptation to put 
the application in. But with the reactive one, your competitor will almost always be in 
the same field.” 
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As such research methods are not considered just in terms of their technical utility for answering 
scientific questions. Strategically early-career researchers look to learn skills which will facilitate 
future credibility conversions. Often this means calculating what is the path of least resistance 
and following the fashion culture. At the time of fieldwork two respondents were ‘learning the 
ropes’ with regards how to perform multi-centre trials, albeit at different stages of career 
development. Kumar had just undertaken the role of ‘Project Coordinator’ on two clinical 
studies, the first time she had undertaken responsibilities of this kind. At a different stage of 
early-career research, Pereira the post-doc sat in on the trial meetings in order to ‘get a sense’ 
for how these type of studies work, signalling that such skills will come in useful in order for him 
to become established as a professional scientist in this field (indication that multi-centre studies 
were considered ‘where things are going’). Although not committing his career to this particular 
group, Pereira described how he had applied for this temporary job in the hope of learning a 
new set of skills which would make him more ‘marketable’ as an employee in his home country; 
skills which he could re-invest in future credibility cycles. 
Respondents thus did not invest in clinical trials exclusively on the basis that they will deliver 
best patient outcomes or constitute the best spending of public funds. What I observed here was 
that clinical trials were being invested in as (hopeful) means of gaining professional and 
employment status. I would make the tentative point that researchers are likely to invest in 
those sets of problems for which there is perceived demand and for which they can re-apply 
some of their existing skills and resources.    
Despite normative statements to the contrary, it became clear across the course of the study 
that it is not necessary for the respondents to align every decision at the level of experimental 
and laboratory work with the pressures for them to produce ‘translational research’. Indeed this 
appears compatible with Fujimura’s argument that scientists will routinely ‘respond to the 
demands and concerns of several audiences’ (1987, 265), sometimes even in contradictory 
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fashion. Quereshi and the faculty head were those charged with aligning the local research 
practices of the group and the host institution (respectively) with broader patterns in the 
research environment. Outside of the ‘managerial’ roles, researchers rarely spoke of 
translational research itself explicitly in terms of investing in a position in the social world, but 
more as a normative framework with which they could broadly identify their work. Again this 
might be due to the relative success and power of the field in which they are positioned. The 
demands to produce translational research are perhaps just one of the external pressures 
exerted on them, yet compared to struggles of credibility the need to appear broadly relevant 
and legitimate appeared rather slight. Perhaps this is due to their ability to ‘piggy-back’ (Latour, 
1987) onto state-sponsored NIHR-HTA programming and its associated infrastructure (see Rip, 
1994, 11). For scientists in this case, who had already carved out reputations in HTA, 
translational research constitutes a re-branding of what they had been doing already and 
therefore was not depicted as high-risk. Indeed, it was barely even spoken of as an ‘investment’ 
by participants, perhaps because it was already internalised in their practices.  
Chapter Conclusion  
This chapter has reported the findings of a case study in this thesis. It was organised around 
applying Latour and Woolgar’s (1986) four concepts for studying mundane work activities of 
scientists to the primary empirical data collected on this case. Having set-out the findings in this 
manner, I will now delineate the key empirical and theoretical findings which in conjunction with 
other case studies will be used to set-out the original contribution of this thesis. 
The findings from history of the laboratory framework elucidate how translational research is 
given meaning in the context of this group of applied health researchers. It also allows one to 
make the link tentatively to organisation studies concerned with how ideas spread in 
contemporary organisations exposed to management fads and messages, where people have 
the propensity pick-up and use ideas without necessarily being aware of their provenance or 
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original meanings (Clark, 2001). One of the puzzling factors of this case was that they had 
appropriated this label without being under any explicit calls to change the name of what they 
were doing. In all likelihood the name added normative justification to their existing practices 
(Meyer and Rowan, 1977). Although the interpretation that respondents were mostly doing the 
same things as before but under a catchier name may sound cynical, it belies the simple fact that 
‘names travel with ease and with great speed’ (Czaniawska and Sevon, 2005, 10) and that in 
open systems organisations tend to mimic one another (DiMaggio & Powell, 1983).  
Analysing the respondents’ activities in terms of acts of inscription reveals that the pressure of 
translational research does not require a significant extension of their persuasive skills to 
accommodate relevance in the context of writing journal articles. However, the framework’s 
application does suggest that those engaging in large-scale ‘translational’ projects like multi-
centre trials must extend their persuasive skills in order to enrol the workforce necessary to 
perform parts of these studies (e.g. data collection). In such interactions as presentations to 
CLRN, the need to assure audiences of the relevance of their work is brought into view. This 
section has explored some of the forms of persuasion mobilised by participants in the course of 
producing facts from multi-centre trial studies. It appeared that in terms of interaction with the 
immediate social world of other scientists, the promissory language of translational research was 
not mobilised, with discourse of scientific journal articles reserved for more traditional forms of 
‘passive’ rhetoric. However, ethnographic fieldwork produced traces regarding the tremendous 
effort and cost that goes into producing such inscriptions in the context of production work of 
the multi-centre trials. This type of project appears to require a shift in the coordination and 
organisation of inscriptions away from a single production site (in laboratory studies) towards a 
‘bioclinical collective’ (Rabeharisoa and Bourret, 2009) model where researchers bid for 
outsourced labour to carry-out important inscription work (e.g. filling-out questionnaires) at the 
level of data production. To enrol this outsourced labour requires both a persuasive currency 
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and infrastructure to be enacted. The translational promise of their research was a rhetorical 
resource mobilised to market their projects to prospective allies needed to produce inscriptions 
from experiments which could be returned to their centre of calculation via immutable mobiles 
(e.g. questionnaires) (Latour, 1987). This appears to require an extension of the persuasive skills 
of researchers investing in these types of collaborative studies, that was not accounted for in 
earlier laboratory studies of single-site ‘factories’ (Knorr-Cetina, 1981, Latour and Woolgar, 
1986). Although these respondents still appeared to be in the business of persuading and being 
persuaded by others in the production of inscriptions, the geography of this production 
appeared much more diffuse than in earlier laboratory studies. Although Latour and Woolgar’s 
account of scientific production processes stated that skill and effort is needed to coordinate 
production and mobilisation of inscriptions, the cost of doing so appeared less constraining in 
their disciplinary laboratory than it did in this form of multi-sited ‘big science’ production 
context. I would like to emphasise here just how difficult and expensive it was to produce 
inscriptions even at the mundane level of running ‘experiments’, given the need to coordinate 
multiple forms of organisation, regulation, and paradigm. Nonetheless, Latour and Woogar’s 
notion of scientific facts (and clinical ‘evidence’) as inscriptions is helpful for retracing the 
practised skills and efforts which go into producing and mobilising such black-boxes.  
Considered through the microprocessing of facts lens, the data suggested that the need to 
produce fact-like statements which draw consensus is vital in order for the heterogeneous 
assemblages involved in multi-centre trials to be able to collaborate. Negotiation was 
accomplished in the course of co-present exchanges through reference to common goals and 
boundary objects, such as methods and official standards. Not all of those present during the 
trial steering committee meetings held expert knowledge about certain aspects of the trial 
protocol document. During exchanges different participants would emerge as credible 
‘spokespersons’ on behalf of statements in said document. However, this positioning was not 
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always accepted, in which case participants would deploy various micro-strategies in order to 
close controversies, such as reference towards experiences of a spokesperson, arranging 
another meeting, or ‘pulling rank’.  
Finally the cycles of credit framework enables one to draw inferences about the construction of 
individual scientists and group structures in relation to the work they perform. The findings in 
this chapter show that in order for translational research to ‘work’, it must not interrupt the flow 
of credit conversions taking place in the context of mundane work activities. In this case, as only 
the name travelled, it posed no such problem. Likewise the idea must be consonant with longer-
term investments made by individuals and groups, such the positions they wish to occupy in 
their field in order to build reputation and career. Rather than completely upending existing 
work activities, pressures to consider translational research become yet another aspect of the 
complexities of which these respondents have to make sense. How meaning is attached to this 
and other pressures like publication thus varied considerably across respondents. In this case, 
the idea affected an innovative mode of organising principally in terms of its form rather than 
content. This might feasibly lead one to predict that translational research may travel more 
seamlessly into contexts where it reaffirms existing practices and potentially improves 
consistency of operations, than those contexts where it requires upheaval of routines. Put 
simply, translational research represented for these researchers the most viable forms of 
research to do for disciplinary and economic reasons, and was synonymous with following the 
fashion culture of their field. However, within the group how respondents experienced and 
engaged with this collective path varied considerably. Some were content to play an 
instrumental role in fulfilling the aims of some other agent (e.g. HTA), rather than operate as 
autonomous researchers fulfilling their own intellectual curiosity, because it suited their own 
interests for security, career advancement and reputation. This is an example of ‘equivalence’ 
(Callon, 1995). One anomalous respondent however was disenchanted with the state-of-affairs 
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in which she felt to be the means to someone else’s ends. She appeared to identify much more 
strongly with the rhetoric and norms of the Humboldtian university than with the kind of neo-
liberal, individualistic games in which she found herself caught-up. Although then the goal of 
translation was something with which she strongly identified, she denounced managerial 
performance measures and pressures exerted on academics for being counter-productive to this 
goal. This respondents’ account appears to exemplify the types of ‘culture clash’ between an 
‘old’ logic of ‘academic science’ and a ‘new’ logic of imposing managerial devices from a 
distance, translational research being associated with the latter. Based on my readings of 
scholarly literature on academic’s responses towards re-contextualised science (Webster, 1994, 
Cooper, 2009), what was perhaps surprising here was not to have found more people who 













9. Thesis Conclusion  
 
Introduction 
This chapter starts with a summary of the original aims of the research, approach and design 
that have been taken. Attention then shifts towards an in-depth discussion of the main empirical 
findings from the thesis; its main theoretical contribution; the strengths and limitations of the 
frameworks used in the thesis; policy contribution of the work. The chapter then finishes with a 
series of statements about how sociological studies of translational research should be carried 
forward and what themes this piece of research contributes towards this topic. 
Summary of Research 
The research in this thesis explores how an abstracted, ‘flattened’ framework for science and 
innovation– translational research’- is transformed amongst the local practices of mediators its 
champions are seeking to conquer: academic researchers working in medical research institutes. 
The field of STS was drawn-on as it provides a compelling set of tools for exploring what it is like 
for scientists to work with this idea. Although the field of STS lacks definitive consensus about 
which concepts, case studies, or methods constitute the best way to go about the task of 
subverting translational research, most of the concepts appropriated here were nonetheless 
identifiable and well-known within STS. Two such commitments will now be mentioned briefly. 
One was to treat claims respondents gave about translational research the same and not to 
distinguish between those deemed ‘good/bad’, ‘true/false’, or ‘successful/unsuccessful’. In a 
methodological relativist turn, the thesis considered how versions have been constructed in the 
contexts of each case, rather than searching to uncover a ‘definitive’ version(s) of translational 
research (Bloor, 1976). This selection was made for practical purposes as much as for 
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philosophical ones: given the variation and at times sheer confusion caused by different versions 
of translational research, it seemed to proceed with a closed, definitive version of what the 
phenomenon ‘is’ would be  less productive. This symmetrical strategy was coupled with the 
theoretical selection not to pursue problems of generalisability in relation to translational 
research. Rather the approach followed was one developed in later ANT studies, which explores 
objects in terms of their multiple, situated ontologies (Mol, 2002). This shift towards 
transportability leads to a very different version of materiality than would be the case if one 
pursued a generalised explanatory theory of translational research (Latour, 2005). This is 
because the endurance of the idea is assumed to be contingent on its transformations and 
stabilisations amongst localised practices, rather than because of homogenous properties of the 
idea itself, or its inner glory. With such sensibilities in mind, the research questions were as 
follows:  
How does the idea of translational research transport into local academic knowledge production 
sites of academic medicine which policy authors are seeking to enrol?  
What aspects of the local production practices are adapted to accommodate this goal and where 
do resistances occur?  
In short the thesis is about how translational research is performed and ‘worked out’ in real-
world knowledge producing settings.  
The empirical chapters were structured around three separate case studies of research groups 
hosted by medical schools in English universities. The first empirical chapter studied a group in a 
cancer research centre interested in cell signalling, the second chapter was of a diabetes 




The primary method used to generate data was qualitative interviewing, supported by 
documentary analysis. One case study (Obstetrics) also granted access for observation of 
meetings over an extensive period. In writing each case study the objective was to capture how 
translational research has transformed (or not) the mundane knowledge producing practices of 
researchers in these settings. ‘Frameworks’ deriving from Latour and Woolgar’s (1986) seminal 
text were appropriated in order to capture various dimensions of these ‘mundane’ practices in 
the data. These frameworks were supported where appropriate by sensitising concepts and 
findings from other studies in the STS canon, particularly other laboratory studies and later ANT 
writings.  
Data from each study was transcribed separately onto the Nvivo software program and coded 
using Ritchie and Spencer’s (1994) ‘Framework’ for coding and analysing qualitative data. With 
the aid of this program data pertaining to each of the frameworks could be easily delineated, 
which was helpful in writing-up each of the empirical chapters. Each chapter focussed on the 
localised dynamics of translational research in respect to each of these frameworks, followed by 
a closing summary. The implications of this research will now be further articulated.  
Review of Key Empirical Findings 
The name translational research was read as a label well known amongst respondents in each of 
the cases studied in this thesis and arguably more widely across arenas of contemporary health 
research. Yet whether the practices captured under this idea also travel and transforms at 
locales of knowledge production was found to be affected by all sorts of institutional factors. 
Translational research marks another effort to redefine the science-society contract, which rests 
on the dilemma of how to harness and institutionalise innovation which science promises. It was 
said to me by respondents in my pilot studies that translational research was simply a case of 
scientists re-labelling what they already did in order to meet an agenda. But do the labels have 
some effect (e.g. from a governance level) in terms of priorities and ways research is organised? 
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The findings from my study would suggest they do. Furthermore, even if the transformation of 
local research practices only extends to the displacement of a name, this still signals some 
novelty in terms of how ideas are extended via networks into new sites. If the inventiveness of 
this device is approached  in terms of a novel arrangement alongside other situated activities 
and devices (Barry, 2001, 211-212)  then for each of these cases translational research marks an 
innovative mode of organising, albeit in different ways and to a greater or lesser degree. The 
thesis provides support to the theoretical assertion that in contemporary organisations 
sometimes names travel, sometimes names and practices travel, and sometimes only practices 
travel (Czaniawska and Sevon, 2005, 10). The practices implied by translational research were 
already institutionalised within the organising of the obstetrics group; therefore the cost of 
engaging in ‘translational research’ as opposed to say ‘applied research’ was minimal: it is just 
the name which becomes displaced. For the other two cases, the advent of translational 
research implies certain modes of practices being transformed as well as simply the name of 
what it was they were doing. 
This variation in what has travelled will now be further explicated by comparing how aspects of 
the local mundane practices (history of the lab, inscription, cycles of credit, microprocessing) 
were transformed in relating to the problem of translational research across each case.  
History of the Laboratory 
The approach used in each chapter was to consider translational research as relating to multiple 
situated realities which were being enacted and performed (Mol, 2002). Each empirical chapter 
therefore began with an attempt to map-out the various definitions ascribed to this term within 
the context of each group’s working practices. The movement through space and endurance 
across time of an ‘idea’ is contingent on its reception amongst different hands needed for it to 
spread (Latour, 1987, 138). Methodologically one can study the materiality of an idea by looking 
at its changing shape as it is tied into different people, by exploring how it gets transformed into 
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their local operations (if at all) (ibid.). Conducting case studies of its transformation within 
different organisational contexts is a logical and appealing way of performing this task. How then 
was translational research transformed from an abstract idea in the context of each case? How 
can one account for variations in results in terms of differing networks of practice? Stabilised 
definitions given to translational research in each case therefore varied according to differing 
configurations of institutions shaped by the networks in which the researchers could be located. 
For instance, the varying epistemic machineries (Knorr-Cetina, 1999) in which their practices 
were embedded delimited the kinds of translational work towards to which they could lay claim. 
Certain actions would not befit the institutionalised order told through narratives about their 
forms of science and behaviour appropriate of its practitioners (Czarniawska, 1997, 43). The 
articulation of boundary work in the respondents’ account therefore varied across cases and 
their existing institutional contexts. These findings will now be discussed further. 
One notable feature of the cancer and diabetes cases was the lack of self-evident production 
processes and strongly-convergent networks of practice to search for and scale-up their 
products into novel interventions. The fragility and notoriously high attrition rates associated 
with the extended networks through which their products had to pass in order to deliver market 
or clinical pay-offs, led the respondents to articulate more workable boundaries regarding their 
involvement in these processes. Questions about how they defined translational research in 
relation to their work provoked difficult boundary issues with regards their appropriate role as 
scientists versus engineers. In answering such questions they have come to negotiate several 
institutionally relevant and legitimate practices such as consulting and collaborating in 
partnerships with commercial companies, and licensing and commercialising intellectual 
property. Likewise, articulating ‘disease-oriented’ or ‘clinically relevant’ problem choices in their 
basic research activities enabled the groups to mobilise promises about potential utility of their 
work, thereby contributing to translational research without necessarily having to perform 
226 
 
additional ‘engineering’ work themselves. This strategy resembles Latour’s type II and III 
transformations. In type II, the scientists get interested parties to shift their initial, hasty 
interests, and instead follow those laid-out by the scientists (1987, 111). As achieving such 
‘explicit displacement of interests’ is rare, the scientists deploy another transformation (III) 
strategy, by stating to the interested parties: ‘You cannot reach your goals straight away, but if 
you come my way, you would reach it faster, it would be a short cut’ (ibid). In these contexts, the 
lack of established production and search processes and shifting, weakly-convergent networks 
led to difficulty in defining the boundaries of their involvement in translational research. This 
provides a compelling explanation of why the respondents traced-out a rather fragmented list of 
ways in which they could contribute to this general goal.  
By contrast, in the obstetrics case, availability of well-known inscription devices (notably clinical 
trials) and strongly-convergent networks of practice for scaling-up its products made their local 
transformation of translational research reasonably self-evident. The institutionalisation of the 
HTA amongst the ‘state’s regulatory apparatus in relation to public health’ (Webster, 2007) 
provides a ready-made conduit for scaling-up and implementing the researchers’ products into 
routine clinical practice. Across these extended networks, regulation could be said to have 
facilitated (rather than burdened) ‘the production, circulation, and interchangeability of novel 
entities and practices’ (Keating and Cambrosio, 2003, 332). The focus of NIHR on prioritising 
their type of multi-centre clinical trials also meant there was additional support in place which 
the group had begun to successfully exploit. For example, at the time of fieldwork, with the 
formal backing of the NIHR, the group were in the process of setting-up a ‘sales network’ (Pinch, 
2008) called CLRN to support the production and promotion of their clinical trials in the NHS. 
Having such equivalence with extended networks of HTA meant they were thus able to ‘piggy-
back’ onto a single, much stronger ally than themselves (Latour’s type 1 transformation, see 




Of course there would still be practical obstacles to their translation, however, the presence of 
this ally provoked respondents into arguing their products provided a much more plausible script 
for action in relation to the problem of translational research than does more upstream 
experimental work in basic science. Unlike the other two cases, the obstetrics researchers were 
producing claims (‘evidence’) about the safety and efficacy of new or existing interventions, 
rather than championing the clinical potential of given interventions per se. Their scientific and 
regulatory field of HTA-EBM is disciplined around an ‘institution of objectivity’ (Cambrosio et al., 
2006b). This made striking a balance between problems of representing and intervening, science 
and engineering, much less problematic than was the case for researchers in the other two case 
studies. They were behaving as scientists in making truth-claims (‘facts’) via standard inscription 
devices (clinical trials, systematic reviews). Simultaneously, in producing facts they were also 
providing ‘evidence’ which, because of modern regulatory institutions in healthcare, is 
indispensable in making interventions translate into clinical practice. They were therefore also 
acting as engineers, in helping to test whether translations could be made workable. The label 
translational research therefore did not perturb the boundaries of what they were said to be 
doing to anywhere near the same degrees as for researchers in the cancer and diabetes cases.  
 
Translational research was defined by the researchers through processes of ‘analogical 
reasoning’ (Knorr-Cetina, 1981). But despite the flexibility and mobility of this label-metaphor, it 
is not infinitely malleable: instead respondents’ versions of this problem corresponded to local 
situations and accompanying institutions in which they located their actions. Respondents in 
each case defined translational research according to epistemic machineries with which they 
identified (and the mobility of the inscriptions they could produce), the types of allies with 
whom they could associate themselves, and the relative ease with which they could render 
invisible the subsequent detours to be taken by external allies in order to scale-up their products 
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into clinical/market settings. Hence the objects into which this ‘idea’ gets associated can be 
rendered visible within the contexts of networks traced by respondents (Law and Singleton, 
2005). The ‘translational’ success of such objects is very much contingent not only on the 
formation of such networks, but on subsequent work these associations perform (Czarniawska, 
2004).  Further issues in working with these associations will now be considered with reference 
to Latour and Woolgar’s three remaining frameworks.  
Inscriptions 
For Latour and Woolgar (1986) the products of the laboratory (facts/objects) are made to travel 
and circulate via various forms of writing. The ‘inscriptions’ sections of the case studies explored 
whether Latour and Woolgar’s depiction of the content of laboratories’ written outputs as being 
characterised exclusively by technical discourse and claims to facticity held-up.  This question 
emerged because certain respondents associated translational research as now being de rigueur 
in respect to institutions of writing in science like journal articles and grant applications. This 
claim appeared significant in that, if true, it would suggest that in order for their products to 
travel through forms of inscription, scientists today must also explicate their potential to be 
translated into practical outcomes.  
Primary analysis of the textual outputs produced by respondents in each case study only partially 
supported this hypothesis. Drawing on STS theorising, I will now try to make further sense of 
these results within and across the cases. The obstetrics group apply to one centralised sponsor, 
whereas others apply to more fragmented sets of sponsors. Hence the former simply have to 
‘whistle the tune’ of a single pay-master, whereas others, so to speak, must extend their 
repertoires. The findings show obstetrics group as practising Latour’s (1987) type I 
transformation, where they can ‘piggy-back’ on a stronger ally (HTA) whose translational remit is 
broadly established and pre-specified (e.g. in the form of multi-centre trials and systematic 
reviews) and which has an ready-made infrastructure in place to scale-up the researchers’ 
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findings. The group simply have to deliver a product which meet these criteria, rather than 
promise further proof-of-principal studies. One effect seems to be they do not have to justify 
anew the means by which the project will scale-up into clinical practice each time they apply for 
a clinical trial grant or submit a journal paper. This is a feature of operating within a field whose 
relevance is considered indispensable to a powerful ally, namely a state-supported earmarked 
programming mission: NIHR-HTA (following Rip’s ‘cycles of relevance’ model, see Figure 5 in 
Chapter 3).  
Conversely as  the work of the cancer and diabetes cases must take ‘detours’ (via lengthy 
periods of basic research) before its clinical pay-offs can materialise, the sponsors seek promises 
and reassurances from researchers that funding will indeed actually help them to reach their 
goals (Latour’s type II transformation). Furthermore, compared to the obstetrics case the other 
two groups lack institutionalised and strongly convergent networks of allies like the HTA (which 
in theory have enlisted and drilled a bureaucratic organisation like the NHS in a relatively 
standardised way). A more ‘natural’ ally for the cancer and diabetes cases is the pharmaceutical 
industry. This industry has its own interests, making it harder for the researchers to enlist 
support and render their product indispensable to its companies. Wary of potential to be 
perceived as lacking in relevance and legitimacy, elite members of the field (e.g. journal editors) 
introduce as obligatory practice in writing articles the need for inclusion of promissory 
statements about potential utility of findings. But findings here would suggest this ‘hinterland’ 
(Law, 2004) strategy appears to emerge at the discretion of editors and is not ubiquitous to all 
titles analysed in the different case studies.  
The claims of certain informed respondents in cancer and diabetes cases was that reference to 
translational research constituted more of an obligatory passage point over recent times. The 
extent to which the inclusion of statements providing plausible scripts for practical action 
constitutes a new phenomenon in science remains doubtful. For example Knorr-Cetina’s (1981) 
230 
 
study of applied scientists’ strategies of literary reasoning in scientific journals drew attention to 
the inclusion of such statements in the introduction sections of articles. Although this was based 
only on a single case study her findings would suggest this literary strategy has been a feature of 
applied sciences for some time. Indeed as with ‘plausible scripts for action’ Knorr-Cetina 
identified, those forward-looking statements found in texts of my respondents were written in a 
way as to highlight only possibilities as opposed to practicalities of scaling-up their products. It 
may be plausible for instance that rather than constituting something qualitatively new, 
translational research has simply displaced other labels for describing this aspect of writing 
practice (such as ‘strategic science’). Also plausible is the notion that the forms of literary 
reasoning associated with Knorr-Cetina’s applied scientists has become more commonplace 
amongst more upstream modes of (techno)science, given the blurring of demarcations between 
science and engineering and the reported advent of changes in wider knowledge production 
regimes (Nowotny et al., 2001, Hessels and van Lente, 2008). This is a claim which deserves to be 
followed-up through further study. For now, I would simply add that although respondents 
recognised this intensification as an innovative aspect of the writing practices in cancer and 
diabetes cases, it was not necessarily one towards which they had resisted or struggled to adapt.   
An additional empirical finding was that on their own inscription devices cannot be transformed 
into scripts for action without additional embodied efforts and skills of scientists and those with 
whom they seek to enrol. Notably in getting texts like grant applications and journal articles to 
enrol (potential) allies, scientists also had to attend and/or organise meetings with the allies. In 
the diabetes case study, submitting grant applications would not be sufficient in order to access 
funding, but was supported through an interview process. Likewise, before commercial 
companies invested in the products of the cancer laboratory, the PI and senior lecturer were 
required to present their work in person and sometimes undergo what they felt lengthy cross-
examination processes. In the obstetrics study, it became apparent that the process of moving 
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from one form of inscription to another was hard-fought and costly. In particular in clinical trials 
moving from a device like a questionnaire towards composing a full data set on the relevant 
population required all sorts of mediation work on the part of hospital staff, which in a 
geographically distributed production process like MCTs was not always inevitably forthcoming. 
Holding face-to-face meetings was one tactic by which the scientists and their formal allies 
sought to enlist the support of said group. Common themes amongst each of these stakeholders 
were apathy and/or risks they attributed towards working on the products with which they were 
presented by the scientists. Hence although ‘translational research’ appear to be very much 
dependent on a range of inscription practices, these practices must be supported by additional 
embodied efforts, which, ultimately may fail to materialise on a case-by-case basis. This finding 
suggests that in these ‘translational’ contexts inscriptions were less effective at producing and 
circulating new objects than was the case for those scientists engaging in disciplinary networks 
of practice depicted in Latour and Woolgar’s study27. I suspect this was what one respondent 
was intimating when describing translational research as requiring lots of additional ‘dirty work’.  
Cycles of Credit 
If scientists subscribe to the ‘logic of opportunism’ (Knorr-Cetina, 1981), it follows that 
translational research must have practical use for researchers in order to be taken-up. The 
economic concept of cost is a helpful means of expressing levels of commitment, 
transformation, and resistances calculated by respondents in each case.  
Cost calculations were considered in terms of the risk to existing operations. In the cancer and 
diabetes cases as only certain senior figures had the capital and know-how required to align 
translational research to other levels of work organisation, they became even more 
indispensable to the operations of the group. It appears intuitively convincing to state that 
                                                          
27
 The importance of place in coordinating exchanges will be discussed further in the theoretical review 
later in the chapter. 
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because technicians, post-doctoral researchers, and PhD students are hired by the PI in order to 
fulfil particular roles in the group’s production process (at the ‘experimental level’ of work 
organisation, see Fujimura, 1987), the leaders would not want them to take on responsibilities in 
relation to this problem. ‘Experimentalist’ members were less indispensable in relation to 
translational research, typically acting under the scripts authored by senior figures in the group. 
It is the senior figures who are knowledgeable and accountable for cost calculations. Hence the 
interaction of translational research with the groups’ traditional forms of hierarchical 
organisation did not antagonise and create a particularly strong source of resistance. For 
obstetrics researchers the problem of translational research could be addressed simply through 
cycles of credit and funding conversions. The principle disciplinary measure for this 
organisational motif was publication and acquiring research funds. This disciplining was 
formalised around the organisational device of the REF and imposed on others by the group 
lead.   
Laboratory studies of scientists at work showed how like workers in other organisations, 
scientists worry about their futures. Projections about cost also entered as an important 
consideration with regards calculations about future career actions. As an ‘investment’ 
translational research was related towards scientific careers of the group and individuals in 
different ways, varying according to stage of career development, levels of capital accumulated 
to date, and interpretation of opportunities within their respective agonistic fields. The 
reputation of the group and its lead scientists was seen as significant in determining 
opportunities to compete in their adopted areas of translational research both hitherto and in 
future. For the diabetes group, translational research was seen as a struggle, but one which they 
needed to harness and exploit. The problems of strong competitors and lack of reputation for 
bringing in grant money beyond preliminary studies had the potential to make the terrain too 
treacherous for them to travel in. The aim for the group was to negotiate and eventually master 
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the ‘terrain’ through extensions of actor-networks, in order to make more frequent and rapid 
journeys across this ‘terrain’, therefore benefitting their future ‘empire’. In short, they had to 
overcome and tame initial resistances. For the cancer case study, prior successes in feeding drug 
development and instrumentation had brought a reputation to the laboratory and its leader for 
working on translational research. By associating themselves with the laboratory, post-doctoral 
researchers could enhance their own reputations as commodities in employment markets for 
scientific researchers in academia and industry. For the PI, the professed strategy was to balance 
the need to retain the reputation of the laboratory in this regard, so as to continue rapid 
movement through cycles of credit conversions and meet external agendas, whilst retaining 
their focus as a basic science laboratory whose main product was ‘Science/Nature papers’. 
Further expansion into areas of translational research could stretch resources and result in loss 
of control. As such, translational research marks one means by which the laboratory can attract 
funds and reputations, but does not replace sources associated with institutions of basic science. 
In the obstetrics case study the work of the group was very much aligned already with their 
definition of translational research. The focus for the group lead therefore was to consolidate 
and expand further his group’s reputation in the field of EBM-based obstetric research, 
particularly through conducting large MCTs. For others, such as the senior clinical lecturer and 
post-doctoral researcher, individual career ambitions were centred on mastering the design of 
multi-centre trials and becoming a ‘name’ within this translational territory. For members of this 
case, translational research did not require them to reconstruct their individual career 
trajectories, which I suspect is one of the reasons why the adaptation towards ‘translational 
research’ appeared relatively unproblematic for this group. One anomaly was a senior lecturer 
that was resistant towards the management of research in universities and the problems this 
posed for pursuing patient-centred research: formal performance measurement targets like 
publication and grant money displaced opportunities to orient selections and actions around 
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pursuit of broader patient-centred problems. As a result the individual questioned their long-
term future in this kind of working environment. 
Sociologically it is argued that certain individuals and groups stand-out not because they are 
special or because they are somehow fated to do so, but because they have been able to enrol, 
mobilise, and drill larger numbers of elements, more effectively than others (cf. Latour, 1987). 
Following ANT logic, observed differences were a matter of greater or lesser capital 
accumulation and mobilisation of resources. Clearly then how groups of researchers organise 
their responses and how careers are aligned in relation to this problem is likely to vary according 
to the location of existing stockpiles of capital and calculations about promises of further 
successful accumulation. Where the costs for existing operations and credibility are anticipated 
to be too great, resistances are likely to occur.  
Microprocessing 
STS laboratory study instructs the analyst to treat scientists as following a ‘logic of opportunism’ 
(Knorr-Cetina, 1981). As the history of the laboratory section indicated, translational research 
was a means of packaging production processes which involved them working with certain allies. 
But getting these collaborations to ‘work’ requires hard-fought periods of negotiation. This was 
illustrated in the obstetrics case through observation of trial steering committee meetings in 
which social actors from various professional and disciplinary backgrounds met to agree upon 
the trial protocol document. In formulating this written text it was hoped that they could 
coordinate the clinical trial from a distance. The period of observation enabled me to capture 
some of the difficulties in coordinating and negotiating exchanges and the importance of 
articulating boundary objects in order to do so. Part of the equivalence was based around 
following international standards for conducting clinical trials and methods of EBM. The 
importance of coordination could be inferred also through responses given in interviews across 
the case studies, in which respondents provided detailed examples of how collaborative 
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processes are able to work. Instruments, theory, experiments   were found to be amongst the 
mundane artefacts which brought them together and facilitated coordination of exchange 
(Galison, 1999). In the diabetes case certain pieces of ‘big science’ equipment brought their 
laboratory into close contact with a clinical laboratory in the partnering NHS hospital. In 
collaborating with clinicians, the basic scientists recognised certain experimental techniques as 
providing workable data sets which could be understood across their social worlds.  Researchers 
in the cancer case provided a mass spectrometry machine for other academic and industrial 
laboratories to use and were positioned as expert consultants offering a paid service for 
facilitating its transition into these extended spaces. Here a locally developed niche product was 
able to develop and ‘translate’ amongst people with different qualifications.  
Literature on translational research has equated the idea with the linear model of innovation. 
This is argued as being doomed to failure, for example because it fails to accommodate issues of 
incommensurability between various social worlds needed to make the process of translation 
possible. Whilst I share this broad perspective, one of the shortcomings of these studies is they 
render opaque the fact that it is possible to translate in science. Research on the significance of 
‘trading zones’ appears to be supported by findings in the case studies. One of the most striking 
findings which goes against existing emphases in social studies of translational research is that 
the different participants within these assemblages need not always necessarily talk past one 
another (what Kuhn (1970) termed ‘incommensurability’). This renders opaque altogether how 
those from different domains might establish common ground. I propose, borrowing from 
Galison (1999), that translation process be studied not in terms of Kuhnian paradigm shifts, but 
as overlapping tectonic plates of ‘interlocution’. Galison argues that history of science 
demonstrates precedents of different branches converging and talking to each other, although 
managing such efforts is far from straight-forward and predictable.  The importance of place in 
erecting spaces of interlocution required for translation to occur will now be considered further, 
236 
 
with special reference to how findings in the thesis can contribute to recent theoretical advances 
on this issue.  
Theoretical Contribution - On the Enduring Significance of Place  
Although STS literature remains sceptical to the notion that linear models will solve problems of 
how to ‘institutionalise’ innovation, it also shows how in practice innovation works as a recursive 
process between those with ideas and those who are searching for ideas to develop. It is search 
processes as much as provision processes which brings associations together and if there is some 
sort of mutual meeting ground then it is possible translate. But that mutual meeting ground is 
not self-evident: it has to be constructed. One theoretical current which helps to account for 
how such networks of practice manage to interact is recent work on ‘emplaced science’ (Henke 
& Gieryn, 2008).  The authors argue that although focus on fluidity by Law, Mol and Callon is 
useful, it risks diminishing ‘the apparent significance of the specific geographical spaces where 
the actants pass through or end up’ (2008, 355). They contend that places of science still hold an 
importance in regards to how science travels (ibid.). The authors then conducted a literature 
review in order to theorise ‘how place has consequence for scientific knowledge and practices’. 
The findings from this thesis on the travels of translational research provide useful empirical 
flesh to support and extend these theoretical bones. I will focus in particular on the importance 
of scientific sites in terms of reputation and capital accumulation, and in terms of providing 
places in which ‘trading zones’ (Galison, 1999) can be articulated.  
Henke and Gieryn mention in passing that ‘accumulation of people at a place serves as its own 
magnet’ for other scientists (2008, 357). Certainly this was the case for early-career researchers 
who recognised the likely importance of translational research in developing their future 
careers, and the ability as individual scientists to attach themselves to this problem through 
working in their group and/or host institute, given their existing reputations. But I also found 
that the articulation of faculties and institutes which drew together the ‘presence’ of hospitals, 
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charities, clinicians and laboratory scientists were intended by university management figures to 
serve as a magnet to enlist others in their pursuits of translational research. Speaking to 
respondents like Deans, it was clear such collaborations were designed to be seen, so as to 
proclaim the organisation as a ‘hotspot’ for translational research. Building this reputation would 
be an advantage for the institute and its researchers when pursuing further cycles of credit 
accumulation and investment. Each of the institutions (medical schools) in which the groups of 
my case studies were hosted pursued strategies analogous with this kind of model. Hence 
although translational research often implies a geographically and temporally distributed 
production process, assembling in the same location some of the different elements needed to 
drive forward this process was a strategy being pursued in each of the cases and is arguably a 
wider mimetic trend currently being followed by larger medical schools and institutes in England 
more generally. This is seen as the way to build the reputation of such institutes and to stand-
out from the crowd.  
Assembling these different parties was not just a matter of frontstage performance, but also of 
actually encouraging and facilitating greater degrees of interaction between such social actors. 
Having these ingredients in place was intended to build and reinforce networks and provide 
infrastructures so that promising ideas could be capitalised on where they arise. Also, by 
establishing formal partnerships between university and local hospitals it was hoped that this 
would enable peripatetic movement of people and flows of information and materials (what 
Latour, 2005 calls ‘mediators’) back and forth across the two-sites (Henke and Gieryn, 2008, 
357). This can be seen as a form of ‘knowledge architecture’ in which the building of material 
spaces is at once material and social (ibid). To some extent this strategy was also underlined by a 
somewhat hopeful  belief that simply bringing these diverse collectives together would engender 
feelings of awareness and co-presence, which would ultimately encourage them to do more to 
be ‘translational’ in their behaviours. Whether such compositions did in fact engender closer 
238 
 
sense of ‘co-presence’ (Goffman, 1967) was debatable, particular amongst junior scientists, 
several of whom expressed indifference and/or dismissed such efforts as ‘PR’.  
In order for translation to occur, participants recognise a need to hold face-to-face meetings. 
The function of meetings appeared important across the case studies in a number of senses. 
First they were important in order to engender trust between participants. As success or failure 
of their enterprises was seen to rest on the ability of allies to carry-out certain actions, meetings 
constitute an important occasion to establish trust relations. The significance of trust is not lost 
despite the rise of geographically distributed production processes. This has been argued by Urry 
who has developed a notion he calls ‘meetingness’. He states:  
“Because networked relationships are conducted at-a-distance so encountering, visiting 
and seeing networks members face-to-face is crucial. Indeed in some contexts the 
network will be made up of those who are not known to each other except by ‘name’ 
and hence it is essential to ‘put a face to a name’, as with many professional and 
business meetings.” (Urry, 2003, 162) 
This appeared to resonate with the PI’s story in the cancer case study about drug company’s 
practices of arranging meetings to ‘suss out’ scientists with whom they were interested in 
collaborating. Additionally, in the obstetrics case, holding trial steering committee meetings 
enabled occasions for participants to debate and negotiate the credibility of the trial protocol 
document and by extension, the credibility of those with whom they were collaborating and the 
clinical trial itself. Hence the dawn of geographically distributed work production sites does not 
displace the importance of meeting face-to-face, but appears to reinforce it. Translational 
research is thus not ‘placeless’ science.  
Another function of meeting face-to-face is to exchange tacit knowledge. Forms of knowing not 
explicated in standardised documents and other formal media could be shared on these 
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occasions, through talk and gestures rather than simply following printed texts like SOPs and 
textbooks. The most explicit acknowledgement of this idea came from observing the discussions 
which led-up to the post-doctoral researcher in the obstetrics case study deciding to attend the 
TSC meetings. It was assumed that in order to become a competent skilled practitioner 
eventually in running multi-centre trials, it was necessary to gain direct sensory experience of 
these meetings. The prevalence of meetings in the other two case studies also supported this 
assertion, as they were seen as providing occasions in which to ‘troubleshoot’ and ‘learn’ from 
colleagues and superiors.  
A third function of place was to provide a protected space in which aspects of the experiments 
were allowed to fail. ‘Experiments without borders’ theses therefore received only partial 
support in these findings. This notion that the boundaries of laboratories as single, largely 
invisible production sites which have been undermined in recent times was corroborated by the 
stringent forms of regulation and accountability placed on researchers in this case, in terms of 
ethical scrutiny and accounting for full economic costing of their research. Likewise, for clinical 
research projects, particularly MCTs, it could be said that the hospital constituted a new type of 
laboratory in which experiments took place. But places where people met for ‘troubleshooting’ 
suggested a backstage in which various ideas were considered and tried out before selections 
were made public. For instance, trial steering committee meetings enabled debates to occur 
over the best means by which to design and implement a clinical trial in which ideas were 
suggested but omitted from the final submitted version. The absence of particular audiences 
from these occasions was conspicuous, as it became clear that, say sponsors, were interested 
only in formalised textual outputs of the research team and not the processes of ‘laboratory 
reasoning’ (Knorr-Cetina, 1981). Hence although multi-centre trials constitute geographically 
dispersed production processes (compared with earlier ethnographic accounts of single 
laboratory sites), the erection of a frontstage/backstage distinction remains important (Goffman, 
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1969). To articulate this divide meetings are organised in which some are invited and others are 
not. On visiting the cancer laboratory it struck me that only members of the organisation were 
able to access (or even probably locate) this production site. This reinforced what respondents 
had been saying about translational research: that it was about trying to control at-a-distance. 
Hence those sponsoring their research did not make them accountable by way of regular spot-
check visits into their sites of production. Instead these messages were communicated via forms 
of media like grant applications and forms of talk such as when applicants attended interviews at 
sponsors’ offices. In other words, the actual day-to-day performance of the research was not 
observed directly by the sponsors. The laboratory thus provided a private enclave in which 
various ideas could be tried-out and finessed before being made public.  
My findings added fresh empirical support for each of the theoretical assertions that trust, tacit 
knowledge, privacy, and reputation are important functions of  places in science (as well as 
perhaps others forms of business and professional activity) (Henke & Gieryn, 2008). But findings 
in the obstetrics case also led me to infer the importance physical meeting sites  have in terms of 
engendering motivation/excitement for participation in large clinical trial projects: in a 
vernacular way respondents appeared to subscribe to the notion that co-presence brings about 
what some in interaction ritual theory call ‘emotional energy’ (Collins, 2004). This aspect relating 
to the importance of place which has been neglected by recent works on the importance of 
place in STS (Henke and Gieryn, 2008, Wainwright and Williams, 2008) and mainstream sociology 
(Gieryn, 2000, Urry, 2003).  Inspired by Goffman (1967), research in interaction ritual theory 
argues that key to understanding and shaping social order and conflict are shared co-present 
encounters between people. In interaction rituals participants come together (as ‘emotionally 
charged bodies’), following rules and rituals which ‘not only show respect for sacred objects, but 
also constitute objects as sacred’ (Collins, 2004, 17). Although human beings generally crave 
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order from social interactions, the volatile combination of emotions that such episodes 
sometimes concoct can lead to unanticipated outcomes: 
“Interaction rituals begin with emotional ingredients (which may be emotions of all 
sorts); they intensify emotions into the shared excitement that Durkheim called 
'collective effervescence'; and they produce other sorts of emotions as outcomes 
(especially moral solidarity, but also some aggressive emotions such as anger).” (Collins 
2004, 105) 
According to Collins it is the propensity of interaction rituals to reproduce and transform actors’ 
emotions and motivations that make them such interesting and important parts of sociological 
analysis. The process of shared emotions being carried-over by individuals from one interaction 
ritual to another is described as ‘interaction ritual chains’.  
This work has been criticised for placing unsubstantiated faith in the primacy of interaction in 
the social order. I am not interested here in wider theoretical debates, but merely wish to point 
out that respondents in the obstetrics case were observed as enacting a lay version of this 
theory. As a tactic for motivating allies, the notion of meeting face-to-face was explicitly 
supported during team meetings. This belief appeared to be passed on in these encounters as a 
form of tacit knowledge about how to run clinical trials, which although not codified or 
formalised in normal science textbooks, was nonetheless earmarked as important for the 
success of running these kinds of clinical studies. They projected that enthusing NHS trusts and 
workers to help implement their clinical trials would require the semi-regular organisation of 
face-to-face meetings and conference-type presentations, alongside emails and newsletters to 
‘top-up’ enthusiasm. Similarly I recorded in fieldnotes how during intervals of these meetings, 
two clinicians whom were the target audience of presentations had echoed the importance of 
co-present interactions in supporting their continued enthusiasm for such projects. This suggests 
that further research on place in science and organisational sociology more generally should 
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consider the importance of meetings in engendering ‘collective effervescence’ towards 
geographically distributed work production processes. How important such occasions are for 
marketing and enrolling allies into different types of translational projects is a question worthy 
of future attention. Interaction ritual theory may be useful in accounting for function of place in 
terms of its importance for generating enthusiasm amongst potential recruits. This insight has 
been overlooked in concepts like ‘trading zones’ and was also absent in Henke and Gieryn’s 
(2008) literature review, but seems something in which future researchers interested in 
emplaced science should take more of an interest.   
Concepts like actor-network and trading-zone are useful for studying how scientists go about 
constructing the spaces necessary for translation. But then of course there is the question about 
the actual appropriability of new ideas: whether developers and users then have the capacities 
(in all sorts of sociological senses) to appropriate, use, exploit ideas is likely to have a significant 
influence on the ability to translate. This was indicated in the history of the laboratory section 
with reference to the diverse actor-networks on which the different cases were dependent for 
‘scaling-up’ their ideas and the varying ‘transformation’ strategies available in getting them to do 
so (Latour, 1987). Although places appear indispensable in order for translation to occur, in and 
of itself constituting them anew does not guarantee translation.  
Critically Considering the Framework  
So far the chapter has attempted to assemble a strong case for using ANT and related STS 
resources for studying translational research. However, it would be unsatisfying to take the 
framework adopted here as a straightforward heuristic to be applied onto this target concept. 
Therefore in the spirit of STS I would now like to consider the approach used in this thesis as a 
topic and not just resource of inquiry.  The theoretical utility of Latour and Woolgar’s 
frameworks and STS laboratory studies more generally can be understood in terms of the 
deductive inferences it allowed for in the context of the analysis. These were rehearsed above. 
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However, there were also some inductive inferences made during the analysis which expose 
certain issues and shortcomings in applying the original model to the context of this case study.  
The appropriation of the laboratory over historical periods framework stands out as a useful 
means of sensitising the analysis of an otherwise promiscuous and  unruly idea like translational 
research in the context of participants’ local research practices. The transformation of this idea 
into objects and associated practices which are made visible within network of relations made it 
possible to locate this ‘idea’ in time and space. In an effort to retrieve an abstracted idea from 
mobilisation processes, ‘translational research’ was studied as an immutable mobile and 
boundary object, albeit not necessarily an entirely successful one, which gets variously 
embedded into the local practices of each group. As these practices are always local, one should 
refrain from starting with a ‘real meaning’ of translational research, but rather take its definition 
as an empirical question.  
Cycles of credit has also been deduced as a useful model in explaining the behaviour of 
respondents, who were observed as being persistently concerned with converting forms of 
credit. Yet the model, as originally conceived was ill-equipped to capture problems of relevance 
and legitimacy scientists in my study faced in respect to certain institutions. To temper this 
emergent shortcoming, I followed a version of the credibility cycle which accommodated these 
emergent struggles (Rip, 1994). But even working with this ‘improved’ framework, I have 
reached certain conclusions. In the case of the obstetrics group, the extension of the credibility 
cycle to accommodate struggles for relevance appeared less constraining than in other case 
studies, possibly due to the institutionalisation of HTA within wider apparatus of public health. 
Likewise in the context of the cancer case, the credibility cycle of respondents had not expanded 
to incorporate struggles for legitimacy, which could plausibly be explained by the researchers’ 
ability to associate their basis research activities with a more powerful and legitimate set of 
allies: cancer research. Thus the extent to which Rip’s model provides an apt model for framing 
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the situation of scientists should not be pre-determined, but considered over the course of 
inquiry. Rip does however provide a better working model than Latour and Woolgar’s original.  
A further criticism of the credibility cycle (and by extension laboratory studies) is that it is not 
particularly adept at capturing field-level and discipline derived influences on scientists, such as 
the funding landscape of particular scientific fields (e.g. Slaughter & Rhodes, 2004, 78). This 
(plausible) criticism appears to have been corroborated by my experience of observing and 
interviewing scientists, who although providing numerous useful traces, through which their 
networks were organised, only occasionally pointed me towards this particular type of 
institutional constraint. Therefore, future analyses could benefit from following and developing 
versions of the credibility cycle model that have attempted to accommodate ‘cosmopolitan’ 
level concerns (e.g. Rip, 1997, Hessels et al., 2009).  
Laboratories are atypical forms of organisational units which can often ‘stock’ certain elements 
for periods of time in order to utilise them when appropriate (Knorr-Cetina, 1999, 27). 
Conversely most modern organisations are thought of as having to respond to pressures in their 
environments almost at the moments they occur (Czarniawska, 2004, 777). This posed certain 
questions of Latour and Woolgar’s account of scientists’ ability to mobilise various forms of 
inscription. The need to extend powers of persuasion to enrol ‘technicians’ to run their trials 
suggests respondents in the obstetrics case must organise in a manner more akin to 
Czarniawska’s ‘modern organisations’, for instance by engaging with a fluctuating market rather 
than organised hierarchy of labour. In the context of this case it was found that respondents had 
to deploy persuasive skills in a manner beyond their counterparts in Latour and Woolgar’s 
original study: the hospital might even be described as an extended laboratory (Löwy, 1996, Mol, 
2006). The ‘technicians’ themselves are now an important audience whom the scientists must 
seek to enrol through persuasive presentations/demonstrations and media like emails and 
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newsletters. The translational promise of the research appeared as an important rhetorical 
resource in alliance-building.  
Methodologically the practical utility of Latour and Woolgar’s original description of the 
organisation of laboratories through inscription was also brought into doubt in the course of this 
case study. Whereas the laboratory constitutes a kind of production line for the creation of facts 
through literary inscription, many such inscriptions appeared to be performed ‘off-site’ in the 
context of the obstetrics case. At no time was I able to observe, for instance, occasions when 
researchers sat down to read journal articles, or at their computers to write-up their articles. At 
weekly team meetings, participants would simply provide a verbal summary of their progress on 
writing particular papers in respect to completion. This part of the writing act occurred 
elsewhere, in their offices or on personal home computers. This was also a problem in applying 
the microprocessing of facts framework, as the various routine exchanges Latour and Woolgar 
were able to observe in a single site, here occurred in geographically dispersed locales, such as 
hospital wards, and across extended periods of time (up to three years). For the observer this 
poses a range of practical questions about what to observe and where. In this section, what was 
observed was one phase of the process of fact production taking place in a centre of calculation 
(the trial steering committee) rather than the locales (hospital wards). Some have suggested that 
geographically distributed forms of technoscientific production might better be studied via 
multi-sited ethnographies (Hine, 2007), yet the efficacy of this in regard to processes as 
extended and fragmented as clinical trials needs to be explored further.  
In addition to the methodological issues posed in relation to applying the mircoprocessing 
framework in its original form, there were also some empirical discontinuities in the conclusions 
the data allowed me to reach. Applying this framework has provoked a more substantial set of 
issues with regards the importance of place in performing translational research and the 
acknowledgement of this by existing literature, which will be addressed in the next section. For 
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now, reporting on observations made of the obstetrics case study’s trial steering committees, 
when controversies emerged in interactions regarding the validity of long-established facts, 
protracted debates ensued (contra Latour and Woolgar’s findings), not all of which were settled 
fully there and then. From this I have posited the tentative conclusion that shift from observing 
exchanges in disciplinary, ‘laboratory’ settings to those multi-disciplinary ‘hybrid’ settings will 
likely reveal greater prevalence of controversies regarding long-established facts, given 
asymmetries of expertise within these assemblages. Possible topics for further research include 
what kinds of closure mechanisms appear most prevalent when controversies break-out in such 
contexts. Furthermore, how new controversial facts are negotiated by hybrid collectives is a 
topic which may be facilitated by more extensive ethnographic fieldwork in sites where these 
hybrids meet. Again it is not clear the extent to which this question was difficult to answer here 
due to the practical limitations of the fieldwork, or because new controversial facts are simply 
less likely to occur in these multi-disciplinary situations. It is also instructive to note for purposes 
of future studies how the lack of data pertaining to Type II and III statements resulted from only 
observing one type of meeting in a centre of calculation as opposed to more extensive exposure 
to other, perhaps more peripheral, places in the knowledge production context.  
One of the general appeals of ANT, in terms of its utility in answering the questions about 
mobility and durability of translational research was in helping to capture how people attribute 
different types of characteristics, parameters, dimensions towards actants that are involved in 
their production processes, which they regarded as being more or less workable with. This helps 
one to retrieve the practice from translational research which was rendered invisible in the 
discourse I had encountered amongst public statements of scientists and strategic policy 
documents. But in adopting some of the motifs of ANT, one of the challenges of the thesis 
methodologically was to try to identify with precision the boundaries of actants when those 
boundaries themselves are being constantly redefined all the time by different agents and 
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people. For example, translational research was not some sort of durable object in and of itself, 
but had variability to it. At this point one has to concede humility and acknowledge that any 
orders and stabilisations described from observations in the context of each case are more-or-
less reversible. A lack of invariable reference points (accounts) therefore means that a single 
definitive version of the actants is not possible, instead one must settle for historically specific 
accounts on which to base findings and conclusions. However, as these accounts were generated 
through ‘following the actors around’, the lack of a definitive version of translational research is 
not necessarily a shortcoming of this thesis, but a consequence of respondents having 
communicated the sheer messiness of the realities they face in their mundane practices. 
Providing a definitive, generalisable version of translational research therefore might be 
professionally or politically expedient, yet it would surely provide an inauthentic version of what 
it is like to work with translational research.  
In sum the sensitising concepts selected to aid analysis, derived mainly from ANT, have provided 
a largely useful and workable set of devices with which to confront the problems posed by my 
research questions. Yet these tools should not be immune from criticism, especially if STS is to 
refrain from becoming a bland formula to be applied readily towards emergent problems like 
translational research. By recalling some of the issues which have emerged in the course of 
inquiry, it is hoped that the thesis is adding to an existing set of approaches which can be used 
by others to provoke contention in relation to translational research in future social studies.  
Policy Implications 
Translation was found to be used metaphorically in discourse of scientists and policymakers 
(Martin et al., 2008). Part of its appeal is that it can be quite an ambiguous and empty concept, 
which is adaptable as a solution towards a number of problems. For example, in policy discourse 
it has been picked-up as offering a promising solution to significant problems with regards how 
publicly funded academic medical science relates to innovation. This can be seen in terms of 
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how it is related to both T1 and T2 ‘gaps’ in medical and health innovation. But research in this 
thesis has shown that when it becomes operationalised, the idea becomes contested and more-
or-less problematic. In showing how academic researchers come to work with translational 
research it became apparent, for instance, that their primary concerns were connected to 
research, rather than translation. Inversely, it could be said that for policymakers, the primary 
orientation is towards translation as opposed to research. Crudely speaking, then, there appears 
to be some discrepancy between translational research vs. translational research. One of the 
questions I would pose towards policymakers in the UK is which of these constructs they wish to 
prioritise. The answer they give is likely to have a significant impact on how health research is 
organised in the next few years. If translational research continues to be influential then 
presumably this would mean researchers modifying their practices in order to accommodate this 
goal. However, if translational research took precedent, then it could imply a moratorium on 
those types of research which fail to relate to this goal. Of course, in practice, these logics co-
exist and are subject to re-negotiation. However, at the time of writing I would argue that 
although the latter do appear to be ‘speaking-back’ to science, researchers still retain some 
autonomy from the intervention of interested parties. The situation is therefore one of 
‘muddling through’. Which polarity to pursue is a difficult decision as both provide certain 
dilemmas.  
If translational research is to continue, then expectations about the likely impact it will have 
should not be exaggerated. Continuing to promote the circulation of promising labels and 
metaphors may lead to modest impact in shifting priorities and ways research is organised, but is 
unlikely to provide a magic bullet that will ‘institutionalise’ innovation from the public medical 
sciences. One of the issues is that there are a number of other external agendas researchers in 
these cases were expected to meet, not all of which were conducive to working further with 
translational allies. Researchers, as logical opportunists, will likely seek to satisfy the 
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expectations of external audiences as best they can, rather than organise their operations 
around their goals.  
The research in this thesis shows also how in practice the multiple goals policymakers have for 
medical sciences (as sources of health, wealth and excellence) do not necessarily complement 
each other. As respondents in each case made me aware, the goals of wealth promised by 
biomedical innovation and scepticism about the ability to adopt health technologies into routine 
clinical practice can often be in tension. Thus the dual goals of improving healthcare (T2) and 
producing wealth (T1) underpinning health research policy texts like the Cooksey Report are not 
always commensurable. By continuing to ‘muddle through’ it thus appears logical to state that 
any success in plugging one of these gaps would not necessarily be conducive to plugging the 
other.  
A whole-scale shift in the medical sciences towards translational research would clearly require 
a systematic revolution of how these sciences are organised and what their stated goals would 
be. The strategy governments have exercised towards public sciences has typically been 
characterised as one of steering from a distance, often via intermediaries like research councils 
(van der Meulen and Rip, 1998). However, this approach has always been subject to continued 
re-negotiations, with the balance between autonomy and control, absence and presence 
undergoing transformations. In a period of so-called ‘re-contextualised’ science (Nowotny, 
2001), the temptation of interested parties like governments would appear to be imposition of 
further, stricter unitary measures to control quite diverse knowledge production practices. But 
stricter control over research practices is unlikely to elicit the proliferations in translation 
policymakers and other ‘communities of promise’ hope will emerge. Indeed reified unitary 
frameworks like translational research may even prove counter-productive in their capacity to 
undermine existing successes researchers have achieved in organising their knowledge 
production processes (Whitley, 2000, Lehoux et al., 2010). Furthermore, exactly what constitutes 
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a satisfactory level of engagement and contribution towards this wider goal is still being 
contested and negotiated across different organisational levels of the sciences. Relevance and 
robustness of different areas of the sciences after all are neither relative nor absolute concepts, 
but relational ones (Nowotny, 2006, see also Latour, 2005). This means the act of associating 
with translational research does not guarantee relevance. Critics have already pointed-out that 
policy initiatives like the Cooksey Report threaten to side-line areas of the health sciences which 
do not fit its rigid criteria for what constitutes quality research (usually thought of in terms of 
biomedical innovation) (Shaw and Greenhalgh, 2008). Medical treatment in other words should 
not be considered the sole guarantor of future health (Collins and Pinch, 2005). Policymakers 
might therefore consider on more of a case-by-case basis the extent to which sciences are 
providing products which conform to their interests, rather than imposing a de-contextualised 
linear innovation framework emanating from pharmaceutical development onto the whole vast 
tapestry of health research.  
Whichever of these two polarities takes precedent, there will remain certain challenges with 
regards institutionalising translational research. For one the interpretive flexibility around the 
idea of translational research, as well as bringing people together, can also make coordinating 
exchanges between different parties difficult as they attribute different meanings and 
resistances towards it, thereby shaping subsequent actions in ways which cause disagreements. 
Arriving at a successful stabilisation of translational research across the medical sciences will 
therefore be a contested process. This is unavoidable. There needs to be common ground 
between producers and users of novel ideas in order for translation to occur, but managing and 
predicting the appropriability of novel ideas is fraught with difficulties for all sorts of sociological 
reasons. Those cases exhibiting relative success at translation were able to draw-on largely 
stable, strongly convergent networks for scaling-up academic products into clinical pay-offs. But 
there is not a simple algorithm available for constructing such networks elsewhere in the 
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sciences. A difficulty then for scientists and policymakers alike will be design and implementation 
of institutions, organisations and infrastructures which are adaptable towards goals of 
interdisciplinary, translational research. Part of the difficulty with organisations like universities 
and NHS seems that they display signs of being non-adaptive to this purpose (for instance 
through many cumbersome performance measures). People working within these settings 
follow their own institutions and interests in ways which do not necessarily always match-up 
with those practised by other social worlds. ‘Trading zones’ appear indispensable in order for 
translation to occur, but efforts to construct them are not guaranteeing of success. Hence 
although there does appear to be some intuitive logic to some of the efforts to foster translation 
observed in these cases, whether ‘trading zones’ can be established through simply bringing 
different entities together in the same place is not certain. However, at present, erecting such 
spaces would appear to be one of the few promising strategies for coordinating greater levels of 
translation from the medical sciences. Of course whether existing organisations like universities 
and NHS and their institutions can be made sufficiently flexible and adaptable in order to foster 
innovation is a key question.  
In sum there are no easy answers to how translational research can be made to ‘work’ better in 
contemporary research policy and practice, or whether indeed translational research will 
provide a satisfactory solution to longstanding problems regarding appropriating innovation 
from public sciences. Part of the contribution this research can make towards policymaking is 
simply to point-out a set of problems. Taking the ANT approach enables one to account for 
differences in versions of translational research between cases and in doing so problematise 
assumptions which lie behind prominent versions of translational research. By using a reflexive 
set of methods and concepts the thesis can be used as a tool for allowing researchers and 
policymakers alike to  begin to think more reflexively about how they might better articulate and 
implement this idea. It does so by allowing them to retrieve the practices from translational 
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research and de-mystify some of its characteristics. Conducting further empirical studies using 
STS concepts is an important means for opening-up substantive knowledge on this topic, which 
without such concepts would almost certainly remain hidden.  
Concluding Remarks: An Agenda for Further Substantive Studies  
Having done an STS-style study it would seem inappropriate to stipulate what should be found 
by future research in social studies of translational research. Instead what I would like to set-out 
here are certain provocations with regards existing studies and themes with which future studies 
should benefit from engaging. I believe the task of social studies of translational research now 
should be to begin looking at performances of this idea in various other epistemic 
settings/places. Whether future studies are through single or comparative case studies, this 
thesis provides a theoretical/methodological tool-set with which to do so.  
Previous studies have glossed over the problem of how to conceptualise the term translational 
research, accepting instead policy definitions like ‘bench-to-bedside’ as their point-of-reference. 
But I would argue that to appreciate better the dynamics of translational research in 
organisation of contemporary public science, social scientists need to consider the real-world 
performances of the idea. Having tackled this problem by introducing terms like boundary object 
and immutable mobile, I find aspects of these earlier studies dissatisfying in a number of ways. 
Part of the frustration comes because in these stories ‘policymakers’ seem to be deployed as 
strawman figures made to speak on behalf of linear models of innovation. This representation 
then allows authors to knock them down with arguments typically pointing towards the futility 
of linear innovation models and the presence of feedback between sites of production, 
development and use (‘bedside-to-bench’). One of the immediately obvious weaknesses was 
that it is not made at all clear who these policymakers are or how their attitudes have come to 
be known. Although I share many of these basic sentiments about how innovation works, I 
suspect that these arguments may be somewhat oversimplified for polemic purposes. This was 
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reinforced when, reading through policy texts like the Cooksey Report (2006), to my surprise 
finding them not to propound versions of innovation processes quite as naïve and linear as I had 
come to expect having read social studies of translational research arguments about 
‘policymakers’ approach towards science-innovation. Parts of the text even acknowledged that 
translational research involves a two-way feedback processes. The term immutable mobile 
implies specific transformations of definitions as the idea gets extended and mobilised, meaning 
claims about policymakers’ supposed devotion to a singular, simplified definitions like ‘bench-to-
bedside’ appear slight. Until further empirical work is done on how policymakers engage with 
this term, it appears equally plausible to state that translational research is seen by them in 
largely instrumental terms as a label to be ‘filled-in’ by scientists and their allies. It may be that 
they are prepared to promote simplified, singular, de-modalised versions of reality, not because 
they believe they are likely to emerge exactly as specified, but because they are seen as helpful 
for getting things done at a distance and provide renewed hope for bridging innovation 
paradoxes. Furthermore as translational research is no longer synonymous simply with promises 
of biomedical breakthroughs, but also incorporates ‘T2’ approaches articulating some scepticism 
towards biomedical innovation, can the term any longer be made interchangeable with linear, 
deterministic models of innovation? I would suggest a more nuanced approach is needed which 
is able to accommodate differences in the handling of the term as it moves across different 
networks of practitioners.  My study provides a useful basis for an analytic framework which can 
capture such complex developments.  
Previous studies have also paid little attention to how this labelling device is accommodated and 
resisted within the mundane contexts of scientists’ work practices. Averting analytic attention 
towards these activities is likely to prove fruitful in terms of exploring the barrier towards 
translation which is surely of central interest to all of those interested in this topic. Several of my 
insights can be usefully taken-forward on further research journeys into this topic. Translation 
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can be understood as a metaphor used by scientists and other interested parties like 
policymakers and industry to describe science and innovation (Martin et al., 2008). In particular, 
I found this metaphor to be mobilised in the extension efforts of technoscientific networks. For 
the scientists’ part, a metaphor like translational research was important in helping them to 
present an equivalence between what it was they were doing and what has been successful 
elsewhere (Knorr-Cetina, 1981, 57). Respondents recognised how this metaphor evokes 
something of a ‘hinterland’ for audiences (Law, 2004) to whom they were variously accountable, 
particularly interested parties like sponsors and evaluation regimes. Hinterlands are sets of 
existing statements which a novel statement must sit alongside, support and/or reinforce in 
order to be accepted and transform wider networks (ibid, 28). Translational research was as a 
label scientists attached to their products in an attempt to make them more accessible and 
transportable as they come up against the hinterlands of potential allies. The argument then 
that the metaphor translation performs a dramaturgical function in ‘packaging’ their activities 
has some currency. Certainly the term would appear to have some stylistic appeal to audiences. 
Dismissing ‘translation’ as mere decoration of scientists’ activities would be mistaken, given how 
decoration was recognised by them as important with respect to a number of facets of their 
production process, such as obtaining funding and meeting performance criteria. Metaphors, 
therefore, far from ‘having no serious place’ in discussions about organised activities, are in fact 
crucial for ‘[plugging] gaps in literal vocabulary’ and ‘supply[ing] the want of convenient 
abbreviations’ (Black, 1962, 32-33). As academic sciences are in a peculiar situation of being 
highly specialised and self-referential collectives whilst still being dependent upon ‘outsiders’ for 
support and legitimacy, efficient and effective means for ‘plugging’ gaps in their audiences’ 
understanding remain highly important. This is why metaphors in science like translation should 
not be treated as trivial matters. They help science to ‘work’.   
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Future STS research can follow the logic that researchers’ articulations of definitions for 
‘translation’ is not self-evident, but must be worked-out in relation to all sorts of local 
organisational considerations and competencies. The local configurations of institutions found to 
be practised in these ‘peripheral’ places appears crucial for how (if at all) ideas get transformed 
and whether they are deemed ‘workable’. STS presents workability as a pragmatic and relational 
concept which points towards the scientific production process as being informed by a number 
of practical considerations by scientists, not least their existing situations in respect to ‘worlds of 
instrumentation, collaboration, publication, and investment’ (Knorr-Cetina, 1981, 58). As ‘logical 
opportunists’ scientists organise their actions and selections around unrealised solutions which 
they calculate as promising strong chances of success (Knorr-Cetina, 1981, 57). In (research) 
practice then there are multiple stabilisation efforts being enacted around a host of other, 
sometimes antagonistic objects (Mol, 2002, 150). My study’s contribution develops these STS 
insights to show how the ‘workability’ of translational research was shown to be very much 
related to the presence (or otherwise) of stable networks of allies for constructing and 
appropriating their ideas. Where such relations are weakly convergent the ‘workability’ of 
translational research is likely to recede. The empirical chapters also showed that when 
translational research marks a shift away from ‘what can be done’ (Knorr-Cetina, 1981, 58; 
Fujimura, 1987) in sites of scientific production, high costs of adaptation are likely to be coupled 
with emergence of resistances (cf. Pickering, 1995). Therefore, in order for some form of 
translational research to transform local research practices, it has to promise success as a 
solution towards locally-conceived problems (cf. Knorr-Cetina, 1981). Following this line of 
argument, it appears improbable that scientists ‘at the coalface’ will make a gestalt switch 
towards problems incommensurable with their existing institutional narratives, competencies 
and capital investments. The experienced and/or expected cost of extensions is therefore a 
central register in helping to conceive of scientists’ accommodation and resistance towards this 
problem (Latour & Woolgar, 1986). The empirical findings suggest that there were a number of 
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competing pressures and demands placed upon researchers in these institutional settings, and 
that in pursuing goals which are deemed economically, politically, or epistemically viable, 
researchers will indeed follow certain fashions. 
As a topic of inquiry translational research should be understood by social studies analysts as it 
relates to the extension efforts and practices performed within networks indexical to 
contemporary research and innovation systems, particularly in domains associated with the 
‘medical industrial complex’. Analysts should focus on struggles to stabilise and accommodate 
this goal within production settings and/or other centres-of-calculation thought central to 
research management and organisation. Of these, other promising sites for fieldwork might 
occur in institutions located elsewhere in the triple helix (university, government, industry), 
‘hidden research system’ (hospitals and other health care settings), and/or civil society groups 
(e.g. medical research charities or patient activist groups), all concerned with this phenomenon 
in one way or another. In doing so one of the key aims should be to describe the coordination 
work through which translational research is made workable (or not) within such arrangements. 
Clearly any study which takes this task seriously should describe the diversity of institutions in 
these specific local settings, but there are some themes from this story of academic researchers 
to be taken-forward and engaged with in producing further accounts. As intimated in the 
theoretical discussion, one factor which appears to make translational research workable is the 
articulation of places in which to meet and communicate. Other themes such as the 
identification of appropriate networks of practice, mobilising promises and incentive structures 
appeared highly important to coordinating exchanges.  
As with other devices, there are certain typical features required of a label like translational 
research in order for it to act at a distance with any success. One is that its definitions need to 
circulate in networks through everyday actions like writing, talking, and demonstrating, with the 
aid of mundane items to help inscriptions retain their shape, like strategic policy documents, 
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grant application forms, curriculum vitae, journal pages, websites, email, PowerPoint slides and 
so on.  These constituted some of the mediating practices and ‘flat surfaces’ (Latour, 1990) 
necessary for this device to act at a distance. This would likely be a feature of studies of 
translational research located in institutional settings elsewhere. Another feature in common 
with immutable mobiles is that in order to work, definitions needed to be transformed in a way 
which was deemed useful, workable, and/or unavoidable at local sites of practice.  
The set of themes presented here is not exhaustive, as it is hoped there are others to be 
identified through further empirical inquiry. Indeed this thesis should not mark the closure for 
social studies about the performative effects of translational research in contexts of practice, but 
a new beginning into this important topic of inquiry.  The ‘appropriateness’ of various 
transformations by novel actors and therefore the success of immutable mobiles are not 
predictable prior to their mobilisation, as these evaluations are socially constructed and 
negotiated (Latour, 1987, 112). This means that over time, transformations of translational 
research by academic scientists could begin to be read as ‘treasonous’ by interested parties (cf. 
Callon, 1986). It should be noted that within this arrangement it is the customers of science who 
play an important role in determining the worth of research. At present, although translational 
research appears as an idea whose stock is on the rise in academic sciences in England, it is 
worth remembering that its stability is not given or absolute, but relational and therefore ‘drop-
able’ should networks keeping it stable begin to break apart. This is one of the reasons why the 
topic of translational research is shaping-up to be one of immense interest for STS scholars. 
If/when such developments occur I believe STS tools developed here and provided elsewhere 
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Appendix 1: Interview Respondents 
Clinical Trials Unit 
Additional Pilots 
Cancer 
Participant Role Format Length of Interview 
Marketing Director  Face-to-face 39 min 
Senior Trial Physician Face-to-face 48 min 
Director CTU Face-to-face 50 min 
Senior Medical Officer Face-to-face 1 hr. 13 min 
Head of TT  Face-to-face 36 min 
Participant Role Format Length of Interview 
Professor Primary Care. 
Institute Director 
Face-to-face 36 min 
Professor of Primary Care. 
Director of Translational 
Research Unit 
Face-to-face 1 hr. 5 min 
Participant Role Format Length of Interview 
Institute Director  Face-to-face 48 min 
PI Cancer Lab Face-to-face 1 hr. 17 min 
Local Engagement Manager Phone 36 min 
Post-doc 1  Face-to-face 1 hr. 18 min 





















Participant Role Format Length of Interview 
Centre Lead  Face-to-face 48 min 
Senior CT Manager Face-to-face 35 min 
Consultant obstetrician Face-to-face 23 min 
S/L HTA Face-to-face 32 min 
Post-doc Face-to-face 55min 
S/L Obstetrics  Phone 55 min 
Participant Role Format Length of Interview 
Dean  Phone 19 min 
PI  Phone 52 min 
Clinical Collaborator Phone 47 min 
Clinical Fellow/PhD Phone 25 min 
Clinical Fellow/PhD Phone 40min 
PhD  Phone 46 min 
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Appendix 2: Favourable Ethical Opinion 
 









Appendix 3: Consent Form  





 I the undersigned voluntarily agree to take part in the study on Translational Research  
 
 I have read and understood the Information Sheet provided. I have been given a full 
explanation by the investigators of the nature, purpose, location and likely duration of 
the study, and of what I will be expected to do.    
 
 I consent to my personal data, as outlined in the accompanying information sheet, 
being used for this study and other research.  I understand that all personal data 
relating to volunteers is held and processed in the strictest confidence, and in 
accordance with the Data Protection Act (1998). I understand that the data may be 
published, on the agreement that my identity is anonymised.  
 
 I understand that I am free to withdraw from the study at any time without needing to 
justify my decision and without prejudice. 
 
 I understand that should I need to complain about the study, I should contact Mr. 
Alex Rushforth (University of Surrey) email: a.rushforth@surrey.ac.uk 
 
 I confirm that I have read and understood the above and freely consent to 
participating in this study.  I have been given adequate time to consider my 
participation and agree to comply with the instructions and restrictions of the study. 
 
Name of volunteer (BLOCK CAPITALS)       ........................................................  
Signed                   ........................................................  
Date  ......................................  
 
 
Name of researcher/person taking consent (BLOCK CAPITALS) ........................................................  
Signed                                         ........................................................  






Appendix 4: Participant Information 
 
Information Sheet for Participants  
Translational Research in the Making  
What is the research about? 
The research is about how individuals and organisations make sense of the challenges 
of translating research into a clinical 'pay-off' (understood here under the general term 
translational research). The study is to be based in part on interviews in which people are 
asked to describe their own experiences in setting-up and/or working on research that 
has this broad goal in mind, and reflect upon obstacles/challenges that they may have 
negotiated in their own work. The research is also interested in how researchers interpret 
the general prospects for this broad type of endeavour and any opportunities/difficulties 
they might foresee arising from it.      
What will be the set-up of the interviews? 
The interviews will be of a semi-structured style, meaning that it may be closer to a 
conversation than a rigid question and answer session. You will be asked to recall and 
describe certain things and further questions/clarifications may well be sought at certain 
points in the interview. Documents may be shown to you as prompts during the sessions. 
There will be pen and paper available should you wish to make notes or visual displays 
corresponding to your answers. These may be requested to be taken away after the 
interviews, but of course you retain the right to say no to this. The interviews will be 
recorded on a Dictaphone.  
What will I be asked to talk about? 
Semi-structured interviews are designed to be free-flowing, meaning it is quite possible 
that the sessions will cover a diverse range of issues. You may be asked to reflect on the 
wider field of ‘translational research’ and where you place yourself and your organisation 
in relation to it. Examples of what you may be asked to describe include the type of 
professional activities you engage in, the challenges that come with working with 
partners on projects or how you might seek to promote the work of the organisation. Also 
of interest is how you perceive the future prospects for translational research and any 
possible obstacles to achieving this. Where appropriate, it may be useful to relate to your 
own experiences on these matters.   
How long will the sessions last? 
Preferably around 45 minutes, although if you can spare longer then this would be much 
appreciated. I recognise that you are all busy people, so if you cannot afford to give-up 
this much time shorter sessions can be arranged. If you need to stop the interview at any 
stage please say so.  
What will happen to the data? 
Once recorded the data on the tape will be transcribed, coded, analysed and where 
appropriate, published in the thesis and elsewhere. The tapes will be secured under a 
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lock and key, and be destroyed after transcription. Procedures will follow the Data 
Protection Act 1998.   
Will I be made anonymous? 
Yes, the details of the project, including its name and location will be anonymised, as will 
job titles and names of people.    
Will I be able to withdraw comments at a later date? 
Yes. You will have the opportunity to request to view any of the comments you have 
made before they are submitted into the thesis or any other publication in the consent 
form. Should you feel uncomfortable about the comments at a later date, but have not 
specified this on the consent form, then please contact me as soon as you can.  
 
This information sheet has been given a favourable ethical opinion by the 
University of Surrey Ethics Committee.  
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